SUPPLEMENT

FY2021 — Annual financial statements

FY2021PDF · 219 pages3.7 MB
for the year ended 30 June 2021
ANNUAL FINANCIAL STATEMENTS

-- 1 of 219 --

CONTENTS
CONSOLIDATED FINANCIAL STATEMENTS
Directors’ responsibility statement 	2
Chief executive and chief financial officer internal
financial control responsibility statement 	3
Certificate by the Company Secretary 	3
Report of the Discovery Limited Audit Committee 	4
Independent auditor’s report 	13
Directors’ report 	19
Statement of financial position 	26
Income statement 	27
Statement of other comprehensive income 	28
Statement of cash flows 	29
Statement of changes in equity 	30
Notes to the Group annual financial statements 	31
DISCOVERY LIMITED COMPANY
Statement of financial position 	143
Income statement 	144
Statement of other comprehensive income 	144
Statement of cash flows 	145
Statement of changes in equity 	146
Notes to the Company annual financial statements 	147
ANNEXURE A – ACCOUNTING POLICIES 	165
ANNEXURE B – DIRECTORATE 	191
ANNEXURE C – ANALYSIS OF SHAREHOLDERS 	196
ANNEXURE D – EMBEDDED VALUE
Assurance report of the independent auditors 	197
Embedded value statement 	198
ANNEXURE E – FIVE-YEAR REVIEW 	210
ANNEXURE F – PRODUCT DESCRIPTIONS 	211
GLOSSARY OF TERMS 	217
BASIS OF PREPARATION
The consolidated and separate Annual Financial Statements have
been prepared in accordance with International Financial Reporting
Standards (IFRS) as issued by the International Accounting
Standards Board (IASB), its interpretations adopted by the IASB, the
South African Institute of Chartered Accountants (SAICA) Financial
Reporting Guides as issued by the Accounting Practices Committee,
Financial pronouncements as issued by Financial Reporting
Standards Council, the JSE Listings Requirements, JSE Debt Listings
Requirements as well as the South African Companies Act. They
have been prepared in accordance with the going concern principle
using the historical cost basis except where otherwise stated in the
accounting policies (refer Annexure A).
The Annual Financial Statements have been prepared under the
supervision of Mr DM Viljoen CA(SA) the Group Chief Financial
Officer. The Annual Financial Statements are reviewed by
management, the Discovery Limited Audit Committee and Board
and are audited by the external auditors of the Group.
Embedded value statement prepared by P Bolink (FASSA) and
supervised by A Rayner (FASSA, FIA).
How we report to our
stakeholders
Our INTEGRATED ANNUAL REPORT – our primary report to
our shareholders, providers of financial capital and other
stakeholders – details our financial, economic and social
performance (2023 Ambition and beyond).
Our ANNUAL FINANCIAL RESULTS Presentation provides an
overview of Discovery’s financial performance.
Our 2021 Annual Financial Results Presentation can be accessed
at www.discovery.co.za/corporate/investor-relations
Our FULL ANNUAL FINANCIAL STATEMENTS include the
consolidated financial results of Discovery and its
subsidiaries, the embedded value statement and five-year
review.
Our 2021 Annual Financial Statements can be accessed
at www.discovery.co.za/corporate/investor-relations
Our SUSTAINABLE DEVELOPMENT REPORT, along with our
detailed website, provides information on how the Group
delivered on its commitment to be a powerful force for social
good for our clients, our business and broader society.
Our GOVERNANCE REPORT includes information on our
governance philosophy, leadership and our compliance
with King IV™
DISCOVERY LIMITED
Registration number 1999/007789/06
1 Discovery Annual Financial Statements 2021

-- 2 of 219 --

DIRECTORS’ RESPONSIBILITY STATEMENT
for the year ended 30 June 2021
DIRECTORS’ RESPONSIBILITY TO THE SHAREHOLDERS OF
DISCOVERY LIMITED AND ITS SUBSIDIARIES (DISCOVERY OR THE GROUP)
The directors of Discovery are required by the Companies Act, Act 71 of 2008 (Companies Act), to maintain adequate accounting records
and to prepare financial statements for each financial year which fairly present the state of affairs of Discovery at the end of the financial
year, and of the results and cash flows for the period. In preparing the accompanying Annual Financial Statements, International Financial
Reporting Standards have been used and reasonable estimates have been made. The Annual Financial Statements incorporate full and
responsible disclosure, in line with Discovery’s philosophy on corporate governance.
The directors have reviewed Discovery’s budget and cash flow forecast for the year to 30 June 2022. On the basis of this review, and in light
of the current financial position and available cash resources, the directors have no reason to believe that Discovery will not be a going
concern for the foreseeable future. The going concern basis has therefore been adopted in preparing the Annual Financial Statements.
The directors are responsible for Discovery’s systems of internal control, which include internal financial controls in the various subsidiaries
that are designed to provide reasonable, but not absolute, assurance against material misstatement and loss. Discovery maintains
internal financial controls to provide assurance regarding:
❚ 	Safeguarding of assets against unauthorised use or disposition, and
❚ 	The maintenance of proper accounting records, written or electronic and the reliability of financial information used within the business,
or for the publication thereof, including submissions to the companies and Intellectual Property Commision (CIPC).
The controls contain self-monitoring mechanisms, and actions are taken to correct deficiencies as they are identified. Even an effective
system of internal control, no matter how well designed, has inherent limitations, including the possibility of circumvention and the
overriding of controls. An effective system of control therefore aims to provide reasonable assurance with respect to the reliability of
financial information and, in particular, the presentation of Annual Financial Statements.
To the best of their knowledge and belief, based on the above, the directors are satisfied that no material breakdown in the operation of
the systems of internal control and procedures has occurred during the year under review.
Discovery’s external auditors, PricewaterhouseCoopers Inc., have audited the Annual Financial Statements and their unqualified report
appears on pages 13 to 18.
The Annual Financial Statements of Discovery for the year ended 30 June 2021, which appear on pages 26 to 196 as well as Annexure F
have been approved by the Board of Directors on 1 September 2021 and are signed on its behalf by:
M Tucker 	A Gore
Chairperson 	Chief Executive Officer
2 Discovery Annual Financial Statements 2021

-- 3 of 219 --

CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICER INTERNAL
FINANCIAL CONTROL RESPONSIBILITY STATEMENT
for the year ended 30 June 2021
CERTIFICATE BY THE COMPANY SECRETARY
for the year ended 30 June 2021
After due, careful, and proper consideration, in accordance with the JSE Listings Requirements 3.84(k), the directors, whose names are
stated below, hereby confirm that:
a) the Annual Financial Statements set out on pages 26 to 195 fairly present, in all material respects, the financial position, financial
performance and cashflows of the issuer in terms of IFRS;
b) no facts have been omitted or untrue statements made that would make the Annual Financial Statements false or misleading;
c) internal financial controls have been put in place to ensure that material information relating to the issuer and its consolidated
subsidiaries have been provided to prepare the financial statements of the issuer effectively; and
d) the internal financial controls are adequate and effective and can be relied upon in compiling the Annual Financial Statements, having
fulfilled our role and function within the combined assurance model pursuant to principle 15 of the King Code.
Where we are not satisfied, we have disclosed to the Discovery Limited Audit Committee and the auditors the deficiencies in design and
operational effectiveness of the internal financial controls and any fraud that involves directors, and have taken the necessary remedial
action.
A Gore 	DM Viljoen
Chief Executive Officer 	Chief Financial Officer
1 September 2021 	1 September 2021
It is hereby certified in terms of section 88(2)(e) of the Companies Act, that Discovery Limited has for the year ended 30 June 2021 lodged
with the Registrar of Companies all such returns as are required by a public company in terms of this Act and that all such returns are
true, correct and up to date.
NN Mbongo
Company Secretary
1 September 2021
3 Discovery Annual Financial Statements 2021

-- 4 of 219 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
for the year ended 30 June 2021
We, the Discovery Limited Audit Committee (DLAC), are pleased to present our report for the financial year ended 30 June 2021. This
report provides details on how the DLAC satisfied its various statutory obligations and the significant matters considered during the
period.
This report has been prepared based on the requirements of the Companies Act, Act 71 of 2008 (Companies Act), as amended, the King
Code of Governance for South Africa (King IV), the JSE Listings Requirements, JSE Debt Listings Requirements and other applicable
regulatory requirements.
TERMS OF REFERENCE, ROLES AND RESPONSIBILITIES
The DLAC is an independent statutory committee constituted under section 94 (7) of the Companies Act. A summary of the DLAC statutory
and governance mandate is provided below. It recognises the important oversight role underpinned by the JSE’s combined assurance
model as well as, following the King IV principle of good governance. Duties are delegated to the DLAC through a formal Terms of
Reference, which is reviewed annually and include the following:
Finance function
Financial statements/
Integrated report
Internal financial control/
Internal audit
External auditor and
external audit
Consider the
appropriateness and
expertise of senior
members of the
finance team and the
CFO.
Review all financial statements
and reports and deal with any
complaints regarding accounting
practices.
The review considers the integrity
and fairness of the information
and the review of significant
estimates and judgements made
by management in producing the
financial information.
Responsible for appointment,
remuneration, 	performance,
and disciplinary action of the
Chief Audit Executive (CAE).
Nominate an independent auditor
for appointment by shareholders.
Undertake a formal
assessment of the
finance function.
Report from the DLAC on how it
discharged its duties during the
financial reporting period.
Approve 	the 	internal 	audit
annual plan.
Determine terms of engagement
and fees.
Review and approve of
annual budgets and
forecasts
Review 	the 	annual 	integrated
report.
The information produced in the
annual integrated report must be
fair, balanced, and consistent with
other information produced, e.g.,
the financial statements.
Submit 	to 	the 	Board 	the
assessment of Internal Control,
Governance 	and 	Risk
Management.
Approve the nature and extent of
non-audit services.
Deal with any
complaints on the
internal financial
control environment
Undertake a formal assessment
of internal audit performance
and deal appropriately with
complaints about the internal
audit.
Satisfy 	itself 	regarding 	the
experience, capacity, and skill of
the audit teams.
Review and assessment of the
combined 	audit 	assurance
model for Discovery.
Structure of the audit committees in Discovery Group
The scope of the DLAC extends to all activities of the Discovery Limited Group and its subsidiaries, both locally and internationally. The
DLAC also acts as the statutory Audit Committee of Discovery Life Limited and Discovery Insure Limited.
The Discovery Group Europe Limited grouping, which includes Vitality Life and Vitality Health, the Discovery Bank Holdings Limited
grouping, and the Vitality Group International Inc grouping each have their own individual audit committees.
There is regular liaison and communication between the Chairperson of the DLAC and the Chairpersons of the various main subsidiary
audit committees on key matters that are relevant to the Group. The DLAC receives regular reports from the various group audit
committees. In addition, the Chair of the DLAC has the opportunity to attend any of the subsidiary audit committee meetings as an
invitee.
4 Discovery Annual Financial Statements 2021

-- 5 of 219 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
for the year ended 30 June 2021
COMPOSITION AND GOVERNANCE
The DLAC consists of a minimum of three independent non-executive directors of the Discovery Limited Board of Directors. During the
financial year ended 30 June 2021, the committee held six meetings as per the standard meeting cycle described below, four meetings to
deal with mandatory audit firm rotation (MAFR), two ad hoc meetings and an annual meeting with the Prudential Authority.
The DLAC has the appropriate balance, diversity of knowledge, financial skills, and experience to execute its duties effectively. The
membership, qualifications, and attendance of the members of the DLAC for the year ended 30 June 2021 are as follows:
Committee member 	Qualifications
Number of meetings
eligible to attend
Number of meetings
attended
D Macready (Chairperson) 	BCom (Hons), CTA, CA (SA) 	6 	6
SE De Bruyn 	LLB (Hons), MA 	6 	6
M Schreuder1 	BCom (Hons), FIA, FASSA 	2 	2
SV Zilwa 	BCompt (Hons), CTA, CA (SA) 	6 	5
1 M Schreuder was appointed with effect from 19 February 2021.
In addition to their membership on the DLAC, the committee members also serve across all key board committees to ensure a collective
and integrated oversight of key matters across the Discovery Group.
Committee member 	Actuarial committee
Risk and compliance
committee
Remuneration
committee
Social and Ethics
committee
D Macready 	x 	x
SE De Bruyn 	x (Chairperson)
M Schreuder 	x 	x (Chairperson)
SV Zilwa 	x 	x (Chairperson)
The Chairperson of Discovery’s Board and other non-executive directors are entitled to attend any meetings on request. The Chief Executive
Officer, Chief Financial Officer, Chairperson of the Actuarial Committee, and executive directors attend meetings or parts of meetings by
invitation only. Other members of management are invited to attend meetings to provide the DLAC with greater insights into specific issues
or areas of the Group. The Chairperson has regular contact with the management team to discuss relevant matters directly.
The DLAC Chairperson meets regularly with the Chief Financial Officer, the Heads of Actuarial, Risk and Compliance, and executive
management where necessary.
The internal and external auditors have direct access to the Chairperson, including closed sessions without management during the year,
on any matter that they regard as relevant to fulfilling the DLAC’s responsibilities. In addition, the Chairperson meets with the internal
audit and the external auditors before each meeting and at other times as necessary by either party before Committee meetings.
5 Discovery Annual Financial Statements 2021

-- 6 of 219 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
for the year ended 30 June 2021
MEETINGS CYCLE FOR THE YEAR
The regular cycle of DLAC meetings during the financial year are as follows:
2020
Review of first-quarter performance.
The DLAC self-assessment was completed and
reviewed.
Review of the governance structure of
subsidiaries, the DLAC constitution, and the
evidence supporting the independence,
accreditation, skills and capacity of external audit.
Review feedback on the accounting practices,
disclosures and annual reports.
Reviewed the co-operations and co-ordination
between the internal and external auditors
OCTOBER
Review of the external audit plan, the internal
audit plan and strategy as well as consideration of
the combined assurance model for the Discovery
Group.
Review of the external audit budgeted fees.
Evaluated the effectiveness of the internal audit
function and assess the management control over
the various Discovery Group entities.
NOVEMBER
2021
Feedback from subsidiary audit committees as
well as other relevant committees such as Risk
and Compliance and Actuarial.
Review of interim results for the six months to
31 December 2020 and SENS announcement.
FEBRUARY
Review of Terms of Reference, the internal audit
charter and Outsourcing.
Reviewed the accounting policies and IFRS
developments, including the JSE proactive
monitoring annual report.
Review of third- quarter results.
APRIL
Review of unaudited year-to-date results and key
financial and accounting judgements as well as
any relevant tax matters.
Formal evaluation of Group Finance and Group
Internal Audit functions.
JUNE
Discussion and review of year-end reports from
the external auditors and Group Internal Audit
(GIA), feedback from subsidiary audit committees
and other relevant committees such as Risk and
Compliance, and Actuarial.
Consideration of going concern.
Review and approval of the annual financial
statements, related SENS announcements and the
Integrated Report.
AUGUST
6 Discovery Annual Financial Statements 2021

-- 7 of 219 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
for the year ended 30 June 2021
KEY FOCUS AREAS DURING THE FINANCIAL YEAR ENDED 30 JUNE 2021
Key audit matters
The DLAC annually assesses the key audit matters reported by the external auditors and considered the key judgements and estimates
pertaining to the annual financial statements. Accordingly, these key audit matters were addressed as follows.
Key Audit Matter 	How the DLAC addressed the matter
Impact of the COVID-19
pandemic
The COVID-19 pandemic is unprecedented and has had a significant impact on the global economy and
business across all industries. There is a significant degree of uncertainty about the further spread of the
virus, the timing and the effectiveness of the vaccine rollout, and the further impact on the world economy.
Accordingly, COVID-19 was a significant focus area of the DLAC during the financial year ended 30 June
2021, with a particular evaluation of:
❚ 	The integrity of internal controls.
❚ 	The valuation of assets and liabilities arising from insurance contracts, including the setting up of
COVID-19 reserves.
❚ 	Impairment of assets not measured at fair value
Valuation of assets and
liabilities arising from
insurance contracts
The DLAC reviewed reports from the Group Chief Actuary and the external auditors on actuarial assumptions
and basis changes. Evaluated the appropriateness of actuarial assumptions used in the setting of reserves,
including negative rand reserves, taking into account recommendations made by the Actuarial Committee.
This includes the supportability of the negative rand reserve (asset) in the Statement of financial position
under various stress scenarios.
The annual assessment
for impairment of
goodwill and intangible
assets
The DLAC reviewed the impairment assessments that were based on the latest business planning inputs. It
considered the sensitivity of these estimates to various scenarios. The DLAC concluded that only the
impairment of goodwill and intangible assets constituted significant estimates as disclosed in Note 4 Significant
accounting estimates and judgement in applying accounting policies.
Significant matters
Significant matters are those matters which, in the view of the DLAC, were considered significant or material in nature, requiring either
the exercise of judgement or matters which were otherwise considered to be subjective from an accounting or auditing perspective. The
following areas received a key focus from DLAC during the year:
The impact of the COVID-19 pandemic
The financial year under review was characterised by the COVID-19 pandemic, the year having commenced during the first wave of the
pandemic and ending during the height of the third wave in South Africa. The impact of COVID-19 was experienced differently across the
Discovery Group of entities. In response, the DLAC adopted a coordinated approach across the various audit, actuarial and risk committees
and the various control functions and assurance providers. This included:
❚ 	continuously re-assessing the impact of the COVID-19 pandemic and the accounting, operational and assurance implications, including
the impact on systems, control environments and key financial and reporting controls;
❚ 	re-assessing, together with the Group Actuarial committee, the applicability of the various scenarios, judgements and estimates used
by management to assess COVID-19 claims and lapse provisioning and the impact on the valuation of assets and liabilities arising from
insurance contracts.
❚ 	reviewing experience, results and financial impacts against forecast information and modelling extrapolations to assess the adequacy
of COVID-19 provisions; and
❚ 	any impacts on solvency, liquidity, and reserving for Discovery Group.
The DLAC also reviewed and approved amendments to internal audit plans in response to COVID-19, which included an enhanced
approach to combined assurance to strengthen risk and control oversight, particularly in any business processes that had changed.
To fulfil its mandate of financial reporting, the DLAC reviewed the various SENS trading updates issued during the financial year, including
those issued in August 2021, to ensure transparent, fair, balanced, and understandable reporting, particularly on the COVID-19 claims
provisioning and utilisation.
7 Discovery Annual Financial Statements 2021

-- 8 of 219 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
for the year ended 30 June 2021
Accelerated reinsurance premiums – VitalityHealth
VitalityHealth has traditionally used quota share reinsurance treaties to manage initial acquisition cost strain. As a result of COVID-19,
VitalityHealth has seen a temporary delay in medical treatment, resulting in reduced claims ratios. VitalityHealth has used the opportunity
to accelerate the repayment profile of certain existing reinsurance treaties, resulting in future savings to offset the catch up in claims.
The use of quota share other than for initial acquisition cost strain and the resultant change in reinsurance payment profile is a change
from previous financial reporting periods. This acceleration had a material impact on the profit for the year ended 30 June 2021. In
response, to ensure transparent, fair, balanced, and understandable reporting, the DLAC has considered enhanced presentation and
disclosures in the Group Income Statement and Segmental information. Furthermore, Note 41 to the annual financial statements sets out
a detailed explanation of this effect.
Progress of IFRS 17 Insurance Contracts
The DLAC continues to monitor the update on the progress of IFRS 17. Building on the previous IFRS 17 development work, during the
year there has been particular focus to understand:
❚ 	the data flow and data system implications across the Group and implement IT solutions that will be deployed and utilised as part of
Discovery’s IFRS 17 solution.
❚ 	the key IFRS 17 accounting policy election, quantification and impacts as well as alternative approaches where appropriate.
❚ 	further refinement of the initial results and observations of IFRS 17 across the Discovery business lines.
❚ 	the process followed to ensure Discovery remains at the forefront of IFRS 17 technical developments and deliberations through active
participation in a number of industry working groups.
The year has seen significant progress in the IFRS 17 project, with the short-term insurance business lines of Discovery Insure, VitalityHealth
and Group Life progressing well. In addition, Discovery Life has completed initial individual life insurance results on a fully retrospective
IFRS 17 basis, with work on refinement of the models and assumptions. Discovery Life is currently progressing in its work of the
reinsurance contracts and the Discovery Invest portfolio. VitalityLife operations are leveraging of the work completed in an efficiency
drive to also align the methodologies and models of IFRS 17 across the Discovery Group.
For the next financial year, the DLAC will focus on the formalisation of the policies in IFRS 17, the audit of IFRS 17 policies and methodologies
and implementation of the parallel systems in preparation for 1 July 2022.
Other significant items also considered
❚ 	Evaluated management’s assessment of impairment of specified assets under IAS 36 Impairment of Assets. During the year, particular
focus was on AIA Vitality (Pty) Limited, an Australian venture with AIA. As a result of the recent losses, the business environment in
Australia coming out of the COVID-19 pandemic and strategic direction, Discovery has evaluated the business which resulted in an
impairment loss of its equity-accounted investment of R149 million. Note 11.2.1 in the financial statements discloses more information
on the estimated and judgements in measuring this impairment.
❚ 	Reviewed the supportability of deferred tax assets raised on assessed losses.
❚ 	The dilution gain on the equity-accounted investments as a result of the CMT/ Truemotion merger.
8 Discovery Annual Financial Statements 2021

-- 9 of 219 --

REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
for the year ended 30 June 2021
Financial statement and accounting practices
The DLAC has reviewed the accounting policies and the consolidated and separate financial statements of Discovery and is satisfied that
they are appropriate and comply with International Financial Reporting Standards (IFRS). This includes consideration of all entities
included in the consolidated Annual Financial Statements, to ensure that it has access to all financial information to the issuer to effectively
prepare and report on the financial statements of Discovery. The DLAC confirmed the going concern basis for the preparation of the
interim and Annual Financial Statements.
During the year, the DLAC reviewed the following financial reporting matters to ensure the integrity and fairness of financial information:
❚ 	The early adoption of amendments of IFRS on the new Interest Rate Benchmark Reforms (IBOR). The IBOR changes affected the UK
Composite, which had some Libor denominated loans restructured to the new SONIA rate. Refer to Annexure A ‘Basis of Preparation’
for more information.
❚ 	Formalised the accounting policy of ‘Normalised headline earnings’, an alternative non-IFRS measure which Discovery presents
alongside its IFRS. The accounting policy and disclosures conform to the guidelines issued in the draft JSE Practice note on alternative
performance measures issue in May 2019. For the accounting policy, refer to Annexure A ‘27. Normalised headline earnings’.
❚ 	Clarification on the valuation and utilisation of discretionary margins within the Individual Life insurance business line. The clarification
was necessitated in light of the COVID-19 operating environment. In particular, the order in which discretionary margins are utilised
between non-economic and economic assumptions was clarified.
❚ 	The DLAC has considered the accounting treatments, significant unusual transactions, and accounting judgements. DLAC has
evaluated management’s judgements and reporting decisions in relation to the annual integrated report and ensured all material
disclosures had been included. In addition, it has reviewed both financial and non-financial information, forward-looking statements,
and sustainability information.
A DLAC process is established to receive and deal appropriately with any concerns and complaints relating to Discovery’s accounting and
reporting practices. The DLAC immediately deals with any issues raised. During the financial year, the DLAC specifically reviewed and
thoroughly investigated an Investment research report issued in the market regarding the accounting practices, actuarial assumptions
and potential IFRS 17 impact of Discovery Limited. The detailed investigation did not provide any further evidence or balanced reasoning
to support the various assertions made.
As part of its annual work plan, the DLAC evaluates management’s assessment of the findings in the most recent JSE’s Pro-active
monitoring report. Management performs a detailed assessment of the JSE findings against Discovery’s Annual Financial Statements to
identify any potential areas of non-compliance or future improvements or enhancement in Discovery’s disclosures. For the financial year
under review, Discovery’s 30 June 2020 Annual Financial Statements and its interim results for the six months ended 31 December 2020
were selected by the JSE in its next cycle of pro-active monitoring. Discovery received two questions on its disclosures, which Discovery
addressed and resolved with the JSE with no changes to its published financial information. The Annual Financial Statements for the year
ended 30 June 2021 includes additional constructive disclosures as required by recent JSE COVID-19 publications.
EXTERNAL AUDIT
Audit accreditation and quality
In terms of the JSE Listings Requirements, and Debt Listings Requirements the evaluation of suitability and relevant accreditation
requirements of the external audit partner is the responsibility of the DLAC, together with specific responsibility around audit quality. The
following considerations were taken into account by the DLAC in the assessment in this regard for the financial year-ended 30 June 2021:
❚ 	Any reputational, legal, or impending issues which could impact the firm.
❚ 	Review of local and international firm audit quality control processes.
❚ 	The results of the last audit firm-wide and individual partner quality reviews by the regulatory body IRBA and the internal firm quality
control reviews.
❚ 	Detail of partners and managers on the Discovery assignment, including relevant audit experience, succession, continuity, and rotation
plans.
In terms of the conditions laid out in section 94(8) of the Companies Act and based on its assessment taking consideration of the criteria
of King IV, the JSE and general guidance to Audit Committees, the DLAC is satisfied with the performance and quality of the external audit,
the external auditors and lead partners for the year ended 30 June 2021.
9 Discovery Annual Financial Statements 2021

-- 10 of 219 --

Auditor appointment, Mandatory audit firm rotation (MAFR), joint audit
and transition plan
The DLAC executed its responsibilities as set out under paragraph 7.3(e) of the Debt Listings Requirements.
A key focus area for DLAC in the current financial year was considering a transition plan to implement MAFR and any applicable joint audit
requirements given the required rotation of PwC from 1 July 2023 to ensure appropriate continuity in external audit throughout the Group.
The rule on MAFR as issued by the South African Independent Regulatory Board of Auditors (IRBA) requires that an audit firm not serve
as the appointed auditor of a public interest entity for more than ten consecutive financial years. After that, the audit firm will only be
eligible for reappointment as the auditor after the expiry of at least five financial years. The requirement is effective for financial years
commencing on or after 1 April 2023. Accordingly, for Discovery, this requirement will apply effective 1 July 2023.
Given the anticipated introduction of joint auditor requirements and so as to minimise the impact of a change given on initial sign-off of
IFRS 17 opening balances which will be rquired by joint auditors, the DLAC intends to allow for an early transition period before 1 July 2023
to stagger both the joint audit and MAFR appointments. DLAC has undertaken a process during the financial year to identify independent
joint independent auditors for Discovery Limited from 1 July 2021 to provide this smooth consistent and strong platform for transition
while PwC are still incumbent.
The DLAC, has nominated KPMG Inc (KPMG) for appointment as independent joint external auditors together with PricewaterhouseCoopers
Inc. (PwC), effective 1 July 2021.
The DLAC then further considered the MAFR requirement, which mandates the rotation of PwC from 1 July 2023 and intends to nominate
Deloitte & Touche to replace PwC from 1 July 2023 and be joint external auditors with KPMG from that date.
The DLAC has satisfied itself that the external auditors are independent of Discovery, and requisite assurance was sought and provided
by the auditors that internal governance processes within each audit firm support and demonstrate its claim to independence.
Furthermore, as set out above in ‘Audit accreditation and quality’ In terms of the conditions laid out in section 94(8) of the Companies Act
and based on its assessment taking consideration of the criteria of King IV, the JSE and general guidance to Audit Committees, the DLAC
is satisfied with the performance and quality of the proposed external auditors and lead partners for the year ended 30 June 2021.
The appointments are subject to the approvals of the South African Prudential Authority, which is currently in progress.
Fees for audit and non-audit services
Audit fees
The DLAC, following consultation with executive management, approved the engagement letter, terms, audit plan and budgeted audit
fees for the year ending 30 June 2021.
Non-audit services
A formal policy exists in respect of the provision of non-audit services by the external auditors of Discovery and its subsidiaries, and a
formal procedure governs the process whereby the auditors are appointed to provide any non-audit services, including a limitation on
fees for non-audit services which shall not exceed 25% of the audit fees. Effective from 1 July 2021, the policy is amended to consider the
25% threshold to the relative share of each proposed joint auditor audit fee.
The Chairperson of the DLAC approves the nature and extent of any non-audit services that the external auditors provide in terms of the
agreed pre-approval policy, and a schedule of approved non-audit services is reviewed annually by the DLAC.
In addition to Discovery’s formal policies, the external auditors are required to comply with the requirements set out by their firm or
network’s internal policies, the respective regulators such as the IRBA or the United Kingdom Financial Reporting Council (FRC) and the
respective laws of the local jurisdictions in which the various Discovery group of entities operate.
REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
for the year ended 30 June 2021
10 Discovery Annual Financial Statements 2021

-- 11 of 219 --

INTERNAL AUDIT
Internal audit provides independent objective assurance that the governance processes, including professional ethics, the management
of risk and systems of internal controls, are both adequate and effective. The Chief Audit Executive (CAE) has a functional reporting line
to the DLAC Chairperson and an administrative reporting line to the Group Chief Financial Officer (CFO).
❚ 	In assessing the quality, performance and delivery of the internal audit plan, including the scope of the work performed, the level of
resources and coverage of the audit plan, the DLAC took cognisance of the following.
❚ 	Reviewed and approved the internal audit charter and audit plan and evaluated the independence, effectiveness, and performance in
line with its charter.
❚ 	Challenged the audit plan’s focus, relevance, and risk-based emphasis in response to the extraordinary circumstances presented by
the COVID-19 pandemic and the potential impact on the control environments.
❚ 	Considered reports on the Group’s internal control systems, with a specific focus on the effectiveness of internal financial controls,
including financial reporting controls.
❚ 	Reviewed significant issues raised by the internal audit processes and the adequacy of corrective action and accountability taken in
response to such findings.
❚ 	Assessed the independence and effectiveness of the CAE, the internal audit function and the quality and extent of audit resources and
found them to be satisfactory.
The external independent quality assessment of internal audit was conducted by SizweNtsalubaGobodo Grant Thornton (“SNG GT”) from
May to June 2021 and received a rating of “Generally Conforms” to the Institute of IIA Standards and Code of Ethics, as well as to each of
the individual Standards. “Generally conforms” is the best possible rating that can be achieved.
Received the annual assessment provided by internal audit confirming the effectiveness of Discovery’s governance, risk management and
control processes.
Reviewed the external auditors’ annual assessment of internal audit in terms of the requirements of ISA 610, which reaffirmed the extent
of reliance that could be placed on the internal audit work.
FINANCIAL CONTROLS
The DLAC is responsible for assessing Discovery’s system of internal financial and accounting controls. In this regard, the DLAC has,
among other things, evaluated the adequacy and effectiveness of Discovery’s system of internal controls and made appropriate
recommendations to the Board. This has included a formal documented review by the internal audit function of the design, implementation,
and effectiveness of Discovery’s internal financial controls systems.
For the year ended 30 June 2021, the new JSE Equity Listings Requirement 3.84(k) is effective for Discovery Limited’s Annual Financial
Statements. The DLAC reviewed the combined assurance reassessment of the design, documentation, and testing coverage of financial
controls inclusive of financial reporting controls as well as the executive attestation process to support the responsibility statement
attested by the Chief Executive and Chief Financial Officer. The attestation set out on page 3 of the Annual Financial Statements.
Based on the results of these reviews, it is the view of the DLAC that Discovery’s internal financial controls effectively produce accurate
financial information and a fair presentation of the financial performance of Discovery in the Annual Financial Statements.
REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
for the year ended 30 June 2021
11 Discovery Annual Financial Statements 2021

-- 12 of 219 --

OTHER MATTERS CONSIDERED BY THE DLAC
In further fulfilling its duties and discharging its obligations for the year ended 30 June 2021, the DLAC also considered:
Matter considered 	Outcome
Assessment of the effectiveness of
DLAC
During the year, an internally managed assessment of the effectiveness of the DLAC was
satisfactorily completed.
Evaluation of the expertise and
experience of the finance function
and financial director
The DLAC reviewed and satisfied itself with the appropriateness of Discovery's finance function's
expertise, resources, and experience, including the Chief Financial Officer, Mr DM Viljoen.
Independent 	quality 	assurance
reviews on Discovery internal and
external assurance providers
During the year, Discovery undertook independent quality assurance reviews on the various
internal and external assurance providers, i.e., excluder first-line management. All reviews
have not been finalised at the time of writing this report. Group Risk Management, Group
Compliance, and the Actuarial Function have been completed, obtaining high assurance.
Combined assurance 	The combined assurance model provides an integrated plan of the various activities and
sources of assurance, including risk and compliance, external and internal audit, corporate
finance functions and the Actuarial Committees. The DLAC has reviewed the combined
assurance model, which has been implemented throughout the Group and has concluded
that the model is both appropriate and effective in addressing the risks facing Discovery.
Whistleblowing 	The DLAC receives and deals with any whistleblowing, whether from within or outside
Discovery, relating to the accounting practices and internal audit of Discovery, the content or
auditing of Discovery’s financial statements, the internal financial controls of Discovery and
related matters. No such whistleblowing was received during the financial year.
Ethics and compliance 	The DLAC is responsible for reviewing any major breach of Discovery’s code of conduct and
ethics and relevant legal, regulatory, and other obligations reported to the DLAC by the Social
and Ethics Committee. The DLAC is satisfied that there has been no material breach of these
standards or material non-compliance with laws and regulations. The DLAC is satisfied that it
has complied with all its legal, regulatory, and other obligations during the period under review.
KEY FOCUS AREAS FOR 2021/22
❚ 	A post-COVID-19 impact review to evaluate and assess the estimates made as at 30 June 2021;
❚ 	Review project progress for the implementation of IFRS 17, including implementation of policies, methodology and disclosures in
preparation for the parallel run; and
❚ 	Review progress and implications of the Prudential Book transfer in Vitality Life UK.
CONCLUSION
Based on the information and explanations given by management and discussions with the independent external auditors regarding
their audit results, the DLAC is satisfied that there was no material breakdown in the internal financial controls during the financial year
under review.
The DLAC has reviewed the consolidated and separate financial statements of Discovery Limited for the year ended 30 June 2021 and,
based on the information provided to the DLAC, considers that Discovery complies, in all material respects, with the requirements of the
Companies Act and International Financial Reporting Standards (IFRS).
The DLAC has recommended the Annual Financial Statements to the Board for approval. The Board has subsequently approved the
Annual Financial Statements, which will be open for discussion at the forthcoming Annual General Meeting.
D Macready
Chairman: Discovery Limited Audit Committee
1 September 2021
REPORT OF THE DISCOVERY LIMITED AUDIT COMMITTEE
continued
for the year ended 30 June 2021
12 Discovery Annual Financial Statements 2021

-- 13 of 219 --

INDEPENDENT AUDITOR’S REPORT
for the year ended 30 June 2021
TO THE SHAREHOLDERS OF DISCOVERY LIMITED
REPORT ON THE AUDIT OF THE CONSOLIDATED AND SEPARATE FINANCIAL
STATEMENTS
Our opinion
In our opinion, the consolidated and separate financial statements present fairly, in all material respects, the consolidated and separate
financial position of Discovery Limited (the Company) and its subsidiaries (together the Group) as at 30 June 2021, and its consolidated
and separate financial performance and its consolidated and separate cash flows for the year then ended in accordance with International
Financial Reporting Standards and the requirements of the Companies Act of South Africa.
What we have audited
Discovery Limited’s consolidated and separate financial statements set out on pages 26 to 195 comprise:
❚ 	the group and company statements of financial position as at 30 June 2021;
❚ 	the group and company income statements for the year then ended;
❚ 	the group and company statements of other comprehensive income for the year then ended;
❚ 	the group and company statements of changes in equity for the year then ended;
❚ 	the group and company statements of cash flows for the year then ended; and
❚ 	the notes to the financial statements, which include a summary of significant accounting policies.
Certain required disclosures have been presented elsewhere in the document titled “Discovery Annual Financial Statements for the year
ended 30 June 2021”, rather than in the notes to the financial statements. These are cross-referenced from the financial statements and
are identified as audited.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (ISAs). Our responsibilities under those standards are
further described in the Auditor’s responsibilities for the audit of the consolidated and separate financial statements section of our
report.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Independence
We are independent of the Group in accordance with the Independent Regulatory Board for Auditors’ Code of Professional Conduct for
Registered Auditors (IRBA Code) and other independence requirements applicable to performing audits of financial statements in South
Africa. We have fulfilled our other ethical responsibilities in accordance with the IRBA Code and in accordance with other ethical
requirements applicable to performing audits in South Africa. The IRBA Code is consistent with the corresponding sections of the
International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (including International
Independence Standards).
Our audit approach
Overview
Materiality
Group
scoping
Key audit
matters
Overall group materiality
❚ 	The final Group overall materiality level amounted to R367.9 million. Overall materiality is calculated
using a rule of thumb of 5% of a 3 year average of profit before tax (PBT).
Group audit scope
❚ 	Our group scoping included full scope audits for twenty six components based on financial significance,
audit risks and statutory audit requirements.
Key audit matters
❚ 	Valuation of assets and liabilities arising from insurance contracts; and
❚ 	Annual impairment of Goodwill for the Discovery Bank CGU
13 Discovery Annual Financial Statements 2021

-- 14 of 219 --

INDEPENDENT AUDITOR’S REPORT continued
for the year ended 30 June 2021
As part of designing our audit, we determined materiality and assessed the risks of material misstatement in the consolidated and
separate financial statements. In particular, we considered where the directors made subjective judgements; for example, in respect of
significant accounting estimates that involved making assumptions and considering future events that are inherently uncertain. As in all
of our audits, we also addressed the risk of management override of internal controls, including among other matters, consideration of
whether there was evidence of bias that represented a risk of material misstatement due to fraud.
Materiality
The scope of our audit was influenced by our application of materiality. An audit is designed to obtain reasonable assurance whether the
financial statements are free from material misstatement. Misstatements may arise due to fraud or error. They are considered material
if individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the
consolidated financial statements.
Based on our professional judgement, we determined certain quantitative thresholds for materiality, including the overall group
materiality for the consolidated financial statements as a whole as set out in the table below. These, together with qualitative
considerations, helped us to determine the scope of our audit and the nature, timing and extent of our audit procedures and to evaluate
the effect of misstatements, both individually and in aggregate on the financial statements as a whole.
Overall group materiality 	R367.9 million
How we determined it 	5% of adjusted consolidated profit before tax over a three-year period
Rationale for the
materiality benchmark
applied
We chose consolidated profit before tax as the benchmark because, in our view, it is an appropriate
measure of underlying performance and the benchmark against which the performance of the Group
is most commonly measured by users.
The consolidated profit before tax was adjusted for unusual items included within the transfer from
assets/liabilities under insurance contracts financial statement line item. The following impacts have
been excluded because they are considered unusual and not reflective of the normal operational
performance of the Group:
❚ 	future mortality, morbidity and economic effects of the Covid-19 pandemic; and
❚ 	economic assumption adjustments net of discretionary margins and interest rate derivative.
We chose 5% which is consistent with quantitative materiality thresholds used for profit-oriented
companies in this sector.
How we tailored our group audit scope
We tailored the scope of our audit in order to perform sufficient work to enable us to provide an opinion on the consolidated financial
statements as a whole, taking into account the structure of the Group, the accounting processes and controls, and the industry in which
the Group operates.
The Group has nine operating segments comprising forty two components (including unit trust funds) that operate across various
countries but predominantly in South Africa, the United Kingdom and the United States of America. Full scope audits were performed for
twenty six of the Group’s components due to their financial significance, significance of audit risks within the components and their
statutory audit requirements. For the remaining components, we performed high-level analytical reviews.
In establishing the overall approach to the Group audit, we determined the type of work that needed to be performed by us, as the Group
engagement team, and component auditors from other PwC network firms and other firms operating under our instruction. Where the
work was performed by component auditors, we determined the level of involvement we needed to have in the audit work at those
components to be able to conclude whether sufficient appropriate audit evidence had been obtained as a basis for our opinion on the
consolidated financial statements as a whole.
Key audit matters
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated and
separate financial statements of the current period. These matters were addressed in the context of our audit of the consolidated and
separate financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these
matters.
14 Discovery Annual Financial Statements 2021

-- 15 of 219 --

INDEPENDENT AUDITOR’S REPORT continued
for the year ended 30 June 2021
Consolidated Financial Statements
Key audit matter 	How our audit addressed the key audit matter
Valuation of assets and liabilities arising from insurance
contracts
Refer to Section 13 of Annexure A – Accounting policies and Notes 2,
4.1, 5 and 18 to the financial statements
The Group has recognised assets arising from insurance contracts
to the value of R 51 billion, and liabilities arising from insurance
contracts of R101 billion as at 30 June 2021.
The actuarial value of assets and liabilities arising from insurance
contracts is determined based on a prospective discounted cash
flow valuation basis, calculated as the difference between the
present value of future benefit payments plus expenses and the
present value of future premiums.
In valuing the assets and liabilities arising from insurance contracts,
various assumptions are made, which include 	best estimate
assumptions regarding the future expected claims experience,
premium income, expenses and commission. Changes to these
assumptions may result in a material change to the valuation. The
most significant assumptions made in determining the value of the
assets and liabilities arising from insurance contracts relate to:
Using our actuarial specialist, we performed the following
procedures with respect to these balances:
❚ 	As per the ISA 315 requirements we have obtained an
understanding of the Group’s actuarial control environment
and governance, including the functioning of the Actuarial
Committee (and subsidiary Actuarial Committees).
❚ 	Inspecting the liability build-up control performed by
management to explain the sources of profit and corroborating
to relevant information.
❚ 	Challenging the appropriateness of all significant assumptions
adopted by management, by comparing the assumptions to
results of actuarial experience investigations conducted by
management and benchmarking the assumptions to South
African life insurance industry trends. We found management’s
Impact of the Vitality programme on the valuation of assets and
liabilities arising from insurance contracts:
As for most life insurers, assumptions relating to mortality,
morbidity and the level of lapses are significant in the determination
of the value of policyholder liabilities and assets. The Group is
unique due to its Vitality programme. In terms of this programme,
policyholders are provided access to a number of services and
benefits to encourage them to become healthier. Policyholders
earn Vitality points which determine their Vitality status. The
mortality, morbidity and lapse assumptions within the valuation of
policyholder liabilities and assets in the Group are specifically
impacted by the Discovery Vitality policyholder statuses.
The Discovery Vitality policyholder statuses inform the policyholder
behaviour experience expected in future and therefore these
assumptions. The Vitality status distribution is updated every year
based on the actual Vitality status of the policyholders.
Impact of the Vitality programme on the valuation of assets and
liabilities arising from insurance contracts:
We assessed the assumptions used by the Group in the valuation
of the insurance contract assets and liabilities in terms of the
Financial Soundness Valuation (FSV) basis as described in the
Standard of Actuarial Practice (SAP) 104 and the Group accounting
policy as set out in Section 13 of Annexure A - Accounting policies.
In particular, we tested:
❚ 	The reasonability of the assumptions used by the Group in
setting the Vitality status distribution and the progression
between statuses by comparing these to historical experience;
and
❚ 	The data inputs into the model by verifying that these are
consistent with actual experience.
We found the assumptions to be comparable with the underlying
evidence.
Use of discretionary margins with respect to profit recognition:
The life insurance operations sell profitable insurance products.
Applying the reserving basis using only compulsory margins as
prescribed by regulations would result in an upfront profit being
recognised at the inception of new business contracts. Profits
recognised at initial recognition of the insurance contracts are,
however, limited to the extent of actual acquisition costs incurred
through the addition of discretionary margins. The discretionary
margins are reset at every valuation date to reflect the underlying
profitability of the portfolio and are released over the term of a
policy in line with the risk borne. Changes to the discretionary
margins have a direct impact on the profit recognition in a period
and therefore need careful consideration to ensure compliance
with the Section 13 of Annexure A – Accounting policies.
Use of discretionary margins with respect to profit recognition:
Our work included the following procedures:
❚ 	Consideration whether all acquisition costs were captured in
the determination of the discretionary margins at 30 June
2021 through comparison to the acquisition cost amounts in
the income statement.
❚ 	Consideration of the calculation of the discretionary margin
transfer against the methodology outlined by the accounting
policy
Allowance for COVID-19 within the valuation basis:
COVID-19 is expected to have an impact on future demographic
and economic experience. Management has allowed for this in the
best estimate assumptions of the assets and liabilities arising from
insurance contracts. Given the lack of historical experience, these
assumptions are highly subjective and judgement based.
We considered the valuation of assets and liabilities arising from
insurance contracts to be a matter of most significance to our audit
as it involves complex and subjective judgement about future
events, policyholder behaviour and economic conditions.
Allowance for COVID-19 within the valuation basis:
Our work included the following procedures:
❚ 	Consideration of the process which management went
through to determine the adjustment to the best estimate
assumptions.
❚ 	Testing the magnitude of the impact on the insurance
contract assets and liabilities due to the additional COVID
19 allowances within the model.
15 Discovery Annual Financial Statements 2021

-- 16 of 219 --

INDEPENDENT AUDITOR’S REPORT continued
for the year ended 30 June 2021
Key audit matter 	How our audit addressed the key audit matter
Annual impairment assessment of Goodwill for the Discovery
Bank CGU
Refer to Section 7 of Annexure A – Accounting policies and Notes 4.2
and 10 to the financial statements
The Group tests each cash-generating unit (CGU) containing goodwill
for impairment as per the International Accounting Standard -
Impairment of assets (IAS 36) on an annual basis. The recoverable
amount of each CGU is estimated based on value in use or fair value
less costs to sell. Inherent in the determination of fair value less
costs to sell is estimation uncertainty.
As at 30 June 2021 the Group has recognised goodwill of R4.88
billion which arose from the following acquisitions:
❚ 	The acquisitions of Vitality Health, Insure Your Health and KYS
Paid Limited (Vitality Health CGU) and Vitality Life (Vitality Life
CGU) as part of business combinations in the UK with a balance
of R2.44 billion at year-end; and
❚ 	The acquisition of the DiscoveryCard business (Discovery Bank
CGU) which resulted in the recognition of goodwill of R2.42
billion; and
❚ 	The acquisition of Liberty Health Administrators (LHA CGU) by
Discovery Health in the current year resulted in a goodwill of
R0.02 billion.
The goodwill assessment for the DiscoveryCard business goodwill
was noted as a significant accounting estimate and is considered a
Key Audit Matter as the methodology and assumptions applied in
determining the recoverable amounts of this CGU required
significant judgement. These methodologies and assumptions are
set out below:
Discovery Bank CGU
In determining the recoverable amount of the Discovery Bank CGU
(using fair value less costs to sell) 	management has applied
assumptions and judgement relating to the assets that are
attributed to the CGU, the forecasted cash flows, the discount rate
applied in discounting the cash flows (specifically the risk-free rate
and the beta factor that was applied), customer growth rates and
the expensing of system build costs and intangible assets acquired
in the business combination over the useful lives of 10 years.
For the year ended 30 June 2021, management has engaged
independent external valuation experts to benchmark the key
assumptions and ratios within the South African market.
We considered management’s annual impairment assessment of
goodwill to be a matter of most significance to our audit, as it is
subject to estimation uncertainty and significant judgement by
management with respect to the inputs into the calculation of the
recoverable amount.
The accounting estimate relating to the impairment calculation of
Vitality Life CGU, Vitality Health CGU and LHA CGU were not
considered Key Audit Matters.
In relation to the Discovery Bank CGU we obtained management’s
independent external valuation experts calculation of the
recoverable amount of the CGU and performed the following
procedures:
❚ 	We assessed whether the methodology and source of
information for the impairment calculation was consistent
with IAS 36 requirements and consistent with that used in
prior years.
❚ 	We obtained an understanding of the key and other
assumptions used by management in the valuation models by
inspecting the valuation calculation prepared by the
management’s valuation experts and impairment testing
memorandum prepared by management.
❚ 	Using our valuation and economic expertise, we have
assessed the valuation methodology and calculations used.
This includes the discount rate (Risk free rate and beta factor)
assumption used in the calculation. We have also assessed
the customer numbers and spend assumptions that drive
income and the reasonableness of expense and other cash
flow assumptions used (including capital requirements and
consideration of the credit loss ratios applied in the business
valuation).
❚ 	We 	performed 	various 	sensitivity 	calculations 	to
management’s assumptions applied for the terminal growth
rate, discount rate, estimated customer numbers and
customer profits.
❚ 	We have agreed the actual results from the 30 June 2021
financial year to those assumptions included in the valuation
model and performed a comparison to the 30 June 2020
assumptions to develop an independent expectation to
calculate an independent valuation of the Discovery CGU.
We performed an independent valuation of the Discovery Bank
CGU and noted that sufficient headroom is available when
compared to the carrying value of the CGU, thus resulting in no
impairment on the Discovery Bank CGU.
Separate financial statements
We have determined that there are no key audit matters in respect of the separate financial statements.
16 Discovery Annual Financial Statements 2021

-- 17 of 219 --

INDEPENDENT AUDITOR’S REPORT continued
for the year ended 30 June 2021
Other information
The directors are responsible for the other information. The other information comprises the information included in the document titled
“Discovery Annual Financial Statements for the year ended 30 June 2021”, which includes the Directors’ Report, the Report of the Audit
Committee and the Certificate by the Company Secretary as required by the Companies Act of South Africa, which we obtained prior to
the date of this auditor’s report, and the document titled “Discovery Integrated Annual Report 2021”, which is expected to be made
available to us after that date. The other information does not include the consolidated or the separate financial statements and our
auditor’s report thereon.
Our opinion on the consolidated and separate financial statements does not cover the other information and we do not express an audit
opinion or any form of assurance conclusion thereon.
In connection with our audit of the consolidated and separate financial statements, our responsibility is to read the other information
identified above and, in doing so, consider whether the other information is materially inconsistent with the consolidated and separate
financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated.
If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required
to report that fact. We have nothing to report in this regard.
Responsibilities of the directors for the consolidated and separate
financial statements
The directors are responsible for the preparation and fair presentation of the consolidated and separate financial statements in
accordance with International Financial Reporting Standards and the requirements of the Companies Act of South Africa, and for such
internal control as the directors determine is necessary to enable the preparation of consolidated and separate financial statements that
are free from material misstatement, whether due to fraud or error.
In preparing the consolidated and separate financial statements, the directors are responsible for assessing the Group and the Company’s
ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of
accounting unless the directors either intend to liquidate the Group and/or the Company or to cease operations, or have no realistic
alternative but to do so.
Auditor’s responsibilities for the audit of the consolidated and separate
financial statements
Our objectives are to obtain reasonable assurance about whether the consolidated and separate financial statements as a whole are free
from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable
assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material
misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate,
they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated and separate
financial statements.
As part of an audit in accordance with ISAs, we exercise professional judgement and maintain professional scepticism throughout the
audit. We also:
❚ 	Identify and assess the risks of material misstatement of the consolidated and separate financial statements, whether due to fraud or
error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to
provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting
from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
❚ 	Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group’s and the Company’s internal
control.
❚ 	Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures
made by the directors.
❚ 	Conclude on the appropriateness of the directors’ use of the going concern basis of accounting and, based on the audit evidence
obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group’s and the
Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention
in our auditor’s report to the related disclosures in the consolidated and separate financial statements or, if such disclosures are
inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report.
However, future events or conditions may cause the Group and/or Company to cease to continue as a going concern.
17 Discovery Annual Financial Statements 2021

-- 18 of 219 --

INDEPENDENT AUDITOR’S REPORT continued
for the year ended 30 June 2021
❚ 	Evaluate the overall presentation, structure and content of the consolidated and separate financial statements, including the
disclosures, and whether the consolidated and separate financial statements represent the underlying transactions and events in a
manner that achieves fair presentation.
❚ 	Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the group
to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of
the group audit. We remain solely responsible for our audit opinion.
We communicate with the directors regarding, among other matters, the planned scope and timing of the audit and significant audit
findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide the directors with a statement that we have complied with relevant ethical requirements regarding independence, and
to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where
applicable, actions taken to eliminate threats or safeguards applied.
From the matters communicated with the directors, we determine those matters that were of most significance in the audit of the
consolidated and separate financial statements of the current period and are therefore the key audit matters. We describe these matters
in our auditor’s report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances,
we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably
be expected to outweigh the public interest benefits of such communication.
REPORT ON OTHER LEGAL AND REGULATORY REQUIREMENTS
In terms of the IRBA Rule published in Government Gazette Number 39475 dated 4 December 2015, we report that PricewaterhouseCoopers
Inc. has been the auditor of Discovery Limited for 21 years.
PricewaterhouseCoopers Inc.
Director: Andrew Graham Taylor
Registered Auditor
Johannesburg
2 September 2021
18 Discovery Annual Financial Statements 2021

-- 19 of 219 --

The directors present their 22 nd annual report, which forms part of the consolidated and separate annual financial statements of
Discovery Limited for the year ended 30 June 2021.
NATURE OF BUSINESS
Discovery Limited (the Company) is listed on the JSE Limited and is an integrated financial services organisation specialising in
health insurance, life assurance, wellness, investments and savings products, short-term insurance and banking products.
Discovery is a shared value insurance company whose purpose and ambition are achieved through a pioneering business model
that incentivises people to be healthier, and enhances and protects their lives. Our shared value insurance model delivers better
health and value for clients, superior actuarial dynamics for the insurer, and a healthier society.
Discovery continues to drive the execution of existing market-specific strategies through its composite model, with the following strategic
vision established for each:
❚ 	South Africa: To be the perfect composite model, number 1 in every industry, and the Bank pivoting to growth as the composite-maker
within SA
❚ 	United Kingdom: To have best in breed products across businesses and operating as a fully integrated composite business with a
seamless One Vitality client journey and to have a successful entry into motor insurance
❚ 	Ping An Health Insurance: To be the leading health insurer in China with over 50 million clients
❚ 	Vitality Group: To be the world’s largest and most sophisticated behavioural platform linked to financial services
COVID-19 has accelerated the blurring of lines between health, wellness, resilience and mortality through the underlying behavioural
drivers of risk. As these have coalesced with the rising trends of technology adoption and socially driven purpose-led models,
Discovery has been evolving its growth model to offer multi-dimensional growth prospects; these being (1) Organic growth, (2)
Geographic growth of the Global Vitality businesses, (3) Structural growth through its platform and the institutions it serves and (4)
Composite ecosystems.
Group Structure
The Company is directly and indirectly the holding company of subsidiaries and investments as set at the end of this report. In
addition, Discovery consolidates unit trusts which are deemed to be under the Group’s control in terms of IFRS 10 Consolidated
Financial Statements. These are also set out at the end of the report.
YEAR UNDER REVIEW
Discovery’s results for the full year ended 30 June 2021 (reporting year or year under review) were characterised by three key attributes:
❚ 	A multifaceted focus on the impact of and response to the COVID-19 pandemic, which has been profound and tragic over the period.
In terms of the Group’s financial results, the notable material impact has been the effect of elevated mortality in South Africa (SA) in
Discovery Life.
❚ 	Notwithstanding the above, an excellent operational performance, with robust growth, retention and strong actuarial experience
across the Group.
❚ 	A pivot to growth by capitalising on the applicability of its Vitality Shared-Value model to ensure growth in local and global markets,
and excellent traction in Discovery’s new and emerging businesses.
Discovery’s results for the full year ended 30 June 2021 were robust, summarised by the following:
❚ 	Normalised profit from operations increased 7% for the year under review, notwithstanding the R2.4 billion COVID-19 impact for
Discovery Life as compared with the R1.1 billion for the year ended 30 June 2020.
❚ 	New Business API (Annual Premium Income) increased by 11%, while retention levels across the group were excellent and better than
expected.
❚ 	Performance was robust across all the Established businesses, outside of the COVID-19 driven elevated mortality in Discovery Life;
Emerging businesses delivered particularly strong growth, with normalised profit from operations having increased 46% and spend
on new initiatives reduced by 7% while delivering exceptional growth in new business, with new business API for new businesses
increasing 156%.
❚ 	Normalised Headline Earnings decreased 9%, impacted by mark-to-market foreign currency losses arising from a recovery of the Rand
during the reporting year compared to a gain in the previous financial year.
❚ 	Headline Earnings increased increase 910% as the stabilisation of long term interest rates in SA and the UK resulted in materially lower
economic basis changes than the prior year.
❚ 	Earnings per share additionally benefited from a material unrealised gain of R537 million from the transaction in which Cambridge
Mobile Telematics (CMT) acquired TrueMotion through an issuance of shares, as announced by CMT on 16 June 2021. See note 11 in
the annual financial statements for more information.
DIRECTORS’ REPORT
for the year ended 30 June 2021
19 Discovery Annual Financial Statements 2021

-- 20 of 219 --

DIRECTORS’ REPORT continued
for the year ended 30 June 2021
COVID-19 impact on results
The financial year under review was framed by the COVID-19 pandemic, the year commencing during the first wave of the pandemic
and ending during the height of the third wave in SA. The epidemic in SA has been significantly worse than anticipated at the end of
June 2020. At that time, Discovery projected a severe second wave for SA, but the actual second wave experience was still somewhat
worse than expected due to the emergence of the Beta variant. In addition, SA suffered a very significant third wave, driven by the
Delta variant. By contrast, whilst the United Kingdom (UK) also experienced a severe second wave, it has largely avoided any negative
mortality impact in its third wave due to its extraordinarily effective and early vaccine campaign. On a risk adjusted basis, we believe
that the South African epidemic has turned out to be significantly more severe than the epidemic in the UK. In the UK, the extended
lockdowns caused by the second and third wave of infections did however cause further delays to elective medical procedures.
Despite these complex and varied dynamics, the Group was remarkably resilient across all its businesses, with the notable material
impact on operating profit being the effect of elevated mortality in SA experienced within Discovery Life.
Normalised profit from operations over prior year
The following table demonstrates the contribution of key businesses to the growth in normalised profit from operations of 7%
compared to the prior year.
Business
Normalised profit
from operations
% change
12 months ended
30 June 2021 to
12 months ended
30 June 2020
Discovery Health 	+7%
Discovery Life 	-55%
Discovery Invest 	+31%
Discovery Vitality 	+514%
VitalityHealth 	+15%*
VitalityLife 	+337%
(reversal of prior year loss)**
Profit from Established businesses 	-1%
Discovery Insure 	+2%
Vitality Group 	+35%
Ping An Health 	+126%
Total Emerging businesses 	+46%
New initiatives (Excluding Bank) 	Spend reduced by 7%
Discovery Bank 	Spend reduced by 7%
Normalised Profit from operations 	+7%
* For VitalityHealth, a key feature of the UK health market in the financial year has been the continued delay in claims catch-up relating to elective medical
procedures with the second and third wave of COVID-19 infections. Vitality Health has modelled the expected catch-up in claims into future periods and is
managing the underlying claims experience over time in the following two ways. Firstly, a £14 million unearned premium reserve (UPR) has been established
at the end of the reporting year to cover delayed claims that are anticipated within the short-term contract boundaries. Most anticipated claims are however
expected to transpire over a much longer period and mostly well beyond the short-term nature of the insurance contract boundaries; this presented the
business with an opportunity to accelerate the repayment terms of its existing reinsurance programme in the reporting year, with a net in period cost of
£39.7 million, which results in better matching the underlying claims experience expected from the catch-up in claims in future years. VitalityHealth’s robust
operating profit in the table above is after the effect of these factors. Refer to Note 41 in the Annual Financial Statements for more information.
** VitalityLife performed better than expected over the financial year both in terms of mortality and lapses and a relatively immaterial additional provision was
deemed necessary to cover the potential effects of a possible 4th wave in the UK.
20 Discovery Annual Financial Statements 2021

-- 21 of 219 --

SHARE CAPITAL
Details of the authorised and issued share capital, together with details of shares issued during the year, appear in note 17 to the
Annual Financial Statements.
DIVIDENDS
Dividends paid during the current and prior financial year
B preference shares
Payment date 	Nature and financial period 	Dividend declared per share
15 March 2021 	Interim dividend Financial year 2021 	354.52055 cents
(283.61644 cents net of dividend withholding tax)
28 September 2020 	Final dividend Financial year 2020 	433.21918 cents
(346.57534 cents net of dividend withholding tax)
16 March 2020 	Interim dividend Financial year 2020 	505.41097 cents
(404.32878 cents net of dividend withholding tax)
Ordinary shares
Payment date 	Nature and financial period 	Dividend declared per share
Due to the uncertainty and potentially volatile economic environment caused by the COVID-19 pandemic, Discovery did not pay any
ordinary dividends during the year ended 30 June 2021.
23 March 2020 	Interim dividend Financial year 2020 	101 cents
(80.8 cents net of dividend withholding tax)
Final dividends declaration in respect of the 2021 financial year
Details of the dividends appear in Note 42.
CAPITAL
Solvency and liquidity test
The directors have performed the requisite solvency and liquidity tests where required by the Companies Act, 71 of 2008, as
amended.
Statutory capital requirements
With effect from 1 July 2018, the Insurance Act 18 of 2017 (Insurance Act), and the related Prudential Standards were implemented
in South Africa. Discovery Life and Discovery Insure are regulated under the Insurance Act, while Vitality Health and VitalityLife are
regulated under the European Solvency II regulatory regime, which was implemented from 1 January 2016. The values below are
estimated based on information extracted from the audited financial statements.
2021 	2020
Statutory Capital Requirements 	Cover 	Statutory Capital Requirements 	Cover
Discovery Life 	R17 647 million 	1.8 times 	R14 835 million 	1.8 times
Discovery Insure 	R1 079 million 	1.6 times 	R885 million 	1.8 times
Vitality Health 	GBP 105.6 million (R2 084 million) 	1.6 times 	GBP 102.3 million (R2 194 million) 	1.7 times
VitalityLife Limited 	GBP 225.5 million (R4 451million) 	2.4 times 	GBP 228.3 million (R4 896 million) 	2.0 times
DIRECTORS’ REPORT continued
for the year ended 30 June 2021
21 Discovery Annual Financial Statements 2021

-- 22 of 219 --

DIRECTORS’ REPORT continued
for the year ended 30 June 2021
A disciplined long-term capital plan remains a key focus as Discovery continues to follow a highly structured approach to navigating
the impact of COVID-19 while ensuring that the Group remains resilient and able to continue to fund its growth initiatives. Each of
the Group’s businesses are strongly capitalised with capital metrics above set targets, and across the Group there is an excess of
liquid assets above minimum regulatory capital requirements of R13.4 billion, held predominantly within the businesses, with
excess liquidity held at the centre in SA of R2 billion. The Group’s Financial Leverage Ratio stabilised at 25.7%1 and is comfortably
within the internally set guidance level of 28% and expected to trend down over time.
Ping An Health Insurance (PAH)
During the period under review, the Group became aware that due to the combined effect of the future growth prospects of Ping
An Health Insurance (PAH) and its expanding product mix, with the evolving prudential regulatory requirements in China, PAH
requires additional capital of RMB2.6 billion (approximately R6 billion). Discovery’s contribution, amounting to approximately R1.5
billion, will be required in the near future. Discovery is committed to its investment in PAH and its intention is to follow its rights in
this regard, aligned with previous capital contributions it has made, and is evaluating the optimal funding mechanism in the context
of COVID-19 aligned with the discipline of the capital plan. Discovery has previously responded to fund such growth opportunities
through equity rather than debt, as was the case of the final buy-out of the FNB credit card book in 2018. The prospects for private
healthcare and private health insurance in China provide an excellent long-term opportunity, supported by recent government
policies emphasising the development of healthcare and private health insurance.
DIRECTORS AND PRESCRIBED OFFICERS
The following were directors and prescribed officers of the Company during the current and prior financial year unless otherwise
indicated:
Executive directors 	Non-executive directors
A Gore 	HL Bosman
HD Kallner 	R Farber
NS Koopowitz 	HP Mayers (retired 26 November 2020)
Dr A Ntsaluba 	Independent non-executive directors
A Pollard 	ME Tucker (Chairperson)
B Swartzberg 	Dr BA Brink
DM Viljoen 	SE De Bruyn
F Khanyile
D Macready
Dr TV Maphai
M Schreuder (appointed 19 February 2021)
SV Zilwa
Ms. M Hlahla has been appointed as an independent non-executive director with effect from 15 August 2021. Ms. M Hlahla will be
a member of the audit committee as well as the social and ethics committee. Ms. Hlahla’s appointment strengthens the independence
and business skills on the board and the committees.
The notice for the forthcoming Annual General Meeting of shareholders will include those names of individuals that retire by
rotation and are eligible and available for re-election.
The Companies Act and associated regulations introduced the concept of Prescribed Officers and related remuneration disclosure.
The Remuneration Committee (RemCo) considers the Act, seeks legal opinion and assesses this definition every year against the
roles and responsibilities of employees. Following restructuring of reporting lines and formalising geographical composite strategies
and leadership structure composites in the prior year, RemCo resolved that Executive Directors of Discovery are Prescribed Officers
of the Group.
Details of the directors’ emoluments, participation in share incentive schemes and interests in the Company are reflected in
Annexure B and in the Group’s Remuneration report.
22 Discovery Annual Financial Statements 2021

-- 23 of 219 --

DIRECTORS’ REPORT continued
for the year ended 30 June 2021
COMPANY SECRETARY
Ms NN Mbongo replaced Mr MJ Botha, following his formal retirement, as Company Secretary effective 1 December 2020.
Registered office 	Postal address
1 Discovery Place 	PO Box 786722
Sandton 	Sandton
2196 	2146
DIRECTORS’ INTERESTS IN CONTRACTS
No material contracts involving directors’ interests were entered into in the current year. The directors had no interest in any third
party or company responsible for managing any of the business activities of Discovery.
BORROWING POWERS
The directors may exercise all the powers of the Company to borrow money. In terms of the Memorandum of Incorporation, the
borrowing powers of the Company are unlimited. In terms of the Insurance Act, both Discovery Life and Discovery Insure may not
encumber its assets or directly or indirectly borrow.
INDEMNIFICATION AND INSURANCE OF DIRECTORS AND OFFICERS
The Company entered into agreements to indemnify its directors to the extent permitted by law against all liabilities including legal
costs incurred by the director in connection with or as a consequence of the director acting in any capacity, including as an
authorised representative of a Group company.
During the financial year, the Company paid insurance premiums in respect of a Directors and Officers Liability insurance contract,
which insures directors and officers of the Company against certain liabilities arising in the course of their duties to the Company
or Group companies. Details of the nature of the liabilities covered and the amount of premium paid are not disclosed as such
disclosure is prohibited under the terms of the contract.
EVENTS AFTER THE REPORTING DATE
There are no other significant events after the reporting date, being 30 June 2021, to the date of the approval of the Annual Financial
Statements, namely, 1 September 2021.
AUDITORS
It will be proposed at the Annual General Meeting of shareholders, that PricewaterhouseCoopers Inc. continue in office in accordance
with section 90(1) of the Companies Act and, in light of the future requirements by the Prudential Authority for the Company to
appoint joint auditors and also in anticipation of mandatory audit firm rotation requirements of IRBA, both becoming applicable in
2023, that KPMG Inc will be appointed as joint auditors effective 1 July 2021 with PricewaterhouseCoopers Inc.
23 Discovery Annual Financial Statements 2021

-- 24 of 219 --

DIRECTORS’ REPORT continued
for the year ended 30 June 2021
GROUP STRUCTURE
Discovery is directly and indirectly the holding company of:
Audited information
Percentage
holding 	Country
Discovery Central Services Proprietary Limited 	100% 	SA
Discovery Connect Distribution Services Proprietary Limited 	100% 	SA
Discovery Health Proprietary Limited which holds the interests in: 	100% 	SA
– Discovery Third Party Recovery Services Proprietary Limited 	100% 	SA
– Discovery HealthCare Services Proprietary Limited which holds the interests in: 	100% 	SA
○ Discovery Medical Suppliers Proprietary Limited 	100% 	SA
○ Grove Nursing Services Proprietary Limited 	100% 	SA
○ Southern RX Distributors Proprietary Limited 	100% 	SA
– Liberty Health Administrators Proprietary Limited 	100% 	SA
– Medical Services Organisation International Proprietary Limited which holds the interest in: 	70% 	SA
○ MSO Eswatini Swaziland 	51% 	Swaziland
– MSO International (Isle of Man) which holds the interest in: 	70% 	Isle of Man
○ Global Access Health Network SARL 	80% 	DRC
○ MSOI Health Risk Managers Limited 	85% 	Nigeria
Discovery Insure Limited which holds the interest in: 	100% 	SA
– Discovery Telematic Services Proprietary Limited 	100% 	SA
Discovery Investment Management Proprietary Limited (dormant) 	100% 	SA
Discovery Life Collective Investments Proprietary Limited 	100% 	SA
Discovery Maritius Asset Management 	100% 	Mauritius
Discovery International Collective Investments PLC 	100% 	Mauritius
Discovery Life Investment Services Proprietary Limited which holds the interest in: 	100% 	SA
– Discovery Life Nominees Proprietary Limited 	100% 	SA
Discovery Life Limited 	100% 	SA
Discovery Bank Holdings Limited which holds the interest in: 	100% 	SA
– Discovery Bank Limited 	100% 	SA
Discovery Vitality Proprietary Limited 	100% 	SA
Discovery Partner Markets Asia Private Limited which holds the interest in: 	100% 	Singapore
– Discovery Partner Markets Services Private Limited 	100% 	Singapore
Discovery Finance Company Europe Limited 	100% 	UK
Discovery Group Europe Limited which holds the interests in: 	100% 	UK
– Discovery Offshore Holdings No 2 Limited (dormant) 	100% 	UK
– Discovery Holdings Europe Limited which holds the interests in: 	100% 	UK
○ Better Health Insurance Advice 	100% 	UK
○ Vitality Corporate Services Limited which holds the interest in: 	100% 	UK
○ Vitality Healthy Workplace Limited 	100% 	UK
○ Vitality Life Limited which holds the interests in: 	100% 	UK
○ Vitality Health Insurance Limited which holds the interest in: 	100% 	UK
○ Vitality Health Limited 	100% 	UK
○ Vitality Invest Trustee Company Limited 	100% 	UK
Vitality Group International Inc., which holds the interests in: 	100% 	USA
– Discovery Vitality Australia Proprietary Limited 	100% 	Australia
– Vitality Management Company LLC 	100% 	USA
– The Vitality Group Inc*., which holds the interests in: 	99.9% 	USA
○ The Vitality Group LLC 	100% 	USA
Abbreviations: SA – South Africa, DRC – Democratic Republic of the Congo, UK – United Kingdom, USA – United States of America
* The balance of the interest is held by senior management of this subsidiary.
24 Discovery Annual Financial Statements 2021

-- 25 of 219 --

In addition to the above subsidiaries, Discovery consolidates unit trusts which are deemed to be under the Group’s control in terms
of IFRS 10 Consolidated Financial Statements. The consolidated unit trusts include:
Discovery Aggressive Dynamic Asset Optimiser Fund of Funds 	Discovery Target Retirement 2025 Fund
Discovery Balanced Fund 	Discovery Target Retirement 2030 Fund
Discovery Cautious Balanced Fund 	Discovery Target Retirement 2035 Fund
Discovery Conservative Dynamic Asset Optimiser Fund of Funds 	Discovery Target Retirement 2040 Fund
Discovery Diversified Income Fund 	Discovery Target Retirement 2045 Fund
Discovery Equity Fund 	Discovery Target Retirement 2050 Fund
Discovery Flexible Property Fund 	Discovery Target Retirement 2055 Fund
Discovery Global Equity Feeder Fund 	Discovery Target Retirement 2060 Fund
Discovery Global Real Estate Securities Feeder Fund 	Discovery Global Multi Asset Fund (previously named
Discovery Global Value Equity Feeder Fund 	Discovery Worldwide Best Ideas Fund)
Discovery Moderate Balanced Fund 	Discovery Strategic Bond Fund
Discovery Moderate Dynamic Asset Optimiser Fund of Funds 	Discovery Global Conservative Fund (Mauritius)
Discovery Money Market Fund 	Discovery Global Moderate Fund (Mauritius)
Discovery Target Retirement 2015 Fund 	Discovery Global Growth Portfolio Fund (Mauritius)
Discovery Target Retirement 2020 Fund
DIRECTORS’ REPORT continued
for the year ended 30 June 2021
25 Discovery Annual Financial Statements 2021

-- 26 of 219 --

GROUP STATEMENT OF FINANCIAL POSITION
at 30 June 2021
R million 	Notes
Group
2021
Group
2020
Assets
Goodwill 	10 	4 879 	5 070
Intangible assets 	7 	6 371 	6 381
Property and equipment 	6 	4 188 	4 643
Assets arising from insurance contracts 	5 	50 483 	48 042
Deferred acquisition costs 	8 	585 	632
Assets arising from contracts with customers 	9 	1 248 	954
Investment in equity-accounted investees 	11 	3 459 	2 713
Deferred income tax asset 	23 	3 948 	3 511
Financial assets
– Loans and advances to customers at amortised cost 	12 	3 361 	1 848
– Investments at amortised cost 	12 	5 604 	2 523
– Investments at fair value through profit or loss 	12 	130 937 	102 714
– Derivative financial instruments at fair value through profit or loss 	13 	249 	1 370
Insurance receivables, contract receivables and other receivables 	14 	10 533 	11 436
Current income tax asset 	391 	182
Reinsurance contracts 	15 	445 	400
Cash and cash equivalents 	16 	20 013 	17 909
TOTAL ASSETS 	246 694 	210 328
Equity
Capital and reserves
Ordinary share capital and share premium 	17.1 	10 151 	10 148
Perpetual preference share capital 	17.2 	779 	779
Other reserves 	1 935 	3 269
Retained earnings 	33 550 	30 353
46 415 	44 549
Non-controlling interest 	4 	4
TOTAL EQUITY 	46 419 	44 553
Liabilities
Liabilities arising from insurance contracts 	18 	100 977 	82 411
Liabilities arising from reinsurance contracts 	19 	12 525 	12 465
Deferred income tax liability 	23 	8 814 	8 514
Contract liabilities to customers 	9 	776 	808
Financial liabilities
– Borrowings at amortised cost 	20 	19 493 	19 836
– Other payables at amortised cost 	22 	14 904 	14 233
– Deposits from customers 	8 985 	2 427
– Investment contracts at fair value through profit or loss 	21 	32 291 	23 012
– Derivative financial instruments at fair value through profit or loss 	13 	826 	992
Employee benefits 	24 	315 	284
Current income tax liability 	369 	793
TOTAL LIABILITIES 	200 275 	165 775
TOTAL EQUITY AND LIABILITIES 	246 694 	210 328
26 Discovery Annual Financial Statements 2021

-- 27 of 219 --

GROUP INCOME STATEMENT
for the year ended 30 June 2021
R million 	Notes
Group
June
2021
Group
June
2020
Insurance premium revenue 	55 935 	49 775
Reinsurance premiums 	(7 729) 	(6 308)
Accelerated reinsurance premiums 	41 	(823) 	–
Net insurance premium revenue 	25 	47 383 	43 467
Fee income from administration businesses 	11 700 	11 337
Net banking fee and commission income 	480 	150
Banking fee and commission income 	633 	182
Banking fee and commission expense 	(153) 	(32)
Vitality income 	3 340 	3 875
Other income 	1 372 	1 100
Receipts arising from reinsurance contracts 	19 	500 	–
Investment income using the effective interest rate method 	26 	280 	379
Net bank interest and similar income 	241 	71
Bank interest and similar income using the effective interest rate 	627 	162
Bank interest and similar expense using the effective interest rate 	(386) 	(91)
Net fair value gains on financial assets at fair value through profit or loss 	27 	11 891 	4 093
Net income 	77 187 	64 472
Net claims and policyholders’ benefits 	28 	(28 178) 	(23 246)
Claims and policyholders' benefits 	(33 972) 	(26 856)
Insurance claims recovered from reinsurers 	5 794 	3 610
Acquisition costs 	29 	(5 033) 	(6 547)
Marketing and administration expenses 	30 	(22 679) 	(22 118)
Amortisation of intangibles from business combinations 	(66) 	(76)
Expected credit losses 	(271) 	(181)
Recovery of expenses from reinsurers 	2 773 	2 876
Net transfer to/from assets and liabilities under insurance contracts 	(14 795) 	(13 497)
– change in assets arising from insurance contracts 	545 	2 038
– change in assets arising from reinsurance contracts 	56 	53
– change in liabilities arising from insurance contracts 	(17 941) 	(9 418)
– change in liabilities arising from reinsurance contracts 	1 755 	(462)
– economic assumption adjustments net of discretionary margins 	790 	(5 708)
Fair value adjustment to liabilities under investment contracts 	(3 634) 	(151)
Profit from operations 	5 304 	1 532
Finance costs 	32 	(1 648) 	(1 568)
Foreign exchange (losses)/gains 	(389) 	578
Impairment of goodwill 	– 	(9)
Gain on dilution and disposal of equity-accounted investments 	554 	3
Impairment of equity-accounted investments 	(149) 	–
Share of net profits from equity-accounted investments 	523 	264
Profit before tax 	4 195 	800
Income tax expense 	34 	(975) 	(624)
Profit for the year 	3 220 	176
Profit/(loss) attributable to:
– ordinary shareholders 	3 157 	97
– preference shareholders 	63 	81
– non-controlling interest 	* 	(2)
3 220 	176
Earnings per share for profit attributable to ordinary shareholders of the company
during the year (cents): 	35
– basic 	480.7 	14.8
– diluted 	475.4 	14.7
27 Discovery Annual Financial Statements 2021

-- 28 of 219 --

GROUP STATEMENT OF OTHER COMPREHENSIVE INCOME
for the year ended 30 June 2021
R million
Group
June
2021
Group
June
2020
Profit for the year 	3 220 	176
Items that are or may be reclassified subsequently to profit or loss:
Currency translation differences 	(1 576) 	2 800
Cash flow hedges 	260 	(430)
– unrealised losses 	360 	(762)
– tax on unrealised gains/losses 	(25) 	59
– (gains)/losses recycled to profit or loss 	(90) 	319
– tax on recycled gains/losses 	15 	(46)
Share of other comprehensive income from equity-accounted investments 	(312) 	293
– change in fair value of debt instruments at fair value through other comprehensive income 	15 	3
– currency translation differences 	(327) 	290
Other comprehensive (losses)/income for the year, net of tax 	(1 628) 	2 663
Total comprehensive income for the year 	1 592 	2 839
Attributable to:
– ordinary shareholders 	1 529 	2 760
– preference shareholders 	63 	81
– non-controlling interest 	* 	(2)
Total comprehensive income for the year 	1 592 	2 839
* Amount is less than R500 000.
28 Discovery Annual Financial Statements 2021

-- 29 of 219 --

GROUP STATEMENT OF CASH FLOWS
for the year ended 30 June 2021
R million 	Notes
Group
June
2021
Group
June
2020
Cash flow from operating activities 	10 407 	8 065
Cash generated by operations 	36.1 	26 457 	19 000
Purchase of investments held to back policyholder liabilities 	(54 661) 	(37 316)
Proceeds from disposal of investments held to back policyholder liabilities 	38 709 	26 218
10 505 	7 902
Dividends received 	303 	342
Interest received 	2 513 	2 516
Interest paid 	(1 197) 	(1 406)
Taxation paid 	36.2 	(1 717) 	(1 289)
Cash flow from investing activities 	(6 740) 	(3 030)
Purchase of financial assets 	(32 569) 	(26 497)
Proceeds from disposal of financial assets 	27 828 	25 532
Purchase of property and equipment 	(277) 	(290)
Proceeds from disposal of property and equipment 	21 	4
Purchase of software and other intangible assets 	(1 587) 	(1 726)
Acquisition of business net of cash 	(25) 	16
Additional investment in equity-accounted investments 	(240) 	(69)
Dividends from equity-accounted investments 	109 	–
Cash flow from financing activities 	(590) 	2 202
Purchase of treasury shares 	– 	(4)
Dividends paid to ordinary shareholders 	– 	(1 413)
Dividends paid to preference shareholders 	(63) 	(81)
Proceeds from borrowings 	36.3 	1 839 	10 339
Repayment of borrowings 	36.3 	(2 366) 	(6 639)
Net increase in cash and cash equivalents 	3 077 	7 237
Cash and cash equivalents at beginning of the year 	17 909 	9 403
Exchange (losses)/gains on cash and cash equivalents 	(973) 	1 269
Cash and cash equivalents at end of the year 	16 	20 013 	17 909
29 Discovery Annual Financial Statements 2021

-- 30 of 219 --

GROUP STATEMENT OF CHANGES IN EQUITY
for the year ended 30 June 2021
Attributable to equity holders of the Company 	Attributable to equity holders of the Company
R million
Share
capital
and share
premium
Preference
share
capital
Share-based
payment
reserve
Investment
reserve1
Foreign
currency
translation
reserve
Hedging
reserve
Retained
earnings 	Total
Non-
controlling
interest 	Total
Year ended 30 June 2020
At beginning of the year 	10 142 	779 	41 	– 	585 	(174) 	31 669 	43 042 	* 	43 042
Total comprehensive income for the year 	– 	81 	– 	3 	3 090 	(430) 	97 	2 841 	(2) 	2 839
Profit for the year 	– 	81 	– 	– 	– 	– 	97 	178 	(2) 	176
Other comprehensive income 	– 	– 	– 	3 	3 090 	(430) 	– 	2 663 	– 	2 663
Transactions with owners 	6 	(81) 	154 	– 	– 	– 	(1 413) 	(1 334) 	6 	(1 328)
Delivery of treasury shares 	10 	– 	(10) 	– 	– 	– 	– 	– 	– 	–
Increase in treasury shares 	(4) 	– 	– 	– 	– 	– 	– 	(4) 	– 	(4)
Acquisition of subsidiaries with non-controlling interest 	– 	– 	– 	– 	– 	– 	– 	– 	6 	6
Employee share option schemes:
– Value of employee services 	– 	– 	164 	– 	– 	– 	– 	164 	– 	164
Dividends paid to preference shareholders 	– 	(81) 	– 	– 	– 	– 	– 	(81) 	– 	(81)
Dividends paid to ordinary shareholders 	– 	– 	– 	– 	– 	– 	(1 413) 	(1 413) 	– 	(1 413)
At end of the year 	10 148 	779 	195 	3 	3 675 	(604) 	30 353 	44 549 	4 	44 553
Year ended 30 June 2021
At beginning of the year 	10 148 	779 	195 	3 	3 675 	(604) 	30 353 	44 549 	4 	44 553
Total comprehensive income for the year 	– 	63 	– 	15 	(1 903) 	260 	3 157 	1 592 	* 	1 592
Profit for the year 	– 	63 	– 	– 	– 	– 	3 157 	3 220 	* 	3 220
Other comprehensive (loss)/income 	– 	– 	– 	15 	(1 903) 	260 	– 	(1 628) 	– 	(1 628)
Transactions with owners 	3 	(63) 	294 	– 	– 	– 	40 	274 	– 	274
Issue of shares 	907 	– 	– 	– 	– 	– 	– 	907 	– 	907
Delivery of treasury shares 	3 	– 	(36) 	– 	– 	– 	40 	7 	– 	7
Increase in treasury shares 	(907) 	– 	– 	– 	– 	– 	– 	(907) 	– 	(907)
Employee share option schemes:
– Value of employee services 	– 	– 	330 	– 	– 	– 	– 	330 	– 	330
Dividends paid to preference shareholders 	– 	(63) 	– 	– 	– 	– 	– 	(63) 	– 	(63)
At end of the year 	10 151 	779 	489 	18 	1 772 	(344) 	33 550 	46 415 	4 	46 419
1 This relates to fair value adjustments on those equity instruments designated at fair value through other comprehensive income and those debt instruments
measured at fair value through other comprehensive income.
* Amount is less than R500 000.
30 Discovery Annual Financial Statements 2021

-- 31 of 219 --

1. 	SEGMENT INFORMATION
Discovery’s operating segments are reported in a manner consistent with the internal reporting provided to the chief operating
decision-maker (CODM). The CODM have been identified as the Chief Executive Officers of Discovery’s businesses, as identified
in the segment information, who make strategic decisions regarding these businesses.
An operating segment is a component of an entity:
(a) 	That engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses
relating to transactions with other components of the same entity);
(b) Whose operating results are regularly reviewed by the entity’s CODM to make decisions about resources to be allocated to
the segment and assess its performance; and
(c) 	For which discrete financial information is available.
An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations
may be operating segments before earning revenues.
Discovery will report separately information about an operating segment that meets any of the following quantitative thresholds:
(a) 	Its reported revenue, including both sales to external customers and intersegment sales or transfers, is 10 per cent or more
of the combined revenue, internal and external, of all operating segments;
(b) The absolute amount of its reported profit or loss is 10 per cent or more of the greater, in absolute amount, of (i) the
combined reported profit of all operating segments that did not report a loss and (ii) the combined reported loss of all
operating segments that reported a loss; and
(c) 	Its assets are 10 per cent or more of the combined assets of all operating segments.
Operating segments that do not meet any of the quantitative thresholds may be considered reportable, and separately disclosed,
if management believes that information about the segment would be useful to users of the financial statements.
Discovery may combine information about operating segments that do not meet the quantitative thresholds with information
about other operating segments that do not meet the quantitative thresholds to produce a reportable segment only if the
operating segments have similar economic characteristics.
The Group has identified its reportable segments based on a combination of products and services offered to customers and the
location of the markets served.
The following summary describes the operations of each of the Group’s reportable segments:
(i) 	Health South Africa: administers and provides managed care services to medical schemes and renders administration
services to other business segments within the Group.
(ii) 	Life South Africa: offers a range of insurance and financial solutions to the Group’s clients against the financial impact of
lifestyle-changing events in South Africa.
(iii) Invest South Africa: offers, through a range of investment fund choices, including Discovery managed unit trusts, a
comprehensive and flexible range of investment choices. These products are sold through a number of investment wrappers
including Discovery Life policies and are offered to individuals in South Africa.
(iv) Vitality South Africa: offers health and lifestyle benefits with selected partners to the Group’s clients.
(v) 	Insure South Africa: offers a range of personal line insurance (motor, building, household content and portable possessions)
to the Group’s clients against the financial impact of loss or damage. The segment also includes Discovery’s interest in
Cambridge Mobile Telematics (CMT).
(vi) Bank South Africa: offers retail banking solutions, including deposits and loans and advances, to clients in the South African
market. The Bank is still in start-up phase. It also includes DiscoveryCard.
(vii) Health United Kingdom: offers consumer-engaged private medical insurance products to employer groups and individuals
in the United Kingdom. All contracts in this segment are short-term insurance contracts.
(viii) Life United Kingdom: offers a risk-only life assurance product. All contracts in this segment are long-term assurance
contracts offered to both employer groups and individuals in the United Kingdom.
(ix) All other segments: includes those segments that do not meet the quantitative thresholds set out in IFRS 8 and cannot be
aggregated with another reportable segment. It includes the following operating segments:
– Insure South Africa commercial: provides commercial short-term risk insurance products to the South African market.
– SA Distribution: provides sales and distribution services in respect of all SA products.
– Vitality Group: provides a Vitality platform to international insurance businesses.
– Other new business development costs: expenses incurred to investigate new products and markets.
– UK, US, SA and Singapore head office costs, where not allocated to another segment.
– Invest United Kingdom: offers a comprehensive range of investment products to individuals in the United Kingdom.
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS
for the year ended 30 June 2021
31 Discovery Annual Financial Statements 2021

-- 32 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
1. 	SEGMENT INFORMATION continued
The Chief Executive Officers assess the performance of the reportable segments based on normalised profit/loss from operations.
Items which are excluded from the normalised profit/loss from operations are separately disclosed in the segmental information
to reconcile back to the segmental results.
The segment information is presented on the same basis as reported to the Chief Executive Officer. The segment total is then
adjusted for accounting reclassifications and entries required to produce IFRS compliant results. These adjustments include the
following:
(i) The VitalityLife results are reclassified to account for the contractual arrangement in respect of the business written on the
Prudential Assurance Company license, as an insurance contract which Discovery issues under IFRS 4 Insurance Contracts;
(ii) Unit trusts which the Group controls in terms of IFRS 10 Consolidated Financial Statements are consolidated into Discovery’s
results for IFRS purposes. The IFRS reporting adjustments include the effects of consolidating the unit trusts into Discovery’s
results, effectively being the income and expenses relating to units held by third parties;
(iii) The effects of eliminating intercompany transactions on consolidation and normalised operating profit adjustments; and
(iv) The effects of reclassifying items to align to IFRS results.
32 Discovery Annual Financial Statements 2021

-- 33 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
1. 	SEGMENT INFORMATION continued
R million
SA
Health
SA
Life
SA
Invest
SA
Insure 2
SA
Vitality
SA
Bank
UK
Health
UK
Life
All other
segments
Segment
total
IFRS reporting
adjustments
IFRS
total
30 June 2021
Income statement
Insurance premium revenue 	294 	13 711 	14 824 	4 091 	– 	– 	11 075 	6 466 	6 351 	56 812 	(877) 	55 935
Reinsurance premiums 	1 	(3 262) 	– 	(66) 	– 	– 	(1 839) 	(3 354) 	(86) 	(8 606) 	877 	(7 729)
Accelerated reinsurance premiums 	– 	– 	– 	– 	– 	– 	(823) 	– 	– 	(823) 	– 	(823)
Net insurance premium revenue 	295 	10 449 	14 824 	4 025 	– 	– 	8 413 	3 112 	6 265 	47 383 	– 	47 383
Fee income from administration businesses 	7 540 	– 	2 401 	16 	– 	2 	28 	– 	1 724 	11 711 	(11) 	11 700
Net banking fee and commission income 	– 	– 	– 	– 	– 	464 	– 	– 	16 	480 	– 	480
Banking fee and commission income3 	– 	– 	– 	– 	– 	633 	– 	– 	– 	633 	– 	633
Banking fee and commission expense 	– 	– 	– 	– 	– 	(169) 	– 	– 	16 	(153) 	– 	(153)
Vitality income 	– 	– 	– 	– 	2 295 	21 	240 	230 	554 	3 340 	– 	3 340
Other income 	968 	3 	– 	– 	– 	312 	60 	– 	10 	1 353 	19 	1 372
Receipts arising from reinsurance contracts 	– 	500 	– 	– 	– 	– 	– 	– 	– 	500 	– 	500
Investment income earned on assets backing policyholder liabilities 	– 	10 	– 	111 	– 	– 	– 	9 	9 	139 	(139) 	–
Net bank interest and similar income 	– 	– 	– 	– 	– 	214 	– 	– 	– 	214 	27 	241
Bank interest and similar income using the effective interest rate 	– 	– 	– 	– 	– 	627 	– 	– 	– 	627 	– 	627
Bank interest and similar expense using the effective interest rate 	– 	– 	– 	– 	– 	(413) 	– 	– 	– 	(413) 	27 	(386)
Finance charge on negative reserve funding 	– 	– 	– 	– 	– 	– 	– 	769 	– 	769 	(769) 	–
Inter-segment funding1 	– 	(714) 	714 	– 	– 	– 	– 	– 	– 	– 	– 	–
Net fair value gains on financial assets at fair value through profit or loss 	6 	637 	9 172 	14 	– 	83 	29 	(792) 	1 358 	10 507 	1 384 	11 891
Net income 	8 809 	10 885 	27 111 	4 166 	2 295 	1 096 	8 770 	3 328 	9 936 	76 396 	511 	76 907
Net claims and policyholders’ benefits 	(129) 	(8 113) 	(12 252) 	(2 270) 	– 	– 	(3 894) 	(837) 	(683) 	(28 178) 	– 	(28 178)
Claims and policyholders’ benefits 	(129) 	(11 949) 	(12 252) 	(2 269) 	– 	– 	(5 219) 	(1 962) 	(761) 	(34 541) 	569 	(33 972)
Insurance claims recovered from reinsurers 	– 	3 836 	– 	(1) 	– 	– 	1 325 	1 125 	78 	6 363 	(569) 	5 794
Acquisition costs 	(40) 	(1 540) 	(1 056) 	(599) 	(61) 	– 	(942) 	(1 719) 	174 	(5 783) 	750 	(5 033)
Expected credit losses 	– 	– 	– 	– 	– 	(271) 	– 	– 	– 	(271) 	– 	(271)
Marketing and administration expenses
– depreciation and amortisation 	(118) 	(7) 	(11) 	(70) 	(13) 	(246) 	(447) 	(57) 	(669) 	(1 638) 	(210) 	(1 848)
– derecognition of intangible assets and property and equipment 	(26) 	– 	– 	(6) 	– 	– 	– 	(18) 	(50) 	– 	(50)
– impairment of intangible assets and property and equipment 	(15) 	– 	– 	– 	(1) 	– 	(5) 	– 	(40) 	(61) 	– 	(61)
– other expenses 	(5 058) 	(2 027) 	(1 031) 	(937) 	(2 177) 	(1 673) 	(3 297) 	(1 831) 	(2 598) 	(20 629) 	(91) 	(20 720)
Recovery of expenses from reinsurers 	– 	– 	– 	– 	– 	– 	912 	1 861 	– 	2 773 	– 	2 773
Net transfer to/from assets and liabilities under insurance contracts
– change in assets arising from insurance contracts 	– 	3 433 	– 	– 	– 	– 	– 	(6 143) 	76 	(2 634) 	3 179 	545
– change in assets arising from reinsurance contracts 	– 	33 	– 	– 	– 	13 	10 	– 	56 	– 	56
– change in liabilities arising from insurance contracts 	– 	(206) 	(11 054) 	(47) 	– 	– 	(155) 	(17) 	(6 436) 	(17 915) 	(26) 	(17 941)
– change in liabilities arising from reinsurance contracts 	– 	(1 115) 	– 	– 	– 	– 	– 	6 049 	– 	4 934 	(3 179) 	1 755
Fair value adjustment to liabilities under investment contracts 	– 	(2) 	(623) 	– 	– 	– 	– 	– 	(255) 	(880) 	(2 754) 	(3 634)
Share of net profits from equity-accounted investments 	– 	– 	– 	13 	– 	– 	(2) 	– 	512 	523 	– 	523
Impairment of equity-accounted investment 	– 	– 	– 	– 	– 	– 	– 	– 	(149) 	(149) 	– 	(149)
Normalised profit/(loss) from operations 	3 423 	1 341 	1 084 	250 	43 	(1 094) 	953 	644 	(150) 	6 494 	(1 820) 	4 674
Economic assumption adjustments net of discretionary margins and interest rate derivative 	– 	(411) 	– 	– 	– 	– 	– 	(108) 	– 	(519) 	1 309 	790
Economic assumption adjustments net of discretionary margins 	– 	(411) 	– 	– 	– 	– 	– 	1 201 	– 	790 	– 	790
Fair value losses on VitalityLife interest rate derivative 	– 	– 	– 	– 	– 	– 	– 	(1 309) 	– 	(1 309) 	1 309 	–
Investment income earned on shareholder investments and cash 	39 	14 	40 	– 	39 	– 	– 	10 	823 	965 	(685) 	280
Net fair value gains/(losses) on financial assets at fair value through profit or loss 	– 	138 	(28) 	– 	– 	– 	– 	139 	(471) 	(222) 	222 	–
Restructuring costs 	– 	– 	– 	– 	– 	– 	– 	(33) 	– 	(33) 	33 	–
Gain on dilution of equity-accounted investments 	– 	– 	– 	537 	– 	– 	– 	– 	17 	554 	– 	554
Expenses related to Prudential Book transfer 	– 	– 	– 	– 	– 	– 	– 	(187) 	– 	(187) 	187 	–
Transaction costs related to VitalityLife interest rate derivatives 	– 	– 	– 	– 	– 	– 	– 	(4) 	– 	(4) 	4 	–
Covid-19 vaccination programme 	– 	– 	– 	– 	– 	– 	– 	– 	(42) 	(42) 	42 	–
Amortisation of intangibles from business combinations 	– 	– 	– 	– 	– 	– 	– 	– 	(66) 	(66) 	– 	(66)
Market rentals related to Head Office building adjusted for finance costs and depreciation 	– 	– 	– 	– 	– 	– 	– 	– 	(228) 	(228) 	228 	–
Finance costs 	(1) 	(26) 	– 	– 	– 	– 	(7) 	(65) 	(1 192) 	(1 291) 	(357) 	(1 648)
Intercompany finance costs 	(268) 	– 	– 	– 	– 	– 	(6) 	(236) 	(315) 	(825) 	825 	–
Foreign exchange (losses)/gains 	(6) 	3 	(25) 	– 	– 	– 	– 	– 	(361) 	(389) 	– 	(389)
Profit before tax 	3 187 	1 059 	1 071 	787 	82 	(1 094) 	940 	160 	(1 985) 	4 207 	(12) 	4 915
Income tax expense 	(894) 	(364) 	(331) 	(207) 	(24) 	334 	(149) 	363 	285 	(987) 	12 	(975)
Profit for the year 	2 293 	695 	740 	580 	58 	(760) 	791 	523 	(1 700) 	3 220 	– 	3 220
1 The inter-segment funding of R714 million reflects a notional allocation of interest earned on the negative reserve backing policyholders’ funds of
guaranteed investment products and hence is transferred to Discovery Invest.
2 This segment relates to SA Insure – Personal lines.
3 The banking fee and commission consists of R305 million of revenue which passes over time, while the interchange revenue of R93.1 million is
recognised at a point in time.
33 Discovery Annual Financial Statements 2021

-- 34 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
1. 	SEGMENT INFORMATION continued
R million
SA
Health
SA
Life
SA
Invest
SA
Insure 2
SA
Vitality
SA
Bank
UK
Health
UK
Life
All other
segments
Segment
total
IFRS reporting
adjustments
IFRS
total
30 June 2020
Income statement
Insurance premium revenue 	252 	12 984 	15 602 	3 544 	– 	– 	9 100 	5 705 	3 330 	50 517 	(742) 	49 775
Reinsurance premiums 	(1) 	(2 564) 	– 	(66) 	– 	– 	(1 589) 	(2 789) 	(41) 	(7 050) 	742 	(6 308)
Net insurance premium revenue 	251 	10 420 	15 602 	3 478 	– 	– 	7 511 	2 916 	3 289 	43 467 	– 	43 467
Fee income from administration businesses 	7 238 	– 	2 246 	12 	– 	137 	30 	– 	1 687 	11 350 	(13) 	11 337
Net banking fee and commission income 	– 	– 	– 	– 	– 	150 	– 	– 	– 	150 	– 	150
Banking fee and commission income3 	– 	– 	– 	– 	– 	182 	– 	– 	– 	182 	– 	182
Banking fee and commission expense 	– 	– 	– 	– 	– 	(32) 	– 	– 	– 	(32) 	– 	(32)
Vitality income 	– 	– 	– 	– 	2 401 	121 	452 	212 	689 	3 875 	– 	3 875
Other income 	883 	39 	– 	– 	– 	120 	69 	– 	18 	1 129 	(29) 	1 100
Investment income earned on assets backing policyholder liabilities 	– 	13 	– 	119 	– 	1 	9 	37 	1 	180 	(180) 	–
Net bank interest and similar income 	– 	– 	– 	– 	– 	63 	– 	– 	– 	63 	8 	71
Bank interest and similar income using the effective interest rate 	– 	– 	– 	– 	– 	162 	– 	– 	– 	162 	– 	162
Bank interest and similar expense using the effective interest rate 	– 	– 	– 	– 	– 	(99) 	– 	– 	– 	(99) 	8 	(91)
Finance charge on negative reserve funding 	– 	– 	– 	– 	– 	– 	– 	(838) 	– 	(838) 	838 	–
Inter-segment funding1 	– 	(762) 	762 	– 	– 	– 	– 	– 	– 	– 	– 	–
Net fair value (losses)/gains on financial assets at fair value through profit or loss 	(20) 	867 	834 	32 	(2) 	92 	29 	768 	59 	2 659 	1 434 	4 093
Net income 	8 352 	10 577 	19 444 	3 641 	2 399 	684 	8 100 	3 095 	5 743 	62 035 	2 058 	64 093
Net claims and policyholders’ benefits 	(100) 	(6 079) 	(10 542) 	(1 915) 	– 	– 	(3 623) 	(798) 	(189) 	(23 246) 	– 	(23 246)
Claims and policyholders’ benefits 	(100) 	(7 926) 	(10 542) 	(1 939) 	– 	– 	(4 796) 	(1 964) 	(229) 	(27 496) 	640 	(26 856)
Insurance claims recovered from reinsurers 	– 	1 847 	– 	24 	– 	– 	1 173 	1 166 	40 	4 250 	(640) 	3 610
Acquisition costs 	(30) 	(1 566) 	(1 080) 	(479) 	(66) 	– 	(797) 	(1 814) 	123 	(5 709) 	(838) 	(6 547)
Expected credit losses 	– 	– 	– 	– 	– 	(181) 	– 	– 	– 	(181) 	– 	(181)
Marketing and administration expenses
– depreciation and amortisation 	(176) 	(7) 	(9) 	(84) 	(15) 	(236) 	(359) 	(46) 	(612) 	(1 544) 	(210) 	(1 754)
– derecognition of intangible assets and property and equipment 	(29) 	– 	– 	(74) 	(9) 	– 	– 	– 	(84) 	(196) 	– 	(196)
– impairment of intangible assets 	– 	– 	– 	– 	– 	– 	– 	– 	(63) 	(63) 	– 	(63)
– other expenses 	(4 844) 	(1 976) 	(984) 	(824) 	(2 302) 	(1 438) 	(3 297) 	(2 063) 	(2 625) 	(20 353) 	260 	(20 093)
Recovery of expenses from reinsurers 	– 	– 	– 	– 	– 	– 	826 	2 050 	– 	2 876 	– 	2 876
Net transfer to/from assets and liabilities under insurance contracts
– change in assets arising from insurance contracts 	– 	1 557 	– 	– 	– 	– 	– 	(2 788) 	29 	(1 202) 	3 240 	2 038
– change in assets arising from reinsurance contracts 	– 	27 	– 	7 	– 	– 	8 	11 	– 	53 	– 	53
– change in liabilities arising from insurance contracts 	– 	(238) 	(5 809) 	(39) 	– 	– 	(28) 	(18) 	(3 110) 	(9 242) 	(176) 	(9 418)
– change in liabilities arising from reinsurance contracts 	– 	678 	– 	– 	– 	– 	– 	2 099 	– 	2 777 	(3 239) 	(462)
Fair value adjustment to liabilities under investment contracts 	– 	(2) 	(190) 	– 	– 	– 	– 	– 	4 	(188) 	37 	(151)
Share of net profits from equity-accounted investments 	17 	– 	– 	13 	– 	– 	– 	– 	222 	252 	– 	252
Normalised profit/(loss) from operations 	3 190 	2 971 	830 	246 	7 	(1 171) 	830 	(272) 	(562) 	6 069 	1 132 	7 201
Investment income earned on shareholder investments and cash 	65 	21 	45 	10 	27 	– 	1 	12 	746 	927 	(548) 	379
Economic assumption adjustments net of discretionary margins and interest rate derivative 	– 	(3 635) 	– 	– 	– 	– 	– 	(1 195) 	– 	(4 830) 	(878) 	(5 708)
Economic assumption adjustments net of discretionary margins 	– 	(3 635) 	– 	– 	– 	– 	– 	(2 073) 	– 	(5 708) 	– 	(5 708)
Fair value gains on VitalityLife interest rate derivative 	– 	– 	– 	– 	– 	– 	– 	878 	– 	878 	(878) 	–
Net fair value gains/(losses) on financial assets at fair value through profit or loss 	– 	128 	4 	– 	– 	– 	– 	(120) 	263 	275 	(275) 	–
Restructuring costs 	– 	– 	– 	– 	– 	– 	– 	(100) 	– 	(100) 	100 	–
Gain on dilution of equity-accounted investments 	– 	– 	– 	3 	– 	– 	– 	– 	– 	3 	– 	3
Impairment of goodwill 	– 	– 	– 	– 	– 	– 	– 	– 	(9) 	(9) 	– 	(9)
Initial expenses related to Prudential Book transfer 	– 	– 	– 	– 	– 	– 	– 	(71) 	– 	(71) 	71 	–
Transaction costs related to VitalityLife interest rate derivatives 	– 	– 	– 	– 	– 	– 	– 	(45) 	– 	(45) 	45 	–
Amortisation of intangibles from business combinations 	– 	– 	– 	– 	– 	– 	– 	– 	(76) 	(76) 	– 	(76)
Market rentals related to Head Office building adjusted for finance costs and depreciation 	– 	– 	– 	– 	– 	– 	– 	– 	(259) 	(259) 	259 	–
Finance costs 	(11) 	– 	– 	– 	– 	– 	(7) 	(257) 	(1 389) 	(1 939) 	371 	(1 568)
Intercompany finance costs 	(275) 	– 	– 	– 	– 	– 	– 	(236) 	(209) 	(720) 	720 	–
Foreign exchange gains 	15 	– 	36 	– 	– 	– 	– 	– 	527 	578 	– 	578
Profit before tax 	2 984 	(515) 	915 	259 	34 	(1 171) 	824 	(2 048) 	(759) 	523 	277 	800
Income tax expense 	(826) 	147 	(256) 	(64) 	(10) 	270 	(129) 	239 	282 	(347) 	(277) 	(624)
Profit for the year 	2 158 	(368) 	659 	195 	24 	(901) 	695 	(1 809) 	(477) 	176 	– 	176
1 The inter-segment funding of R762 million reflects a notional allocation of interest earned on the negative reserve backing policyholders’ funds of
guaranteed investment products and hence is transferred to Discovery Invest.
2 This segment relates to SA Insure - Personal lines.
3 The banking fee and commission consists of R88.6 million of revenue which passes over time, while the interchange revenue of R93.1 million is
recognised at a point in time.
34 Discovery Annual Financial Statements 2021

-- 35 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK
Discovery ’s accounting policy to recognise and measure insurance contracts can be viewed in Annexure A, accounting policy 13.
Discovery issues both short-term and long-term contracts that transfer significant insurance risk. Such contracts may also
transfer financial risk. An insurance contract is a contract in which Discovery as issuer and/or insurer accepts significant insurance
risk from the policyholder by agreeing to compensate the policyholder if a specified uncertain future event (the insured event)
adversely affects the policyholder. A significant insurance risk is the possibility of having to pay benefits, on the occurrence of an
insured event, that are significantly more than the benefits payable if the insured event did not occur. There is uncertainty around
the timing and/or the value of the resulting claim.
A large portfolio of independent but similar insurance contracts, allow for the use of probability theory to predict the number and
value of claims over a defined period. Insurance risk, when considering a large portfolio of insurance contracts, is thus the
probability that the actual number of claims over a defined period is different to those expected. This could in turn result in the
value of insurance liabilities being over or underestimated.
Experience shows that the larger the portfolio of similar insurance contracts, the smaller the relative variability of the expected
outcome will be. Discovery reduces claims variability by underwriting policies and by using reinsurance to protect against single
large claims or catastrophe reinsurance to mitigate concentration risks.
Discovery classifies its insurance contracts into five main categories, depending on the duration of the risk and the type of risk
insured. These are:
Contracts which are long term in nature
– Individual life insurance: These contracts insure against a comprehensive spectrum of risks, including life cover, severe illness,
disability and income continuation cover.
– Investment products with insurance risk: These contracts attract insurance risk arising from additional benefits offered which
mostly insure against life risks.
Contracts which are short term in nature
– Health insurance: These contracts insure policyholders against healthcare-related claims.
– Short-term insurance: These monthly contracts insure policyholders against a comprehensive spectrum of short-term risks
including, but not limited to, motor vehicle, household, business, property and liability cover.
– Group life insurance: These contracts insure against a comprehensive spectrum of protection benefits on a group basis. Life
cover, severe illness, disability and income continuation benefits are offered.
Annexure F includes a detailed description of all products that Discovery offers and whether the contract transfers insurance risk,
financial risk or both. The annexure also summarises the number of policies held and the annual premium income from
these products.
Refer to note 1 Segmental information for premium revenue per segment.
Discovery manages its insurance risk in terms of its risk management framework and holds regulatory and economic capital for
protection against adverse experience. The following summarises the insurance risk associated with the various contracts offered
by Discovery, and how Discovery manages these risks.
Insurance risk 	Description 	How Discovery manages the risk
Risks significant to all insurance business lines
Lapse and surrender
risk
Policyholders have the option to discontinue or
reduce contributions at any time.
Accordingly, there is a risk of financial loss
due to the withdrawal rate, lapses or premium
reductions (with associated reduced cover)
being higher than expected. The risk is highest
during the early duration of the policy since
the 	acquisition 	costs 	and 	commission
incurred at the inception of the policy would
not yet have been recouped.
Lapse risk is managed as follows:
Product design
Products are designed to be sustainable in the long
term. New product offerings are made available
to existing policyholders as far as possible to
prevent lapse and re-entry risk.
Integration between different product offerings
across Discovery enhances the value proposition
of the overall package of products from Discovery.
35 Discovery Annual Financial Statements 2021

-- 36 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
Insurance risk 	Description 	How Discovery manages the risk
Lapse and surrender
risk continued
Contracts that are long term in nature
For individual life insurance products there is a
risk:
– of reduced profits arising from lower than
expected withdrawals at later durations of
certain policies in cases where the reserves
have turned positive. This is since withdrawals
on such policies allow the reserves to be
released as profits in the absence of surrender
values being offered; and
– that withdrawals are selective from a claims
experience point of view. For example, healthy
lives may find it easier to obtain cover
elsewhere compared to less healthy lives.
Future earnings on individual life plans are
dependent on the number of policies remaining
in future years and thus future earnings are
dependent on the lapse rate. The future
expected earnings vary by the premium funding
method chosen by the policyholder. In general,
the higher the increases, the higher the
withdrawal risk to future earnings.
For investment products with insurance risk,
there is a risk:
– that the surrender value may exceed the policy
value, net of expenses, at early durations; and
– that withdrawals are higher than expected.
Future earnings arising from Invest plans
are dependent on the value of assets under
management and thus future earnings are
dependent on the withdrawal and surrender
rate.
Contracts that are short term in nature
For Discovery Insure there is a risk of reduced
profits arising from higher than expected
withdrawals at early durations of policies,
resulting in acquisition costs not being recovered.
For example, Discovery provides unique rewards
and benefits as well as integration to members
which has proven to be a credible risk differentiator.
Premium discounts or cover increases are
available to policyholders who actively engage
in a healthier lifestyle and utilise the Vitality
benefits. Better terms are thus offered to healthy
lives compared to less healthy lives.
No surrender benefit is offered on risk benefits
and thus the loss on withdrawal is reduced.
Commission claw back
Discovery 	predominantly 	distributes 	via
independent brokers, intermediaries and tied
agents.
Commissions are clawed back from intermediaries
where a policy lapses within a specified timeframe
since inception. The amount of commission
clawback depends on the duration of the policy
in months and gradually reduces from 100% to
0% and is over a specified period depending on
product sold.
Experience monitoring
Lapse experience is monitored on a monthly basis
and data is analysed to establish possible trends
for which management action can be taken.
Where there is insufficient historic data to provide
credible results, for example within VitalityLife
Whole of Life, reliance is placed on reinsurers’
advice, industry experience as well as experience
from Discovery Life.
Proactive conservation
Targeted conservation campaigns are run pro-
actively. For example, financial advisors are
notified of clients that do not have certain
features on their policies that are correlated
with good persistency. Financial advisors are
thus encouraged to add such features.
36 Discovery Annual Financial Statements 2021

-- 37 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
Insurance risk 	Description 	How Discovery manages the risk
Modelling and data risk 	Actuarial liabilities are calculated using complex
discounted cash flow models. There is a risk that
the models do not accurately project the policy
cash flows in the future.
The models rely on data from the administration
system and there is thus a further risk that the
data does not accurately reflect the policies
being valued.
Contracts that are short term have simplified
models reducing modelling risk.
The risk is controlled using specialist actuarial
software that is widely used and accepted in the
life insurance industry throughout the world.
This is tailored for Discovery.
The original actuarial models were tested and
verified using an independent but identical
parallel model. Any changes made are externally
and independently reviewed. Parallel models
are developed to test any modelling changes.
The data for the model is extracted from modern
administration 	systems 	and 	subjected 	to
detailed 	checks 	together 	with 	high-level
reasonability checks. Discovery does not have
any legacy systems that could impact on the data
quality. Data is checked at each valuation date.
Capital adequacy
requirements and
protection against
adverse experiences
There is a risk that future premiums, investment
returns and estimates used to calculate liabilities
are insufficient to provide for variations in actual
future experience. Insurance liabilities are
calculated using best estimates plus the addition
of various margins to avoid premature recognition
of profits and to provide for a buffer against
future adverse experience. In addition, Discovery
maintains shareholder capital to meet substantial
deviations in experience beyond those provided
for in the liability calculations.
For discussion on how Discovery manages its
capital adequacy requirements, refer to note 2.1.
Liquidity risk 	Liquidity risk is the risk that an entity will
encounter difficulty in meeting obligations
associated with insurance liabilities due to
insufficient cash being available to meet
commitments as and when they become due.
This is exacerbated by timing mismatches
between assets and liabilities.
Discovery maintains sufficient liquid assets to
meet short-term liabilities under base and
stress assumptions. Sufficient liquid assets held
to allow for the initial cash flow strain when
writing new business.
Contracts that are long-term in nature
Currently, Discovery Life’s and VitalityLife’s
expected outflows are mostly long-term and the
main liquidity requirement is to fund acquisition
expenses on new business and unexpected
fluctuations in benefit payments. As discussed
in note 3.4.3, Discovery invests primarily in
liquid financial assets.
For Discovery Life, large sums assured above a
defined retention level are reinsured, providing
stability in claims experienced and further
reducing liquidity risk.
37 Discovery Annual Financial Statements 2021

-- 38 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
Insurance risk 	Description 	How Discovery manages the risk
Liquidity risk continued 	VitalityLife also receives partial financing for
new business strain from financing reinsurance
treaties with reinsurers.
There is a need to meet liquidity requirements
arising from Invest’s Guaranteed Plan book.
Liquidity requirements are managed to ensure
a liquidity buffer is maintained to meet potential
outflows if exit rates are higher than expected.
The liquidity risk on the existing portfolio is thus
relatively small.
For discussion on managing liquidity risk, refer
to note 2.2.
Contracts that are short-term in nature
VitalityHealth mostly has expected outflows
which are short-term in nature as the vast
majority of claims are expected to be settled
within 12 months of reporting. The existing
book is mature and is cash generative which
covers liquidity required for the cash flow strain
of writing new business.
Discovery Insure holds the majority of working
and solvency capital in cash or near cash
instruments to minimise liquidity risk. Large
sums assured above a defined retention level
are reinsured, providing stability in claims
experience and further reducing the liquidity
risk. Catastrophe reinsurance further reduces
this risk.
Concentration risk 	Claims experience risk
There is a risk that a concentration of risk can
lead to worse than expected experience. The
concentration risk is the highest in group
business, since assured lives live in the same
geographical location and generally work in the
same industry or at the same location.
Discovery has a well-diversified book of business
by source of new business and spread across
brokers and agents.
Furthermore, this risk is mitigated through
catastrophe reinsurance.
For details of diversification refer to note 2.3.
Withdrawal concentration risk
There is a financial risk of the withdrawal of a
block of policies written by a single independent
intermediary.
Operational and
implementation risk
Operational risk is defined as the risk of loss
arising from inadequate or failed internal
processes, people and systems or from external
events. Discovery offers a wide product range,
which grows over time due to further product
enhancements and development.
In order to mitigate operational risk, Discovery
maintains and follows a set of documented
processes and procedures which are reviewed
internally and externally to be in line with
industry 	best 	practice. 	Testing 	protocols
implemented prior to launching new systems/
products 	or 	businesses. 	Embedded 	in
Discovery’s 	processes 	is 	the 	concept 	of
segregation of duties which ensures that there
are multiple checks on outputs by different
areas within the business and protects against
operational and implementation risk. Discovery
does not have any legacy systems and processes
to deal with, thereby reducing operational risk.
2. 	MANAGEMENT OF INSURANCE RISK continued
38 Discovery Annual Financial Statements 2021

-- 39 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
Insurance risk 	Description 	How Discovery manages the risk
Policy wording/
legal risk
There is a risk that Discovery could be financially
exposed 	to 	obligations 	that 	differ 	from
expectations and are not adequately provided
for. The risk could also arise from legal
proceedings.
The risk is managed when new products are
developed and all policy wording is reviewed by
legal advisors and external advice is obtained
where necessary to ensure that terms and
conditions are clearly defined and unambiguous.
Regulatory risk 	Discovery operates in a highly regulated
environment which is currently being scrutinised
and questioned by both consumers and
regulators. This has resulted in the constant review
of the in-force regulations and the interpretation
thereof.
The regulatory risk can thus be defined as the
potential detrimental impact unexpected changes
in regulations, or the interpretation thereof,
may have on Discovery.
Although Discovery endeavours to design
insurance and financial solutions which meet
the requirements of the current regulations in
force, the risk does exist that changes in the
regulations 	or 	the 	interpretation 	of 	the
regulations, over time may result in the current
products not fully complying with the regulations
in force in future.
This risk is managed through constantly seeking
legal advice on new product developments.
Further, all insurance products issued by
Discovery have to be signed off, including sign-
off from a market conduct perspective.
Depending on the business line, these are
signed off either by the Head of the Actuarial
Function or an Actuarial Committee.
Discovery is a member of industry-wide bodies
that engage in discussions with policymakers
and regulators.
Discovery’s compliance department enhances
regulatory compliance through audits and by
monitoring developments in the regulatory
environment.
Tax risk 	Tax risk is the risk that the actual future tax liability
is different to what is currently expected. This
could be as a result of an incorrect interpretation
or application of tax legislation or as a result of
changes to tax legislation.
External tax advice is obtained as required to
ensure that products are structured in a tax
efficient way.
VitalityLife specific
Tax relief on expenses does not apply to
protection business sold from January 2013
onwards.
Expense risk 	Expense risk is the risk of actual expenses being
higher than expected. Expenses could exceed
expectations due to an increase in expense
inflation or due to a reduction in the number of
in-force policies. A reduction in the assets under
management could be an expense risk due to
the number of fixed costs.
Expenses are monitored on a monthly basis
against budgeted expenses. Any deviation from
the budget is investigated, reported and where
necessary, remedial action is taken.
2. 	MANAGEMENT OF INSURANCE RISK continued
39 Discovery Annual Financial Statements 2021

-- 40 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
Insurance risk 	Description 	How Discovery manages the risk
Reputational risk 	Reputational risk is the risk of negative market
reaction towards Discovery. Discovery may thus
not be able to apply management policies to
reduce risk.
Reputational risk is carefully controlled. Decisions
to repudiate claims are reviewed by a review
committee comprising of a senior underwriter
and claims assessor, representatives of the legal
department and the medical team, as well as a
compliance officer.
Marketing material and policy wording are
reviewed and designed to be clear and
unambiguous to avoid creating unreasonable
policyholder expectations.
All products are approved prior to launch, by
either the Head of the Actuarial Function or
Actuarial Committee, depending on the business
line. Sign-off is also done prior to launch from a
market conduct perspective.
For investment products with insurance risk, the
risk on investment returns is mitigated through
the use of reputable experienced fund managers
and unique, innovative products covering specific
risks.
Discovery Life offers policies that integrate with
the product offerings within the Discovery
Group. The reputational risk to Discovery Life is
thus extended to the reputational risk of the
entire 	Discovery 	Group. 	Discovery 	Life
management reviews all product offerings to
minimise the reputational risk.
Reputational risk may also arise on investment
products with insurance risk, if these products
experience worse investment returns than
competitors. This may lead to lower future new
business and higher surrenders.
For VitalityHealth, reputational risk arises from
exclusions of treatments which are provided by
competitors.
Risks significant to long-term insurance
Mismatching and
market risk
Mismatching is the risk that insurance-related cash
outflows (e.g. benefit payments, administration
expenses) do not match expected future cash
inflows (predominately future premiums).
Mismatching risk can also arise when movements
in assets and liabilities are out of line given changes
in market risk, i.e. equity price risk, interest rate risk
or currency risk.
The value of assets and liabilities arising from
insurance contracts are subject to interest rate
risk, thus a risk that a change in the discount
rate could cause a change in the value of the
assets and liabilities arising from insurance
contracts.
For assets arising from contracts, Discovery
covers the insurance related outflows by expected
future cash inflows (predominately future
premiums). This is supported by positive future
net cash flows arising from insurance contracts.
For liabilities arising from insurance contracts,
the insurance related cash outflows are matched
with a combination of a release of policyholder
assets (net of retained fees), investment return
on these assets and cash flows.
For further discussion on how Discovery
manages this risk, refer to note 2.4 more
specifically:
– For mismatching risk, refer note 2.4.1 and
2.4.2;
– For interest rate risk, refer note 2.4.3; and
– For currency risk, refer note 2.4.4
2. 	MANAGEMENT OF INSURANCE RISK continued
40 Discovery Annual Financial Statements 2021

-- 41 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
Insurance risk 	Description 	How Discovery manages the risk
Underwriting
experience risk –
Individual life plans and
investment products
with insurance risk
For individual life plans, there is a risk that actual
mortality and morbidity experience is higher
than expected. This could arise as a result of the
number of claims or the value of claims being
higher than expected. In addition, there is a risk
that the emergence of a new disease or
epidemic can increase the number of claims.
On guaranteed annuities there is a risk that
mortality experience is lower than expected
and thus income payments continue for longer
than expected. Discovery Life does not offer
any deferred annuities where the annuity rate
at a future point in time is guaranteed for new
entrants.
Investment products with insurance risk are not
directly impacted by mortality and morbidity
risks. The Annuity Integrator’s Ill-health booster
boosts retirement income on severe illness. The
Annuity Integrator’s Longevity booster boosts
retirement income every 10 years. The Life
Booster increases the investment fund value by
between 5% and 15% on death, depending on
Vitality status. The costs of the benefits were
allowed for in the product design and pricing of
the benefits.
The risks are managed through various
mechanisms:
Product design and pricing
Products are carefully designed to minimise
adverse selection. Rating factors are applied to
standard 	premium 	rates 	to 	differentiate
between different levels of risk. For example,
premiums 	are 	differentiated 	by 	income,
education level, smoker status, gender, medical
history and age.
– From January 2013 onwards, no
differentiation of premiums or benefits on
the basis of gender is allowed in the UK.
– Discovery Life has the unique ability to take
additional rating factors into account for
example the current medical scheme claims
and lifestyle factors.
All new premium rates are reviewed and
approved by either the Head of Actuarial Function
or Actuarial Committee. Product integration
between the different product offerings in
Discovery helps to attract healthier lives than
average in the market, leading to positive
selection. The product integration incentivises
engagement in the Vitality programme, which
has a positive impact on risk experience.
Selection risk is the risk that worse risks than
expected are attracted and these risks are then
charged inadequate premiums. Selection could
also lead to higher than expected mortality and
morbidity experience on individual life plans or
lower mortality on guaranteed annuity policies.
For certain of the product options offered under
the individual life plans, Discovery has retained
the option to review premium rates annually
throughout the life of the contract because of
uncertainties underlying the value of the
benefits offered. Only premiums that can be
predicted with confidence are guaranteed.
Where guarantees are offered, Discovery
guarantees that premiums can only be reviewed
every 10 years and increased by a maximum of
25% over and above contractual premium
increases. The guarantee provided to the
policyholder will, however, be strengthened
based on the policyholder’s actual annual
historic Vitality status.
Discovery Life predominantly operates in the
high end of the South African insurance market
where the risk of HIV/AIDS is lower than for the
South African market as a whole. The impact of
HIV/AIDS is considered and allowed for during
the product development and pricing.
2. 	MANAGEMENT OF INSURANCE RISK continued
41 Discovery Annual Financial Statements 2021

-- 42 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
Insurance risk 	Description 	How Discovery manages the risk
Underwriting
experience risk –
Individual life plans and
investment products
with insurance risk
continued
Underwriting
Underwriting ensures that only insurable risks
are accepted and that premiums reflect the
unique circumstances of each risk.
Financial underwriting is applied to ensure that
the policyholder can justify the amount of cover
applied for. Premium loadings and exclusions
are applied where high risks are identified.
For Integrated policies, Discovery Life can
dynamically adjust certain premiums using the
information from the health claims experience
of a policyholder who is also a member of the
Discovery Health Medical Scheme and Vitality.
This provides Discovery Life with an advantageous
position in the market.
Monthly internal quality assurance audits are
performed on underwriting to minimise the risk
of incorrect underwriting decisions.
Reinsurance
Reinsurance protects against volatility in claims
experience and against an accumulation of risk.
Reinsurance is further utilised on a facultative
basis if uncertainty exists over the terms that
should be offered to a particular risk.
In addition, reinsurers provide specialist advice
when designing new products.
Discovery Life utilises surplus and facultative
reinsurance to reinsure amounts in excess of
defined retention levels. Discovery Life is thus
protected against large individual claims.
In addition, catastrophe reinsurance reduces
the risk of an accumulation of risk due to a
single event. Both individual life and group
business 	are 	covered 	by 	catastrophe
reinsurance which covers man-made or natural
catastrophe events.
For VitalityLife, the life, serious illness, disability
and income protection benefits are reinsured
with a maximum retention of GBP 150 000. The
unemployment benefit offered as part of the
VitalityLife product is fully reinsured.
Experience monitoring
Experience investigations are conducted and
corrective action is taken where adverse
experience is noted. Experience monitoring is
done on at least a quarterly basis, and in some
business lines monthly.
Where there is insufficient historic data to provide
credible results, such as VitalityLife, reliance is
placed on reinsurers’ advice, industry experience
as well as experience from Discovery Life.
2. 	MANAGEMENT OF INSURANCE RISK continued
42 Discovery Annual Financial Statements 2021

-- 43 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
Insurance risk 	Description 	How Discovery manages the risk
Risks significant to short-term insurance
Underwriting
experience risk
The risk is that claims experience turns out to be
worse than anticipated in the pricing of the
product and that claims reserves are insufficient
to meet insurance liabilities as they fall due.
The principal risk is that the frequency and/or
severity of claims are greater than expected.
Insurance events are, by their nature, random
and the actual number and size of events during
any one year may vary from those estimated
and experienced in prior periods.
Frequency of claims can vary depending on, for
instance, the levels of engagement with the
Vitality programme, and severity of claims can
be influenced by new treatments or changes in
medical inflation. In addition to renewal pricing
changes, 	standard 	terms 	and 	conditions
applicable to the company’s products mitigate
the risk of late reporting of claims.
Group Life
Group Life business is reviewed on a contract by
contract basis, with the review period never
exceeding two years. AIDS risk is specifically
allowed for in the pricing of individual groups.
Group business is underwritten on an employer
by employer basis and additional allowance is
made for the impact of industry class, income
and geographic location on expected claims
experience. The free cover limit is the sum
assured that will be given automatically to a
specific life without further specific underwriting.
The free cover limits are set separately for each
scheme depending on the size and cover chosen
by the specific scheme.
VitalityHealth
New business is written in accordance with
approved pricing assumptions. Underwriting
criteria is defined and aligned to the approved
pricing assumptions.
VitalityHealth’s overall premium levels are
determined by its pricing and lapse experience,
as well as the level of new business written.
VitalityHealth can manage the risk of new
business 	policies 	through 	the 	ability 	to
underwrite policies at inception or at the point
of claim. Aside from large corporate clients, all
other lives covered were underwritten through
either full medical underwriting, continuation of
previous exclusions (if the policy is moving from
another UK health insurer), or moratorium
conditions which limit claims for a specified
period relating to previous conditions.
VitalityHealth is able to manage the insurance
risk in existing business premiums through the
annual repricing of policies at renewal on a risk-
related basis; this is a key differentiator as to
why the UK market is less susceptible to volatility
from insurance risk. Whilst policyholders can
choose to cancel their contract mid-term
between renewals, this is not often experienced
in either the SME or corporate products.
Individual contracts can and do cancel between
renewals however retaining these policies is a
key activity for the business. VitalityHealth is
only obligated to continue to pay for any
authorised treatment whilst premiums are
being received from the policyholder.
2. 	MANAGEMENT OF INSURANCE RISK continued
43 Discovery Annual Financial Statements 2021

-- 44 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
Insurance risk 	Description 	How Discovery manages the risk
Underwriting
experience risk
continued
Discovery Insure
Discovery Insure aims to manage risk through
diversifying the pool of insured risks by
establishing a balanced portfolio of insurance
risks over a wide geographical area. Short-term
insurance risks are priced on an individual basis,
therefore a minimal cross subsidy exists
between risks.
Premiums 	are 	calculated 	using 	statistical
regression techniques. Insurance risk factors
identified would typically include past insurance
history, type and value of asset covered,
measures taken to protect the asset, primary
use of covered item and various other pertinent
factors.
Discovery Insure’s quotation and administration
system calculates risk on an individual basis
based on information captured by brokers and
agents for each risk. Individual risks are
accepted automatically up to cut-off limits which
vary by risk type. Insurance conditions and
exclusions are also automatically set at an
individual risk level.
Individual risks greater than the limit are
automatically referred and underwritten by the
underwriting department. No risks are accepted
which exceed the upper limits of the reinsurance
contracts without the necessary facultative
cover being arranged.
Discovery Insure uses telematics to manage
risk. The telemetry received in respect of
vehicles in which the devices are installed,
highlights speeding, harsh breaking, harsh
cornering and other risk related incidents. By
informing the driver of how they are driving and
in turn rewarding them for driving well, the risk
of an accident is reduced. The ’deep install’
device is also equipped with a stolen vehicle
recovery 	transponder 	that 	increases 	the
probability of recovering a vehicle should it be
stolen.
Reinsurance – VitalityHealth
VitalityHealth currently utilises reinsurance to
better match the high upfront costs of acquisition
with the profit emergence across the lifetime of
the policies written. VitalityHealth currently has
quota share agreements in place with two
reinsurers with an outstanding balance of
GBP 156 million (R3 079 million) at year end
(2020: GBP 175.8 million (R3 770 million)).
2. 	MANAGEMENT OF INSURANCE RISK continued
44 Discovery Annual Financial Statements 2021

-- 45 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
Insurance risk 	Description 	How Discovery manages the risk
Underwriting
experience risk
continued
Reinsurance – Discovery Insure
Discovery Insure mitigates its insurance risk
through its reinsurance programme which is
structured to protect the company against
material losses to either a single insured risk, or
group of insured risks in the case of a
catastrophe where there would tend to be a
concentration of insured risks
Furthermore, Discovery Insure reinsures a
portion of the risk it underwrites to protect the
profitability and the capital of the company. A
variety of treaties are entered into in order to
limit losses resulting from individual and
collective insurance risks.
Additional facultative reinsurance is purchased
for certain individual risks that are in excess of
the relevant treaty limits. Discovery Insure only
enters into reinsurance arrangements with
reinsurers that have adequate credit ratings.
Experience monitoring
Across both premiums and claims, recent actual
experience 	is 	compared 	against 	financial
forecasts, with any deviations investigated. The
results provide a feedback loop into the overall
pricing approach, enabling Discovery to react
quickly to any changes in behaviour.
2.1 	Capital adequacy requirements and protection against adverse
experience
Refer to the Directors’ report for a breakdown of Statutory Capital Requirement cover ratios. Discovery manages its capital
requirements in line with the statutory requirements of the relevant Prudential Authorities. During the period Discovery met the
Statutory Capital Requirements.
2.1.1 Discovery Life
Discovery Life is required to demonstrate solvency to the Prudential Authority (PA) in South Africa in accordance with the
Insurance Act 18 of 2017. Discovery Life thus needs to maintain sufficient shareholder assets (Own Funds), over and above the
assets required to meet policyholder liabilities (best-estimate liabilities plus a prescribed risk margin), to support a multiple of the
Solvency Capital Requirement (SCR). Discovery Life is required to undertake an internal assessment of its risks and capital needs,
in addition to meeting the minimum capital requirements set by the PA. The SCR is calculated in accordance with the Prudential
Standards as issued by the PA. The SCR calculation is intended to approximate a risk-based capital measure and covers the major
areas of insurance risk. It explicitly covers the following key areas of risk to Discovery Life:
– Lapse and withdrawal risk
– Fluctuations in mortality and morbidity experience including catastrophe risk
– Interest rate risk
– Equity and property risk
– Expense risk
– Operational risk
– Spread and counterparty default risk
– Currency risk
– Concentration risk.
2. 	MANAGEMENT OF INSURANCE RISK continued
45 Discovery Annual Financial Statements 2021

-- 46 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.1 	Capital adequacy requirements and protection against adverse
experience continued
2.1.1 Discovery Life continued
Discovery Life regularly reviews the capital position and also considers various new business scenarios. Typically, a five-year new
business projection horizon is allowed for and the capital position is assessed at each valuation date during the projection to
ensure an acceptable capital cover is maintained.
Discovery Life has calculated its solvency position in accordance with the Insurance Act and related Prudential Standards since
30 June 2013. A consistent level of solvency cover, comfortably in excess of the statutory minimum, was observed at all
valuation dates.
2.1.2 VitalityLife
The Vitality Life business comprises business underwritten directly by VitalityLife (from 1 January 2016) and business underwritten
on behalf of VitalityLife on Prudential Assurance Company’s (PAC’s) life insurance license (up to 31 December 2015).
Through a number of contractual and loan arrangements, Discovery retains 100% of the insurance risk associated with the
VitalityLife policies underwritten on the PAC life insurance license. All policies are administered by VitalityLife, and they are
managed as a single portfolio. The arrangement with the PAC is accounted for in substance under IFRS as an insurance contract
that Discovery issues.
Accordingly, all information for VitalityLife, other than the segment information, is presented as a single portfolio, comprising
both the business underwritten by VitalityLife and underwritten on behalf of VitalityLife on the PAC life insurance license.
The business that was underwritten on PAC life insurance license will, as per contractual agreement with PAC, still be valued
under the Solvency I or old capital requirement rules described below until it is transferred to the VLL license. After this date, this
business would need to be fully Solvency II compliant. The business is written on its own life insurance license within VitalityLife
needs to be fully Solvency II compliant.
VitalityLife obtained its own life insurance license at the end of the calendar year 2015. This significant milestone, together with
the implementation of Solvency II in the UK from 1 January 2016, required a change to the capital requirements of VitalityLife.
SOLVENCY I
The Financial Services Authority (FSA) was replaced by two distinct regulators in 2013 namely the Prudential Regulation Authority
(PRA) and the Finance Conduct Authority (FCA). The PRA is a part of the Bank of England and responsible for the prudential regulation
and supervision of insurers. It sets standards and supervises financial institutions. The FCA regulates the financial services industry
in the UK. Their aim is to protect consumers, ensure the industry remains stable and promote healthy competition between financial
services providers. The Prudential Sourcebook for Insurers (INSPRU) contains standards for capital management.
Capital requirements are calculated based on the concept of two pillars:
– Pillar 1, which covers public solvency information that appears within the regulatory returns on the basis of prescriptive rules.
This includes the statutory valuation of liabilities together with a prescribed measure of additional capital, the Long-Term
Insurance Capital Requirement (LTICR); and
– Pillar 2, the Individual Capital Assessment (ICA), which covers a confidential company-specific assessment of solvency. This
assessment is done on a realistic basis with the aim to protect against risks up to the 99.5 percentile over a one-year period.
The LTICR is a minimum required margin for solvency on the statutory valuation basis and covers the following basic risks:
– Mortality risk;
– Expense risk;
– Market risk; and
– Health risk.
The amount of capital that ultimately needs to be held by a life insurance company in the UK is the larger of the Pillar1 and Pillar2
result. VitalityLife is required to provide capital to the Prudential Assurance Company (PAC) equal to one times the Pillar1 capital
requirement. The cover requirements were observed at all valuation dates.
46 Discovery Annual Financial Statements 2021

-- 47 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.1 	Capital adequacy requirements and protection against adverse
experience continued
2.1.2 VitalityLife continued
SOLVENCY II
Capital requirements under Solvency II are calculated using the regulations and guidance published by European Insurance and
Occupational Pensions Authority (EIOPA) and enforced by the PRA in the UK. A Solvency II balance sheet is calculated which has
several components:
– Best estimate liabilities (BEL): policyholder liabilities are calculated on a best estimate basis (excluding any margins) and
discounted at the latest swap curve published by EIOPA;
– Solvency Capital Requirement (SCR): 1-in-200 year stresses are applied to the BEL to stress the key risks and are combined
correlation matrices;
– Risk Margin (RM): 6% of the SCR run-off projected over time is discounted at the latest swap curve;
– Technical Provisions (TP): the sum of the BEL and the RM; and
– Own Funds: the net assets of the company needed to cover the SCR and other liquidity requirements; a negative TP can be
included in the sum of Own Funds to cover the SCR.
A consistent level of solvency cover was observed at all valuation dates.
2.1.3 VitalityHealth
VitalityHealth maintains shareholder capital to meet substantial deviations in experience and to support business growth.
The objective of the VitalityHealth’s capital management policy is to define the principles and guiding philosophy for capital
management that ensures capital and solvency levels are managed effectively in line with the defined risk appetites. The policy
and objectives are reviewed at least annually. Alongside ensuring the Company complies with capital requirements imposed by
its regulator (the PRA), the guiding principles for the policy are to:
– Foster an environment of regulatory compliance within the Company’s culture, strategy and decision making;
– Continually develop and enhance the Group’s regulatory compliance capability;
– Actively communicate the effectiveness and benefits of compliance management to all stakeholders; and
– To provide reasonable and independent assurance to the Company’s key management, board and regulator.
The Company is required to hold sufficient capital (measured in accordance with PRA valuation rules) to meet the PRA capital
requirements. The capital requirements were met at all valuation dates.
With effect from 1 January 2016 the insurance regulatory regime Solvency II was implemented in the UK. Refer to earlier in the
report for discussion on Solvency II. Under this solvency regime, firms have the opportunity to either follow the standard formula
approach, or apply to the regulators to move away from this. VitalityHealth follows a standard formula, and as such has a
Solvency Capital Requirement in line with that prescribed. Annually, the business publicly discloses a Solvency and Financial
Condition Report (SFCR) alongside private disclosures to the regulators on its Own Risk and Solvency Assessment (ORSA). The
standard formula approach is also annually reviewed to determine its appropriateness for the business and as at 30 June 2021
the standard formula review determined it was not an inappropriate assessment of the risks present in VitalityHealth.
The actual and projected capital position of the Company is monitored on a regular basis through a number of forums and
governance committees including the Board of Directors as well as through VitalityHealth’s ORSA. In the event that sufficient
capital is not projected to be available, actions would be taken to obtain additional capital or to reduce the amount of risk
accepted and therefore reduce the capital requirement through, for example, reinsurance or investment strategy.
47 Discovery Annual Financial Statements 2021

-- 48 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.1 	Capital adequacy requirements and protection against adverse
experience continued
2.1.4 Discovery Insure
Similar to Discovery Life, Discovery Insure is required to demonstrate solvency to the Prudential Authority (PA) in accordance with
the Insurance Act 18 of 2017. Discovery Insure thus needs to maintain sufficient shareholder assets (Own Funds), over and above
the assets required to meet policyholder liabilities (best-estimate liabilities plus a prescribed risk margin), to support a multiple
of the Solvency Capital Requirement (SCR). In addition, Discovery Insure is required to undertake an internal assessment of its
risks and capital needs, in addition to meeting the minimum capital requirements set by the PA. The SCR is calculated in
accordance with the Prudential Standards as issued by the PA. The SCR calculation is intended to approximate a risk-based
capital measure and covers the major areas of short-term insurance risk. It explicitly covers the following key areas of risk to
Discovery Insure:
– Catastrophe risk
– Premium and reserve risk
– Lapse risk
– Interest rate risk
– Equity and property risk
– Expense risk
– Operational risk
– Spread and counterparty default risk
– Currency risk
– Concentration risk.
The internal assessment of risks and capital needs usually considers, amongst others, the following risks:
– Lapse risk not captured in the SCR
– New business volume risk
– Expense risk over and above ALAE risk
Discovery Insure regularly reviews the capital position and considers various new business scenarios. Typically, a five-year new
business projection horizon is allowed for and the capital position is assessed at each financial year during the projection to
ensure an acceptable capital cover is maintained. The solvency cover was observed at all valuation dates.
48 Discovery Annual Financial Statements 2021

-- 49 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.2 	Liquidity risk
2.2.1 Contracts that are long-term in nature
DISCOVERY LIFE AND DISCOVERY INVEST
For Discovery Life and Discovery Invest, the discounted expected embedded value cash flows arising from in-force contracts after
policyholder liabilities have been met, net of tax, as at 30 June were as follows:
Gross of reinsurance
R million 	Total 	Year 1 	Years 2 to 5 	Years 6 to 10 	Years 11 to 20 	Years 21+
2021
Discovery Life 	23 560 	(1 174) 	6 721 	6 584 	6 784 	4 645
Discovery Invest 	8 337 	688 	2 318 	2 673 	2 218 	440
2020
Discovery Life 	20 695 	(532) 	5 572 	6 093 	5 623 	3 939
Discovery Invest 	6 518 	612 	1 718 	2 112 	1 723 	353
Net of reinsurance
R million 	Total 	Year 1 	Years 2 to 5 	Years 6 to 10 	Years 11 to 20 	Years 21+
2021
Discovery Life 	19 441 	(721) 	4 895 	5 079 	5 920 	4 268
2020
Discovery Life 	17 217 	(525) 	4 235 	5 053 	4 858 	3 596
The cash flows in the tables above differ from those disclosed on notes 2.4.1 and 2.4.2 since the cash flows in the tables above
are based on best estimate free cash flows after meeting policyholder liabilities, are discounted at the risk discount rate and are
capped at 40 years as per the Discovery Life and Discovery Invest embedded value methodology. Cash flows arising from
investment management contracts are also included. No allowance has been made for new business and related expenses.
VITALITYLIFE, INCLUDING VITALITYINVEST
VitalityLife maintains sufficient liquid assets to meet short-term liabilities and to allow for the initial cash flow strain when writing
new business. Currently, VitalityLife’s expected liabilities are mostly long-term and the main liquidity requirement is to fund
acquisition expenses on new business. The liquidity risk on the existing portfolio is thus relatively small.
2.2.2 Contracts that are short-term in nature
VITALITYHEALTH
VitalityHealth maintains sufficient liquid assets to meet short-term liabilities and to allow for the initial cash flow strain when
writing new business. Currently, VitalityHealth’s expected liabilities are mostly short-term and the main liquidity requirement is
to fund acquisition expenses on new business, with the existing book mature enough to generate sufficient liquidity to cover this
cash flow strain.
DISCOVERY INSURE
Discovery Insure holds the majority of working and solvency capital in cash or near cash instruments to minimise liquidity risk.
Large sums assured above a defined retention level are reinsured, providing stability in claims experience and further reducing
the liquidity risk. Catastrophe reinsurance further reduces this risk.
49 Discovery Annual Financial Statements 2021

-- 50 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.3 	Concentration risk
2.3.1 Claims experience risk
DISCOVERY LIFE
Discovery Life maintains a well-diversified portfolio of policies. Reinsurance is further used to protect against the concentration
of risk. Catastrophe reinsurance protects against the accumulation of claims from a single event, for example an airplane crash.
The catastrophe reinsurance for Discovery Life covers single event disasters for up to R870 million where the net of reinsurance
impact is greater than R44 million. For its biggest four group schemes, a further layer of catastrophe reinsurance cover of
R3 400 million in excess of R914 million is in place.
Reinsurance removes the exposure to large individual claims. The following graph demonstrates that the distribution of policies
by sum assured is shifted towards lower sum assured due to the reinsurance cover. The profile is largely the same as the prior
period, although a shift towards higher sums assured due to annual benefit increases and inflationary impacts on new business
was observed as expected.
0
40 000
60 000
80 000
100 000
0 – 0.5
Before reinsurance 	After reinsurance
20 000
	Number of Lives
>5.0	4.5 – 5.0	4.0 – 4.5	3.5 – 4.0	3.0 – 3.5	2.5 – 3.0	2.0 – 2.5	1.5 – 2.0	1 – 1.5	0.5 – 1.0
Distribution of Sums Retained: before and after reinsurance (Sum retained – Rm)
VITALITYLIFE
VitalityLife maintains a well-diversified portfolio of policies. Reinsurance removes the exposure to large individual claims. The
following graph demonstrates that the distribution of policies by sum assured is shifted towards lower sum assured due to the
reinsurance cover. The profile is largely the same as the prior period, although a shift towards higher sums assured due to annual
benefit increases and inflationary impacts on new business was observed as expected.
Reinsurance results in a reduction in exposure to
large individual sums-at-risk, leading to this transfer
from large to small case sizes.
0
90 000
120 000
150 000
180 000
0 – 25
Before reinsurance 	After reinsurance
60 000
30 000
Number of Lives
>250	225 – 250	200 – 225	175 – 200	150 – 175	125 – 150	100 – 125	75 –100	50 –75	25 – 50
Distribution of Sums Retained: before and after reinsurance (Sum retained – GBP’000)
50 Discovery Annual Financial Statements 2021

-- 51 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.3 	Concentration risk continued
2.3.1 Claims experience risk continued
VITALITYHEALTH
VitalityHealth has the risk of single large medical expense claims arising abroad, or multiple small travel claims due to a single
event which could cause losses. In order to manage these risks VitalityHealth holds a reinsurance policy specifically on travel
benefits which can help to cover the concentration risks from these events. The threshold for a potential claim on the reinsurance
for either of these reasons is GBP 250 000.
DISCOVERY INSURE
There is a risk that a concentration of risk can lead to a worse than expected claims experience. In order to manage this
concentration of insurance risk, Discovery has entered into a catastrophe excess of loss reinsurance treaty that would limit the
loss of the company to pre-determined levels following the occurrence of a localised catastrophe in this area.
Discovery Insure is exposed to a concentration of insurance risk in the Gauteng province in South Africa where 45.6% (2020: 47.1%)
of the total sum insured is domiciled.
2.3.2 Withdrawal concentration risk
DISCOVERY LIFE AND VITALITYLIFE
There is a financial risk of the withdrawal of a block of policies written by a single independent intermediary. In order to manage
these risks. Discovery diversifies its book of business by source of new business and spread across its brokers and agents.
Brokers and agents
Maximum exposure to single
intermediary % of total premium
income
2021 	2020 	2021 	2020
Long term insurance
– Discovery Life 	7 245 	7 683 	1.4% 	2.1%
– VitalityLife 	29 510 	28 580 	2.9% 	3.1%
Small concentration (0 – 99 policies)
Medium concentration (100 – 999 policies)
Large concentration (1 000+ policies)
20%	28%
52%
API concentation by intermediary – Discovery Life
51 Discovery Annual Financial Statements 2021

-- 52 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.4 	Mismatching and market risk
2.4.1 Assets arising from insurance contracts
Assets under insurance contracts in the Statement of financial position include assets for Discovery Life, VitalityLife and
VitalityInvest. Reconciliation of the assets under insurance contracts disclosed in the cash flows below to the Statement of
financial position (refer to note 5):
R million 	2021 	2020
Assets arising from insurance contracts relating to:
– Discovery Life 	35 014 	31 992
– VitalityLife 	15 371 	16 023
– VItalityInvest 	98 	27
50 483 	48 042
Cash flows are calculated in accordance with the accounting policies. Contractual premium and benefit increases are recognised
in the cash flow projections.
The expected discounted future cash flows utilised in the calculation of assets arising from insurance contracts are disclosed in
the table below. Discounting is performed using:
– the prevailing risk-free SA gilt yield curve for Discovery Life; and
– a modified passive rate for VitalityLife whereby the one-year average of the risk-free gilt yield is used. The assumption is only
changed if the one-year average changes by more than a predetermined range around the set passive rate.
R million 	Total 	Year 1 	Years 2 to 5 	Years 6 to 10 	Years 11 to 20 	Years 21+
2021
Discovery Life 	35 014 	589 	10 102 	9 319 	8 926 	6 078
VitalityLife 	15 371 	3 652 	10 131 	6 745 	5 457 	(10 614)
2020
Discovery Life 	31 992 	1 314 	9 225 	8 576 	7 738 	5 139
VitalityLife 	16 023 	4 346 	12 120 	7 880 	5 755 	(14 078)
52 Discovery Annual Financial Statements 2021

-- 53 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.4 	Mismatching risk continued
2.4.2 Liabilities arising from insurance contracts continued
Refer to page 63 for a breakdown of the assets backing these liabilities. A reconciliation of the liabilities arising from insurance
contracts disclosed in the cash flows below to the Statement of financial position (refer to note 18):
R million 	2021 	2020
Long-term insurance contract liabilities with fixed and guaranteed terms 	21 764 	19 998
Negative insurance liability included in unit-linked insurance contracts 	(5 117) 	(4 894)
Discovery Invest value of liabilities arising from insurance contracts 	16 647 	15 104
The expected discounted future cash flows in the calculation of liabilities arising from insurance contracts are disclosed in the
table below, allowing for compulsory and discretionary margins. Discounting is performed using the prevailing risk free SA gilt
yield curve.
R million 	Total 	Year 1 	Years 2 to 5 	Years 6 to 10 	Years 11 to 20 	Years 21+
2021
Discovery Invest
Long-term insurance
contract liabilities with
fixed and guarantee
terms 	(21 764) 	(4 657) 	(16 040) 	(444) 	(381) 	(242)
Negative insurance
liability included in
unit-linked insurance
contracts 	5 117 	170 	1 380 	1 860 	1 742 	(35)
2020
Discovery Invest
Long-term insurance
contract liabilities with
fixed and guarantee
terms 	(19 998) 	(4 420) 	(15 032) 	(262) 	(166) 	(118)
Negative insurance
liability included in
unit-linked insurance
contracts 	4 894 	262 	1 242 	1 709 	1 595 	86
53 Discovery Annual Financial Statements 2021

-- 54 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.4 	Mismatching risk continued
2.4.3 Market risk – Interest rate risk
DISCOVERY LIFE
For Discovery Life, increased nominal or real interest rates would result in an adverse impact on the present value of future
profits. Cash flows on a material segment of the book is linked to inflation. While this retains cash flows in real terms, this
segment is exposed to real interest rate movements. The balance of the book is exposed to changes in the nominal rates.
VITALITYLIFE
As a long-term insurance provider in the United Kingdom (UK), VitalityLife has significant exposure to long-term interest rate risk,
given the impact on reserves of lower investment rate assumptions related to fixed future premium receipts to meet policy
obligations. Accordingly, lower long-term interest rates and yield assumptions may negatively impact on the valuation of future
policy obligations and result in a valuation loss.
Interest rates in the UK have displayed significant volatility and have generally been on a downward trend in recent years. In the
financial year under review, VitalityLife implemented an interest rate risk mitigation strategy to protect itself against further
declines in interest rates by entering into derivative contracts. This strategy ensures that the VitalityLife business operates well
within its pre-determined risk appetite.
The derivative instruments comprise of:
– Interest rate swap, with a nominal value of GBP 323.5 million (R6 385 million). This interest rate swap derivative swaps
exposure to variable interest rates in return for a fixed interest rate referenced to the 25-year UK SONIA swap rate. The fixed
interest rate is 0.6815%. The interest rate swap derivative is in place for an extended period of time; and
– Swaption, with a nominal value of GBP 380.0 million (R7 500 million) that was acquired in the prior year for GBP 12.3 million
(R264 million) and expires May 2023. The swaption gives Discovery the participation in the benefit should interest rates rise
above 1.1541%.
54 Discovery Annual Financial Statements 2021

-- 55 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.4 	Mismatching risk continued
2.4.3 Market risk – Interest rate risk continued
VITALITYLIFE continued
Due to the nature of the underlying exposures, the hedge accounting requirements of IFRS were not met. Therefore, these derivative
instruments were classified at fair value with changes recognised in profit or loss throughout the term which may result in volatility
in the reported IFRS earnings of VitalityLife. As at 30 June, the following mark-to-market positions were recorded:
GBP/Rand million
June 2021 	June 2020
Line item in financial statements 	GBP 	R 	GBP 	R
Statement of Financial Position
Interest rate swap valuation 	(Financial liabilities)/Financial assets:
Derivative – financial instruments at fair value
through profit or loss
(11.8) 	(233) 	44.3 	950
Swaption valuation 	Financial assets:
Derivative – financial instruments at fair value
through profit or loss
6.8 	135 	0.1 	2
Income Statement
Fair value remeasurement 	Net fair value (losses)/gains on financial assets
at fair value through profit or loss
(56.4) 	(1 170) 	(38.4) 	(758)
Transaction costs 	Marketing and administration expenses 	(0.2) 	(4) 	(2.3) 	(45)
DISCOVERY LIFE AND DISCOVERY INVEST
The outstanding claims and incurred but not reported claims are mostly short-term in nature and have consequently been
matched with cash. Reserves backing Income Continuation Benefits in payment are backed by a combination of cash, money
market, gilts and negative rand reserves of appropriate duration.
The risk arising from the Global Linkage Benefit is fully reinsured and Discovery does not face any net direct market risk.
For Discovery Invest, guaranteed return plan liabilities are backed by a combination of negative rand reserves and bonds of
appropriate duration. As maturity approaches, cash flows from negative reserves are invested in bonds and therefore a
reinvestment risk exists. Furthermore, investment policy fee income is dependent on the underlying value of policyholders’
investments, which may be interest rate sensitive.
2.4.4 Market Risk – Currency risk
All of VitalityLife’s insurance benefits and premiums are Sterling denominated as all business is sold in the UK market. A significant
part of operational expenses are Rand denominated as systems and administration are based in South Africa. This creates a
potential mismatching risk.
The Dollar Life Plan, offered by Discovery Life provides a sum insured in US Dollars. Premiums are paid in Rands but linked to the
Rand/Dollar exchange rate. Certain versions of the Dollar Life Plan provide guarantees on the Rand/Dollar exchange rate for a
specified period, thereby exposing Discovery Life to currency risk.
Other insurance business lines do not have significant currency risk.
55 Discovery Annual Financial Statements 2021

-- 56 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.5 	Sensitivity analysis
The financial impact of the key risks that Discovery is exposed to can be demonstrated by considering the sensitivity of the
financial results to a hypothetical change in the underlying assumptions or prevailing market conditions.
Although the sensitivities demonstrate the impact of a change in assumption, the results generally cannot be extrapolated to
demonstrate the impact on future earnings and earnings forecasts.
For each sensitivity illustrated, all other assumptions have been left unchanged. No allowance has been made for any management
action, for example premium increases, to react to the worse-than-expected experience.
The ranges of sensitivity were chosen for illustration purposes and do not represent the extremes of possible experience. The
sensitivities shown under insurance risks consider a change in the long-term assumption used in the projection model.
The following sensitivities are provided under insurance risk:
❚ 	Lapses: The lapse, surrender and withdrawal rates are increased or decreased across all policies and investment plans;
❚ 	Long-term investment return and inflation: A parallel shift is assumed in the yield curve. The investment return, inflation,
renewal expense inflation and inflation-linked premium increases are adjusted consistently;
❚ 	Renewal expenses: Renewal expense per policy is increased or decreased across all policies and investment plans; and
❚ 	Mortality and morbidity: The mortality rate, disability rate and severe illness rates are increased and decreased across all
policies and investment plans.
2.5.1 Discovery Life
Gross exposure 	Net of reinsurance
Assets under
insurance
contracts
R million
Change
from base
assumption
%
Assets under
insurance
contracts
R million
Change
from base
assumption
%
Base: June 2021 assumptions 	35 014 	31 685
Lapses +10% (e.g. from x% to 1.1x%) 	31 065 	(11.3) 	27 875 	(12.0)
Lapses –10% (e.g. from x% to 0.9x%) 	39 746 	13.5 	36 272 	14.5
Investment return and inflation –1% (e.g. from 5% to 4%) 	35 989 	2.8 	32 583 	2.8
Investment return and inflation +1% (e.g. from 5% to 6%) 	34 032 	(2.8) 	30 769 	(2.9)
Expense assumption +10% 	34 498 	(1.5) 	31 166 	(1.6)
Expense assumption –10% 	35 529 	1.5 	32 203 	1.6
Mortality and morbidity +10% 	28 154 	(19.6) 	26 345 	(16.9)
Mortality and morbidity –10% 	41 939 	19.8 	37 092 	17.1
Real curve –1% and inflation +1% 	37 548 	7.2 	33 966 	7.2
Real curve +1% and inflaton –1% 	32 962 	(5.9) 	29 848 	(5.8)
Base: June 2020 assumptions 	31 992 	28 819
Lapses +10% (e.g. from x% to 1.1x%) 	28 583 	(10.7) 	25 572 	(11.3)
Lapses –10% (e.g. from x% to 0.9x%) 	36 092 	12.8 	32 744 	13.6
Investment return and inflation –1% (e.g. from 5% to 4%) 	33 050 	3.3 	29 801 	3.4
Investment return and inflation +1% (e.g. from 5% to 6%) 	30 857 	(3.5) 	27 762 	(3.7)
Expense assumption +10% 	31 505 	(1.5) 	28 332 	(1.7)
Expense assumption –10% 	32 479 	1.5 	29 306 	1.7
Mortality and morbidity +10% 	25 932 	(18.9) 	24 124 	(16.3)
Mortality and morbidity –10% 	38 244 	19.5 	33 712 	17.0
Real curve –1% and inflation +1% 	33 816 	5.7 	30 399 	5.5
Real curve +1% and inflaton –1% 	30 360 	(5.1) 	27 407 	(4.9)
Liabilities arising from insurance contracts consist of outstanding reported claims, IBNR claims and long-term liabilities relating
to fixed and guaranteed contracts and unit-linked contracts. For outstanding reported claims and IBNR claims any deviation from
the best estimate liabilities would have a direct impact on profit.
The above sensitivities reflect the impact on profit or loss if there are no discretionary margins.
56 Discovery Annual Financial Statements 2021

-- 57 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.5 	Sensitivity analysis continued
2.5.1 Discovery Life continued
For long-term insurance liabilities relating to fixed and guaranteed contracts and unit-linked contracts (refer to reconciliation on
note 2.4.2), the sensitivities are detailed in the table below:
Liabilities
under
insurance
contracts
R million
Change
from base
assumption
%
Base: June 2021 assumptions 	16 647
Lapses +10% (e.g. from x% to 1.1x%) 	16 692 	0.3
Lapses –10% (e.g. from x% to 0.9x%) 	16 664 	0.1
Investment return and inflation –1% (e.g. from 5% to 4%) 	17 302 	3.9
Investment return and inflation +1% (e.g. from 5% to 6%) 	16 024 	(3.7)
Expense assumption +10% 	16 769 	0.7
Expense assumption –10% 	16 521 	(0.8)
Mortality and morbidity +10% 	16 660 	0.1
Mortality and morbidity –10% 	16 629 	(0.1)
Real curve –1% and inflation +1% 	16 820 	(1.0)
Real curve +1% and inflaton –1% 	16 499 	(0.9)
Base: June 2020 assumptions 	15 104
Lapses +10% (e.g. from x% to 1.1x%) 	15 225 	0.8
Lapses –10% (e.g. from x% to 0.9x%) 	15 028 	(0.5)
Investment return and inflation –1% (e.g. from 5% to 4%) 	15 680 	3.8
Investment return and inflation +1% (e.g. from 5% to 6%) 	14 554 	(3.6)
Expense assumption +10% 	15 199 	0.6
Expense assumption –10% 	15 008 	(0.6)
Mortality and morbidity +10% 	15 133 	0.2
Mortality and morbidity –10% 	15 073 	(0.2)
Real curve –1% and inflation +1% 	15 000 	(0.7)
Real curve +1% and inflaton –1% 	15 230 	0.8
2.5.2 VitalityLife – assets arising from insurance contracts
Gross exposure 	Net of Reinsurance
Assets
arising from
insurance
contracts
R million
Change
from base
assumption
%
Assets
arising from
insurance
contracts
R million
Change
from base
assumption
%
Base: June 2021 assumptions 	15 371 	8 557
Lapses +10% (e.g. from x% to 1.1x%) 	14 890 	(3.1) 	8 141 	(4.9)
Lapses –10% (e.g. from x% to 0.9x%) 	15 884 	3.3 	9 008 	5.3
Investment return and inflation –1% (e.g. from 5% to 4%) 	12 171 	(20.8) 	5 408 	(36.8)
Investment return and inflation +1% (e.g. from 5% to 6%) 	16 578 	7.9 	9 772 	14.2
Expense assumption +10% 	15 124 	(1.6) 	8 309 	(2.9)
Expense assumption –10% 	15 619 	1.6 	8 805 	2.9
Mortality and morbidity +10% 	13 080 	(14.9) 	7 517 	(12.2)
Mortality and morbidity –10% 	17 685 	15.1 	9 573 	11.9
Real curve -1% and inflation +1% 	16 449 	7.0 	9 664 	12.9
Real curve +1% and inflaton –1% 	13 446 	(12.5) 	6 696 	(21.7)
Base: June 2020 assumptions 	16 023 	8 153
Lapses +10% (e.g. from x% to 1.1x%) 	15 667 	(2.2) 	7 992 	(2.0)
Lapses –10% (e.g. from x% to 0.9x%) 	16 380 	2.2 	8 321 	2.1
Investment return and inflation –1% (e.g. from 5% to 4%) 	13 440 	(16.1) 	5 284 	(35.2)
Investment return and inflation +1% (e.g. from 5% to 6%) 	17 587 	9.8 	9 987 	22.5
Expense assumption +10% 	15 767 	(1.6) 	7 897 	(3.1)
Expense assumption –10% 	16 279 	1.6 	8 409 	3.1
Mortality and morbidity +10% 	13 939 	(13.0) 	7 277 	(10.7)
Mortality and morbidity –10% 	18 115 	13.1 	8 987 	10.2
Real curve -1% and inflation +1% 	17 487 	9.1 	9 959 	22.2
Real curve +1% and inflaton –1% 	13 344 	(16.7) 	5 088 	(37.6)
The above sensitivities reflect the impact on profit or loss if there are no discretionary margins.
57 Discovery Annual Financial Statements 2021

-- 58 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
2. 	MANAGEMENT OF INSURANCE RISK continued
2.5 	Sensitivity analysis continued
2.5.3 VitalityHealth – IBNR Reserves
VitalityHealth’s reserves are set based on the results of a frequency and severity model which looks at the expected cost of
each claim which is authorised for treatment. Historical costs per type of claim and the expected shape of emergence of each
claims costs are compared to the amounts already paid to help determine the appropriate reserve for the business. Within the
monthly reserving process, adjustments to the model results are made where evidence arises that there are changes in
development patterns.
The Reserving Committee considers both the model results and other business indicators when setting the actual reserves and
it is attended by colleagues from across the relevant business areas including operational, clinical and risk specialists.
The IBNR is GBP 35.2 million (R695 million) at 30 June 2021 (2020: GBP 28.1 million (R603 million)), which approximates 1.5 months’
worth of claims – which is the expected delay in claims reporting discussed above. Claims provisions at 30 June 2021 includes a
supplier settlement and disputed claims provision reflecting the probability weighted settlement of supplier invoices and claims
in dispute. The total of such provisions is GBP 2.5 million (R27 million) (2020: GBP 3 million (R54 million)).
VitalityHealth’s IBNR reserves are sensitive to changes in the business’s invoice processing speeds – which has seen significantly
improved stability over the most recent two years. Currently the IBNR is set using the average expected cost of each claim (in the
prior period the IBNR was set as an 80th percentile reserve in recognition of the volatility in the reserving environment). A 50th
and 95th percentile reserve would result in the following:
Million
2021
Rands
2020
Rands
2021
GBP
2020
GBP
Base case 	730.0 	603 	35.2 	28.1
Lower bound 	717.6 	493 	34.6 	23.0
Upper bound 	871.0 	658 	42.0 	29.3
2.5.4 INSURE – IBNR Reserves
Insure’s IBNR reserves are set based on the Bornhuetter-Ferguson model – a reserving model widely used in the short-term
insurance industry. As with other traditional chain ladder models, the model assumes stability in the reporting and settlement
delays and an expected loss ratio to arrive at a view of ultimate claims. In contrast, the outstanding claims reserve (OCR) is set
predominantly by claims assessors.
The claims reserve for the personal lines business – made up of both the IBNR and OCR reserves – is R332 million at 30 June 2021
(2020: R295 million). Sensitivity tests were performed with the results on the outlined below (in the prior period the IBNR reserve
was set at the 71st percentile level). Given the OCR is not probabilistic in nature, the sensitivity tests are performed purely on the
IBNR reserve.
R million 	2021 	2020
Base case 	331.8 	295.0
50th percentile 	322.1 	261.0
95th percentile 	348.0 	355.0
58 Discovery Annual Financial Statements 2021

-- 59 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
Discovery’s activities expose it to a variety of financial risks. Financial risks include market risk, credit risk and liquidity risk.
Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
prices and investment return. Market risk that could impact on future cash flows and hence the value of a financial instrument
arises from:
❚ 	Equity price risk: The impact of changes in equity prices and dividend income.
❚ 	Interest rate risk: The impact of changes in market interest rates.
❚ 	Currency risk: The impact of changes in foreign exchange rates.
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge
an obligation.
Liquidity risk is the risk that Discovery will encounter difficulty in meeting obligations associated with financial liabilities due to
insufficient cash or another financial asset being available to meet commitments as and when they become due.
Financial risks are managed by Discovery as follows:
❚ 	Discovery has appointed reputable external asset managers to manage its investments.
❚ 	The Actuarial Committee reviews the overall matching of shareholder and policyholder assets to their respective liabilities.
❚ 	The Capital, Currency, and Investment Committee (CCIC) is a sub-committee of the Group Executive Committee and meets
quarterly to focus on shareholder assets and the performance of asset managers responsible for managing these assets. The
CCIC also sets exposure limits for exposures to individual counterparties.
❚ 	Discovery periodically engages external consultants to review past investment decisions.
❚ 	The Investment Committee is a sub-committee of the CCIC and meets monthly to make operational decisions regarding
Discovery’s liquidity and foreign currency exposure.
CHANGE IN UNIT OF ACCOUNT
Discovery has not significantly changed the processes used to manage its financial risks from previous periods. During the
current financial period Discovery has simplified the financial risk analysis by revising the unit of account or level at which the
financial risk has been analysed. Historically Discovery has performed the analysis at a very granular level using the look–through
principle to investments in mutual funds. The updated disclosure provides information that is reliable and more relevant to users
of the financial statements and the comparative numbers have been restated accordingly.
59 Discovery Annual Financial Statements 2021

-- 60 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
Discovery’s approach in monitoring credit risk
Discovery’s credit risk rating systems and processes differentiate and quantify credit risk across counterparties and asset classes.
Discovery uses different credit rating approaches to monitor credit risk dependent on the financial assets. For financial assets
with externally rated ratings, e.g. Moody’s, the external rating is always used. For non-Moody’s rated instruments, the following
approaches will apply:
RATING SCALES FOR FUNDS
A credit rating, being a ranking of creditworthiness, is allocated to the obligor. Where external ratings are unavailable, internal
rating assessments are conducted through analysis of the latest financial and other relevant information, in a consistent and
systematic manner. Where external ratings are available, the standard rating classifications used by the external rating agencies
have been applied. The internal rating scale is based on internal definitions and influenced by definitions published by the
external ratings agency, Moody’s. Where applicable, internal ratings are mapped to equivalent external Moody’s rating scales.
The Group’s Internal Rating Scale categories are defined below:
Grading and Group internal rating 	Moody’s Investors Service equivalent of internal rating
Investment grade
Grades Aaa, Aa1, Aa2, Aa3 	Aaa, Aa1, Aa2, Aa3
Grades A1, A2, A3 	A1, A2, A3
Grades Baa, Baa1, Baa2, Baa3 	Baa, Baa1, Baa2, Baa3
Sub-investment grade
Grades Ba, Ba1, Ba2, Ba3, B, B1, B2, B3 	Ba, Ba1, Ba2, Ba3, B
B1, B2, B3
Grades Caa, Caa1, Caa2, Caa3, Ca, Ca1, Ca2, Ca3 	Caa, Caa1, Caa2, Caa3
Ca, Ca1, Ca2, Ca3
Default
Grades C 	C
Moody’s Investor Services define their respective ratings as follows:
Investment grade 	Aaa 	Obligations rated Aaa are judged to be of the highest quality, subject to the lowest level of
credit risk
Aa 	Obligations rated Aaa are judged to be of the highest quality, subject to the lowest level of
credit risk
A 	Obligations rated A are judged to be upper-medium grade and are subject to low credit risk
Baa 	Obligations rated Baa are judged to be medium-grade and subject to moderate credit risk
and as such may possess certain speculative characteristics
Sub-investment grade Ba 	Obligations rated Ba are judged to be speculative and are subject to substantial credit risk
B 	Obligations rated B are considered speculative and are subject to high credit risk
Caa 	Obligations rated Caa are judged to be speculative of poor standing and are subject to very
high credit risk
Ca 	Obligations rated Ca are highly speculative and are likely in, or very near, default, with
some prospect of recovery of principal and interest
Default 	C 	Obligations rated C are the lowest rated and are typically in default, with little prospect for
recovery of principal or interest
A numerical modifier may be added to each generic rating classification. Each modifier indicates the following:
❚ 	the modifier 1 indicates that the obligation ranks in the higher end of its generic rating category.
❚ 	the modifier 2 indicates a mid-range ranking; and
❚ 	the modifier 3 indicates a ranking in the lower end of that generic rating category.
60 Discovery Annual Financial Statements 2021

-- 61 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
Discovery’s approach in monitoring credit risk continued
POOLED FUNDS
The Group invests in funds through which it is also exposed to credit risk of the underlying assets in which the funds are invested.
The Group’s exposure to risk is classified at fund level and not at the underlying asset level. Although funds are not rated, fund
managers are required to invest in credit assets within the defined parameters stipulated in the fund’s mandate. These rules limit
the extent to which fund managers can invest in unlisted and/or unrated credit assets and generally restrict funds to the
acquisition of local currency investment grade assets.
DISCOVERY BANK
Loans and advances to customers are categorised with Discovery Bank’s own internally developed credit models. The Discovery
Bank model uses a 10-point Discovery Risk Grade classification, with each point being in two decrements to further distinguish
risk. The following table summarises how Discovery Bank classifies its loans:
Discovery Risk Category 	Discovery Risk Grades 	Risk of default assessment
Exceptional low risk 	DRG1 – DRG2 	Less than 0.4%
Low risk 	DRG3 – DRG5 	Less than 1.5%
Medium risk 	DRG5 – DRG8 	Less than 6%
High risk 	DRG8 – DRG9 	Less than 24%
Very high risk 	DRG 10 	More than 24%
Categorisation of business in the analysis of financial risk
To assist in the analysis of the financial risks that Discovery and its policyholders are exposed to, the Statement of financial
position has been divided into five categories, based on the nature of the products provided by Discovery and the nature of the
financial assets held to back the policyholder liabilities. Annexure F lists the contracts that Discovery offers and the category they
are included in for financial risk disclosure.
❚ 	Unit-linked investment contracts: this category relates to contracts issued by Discovery where there is a direct relationship
between the returns earned on the underlying portfolio and the returns credited to the contract. Discovery holds the assets
on which the unit prices are based and as a result there is no mismatch. The market risk (including equity price, interest rate
and currency risk) as well as the credit risk for these contracts is therefore borne by the policyholder and not the Discovery
shareholders.
❚ 	Unit-linked insurance contracts: this category relates to insurance contracts issued by Discovery which have a component
that is linked to the units of an underlying portfolio. For this component, Discovery holds the assets on which the unit prices
are based. However, the gross unit liabilities are reduced by the present value of future charges less the present value of
future expenses and risk claims. Under IFRS, the unit-linked component is not accounted for separately from the host
insurance contract. These contracts expose both Discovery shareholders and policyholders to financial risks.
❚ 	Insurance contracts: this category relates to insurance contracts issued by Discovery which Discovery funds with a portfolio
of matching assets, exposing the Discovery shareholders to financial risk. The financial assets in this category include those
financial assets held within specific portfolios matched to specific liabilities, for example claims reserves and claims incurred
but not reported (IBNR).
❚ 	Shareholder financial assets and liabilities: this category includes the financial assets and financial liabilities that expose
the Discovery shareholders to financial risks, including financial assets and cash backing insurance reserves and statutory
capital. This category includes those financial assets that are not held in specific portfolios matched to insurance related
liabilities.
❚ 	Shareholder non-financial assets and liabilities: No financial risk disclosures are required for these items.
61 Discovery Annual Financial Statements 2021

-- 62 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
Categorisation of financial assets continued
The financial assets in each of these categories are sub-categorised into a second tier of classification, namely:
❚ 	Equity portfolios
❚ 	Debt portfolios
❚ 	Money market portfolios
❚ 	Multi-asset portfolios
In applying the definitions below, reliance is placed on the classifications by asset managers.
Equity portfolios
The following have been defined as equity portfolios:
❚ 	Portfolios that invest a minimum of circa 75% of the market value of the portfolio in equities and generally seek maximum
capital appreciation as their primary goal. These portfolios invest in selected shares across the range of large, mid, and
smaller cap shares. While the managers of these portfolios may subscribe to different investment styles or approaches, their
intent is to produce a risk/return profile that is comparable with the risk/return profile of the overall equities market. The
portfolios in this category offer medium to long-term capital growth as their primary investment objective.
❚ 	Investments or portfolios of equity linked notes.
Debt (interest-bearing) portfolios
Interest-bearing portfolios are portfolios that invest exclusively in bond, money market investments and other interest earning
securities. These portfolios may not include equity securities, real estate securities or cumulative preference shares.
In addition to the above the inflation-linked bonds have been defined as Debt portfolios. Inflation-linked bonds are essentially
loans where the principal and interest payments are contractually linked to an inflation measure.
Money Market portfolios
Money market portfolios are portfolios that seek to maximise interest income, preserve the portfolio’s capital, and provide
immediate liquidity. This is achieved by investing in money market instruments with a maturity of less than thirteen months while
the average duration of the underlying assets may not exceed 90 days and a weighted average legal maturity of 120 days. The
portfolios are typically characterised as short-term, highly liquid vehicles.
Multi-asset portfolios
Multi-asset portfolios are portfolios that invest in a wide spread of investments in the equity, bond, money, and property markets
to maximise total returns, comprising capital and income growth over the long term. These portfolios do not fall within the
thresholds that have been determined for the Equity portfolios or the Debt portfolios.
62 Discovery Annual Financial Statements 2021

-- 63 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
Categorisation of financial assets continued
The following tables reconcile the Group Statement of financial position to the classes of risks and the categories listed on the
previous pages.
Group
R million 	Total
Unit-linked
investment
contracts
Unit-linked
insurance
contracts
Insurance
contracts
Shareholder
Financial
assets and
liabilities
Other
assets and
liabilities
Assets arising from insurance contracts 	50 483 	– 	– 	50 483 	– 	–
Loans and advances to customers at
amortised cost: 	3 361 	– 	– 	– 	3 361 	–
Investments at amortised cost:
Unlisted:
– Debt 	4 109 	– 	– 	– 	4 109 	–
– Fixed deposits 	1 495 	– 	– 	– 	1 495 	–
Financial instruments mandatorily at
fair value through profit or loss:
Listed:
– Equity portfolios 	40 508 	13 010 	27 114 	236 	148 	–
– Debt portfolios 	36 452 	5 620 	10 655 	18 674 	1 503 	–
– Money market portfolios 	10 892 	1 004 	1 894 	1 102 	6 892 	–
– Multi-asset portfolios 	33 205 	10 954 	22 083 	114 	54 	–
Unlisted:
– Equity portfolios 	2 854 	52 	2 759 	– 	43 	–
– Debt portfolios 	33 	2 	– 	– 	31 	–
– Money market portfolios 	6 361 	977 	1 911 	3 255 	218 	–
– Multi-asset portfolios 	632 	– 	632 	– 	– 	–
Derivative financial instruments at
fair value:
– used as cash flow hedges 	28 	– 	– 	– 	28 	–
– not designated as hedging
instruments 	221 	3 	4 	– 	214 	–
Receivables:
– Insurance receivables 	6 158 	– 	– 	– 	6 158 	–
– Contract receivables 	1 217 	– 	– 	– 	1 217 	–
– Other receivables 	3 158 	288 	559 	40 	1 302 	969
Reinsurance contracts 	445 	– 	– 	445 	– 	–
Cash and cash equivalents 	20 013 	952 	3 111 	8 	15 942 	–
Other non-financial assets 	25 069 	– 	992 	– 	– 	24 077
Total assets 	246 694 	32 862 	71 714 	74 357 	42 715 	25 046
Liabilities arising from insurance
contracts 	100 977 	– 	64 446 	36 531 	– 	–
Liabilities arising from reinsurance
contracts 	12 525 	– 	– 	12 525 	– 	–
Deposits from customers 	8 985 	– 	– 	– 	8 985 	–
Borrowings at amortised cost 	19 493 	– 	– 	– 	19 493 	–
Other payables at amortised cost 	14 904 	568 	1 154 	404 	12 426 	352
Investment contracts at fair value
through profit or loss 	32 291 	32 291 	– 	– 	– 	–
Derivative financial instruments at
fair value:
– used as cash flow hedges 	461 	– 	– 	– 	461 	–
– not designated as hedging
instruments 	365 	3 	5 	– 	357 	–
Other non-financial liabilities 	10 274 	– 	– 	– 	– 	10 274
Total liabilities 	200 275 	32 862 	65 605 	49 460 	41 722 	10 626
63 Discovery Annual Financial Statements 2021

-- 64 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
Group
R million
Shareholder
Total
Unit-linked
investment
contracts
Unit-linked
insurance
contracts
Insurance
contracts
Financial
assets and
liabilities
Other
assets and
liabilities
30 June 2020
Assets arising from insurance contracts 	48 042 	– 	– 	48 042 	– 	–
Loans and advances to customers at
amortised cost 	1 848 	– 	– 	– 	1 848 	–
Investments at amortised cost:
Unlisted:
– Debt 	439 	– 	– 	– 	439 	–
– Fixed deposits 	2 084 	– 	– 	– 	2 084 	–
Financial instruments mandatorily at
fair value through profit or loss:
Listed:
– Equity portfolios 	31 073 	8 633 	22 019 	189 	232 	–
– Debt portfolios 	30 575 	4 144 	7 864 	16 793 	1 774 	–
– Money market portfolios 	6 532 	391 	979 	213 	4 949 	–
– Multi-asset portfolios 	25 525 	8 036 	17 273 	103 	113 	–
Unlisted:
– Equity portfolios 	1 675 	36 	1 608 	– 	31 	–
– Debt portfolios 	5 	1 	– 	3 	1 	–
– Money market portfolios 	7 068 	1 088 	2 476 	2 949 	555 	–
– Multi-asset portfolios 	261 	– 	261 	– 	– 	–
Derivative financial instruments at
fair value:
– used as cash flow hedges 	14 	– 	– 	– 	14 	–
– not designated as hedging
instruments 	1 356 	– 	– 	– 	1 356 	–
Receivables:
– Insurance receivables 	6 179 	– 	– 	– 	6 179 	–
– Contract receivables 	1 413 	– 	– 	– 	1 413 	–
– Other receivables at amortised cost 	3 844 	420 	806 	15 	1 522 	1 081
Reinsurance contracts 	400 	– 	– 	400 	– 	–
Cash and cash equivalents 	17 909 	483 	2 014 	5 	15 407 	–
Other non-financial assets 	24 086 	– 	854 	– 	– 	23 232
Total assets 	210 328 	23 232 	56 154 	68 712 	37 917 	24 313
Liabilities arising from insurance
contracts 	82 411 	– 	49 783 	32 628 	– 	–
Liabilities arising from reinsurance
contracts 	12 465 	– 	– 	12 465 	– 	–
Deposits from customers 	2 427 	– 	– 	– 	2 427 	–
Borrowings at amortised cost 	19 836 	– 	– 	– 	19 836 	–
Other payables at amortised cost 	14 233 	219 	621 	315 	12 778 	300
Investment contracts at fair value
through profit or loss 	23 012 	23 012
Derivative financial instruments at
fair value:
– used as cash flow hedges 	854 	– 	– 	– 	854 	–
– not designated as hedging
instruments 	138 	1 	2 	– 	135 	–
Other non-financial liabilities 	10 399 	– 	– 	– 	– 	10 399
Total liabilities 	165 775 	23 232 	50 406 	45 408 	36 030 	10 699
64 Discovery Annual Financial Statements 2021

-- 65 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
The financial risks associated with each category are discussed below.
3.1 	Unit-linked investment contracts
Unit-linked investment contracts relate to contracts where there is a direct relationship between the returns earned on the
underlying portfolio and the returns credited to the contract.
Investments held at risk of
policyholders
R million
Group
2021
Group
2020
30 June 2021
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity portfolios 	13 010 	8 633
– Debt portfolios 	5 620 	4 144
– Money market portfolios 	1 004 	391
– Multi-asset portfolios 	10 954 	8 036
Unlisted:
– Equity portfolios 	52 	36
– Debt portfolios 	2 	1
– Money market portfolios 	977 	1 088
Derivative financial instruments at fair value:
– not designated as hedging instruments 	3 	–
Receivables:
– Other receivables at amortised cost 	288 	420
Cash and cash equivalents 	952 	483
Total assets 	32 862 	23 232
Other payables at amortised cost 	568 	219
Investment contracts at fair value through profit or loss 	32 291 	23 012
Derivative financial instruments at fair value:
– not designated as hedging instruments 	3 	1
Total liabilities 	32 862 	23 232
3.1.1 Market risk
EQUITY AND INTEREST RATE RISK
Discovery’s primary exposure to market risk from these contracts is the volatility in asset management fees earned by Discovery,
due to the impact of interest rate, equity price and currency movements on the fair value of the assets held in the linked funds,
on which the investment management fees are based. A decrease of 10% in the value of the assets would reduce the asset
management fees by R55 million per annum (2020: R45 million).
In respect of IFRS-defined investment management contracts there may be an associated asset for the costs of obtaining
contracts. There is a risk that in the event of adverse market movements, future expected management fees may reduce and
consequently this asset may not be realised and therefore necessitate impairment. There were no impairments necessary in the
current or previous financial year.
CURRENCY RISK
The Group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily
with respect to the US dollar and the UK pound. Foreign exchange risk arises from future commercial transactions and recognised
assets and liabilities. The currency risk is borne by the policyholder.
65 Discovery Annual Financial Statements 2021

-- 66 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.1 	Unit-linked investment contracts continued
3.1.2 Credit risk
Credit risk is borne by the policyholder. For the majority of the unit-linked investments, Discovery has invested in mutual funds
in order to provide for obligations under unit-linked investment contract liabilities. Each mutual fund has its own legal constitution
and operates within a mandate that is delegated to the appointed fund manager. Credit risks assumed within the assets held are
controlled by various protection mechanisms within the mandate and in law. Each fund’s trustees or board appoints administrators
who are responsible to ensure that the fund’s mandate and any internal and legislated control procedures are adhered to. In the
event of breach, they are obligated to bring it immediately to the attention of the fund’s trustees or board and management of
the administrators for remedial action.
In the case where unit-linked investment contracts are linked to structured products, Discovery’s policy dictates that these obligations
are matched exactly. At inception of these contracts, assets which have proceeds that exactly match the pay-out under the policy,
with the exception of credit risk, are purchased. Credit risk on these products is therefore also borne by the policyholder.
3.1.3 Liquidity risk
Certain contracts can be surrendered before maturity for a cash surrender value specified in the contractual terms and conditions.
This surrender value is equal to or less than the carrying amount of the contract liabilities. If all the contracts with this option were
surrendered at the financial year-end, a loss of R658 million (2020: R533 million) would have been recorded in profit or loss. This
loss would result from an impairment to the asset raised for costs of obtaining contracts, but the impact is reduced by the
surrender penalties receivable. A maturity analysis based on the earliest contractual repayment date would present 100% (2020:
100%) of the policyholder liabilities due within one year. The assets held to match these policyholder liabilities are realisable in
the short-term.
66 Discovery Annual Financial Statements 2021

-- 67 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.2 	Unit-linked insurance contracts
A unit-linked insurance contract is an IFRS-defined insurance contract with a component that is linked to the units of an underlying
portfolio.
Investments held at risk of
policyholders
R million
Group
2021
Group
2020
30 June 2021
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity portfolios 	27 114 	22 019
– Debt portfolios 	10 655 	7 864
– Money market portfolios 	1 894 	979
– Multi-asset portfolios 	22 083 	17 273
Unlisted:
– Equity portfolios 	2 759 	1 608
– Money market portfolios 	1 911 	2 476
– Multi-asset portfolios 	632 	261
Derivative financial instruments at fair value:
– not designated as hedging instruments 	4 	–
Receivables:
– Other receivables at amortised cost 	559 	806
Cash and cash equivalents 	3 111 	2 014
Other assets 	992 	854
Total assets 	71 714 	56 154
Liabilities arising from insurance contracts 	64 446 	49 783
Other payables at amortised cost 	1 154 	621
Derivative financial instruments at fair value:
– not designated as hedging instruments 	5 	2
Total liabilities 	65 605 	50 406
The assets are greater than the liabilities as a result of the Negative insurance liability of R5 117 milion (2020: R4 894 million) included in unit-linked
insurance contracts (refer to note 18) and the deferred tax asset of R992 million (2020: R854 million) in relation to the Individual Policyholder Fund.
67 Discovery Annual Financial Statements 2021

-- 68 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.2 	Unit-linked insurance contracts continued
3.2.1 Market risk
Discovery’s primary exposure to market risk from these contracts is the volatility in asset management fees due to the impact of
interest rate, equity price and currency movements on the fair value of the assets held in the linked funds, on which the investment
management fees are based. A decrease of 10% in the value of the assets would reduce the asset management fees by
R134 million per annum (2020: R111 million).
3.2.2 Credit risk
The credit risk for the unit-linked insurance contracts is similar to the credit risk for the unit-linked investment contracts. Refer to
section 3.1.2 on the detail for the exposure to the credit risk.
3.2.3 Liquidity risk
All contracts can be surrendered before maturity for a cash surrender value specified in the contractual terms and conditions.
This surrender value is equal to or less than the carrying amount of the contract liabilities. If all the contracts with this option were
surrendered at the financial year-end, a loss of R5 491 million (2020: R5 175 million) would have been recorded in profit or loss.
This loss results from the impairment of assets arising from insurance contracts relating to these contracts, but the impact is
reduced by the surrender penalties receivable.
The assets held to match these policyholder liabilities are highly liquid and are realisable in the short term. A maturity analysis
based on the earliest contractual repayment date is as follows:
Group
R million 	Total
< 1
Year
1 – 2
Years
3 – 5
Years
30 June 2021
Unit-linked insurance contracts 	69 549 	68 947 	122 	480
30 June 2020
Unit-linked insurance contracts 	54 646 	54 433 	23 	190
68 Discovery Annual Financial Statements 2021

-- 69 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.3 	Insurance contracts
For insurance contracts, Discovery funds the insurance liabilities with a portfolio of matching assets.
R million
Group
2021
Group
2020
30 June 2021
Assets arising from insurance contracts 	50 483 	48 042
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity portfolios 	236 	189
– Debt portfolios 	18 674 	16 793
– Money market portfolios 	1 102 	213
– Multi-asset portfolios 	114 	103
Unlisted:
– Debt portfolios 	– 	3
– Money market portfolios 	3 255 	2 949
Receivables:
– Other receivables at amortised cost 	40 	15
Reinsurance contracts 	445 	400
Cash and cash equivalents 	8 	5
Total assets 	74 357 	68 712
Liabilities arising from insurance contracts 	36 531 	32 628
Liabilities arising from reinsurance contracts 	12 525 	12 465
Other payables at amortised cost 	404 	315
Total liabilities 	49 460 	45 408
3.3.1 Market risk
When calculating the liabilities arising from insurance contracts, an increase/decrease in the investments would result in an
increase/decrease in the liability but it may not be an equal Rand value movement, resulting in the difference being accrued to
the shareholders. Discovery aims to closely match liabilities with appropriate assets and maintains sufficient assets to protect
against residual mismatches between assets and liabilities at a 99.5% confidence interval over a one-year time horizon.
3.3.2 Credit risk
Discovery is exposed to credit risk through financial investments comprising money market portfolios and debt portfolios entered
into to match policyholders’ insurance contract liabilities. Discovery is exposed to the issuer’s credit standing on these instruments
which is monitored by the CCIC by setting a minimum credit rating. Discovery has appointed reputable asset managers to manage
these instruments.
69 Discovery Annual Financial Statements 2021

-- 70 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.3 	Insurance contracts continued
3.3.2 Credit risk continued
Group
R million 	Total 	Aaa
Aa1
Aa2
Aa3
A1
A2
A3
Ba1
Ba2
Ba3
Baa1
Baa2
Baa3 	Govt 1
Pooled
funds
30 June 2021
Financial instruments mandatorily
at fair value through profit or loss:
Listed:
– Debt portfolios 	18 674 	64 	51 	5 	167 	– 	18 383 	4
– Money market portfolios 	1 102 	3 	229 	– 	158 	– 	457 	255
Unlisted:
– Money market portfolios 	3 255 	– 	850 	1 841 	564 	– 	– 	–
Reinsurance contracts 	445 	48 	216 	159 	22 	– 	– 	–
Cash and cash equivalents 	8 	6 	2 	– 	– 	– 	– 	–
23 484 	121 	1 348 	2 005 	911 	– 	18 840 	259
30 June 2020
Financial instruments mandatorily
at fair value through profit or loss:
Listed:
– Debt portfolios 	16 793 	951 	223 	6 	– 	– 	15 596 	17
– Money market portfolios 	213 	– 	17 	– 	– 	– 	– 	196
Unlisted:
– Debt portfolios 	3 	3 	– 	– 	– 	– 	– 	–
– Money market portfolios 	2 949 	1 807 	659 	481 	– 	– 	– 	2
Reinsurance contracts 	400 	– 	81 	305 	– 	14 	– 	–
Cash and cash equivalents 	5 	4 	1 	– 	– 	– 	– 	–
20 363 	2 765 	981 	792 	– 	14 	15 596 	215
1 These instruments are held in the South African government.
3.3.3 Liquidity risk
The liquidity risk for assets and liabilities arising from insurance contracts are discussed in insurance risks in Note 2 Management
of Insurance Risk. The financial investments held at fair value through profit or loss are realisable in the short term.
70 Discovery Annual Financial Statements 2021

-- 71 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities
The shareholders are exposed to financial risk through the following financial assets and liabilities:
Investments held at risk of
shareholders
R million
Group
2021
Group
2020
30 June 2021
Loans and advances to customers at amortised cost 	3 361 	1 848
Investments at amortised cost:
Unlisted:
– Debt 	4 109 	439
– Fixed deposits 	1 495 	2 084
Financial instruments mandatorily at fair value through profit or loss:
Listed:
– Equity portfolios 	148 	232
– Debt portfolios 	1 503 	1 774
– Money market portfolios 	6 892 	4 949
– Multi-asset portfolios 	54 	113
Unlisted:
– Equity portfolios 	43 	31
– Debt portfolios 	31 	1
– Money market portfolios 	218 	555
Derivative financial instruments at fair value:
– used as cash flow hedges 	28 	14
– not designated as hedging instruments 	214 	1 356
Receivables:
– Insurance receivables 	6 158 	6 179
– Contract receivables 	1 217 	1 413
– Other receivables at amortised cost 	1 302 	1 522
Cash and cash equivalents 	15 942 	15 407
Total assets 	42 715 	37 917
Deposits from customers 	8 985 	2 427
Borrowings at amortised cost 	19 493 	19 836
Other payables at amortised cost 	12 426 	12 778
Derivative financial instruments at fair value:
– used as cash flow hedges 	461 	854
– not designated as hedging instruments 	357 	135
Total liabilities 	41 722 	36 030
71 Discovery Annual Financial Statements 2021

-- 72 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
3.4.1 Market risk
EQUITY PRICE RISK
INVESTMENTS
Discovery is exposed to equity price risk through its equity investments held that have been classified as investments at fair value
through profit or loss (FVTPL), on the Statement of financial position. To manage its equity risk arising from investments in Equity
portfolios of R191 million (2020: R263 million), the Group diversifies its portfolio and uses experienced asset managers.
For shareholder investments, a reasonable increase of 10% in the equity markets would result in a profit of R62 million before tax
(2020: R9 million). A reasonable decrease of in the equity markets would result in a loss of R62 million before tax (2020: R9 million).
This impact would be recognised in profit or loss and equity. The sensitivity assumes that the equity markets had increased/
decreased by 10% with all other variables held constant.
HEDGE DERIVATIVE INSTRUMENTS
Discovery is also exposed to equity price risk through its cash-settled share incentive schemes, namely the Phantom share
scheme and the Acquisition share scheme, the details of which are described in note 31. This liability has been included in Other
payables at amortised cost in the Statement of financial position. To manage this risk, Discovery has purchased a combination of
total return equity swaps (TRS) and call options from Ba1 (2020: Ba2 – Baa3) South African banks to hedge a portion of its
exposure to changes in the Discovery share price.
Hedge ineffectiveness for TRS and call options can arise from:
– differences between the strike price/initial price per the derivative contract and the Discovery spot price on hedge designation
date.
– difference due to the fixed funding element inherent in TRS which does not exist in the hedged item being the share based
payment liability raised in terms of IFRS 2 Share-based payment.
– differences between the dividend yield for the call options and the option contracts; and
– day one profit or loss on the derivative contract.
The Group sets the hedging ratio by matching the notional amount of the designated hedged items to the notional amount of the
corresponding TRS or call options used as the hedging instruments, after applying expected forfeiture rates to each vesting. The
hedge ratio is 1:1. The hedge accounting relationship is reviewed on a monthly basis and the hedging instruments and hedged
items are de-designated, if necessary, based on the effectiveness test results and changes in the hedged exposure. The Group
hedges the hedged item in its entirety against equity price risk as opposed to just a component of this risk.
Under the Group’s policy, the critical terms of the hedging instrument, such as the settlement dates, maturity dates and notional
amounts are matched with the equity price risk of the hedged item.
72 Discovery Annual Financial Statements 2021

-- 73 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
3.4.1 Market risk continued
I. PHANTOM SHARE SCHEME (INCLUDING CERTAIN OTHER DEVELOPMENT SEGMENT SCHEMES)
As at 30 June 2021, 100% (2020: 100%) of this exposure is hedged. The hedges were designed to be highly effective, where
the critical terms of the hedge or return swaps substantially match that of the phantom share scheme on a per instrument
basis. Combinations of total return equity swaps and call options were designated on a unit for unit basis to substantially
match the terms of the phantom share and call option units.
When these hedges are entered into, they are designated as the hedge of a highly probable forecast transaction and
accounted for as a cash flow hedge.
The cash-settled call options held by the Group at 30 June were:
Maturity date
Strike
price
Number of
call options
2021
Year end June 2022 	114.96 – 141.65 	272 942
Year end June 2023 	141.65 	170 827
2020
Year end June 2021 	110.40 – 141.65 	754 076
Year end June 2022 	110.40 – 141.65 	272 942
Year end June 2023 	141.65 	170 827
The notional value of the outstanding cash-settled call options held by the Group at 30 June 2021 was R60 million (2020:
R161 million).
The fair value of the call options is repriced at each reporting date and calculated on a Black-Scholes model using the same
assumptions as tabled in note 31.
The total return equity swaps held by the Group at 30 June were:
Maturity date
Reference
price
Number of
total return
equity swaps
2021
Year end June 2022 	114.96 – 173.59 	1 655 491
Year end June 2023 	141.65 – 173.59 	1 085 365
Year end June 2024 	147.04 – 173.59 	499 954
2020
Year end June 2021 	114.96 – 173.59 	2 058 914
Year end June 2022 	114.96 – 173.59 	1 655 491
Year end June 2023 	141.65 – 173.59 	1 085 365
Year end June 2024 	147.04 – 173.59 	499 954
The notional value of the outstanding total TRS held by the Group at 30 June 2021 was R499 million (2020: R791 million).
The fair value of the TRS is calculated by discounting the future cash flows of the instruments.
73 Discovery Annual Financial Statements 2021

-- 74 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
II. ACQUISITION SHARE SCHEME
As at 30 June 2021, 100% (2020: 98%) of this exposure is hedged. The hedges were designed to be highly effective, where
the terms of the hedge or total return equity swaps substantially match that of the acquisition share scheme on a per
instrument basis.
When these hedges are entered into, they are designated as the hedge of a highly probable forecast transaction and
accounted for as a cash flow hedge.
The total return equity swaps held by the Group at 30 June were:
Maturity date
Reference
price
Number of
total return
swaps
2021
Year end June 2022 	129.00 – 150.38 	704 682
Year end June 2023 	147.50 – 150.38 	681 833
Year end June 2024 	105.51 – 150.38 	659 583
Year end June 2025 	105.51 – 125.44 	194 373
Year end June 2026 	125.44 	88 519
2020
Year end June 2022 	118.31 – 150.38 	618 591
Year end June 2023 	129.00 – 150.51 	698 716
Year end June 2024 	147.50 – 150.51 	579 914
Year end June 2025 	150.38 – 150.51 	119 956
Year end June 2026 	150.51 	97 818
The notional value of the outstanding total return equity swaps held by the Group at 30 June 2021 was R292 million (2020:
R324 million). The fair value of the total return equity swaps is calculated by discounting the future cash flows of the
instruments.
At 30 June 2021, the fair value of the derivative instruments purchased to hedge the Phantom and Acquisition share schemes, is
R106 million (2020: R324 million) (refer to note 13). To reduce the credit risk exposure from the hedge derivative instruments
purchased, Discovery has entered into collateral agreements with the relevant financial institutions to post cash collateral
periodically, equal to the fair value of the derivatives.
A total of R154 million (2020: R407 million) cash collateral is being held by counterparty banks (refer to note 14) at 30 June 2021.
The posting of the collateral does not result in legal settlement of the outstanding derivative balance. The collateral will only be
used to settle the derivative upon default or bankruptcy of either party. The offsetting requirements of IAS 32 are therefore
not met.
Discovery recognises the effective portion of fair value changes of derivatives that are designated and qualify as cash flow hedges
and prove to be highly effective in relation to the hedged risk, in the cash flow hedging reserve in the Statement of other
comprehensive income. The gain or loss relating to the ineffective portion is recognised immediately in profit or loss. A gain of
R8 million (2020: R13 million loss) was recognised in profit or loss during the current year as a result of ineffectiveness. This
amount has been included under ’Net fair value gains on financial assets at fair value through profit or loss’, in the Income
statement (refer to note 27).
The movement in the hedging reserve relating to the Phantom and Acquisition share schemes, is summarised in the table below:
R million
Group
2021
Group
2020
Balance at beginning of the year 	87 	–
Unrealised losses accumulated in equity 	(171) 	409
Tax on unrealised losses 	26 	(59)
Recycled to profit or loss during the current year1 	82 	(309)
Tax on recycled gains 	(15) 	46
Balance at end of the year 	9 	87
1 Presented in ’Marketing and administration expenses’ and ’Acquisition costs’.
74 Discovery Annual Financial Statements 2021

-- 75 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
R million
Group
2021
Group
2020
Recycled to profit or loss within one year 	4 	12
Recycled to profit or loss within two to five years 	5 	75
Balance at end of the year 	9 	87
INTEREST RATE RISK
Sensitivity to changes in interest rates is relevant to financial assets and financial liabilities bearing floating interest rates due to
the risk that future cash flows will fluctuate. However, sensitivity will also be relevant to fixed-rated financial assets and financial
liabilities that are re-measured to fair value. The table below details the specific interest rate risk that the Group is exposed to:
Group
R million
Carrying
amount 	Fixed 	Floating
Non-interest
bearing
30 June 2021
Loans and advances to customers at amortised cost 	3 361 	– 	3 361 	–
Investments at amortised cost:
Unlisted:
– Debt 	4 109 	4 109 	– 	–
– Fixed deposits 	1 495 	1 221 	274 	–
Financial instruments mandatorily at fair value through
profit or loss:
Listed:
– Debt portfolios 	1 503 	1 006 	489 	8
– Money market portfolios 	6 892 	2 953 	3 872 	67
– Multi-asset portfolios 	54 	– 	– 	54
Unlisted:
– Debt portfolios 	31 	1 	30 	–
– Money market portfolios 	218 	25 	193 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	28 	5 	– 	23
– not designated as hedging instruments 	214 	– 	155 	59
Receivables
– Insurance receivables 	6 158 	– 	– 	6 158
– Contract receivables 	1 217 	– 	42 	1 175
– Other receivables at amortised cost 	1 302 	28 	457 	817
Cash and cash equivalents 	15 942 	894 	14 641 	407
Total financial assets 	42 524 	10 242 	23 514 	8 768
Deposits from customers 	8 985 	3 763 	5 222 	–
Borrowings at amortised cost 	19 493 	10 034 	9 459 	–
Other payables at amortised cost 	12 426 	6 608 	2 	5 816
Derivative financial instruments at fair value:
– used as cash flow hedges 	461 	332 	– 	129
– not designated as hedging instruments 	357 	– 	235 	122
Total financial liabilities 	41 722 	20 737 	14 918 	6 067
75 Discovery Annual Financial Statements 2021

-- 76 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
Group
R million
Carrying
amount 	Fixed 	Floating
Non-interest
bearing
30 June 2020
Loans and advances to customers at amortised cost 	1 848 	– 	1 848 	–
Investments at amortised cost:
Unlisted:
– 	Debt 	439 	439 	– 	–
– 	Fixed deposits 	2 084 	246 	1 838 	–
Financial instruments mandatorily at fair value through
profit or loss:
Listed:
– Debt portfolios 	1 774 	1 257 	517 	–
– Money market portfolios 	4 949 	2 278 	2 671 	–
– Multi-asset portfolios 	113 	– 	– 	113
Unlisted:
– Debt portfolios 	1 	1 	–
– Money market portfolios 	555 	25 	530 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	14 	14 	–
– not designated as hedging instruments 	1 356 	– 	1 093 	263
Receivables
– Insurance receivables 	6 179 	23 	– 	6 156
– Contract receivables 	1 413 	– 	39 	1 374
– Other receivables at amortised cost 	1 522 	29 	620 	873
Cash and cash equivalents 	15 407 	1 308 	13 924 	175
Total financial assets 	37 654 	5 619 	23 081 	8 954
Deposits from customers 	2 427 	599 	1 828
Borrowings at amortised cost 	19 836 	10 172 	9 664 	–
Other payables at amortised cost 	12 778 	158 	7 405 	5 215
Derivative financial instruments at fair value:
– used as cash flow hedges 	854 	854 	– 	–
– not designated as hedging instruments 	135 	41 	5 	89
Total financial liabilities 	36 030 	11 824 	17 074 	7 132
76 Discovery Annual Financial Statements 2021

-- 77 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
INVESTMENTS
For shareholder investments, a 1% increase in the local interest rate would result in an increase of R9 million of investment
income from these investments (2020: R7 million). A 1% decrease in the local interest rate would result in a decrease of R9 million
of investment income from these investments (2020: R5 million). The sensitivity assumes that the interest rate had increased/
decreased by 1% with all other variables held constant.
BORROWINGS AT AMORTISED COST AND RELATED HEDGES
Discovery is exposed to interest rate risk through long-term borrowings held with various financial institutions. Refer to note 20
Borrowings at amortised costs for a breakdown of the borrowings, including details of fixed rate and floating rate facilities.
2021 	2020
Group
R million 	Ref
Carrying
value
Facility
value
Carrying
value
Facility
value
Interest rate risk from borrowings from banks
Fixed interest rate loan facilities 	5 773 	5 850 	5 792 	5 796
Floating interest rate facilities with floating-to-fixed
interest rate swap 	i 	5 034 	5 000 	4 536 	4 500
Floating interest rate facilities 	659 	500 	1 630 	1 500
Foreign floating interest rate facilities 	3 764 	4 224 	3 498 	4 460
Total bank borrowings (refer to note 20) 	15 230 	15 574 	15 456 	16 256
i. During prior years and in the current financial year, Discovery entered into long-term borrowing facilities at floating interest
rates, which expose Discovery to cash flow interest rate risk. This risk has been managed by using floating-to-fixed interest
rate swaps. These interest rate swaps have the economic effect of converting the borrowings from floating to fixed rates.
Interest is payable quarterly in arrears, with capital repayable on maturity. The hedge ratio is 1:1.
The Group enters into interest rate swaps that have similar critical terms as the hedged item, such as reference rate, reset
dates, payment dates, maturities, and notional amount. As all critical terms matched during the year, there is an economic
relationship.
Under the Group’s policy, the critical terms of the hedging instrument, such as the settlement dates, maturity dates and
notional amount, are matched with the interest rate risk of the hedged item.
Hedge ineffectiveness for interest rate swaps can arise from:
– day one fair value of the swap,
– events leading to mismatch in terms; and
– the credit value/debit value adjustment on the interest rate swaps which is not matched by the loan.
The fair value movement of the notional cash flow interest rate hedge accumulated in equity is as follows:
Group
R million 	2021 	2020
Balance at beginning of the year 	516 	173
Unrealised (gains)/losses accumulated in equity 	(189) 	353
Tax on unrealised losses 	– 	–
Recycled to profit or loss during the current year1 	8 	(10)
Tax on recycled gains 	– 	–
Balance at end of the year 	335 	516
The cash flow hedge will be recycled to profit or loss as follows:
Recycled to profit or loss within one year 	– 	–
Recycled to profit or loss within two to five years 	232 	377
Recycled to profit or loss within six to ten years 	103 	139
335 	516
1 Disclosed as finance costs in profit or loss.
77 Discovery Annual Financial Statements 2021

-- 78 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
The interest rate swaps held by the Group at 30 June were:
Group
R million
2021 	2020
Nominal
value
Fair value
liability
Nominal
value
Fair value
liability
Maturity date:
21 November 2022 	500 	(25) 	500 	(47)
21 November 2024 	800 	(74) 	800 	(110)
21 August 2026 	700 	(80) 	700 	(107)
02 March 2023 	1 000 	(55) 	1 000 	(99)
21 August 2023 	500 	5 	– 	–
21 August 2026 	300 	(22) 	300 	(32)
21 November 2024 	1 200 	(76) 	1 200 	(121)
5 000 	(327) 	4 500 	(516)
Group
R million
2021
Carrying
value
2020
Carrying
value
Term deposits from customers – fixed rate 	3 763 	599
Term deposits from customers – variable rates 	3 798 	1 513
On demand deposits from customers – variable rate 	615 	315
Wholesale NCD's (Negotiable Certificate of Deposit) – variable rate 	809 	–
Total customer deposits Discovery Bank 	8 985 	2 427
NON-HEDGE DERIVATIVE FINANCIAL INSTRUMENTS
I. INTEREST RATE SWAP
VitalityLife has significant exposure to long-term interest rate risk, given the impact on reserves of lower investment rate
assumptions related to fixed future premium receipts to meet policy obligations. Accordingly, lower long-term interest rates
and yield assumptions may negatively impact on the valuation of future policy obligations and result in a valuation loss. Refer
to note 2.4.3 for details of the interest rate mitigation strategy implemented.
In addition to the above, VitalityLife has an exposure to the ’FTSE Actuaries UK Conventional Gilts over 15 Year Index (“the
index”) as a result of products underwritten by the Prudential Assurance Company on behalf of VitalityLife. In order to
economically hedge the Vitality UK group’s exposure to the index, Discovery Holdings Europe Limited (DHEL) has been party
to a number of over-the-counter total return interest rate swap derivatives during the financial year. These derivatives provide
DHEL with the capital depreciation/appreciation and coupon payments on a basket of Gilts designed to closely match that of
the index in return for a payment of fixed interest to the counterparty.
As at 30 June 2021 DHEL is party to two (2020: one) open derivative contracts. The fixed interest payable is 0.18% (2020: 0.99%)
on a notional derivative value of GBP 311.8 million (2020: GBP 279.8 million). At 30 June 2021 the fair value of the derivative
was an asset of GBP 1.0 million (R20 million) (2020: GBP 6.5 million (R139 million)).
Although these instruments reduce the exposure to the volatility of the index, they do not qualify for hedge accounting.
Accordingly, these derivatives have been classified as financial assets or liabilities carried at fair value through profit or loss.
Fair value adjustments of GBP 38.1 million (net loss) (R792 million) have been recognised in ‘Net fair value gains on financial
assets at fair value through profit or loss’ (2020: GBP 38.9 million (net gains) (R768 million)). The current open derivative
contracts expire on 14 July 2021.
78 Discovery Annual Financial Statements 2021

-- 79 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
II. DERIVATIVE INSTRUMENTS USED BY DISCOVERY’S ASSET MANAGERS
Discovery’s asset managers use derivative instruments as mandated to limit or reduce risk. The majority of derivatives are
exchange traded (SAFEX or Yield-X). Exchange traded derivatives are settled daily by reducing exposures (and hence credit
risk) to zero at the end of each day. Discovery also has interest rate swap agreements and the value of exposure towards these
parties was calculated by taking into consideration the ISDA agreements in place which allow for netting off between positive
and negative exposures.
The table below details the Group’s total derivative exposure:
Group
R million
Notional
amount
Fair value
asset
Fair value
liability
June 2021
Interest rate contracts:
– floating for fixed swaps 	56 	– 	(3)
56 	– 	(3)
June 2020
Interest rate contracts:
– floating for fixed swaps 	70 	– 	5
70 	– 	5
79 Discovery Annual Financial Statements 2021

-- 80 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
CURRENCY RISK
The Group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily
with respect to the US dollar and the UK pound. Foreign exchange risk arises from future commercial transactions and recognised
assets and liabilities. The following table segregates the currency exposure by major currency:
Group
R million 	Total 	Rand
GBP in UK
subsidiary
GBP
other
USD in US
subsidiary
USD
other
Other
currencies
30 June 2021
Loans and advances to customers
at amortised cost 	3 361 	3 361 	– 	– 	– 	– 	–
Investments at amortised cost:
Unlisted:
– Debt 	4 109 	4 109 	– 	– 	– 	– 	–
– Fixed deposits 	1 495 	1 291 	204 	– 	– 	– 	–
Financial instruments mandatorily
at fair value through profit or loss:
Listed:
– Equity portfolios 	148 	48 	16 	– 	– 	70 	14
– Debt portfolios 	1 503 	497 	988 	– 	– 	10 	8
– Money market portfolios 	6 892 	2 817 	4 075 	– 	– 	– 	–
– Multi-asset portfolios 	54 	13 	2 	– 	– 	39 	–
Unlisted:
– Equity portfolios 	43 	20 	– 	– 	– 	23 	–
– Debt portfolios 	31 	31 	– 	– 	– 	– 	–
– Money market portfolios 	218 	218 	– 	– 	– 	– 	–
Derivative financial instruments
at fair value:
– used as cash flow hedges 	28 	28 	– 	– 	– 	– 	–
– not designated as hedging
instruments 	214 	59 	155 	– 	– 	– 	–
Receivables
– Insurance receivables 	6 158 	2 374 	3 736 	– 	– 	48 	–
– Contract receivables 	1 217 	771 	– 	– 	214 	11 	221
– Other financial receivables at
amortised cost 	1 302 	962 	122 	163 	17 	34 	4
Cash and cash equivalents 	15 942 	4 812 	9 508 	119 	443 	1 001 	59
Total financial assets 	42 715 	21 411 	18 806 	282 	674 	1 236 	306
Deposits from customers 	8 985 	8 985 	– 	– 	– 	– 	–
Borrowings at amortised cost 	19 493 	15 368 	4 066 	– 	59 	– 	–
Other financial payables at
amortised cost 	12 426 	3 234 	8 945 	– 	202 	9 	36
Derivative financial instruments
at fair value:
– used as cash flow hedges 	461 	461 	– 	– 	– 	– 	–
– not designated as hedging
instrument 	357 	125 	232 	– 	– 	– 	–
Total financial liabilities 	41 722 	28 173 	13 243 	– 	261 	9 	36
80 Discovery Annual Financial Statements 2021

-- 81 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
Group
R million 	Total 	Rand
GBP in UK
subsidiary
GBP
other
USD in US
subsidiary
USD
other
Other
currencies
30 June 2020
Loans and advances to customers at
amortised cost 	1 848 	1 848 	– 	– 	– 	– 	–
Investments at amortised cost:
Unlisted:
– Debt 	439 	439 	– 	– 	– 	– 	–
– Fixed deposits 	2 084 	1 864 	220 	– 	– 	– 	–
Financial instruments mandatorily at
fair value through profit or loss:
Listed:
– Equity portfolios 	232 	51 	3 	– 	– 	175 	3
– Debt portfolios 	1 774 	598 	1 176 	– 	– 	– 	–
– Money market portfolios 	4 949 	1 354 	3 595 	– 	– 	– 	–
– Multi-asset portfolios 	113 	26 	– 	– 	– 	76 	11
Unlisted:
– Equity portfolios 	31 	20 	– 	– 	– 	11 	–
– Debt portfolios 	1 	1 	– 	– 	– 	– 	–
– Money market portfolios 	555 	554 	– 	1 	– 	– 	–
Derivative financial instruments at
fair value:
– used as cash flow hedges 	14 	14 	– 	– 	– 	– 	–
– not designated as hedging
instruments 	1 356 	252 	1 092 	– 	– 	12 	–
Receivables
– Insurance receivables 	6 179 	1 810 	4 333 	– 	– 	36 	–
– Contract receivables 	1 413 	758 	– 	– 	456 	1 	198
– Other receivables at
amortised cost 	1 522 	1 377 	140 	– 	1 	– 	4
Cash and cash equivalents 	15 407 	4 941 	9 426 	193 	455 	339 	53
Total financial assets 	37 917 	15 907 	19 985 	194 	912 	650 	269
Deposits from customers 	2 427 	2 427 	– 	– 	– 	– 	–
Borrowings at amortised cost 	19 836 	15 920 	3 905 	– 	11 	– 	–
Other payables at amortised cost 	12 778 	2 578 	9 835 	6 	253 	68 	38
Derivative financial instruments
at fair value:
– used as cash flow hedges
– not designated as hedging
instruments 	854 	854 	– 	– 	– 	– 	–
Other payables at amortised cost 	135 	135 	– 	– 	– 	– 	–
Total financial liabilities 	36 030 	21 914 	13 740 	6 	264 	68 	38
Financial assets and financial liabilities in respect of the Group’s US and UK subsidiaries are accounted for in their functional
currency. Foreign currency movements will be recognised in the foreign currency translation reserve.
The exchange rates at year-end are detailed in the table below (quoted as Rand per foreign currency):
USD 	GBP
30 June 2021 	14.28 	19.74
30 June 2020 	17.41 	21.44
81 Discovery Annual Financial Statements 2021

-- 82 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
Sensitivity analysis
The Group determined that a 10% change is a reasonable expected strengthening/(weakening) of the US dollar and the UK Pound
against all other currencies. The impact on profit or loss and equity at 30 June is shown below. For the purpose of
the analysis, the foreign exchange impact of intergroup balances which eliminate on consolidation has been excluded. The effect
of translation differences which are recognised seperately in other comprehensive income has also been excluded. This analysis
assumes that all other variables, in particular interest rates, remain constant and ignores any impact of forecast sales and
purchases
Profit or loss 	Equity
R million 	Strengthening 	Weakening 	Strengthening 	Weakening
30 June 2021
USD 	590 	(590) 	590 	(590)
GBP 	38 	(38) 	38 	(38)
30 June 2020
USD 	33 	(33) 	33 	(33)
GBP 	10 	(10) 	10 	(10)
INVESTMENTS
Discovery has offshore assets in its investment portfolios. These offshore investments are made for the purpose of seeking
international diversification. There is a risk to future earnings that the value of these assets reduces due to a strengthening in the
Rand. Performance of foreign currency assets is benchmarked against the MSCI World Index, an international index that represents
large and mid-capitalisation companies across 23 developed market countries. Refer to www.msci.com for further detail.
CURRENCY DERIVATIVE CONTRACTS
To manage its foreign exchange risk arising from future commercial transactions, Discovery enters into various currency
derivative contracts. Discovery entered into these contracts with third party banks which have short term rated risk of P-2 and
P-1, as rated by Moody’s. The fair value of these contracts have been included in financial assets and liabilities. (Refer to note 13).
Discovery entered into these contracts as an economic hedge against foreign currency risk for expenses to be paid in the future.
These transactions are not designated as hedges and as a result gains and losses are recognised in profit or loss. The amount
recognised in profit or loss for the current year was a loss of R298 million (2020: R284 million gain), with a corresponding derivative
asset and liability of R58 million and R100 million respectively, (2020: Derivative asset R263 million and derivative liability R6 million).
The notional value of these contracts are GBP 119.3 million, USD 39.4 million and EUR 7.9 million (2020: GBP 118.65 million,
USD 39.4 million and EUR 7.9 million).
Currency risk for foreign exchange contracts (FEC’s) are determined with reference to the designated pricing (settlement) currency
of each respective contract. The pricing currency is usually the functional currency of the entity taking out the contract. For the
purposes of currency risk, Discovery discloses FEC contracts using the pricing currency.
BORROWINGS
Discovery has long-term borrowings in the UK, which exposes the Group to currency risks. These risks are managed by aligning
the currency exposure to the underlying operational assets for which these borrowings have been raised. The currency risk is
mitigated as the cash flows emerging from the underlying assets are in the same currency (GBP) as the interest and capital
payments.
82 Discovery Annual Financial Statements 2021

-- 83 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
3.4.2 Credit risk
Key areas where Discovery is exposed to credit risk are:
❚ 	Financial investments comprising money market and debt instruments entered into to invest surplus shareholder
funds: Discovery is exposed to the issuer’s credit standing on these instruments which is monitored by the CCIC by setting a
minimum credit rating and maximum exposures per issuer. Discovery has appointed reputable asset managers to manage
these instruments. Information regarding the aggregated credit risk exposure for debt and money market instruments
categorised by credit ratings is provided below.
❚ 	Cash and cash equivalents: This risk is managed by monitoring exposure to external financial institutions against approved
limits per institution. Credit ratings are provided below.
❚ 	Certain accounts within the Statement of financial position category of ’Insurance receivables, contract receivables
and other non-financial receivables’.
❚ 	Reinsurance assets comprising receivables raised for expected recoveries on projected claims (Discovery’s liability as
primary insurer is not discharged) and amounts due from reinsurers in respect of claims already paid: This risk is
limited as risk premiums are paid monthly to reinsurers and claims can be offset against risk premiums. Further, it is expected
that there will be little build-up of actuarial liability on the reinsurers’ side. The risk thus mainly arises following a period of
higher than expected claims. Credit ratings of reinsurers are considered in reinsurance placement decisions. Credit exposure
to reinsurers is also limited through the use of several reinsurers. Reinsurance is placed with reputable international
companies directly or through their national offices. The reinsurance companies used by Discovery are rated A or higher by
A.M. Best, a rating agency with an exclusive insurance industry focus. Refer to www.ambest.com for further detail.
❚ 	Loans and advances to customers at amortised cost, which arises from credit extended to Discovery Bank customers.
83 Discovery Annual Financial Statements 2021

-- 84 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
The following table details the aggregated credit risk exposure that the Group is exposed to, categorised by the rating scale noted
in section 3 ‘Discovery’s approach in monitoring credit risk’.
Group
R million 	Total 	Aaa
Aa1
Aa2
Aa3
A1
A2
A3
Baa1
Baa2
Baa3
Ba1
Ba2
Ba3 	Govt1
Inter-
nally
rated
Pooled
funds
30 June 2021
Loans and advances to customers at
amortised cost 	3 361 	– 	– 	– 	– 	– 	– 	3 361 	–
Investments at amortised cost:
Unlisted:
– Debt 	4 109 	– 	– 	– 	– 	– 	4 109 	– 	–
– Fixed deposits 	1 495 	– 	– 	203 	1 292 	– 	– 	– 	–
Financial instruments mandatorily at fair value
through profit or loss:
Listed:
– Debt portfolios 	1 503 	39 	152 	283 	687 	272 	37 	– 	33
– Money market portfolios 	6 892 	1 044 	1 070 	163 	2 928 	126 	4 	– 	1 557
Unlisted:
– Debt portfolios 	31 	– 	– 	– 	– 	31 	– 	– 	–
– Money market portfolios 	218 	– 	14 	21 	3 	180 	– 	– 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	28 	– 	– 	– 	23 	5 	– 	– 	–
– not designated as hedging instruments 	214 	– 	– 	155 	37 	22 	– 	– 	–
Cash and cash equivalents 	15 942 	14 	8 954 	2 082 	1 237 	2 286 	1 369 	– 	–
33 793 	1 097 	10 190 	2 907 	6 207 	2 922 	5 519 	3 361 	1 590
Group
R million 	Total 	Aaa
Aa1
Aa2
Aa3
A1
A2
A3
Baa1
Baa2
Baa3
Ba1
Ba2
Ba3 	Govt1
Inter-
nally
rated
Pooled
funds
30 June 2020
Loans and advances to customers at
amortised cost 	1 848 	– 	– 	– 	– 	– 	– 	1 848 	–
Investments at amortised cost:
Unlisted:
– Debt 	439 	– 	– 	– 	– 	– 	439 	– 	–
– Fixed deposits 	2 084 	– 	220 	– 	1 618 	246 	– 	– 	–
Financial instruments mandatorily at fair value
through profit or loss:
Listed:
– Debt portfolios 	1 774 	167 	427 	383 	700 	– 	53 	– 	44
– Money market portfolios 	4 949 	– 	2 344 	14 	1 757 	36 	4 	– 	794
Unlisted:
– Debt portfolios 	1 	– 	– 	1 	– 	– 	– 	–
– Money market portfolios 	555 	1 	533 	– 	– 	21 	– 	– 	–
Derivative financial instruments at fair value:
– used as cash flow hedges 	14 	1 	2 	3 	7 	1 	– 	– 	–
– not designated as hedging instruments 	1 356 	– 	1,00 	1 156 	187 	12 	– 	– 	–
Cash and cash equivalents 	15 407 	657 	10 986 	459 	301 	2 223 	781 	– 	–
28 427 	826 	14 513 	2 016 	4 570 	2 539 	1 277 	1 848 	838
1 These instruments are held in the South African government.
Financial instruments included in cash and cash equivalents, fixed deposits and treasury bills have high credit quality based on
the rating of counterparties and/or have relatively short-term maturities. Impairment based on the expected credit loss approach
was assessed and considered immaterial. There are no amounts within these balances which are credit impaired or where there
has been a significant increase in credit risk since initial recognition.
84 Discovery Annual Financial Statements 2021

-- 85 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
CREDIT RISK RELATING TO RECEIVABLES
The table below summarises Discovery’s shareholder insurance receivables, contract receivables and other receivables, at 30 June.
This table only relates to shareholder’s credit exposure and will therefore not agree to note 14.
R million
Group
2021
Group
2020
Receivables arising from insurance and reinsurance contracts:
– Premium debtors 	668 	692
– Less provision for impairment of premium debtors 	(63) 	(93)
– Reinsurance debtors 	5 553 	5 580
Contract receivables:
– Closed scheme debtors 	104 	103
– Discovery Health Medical Scheme 	662 	650
– Other contract receivables 	480 	709
– Less allowance for expected credit losses 	(29) 	(49)
Other loans and receivables:
– Agents and brokers 	412 	491
– BEE partners’ rights-issue funding 	1 	19
– Cash-in-transit debtors 	32 	5
– Consolidated unit trust debtors 	1 	1
– FNB-DiscoveryCard receivable 	– 	52
– Loans to BEE initiatives 	220 	214
– Security deposit on derivatives 	289 	407
– Vitality partner debtors 	112 	116
– Other financial receivables 	696 	653
– Less allowance for expected credit losses 	(461) 	(436)
8 677 	9 114
1 Refer to note 3.7 for an explanation of the nature of the security deposit (cash collateral).
Credit risk relating to receivables is managed as follows:
i. Premium debtors are not rated by Discovery as exposure to any single customer is insignificant. The premium debtors
comprise amounts receivable from individuals and corporates. In addition, Discovery suspends benefits when contributions
are not received. Premium debtors that are past due are handled by a specialist area in business. Where amounts remain
uncollected for more than six months, the debtors are then handed to specialist debt collection agencies.
ii. VitalityHealth makes use of financial reinsurance as a financing tool for new business acquisition costs. The receipt from
the reinsurer is recognised in profit or loss upfront in the year received. GBP 156 million (R3 079 million) (2020: GBP 175.8 million
(R3 770 million)) is outstanding in respect of cashless reinsurance treaties. The credit ratings of these reinsurers are Aa3.
Refer to note 3.4.2 for detail regarding the management of risk in respect of reinsurance receivables raised for expected
recoveries on projected claims and amounts due from reinsurers in respect of claims already paid. Discovery’s liability as
primary insurer is not discharged.
iii. The Discovery Health Medical Scheme (DHMS) has been rated AAA(za) by Global Credit Ratings. The closed schemes have not
been rated. Payments by DHMS and the other closed schemes are managed by Discovery and are paid by the seventh of the
following month.
iv. Agents and brokers are subject to a comprehensive relationship management programme including credit assessment.
Agents and brokers are not rated by Discovery as exposure to any single intermediary is insignificant. The widespread nature
of the individual amounts combined with this close management relationship reduces credit risk. Most commission claw
backs are offset against future payments and hence the risk of outstanding commission clawbacks is reduced.
85 Discovery Annual Financial Statements 2021

-- 86 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
Discovery ages and pursues unpaid accounts on a monthly basis. The ageing of the components of receivables at 30 June was:
Group
R million
Gross
2021
Impairment
2021
Gross
2020
Impairment
2020
Not past due (current) 	7 901 	(69) 	8 196 	(132)
30 days 	201 	(22) 	254 	(33)
60 days 	170 	(16) 	137 	(20)
90 days 	149 	(94) 	133 	(17)
120 days 	169 	(13) 	149 	(35)
150 days 	42 	(8) 	96 	(9)
>150 days 	598 	(331) 	727 	(332)
9 230 	(553) 	9 692 	(578)
Discovery establishes an allowance for expected credit losses that represents its estimate of expected losses in respect of
receivables that are financial assets. The allowance comprises of a specific loss component that relates to individually significant
exposures, and a collective loss component, established for groups of similar assets. The loss allowance is determined based on
historical data of payment statistics for similar financial assets, and where available without undue cost or effort, incorporates
forward-looking information.
For an analysis of the movement in the allowance for expected credit losses as well as provision for impairment of premium
debtors during the year, refer to note 12 Financial assets and note 14 Insurance receivables, contract receivables and other
financial receivables.
3.4.3 Liquidity risk
Cash flow forecasting is performed in the operating entities of the Group and aggregated by Group finance. Group finance
monitors rolling forecasts of the Group’s liquidity requirements to ensure it has sufficient cash to meet operational needs at all
times so that the Group does not breach borrowing limits or covenants (where applicable) on any of its borrowing facilities (refer
to note 20). Such forecasting takes into consideration the Group’s debt financing plans, covenant compliance and, if applicable,
external regulatory or legal requirements – such as capital requirements.
Cash held by the operating entities is managed by Group treasury. Group treasury invests it in interest-bearing accounts, time
deposits and money market deposits, choosing instruments with appropriate maturities or sufficient liquidity to provide sufficient
headroom as determined by the above-mentioned forecasts. For information on the liquidity risk management of contracts with
insurance risk, refer to note 2.2 Liquidity risk.
Discovery Bank manages its liquidity risk by comparing the credit utilisation and expected future utilisation of commited facilities
on its loans and advances against the deposits it holds. Discovery Bank performs normal stresses as well as additional stresses
to ensure that it can meet its obligations continuously. The stresses during the financial period included stresses as a result of
COVID-19 impacts.
86 Discovery Annual Financial Statements 2021

-- 87 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.4 	Shareholder financial assets and liabilities continued
3.4.3 Liquidity risk continued
The table below analyses the Group’s financial assets and liabilities and net-settled interest rate swap derivative financial liabilities
into relevant maturity groupings based on the remaining period at the reporting date to the contractual maturity date. The
amounts are the undiscounted contractual payments and will therefore not agree to the Statement of financial position.
Group
R million 	Total 	<1 year
1 – 2
year
3 – 5
years
6 – 10
years
> 10
years
30 June 2021
Loans and advances to customers at
amortised cost 	3 361 	2 017 	1 344 	– 	– 	–
Investments at amortised cost 	5 604 	5 604 	– 	– 	– 	–
Investments at fair value through profit or loss 	8 889 	7 279 	656 	279 	375 	300
Derivative financial instruments at fair value 	242 	86 	148 	8 	– 	–
Receivables 	8 677 	5 166 	92 	186 	2 982 	251
Cash and cash equivalents 	15 942 	15 942 	– 	– 	– 	–
Total financial assets 	42 715 	36 094 	2 240 	473 	3 357 	551
Deposits from customers 	8 985 	4 232 	4 449 	304 	– 	–
Borrowings net of interest rate swap
– Borrowings 	21 537 	2 732 	5 577 	10 145 	2 729 	354
– Interest rate swap 	639 	193 	171 	260 	15 	–
Other payables at amortised cost 	12 426 	4 773 	7 188 	124 	– 	341
Derivative financial instruments at fair value 	818 	176 	134 	182 	326 	–
Total financial liabilities 	44 405 	12 106 	17 519 	11 015 	3 070 	695
Group
R million 	Total 	<1 year
1 – 2
year
3 – 5
years
6 – 10
years
> 10
years
30 June 2020
Loans and advances to customers at
amortised cost 	1 848 	1 109 	739 	– 	– 	–
Investments at amortised cost 	2 523 	2 098 	425 	– 	– 	–
Investments at fair value through profit or loss 	7 655 	5 394 	789 	440 	486 	546
Derivative financial instruments at fair value 	1 370 	399 	18 	– 	953 	–
Receivables 	9 114 	4 923 	239 	153 	3 684 	115
Cash and cash equivalents 	15 407 	15 407 	– 	– 	– 	–
Total financial assets 	37 917 	29 330 	2 210 	593 	5 123 	661
Deposits from customers 	2 427 	2 146 	281 	– 	– 	–
Borrowings net of interest rate swap
– Borrowings 	26 093 	2 018 	3 322 	14 355 	4 562 	1 836
– Interest rate swap 	717 	168 	167 	332 	50 	–
Other payables at amortised cost 	12 778 	5 656 	123 	801 	20 	6 178
Derivative financial instruments at fair value 	989 	266 	148 	436 	139 	–
Total financial liabilities 	43 004 	10 254 	4 041 	15 924 	4 771 	8 014
87 Discovery Annual Financial Statements 2021

-- 88 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.5 	Capital management
The Group’s capital is defined as capital and reserves attributable to as presented on the consolidated statement of financial
position. The Group’s objectives when managing capital are:
❚ 	To comply with the statutory capital requirements required by the regulators of the insurance markets where the Group operates;
refer to Capital section of the directors’ report for the statutory capital requirements
❚ 	To maintain a capital buffer in excess of the statutory capital requirements in order to reduce the risk of breaching the statutory
requirement in the event of deviations from the main assumptions affecting the Group’s insurance businesses.
❚ 	To ensure that sufficient capital is available to fund the Group’s working capital and strategic capital requirements.
❚ 	To achieve an optimal and efficient capital funding profile; and
❚ 	To consider capital management needs both in the short term and over a five-year planning horizon.
Discovery has a Finance and Capital Committee that ensures alignment in strategic financial management between the centre
and subsidiaries within South Africa, UK and US. The committee is the governance body for all capital allocation activities across
the Group.
A range of capital raising options are available to manage the capital structure of the Group, which includes the issue of new
shares, debt, reinsurance arrangements and other hybrid instruments.
FINANCIAL LEVERAGE RATIO
As part of the capital management process, the Group monitors its capital structure utilising the Financial Leverage Ratio (FLR).
This ratio is calculated as total debt 1 divided by total debt plus total equity. The Group’s strategy is to maintain a prudent FLR of
28% per the Group Risk Appetite statement. However, the 28% is merely a risk appetite indicator, and not a hard line to indicate
any form of a breach in terms of regulatory or covenant restrictions. The table below summarises the FLR as at 30 June.
R million
Group
2021
Group
2020
– Borrowings at amortised cost (refer to note 20)1 	15 230 	14 956
– Guaranteed deposit facilities 	800 	–
Total debt and guarantees1 	16 030 	14 956
Total equity 	46 419 	44 553
Financial Leverage Ratio (%) 	25.7% 	25.1%
1. Excluding all IFRS 16 lease liabilities of R4 263 million (2020: R4 380 million). It further excluded non-guaranteed deposit facilities of R500 million in
the prior year.
The FLR at 30 June 2021 is in line with Discovery’s risk appetite.
Minimum capital requirements
For Group subsidiaries that operate in the insurance and financial services sectors, the regulator specifies the minimum amount
and type of capital that must be held by each of the subsidiaries in addition to their insurance liabilities. The minimum required
capital must be maintained at all times throughout the period.
With effect from 1 July 2018, the Insurance Act 18 of 2017 and the related Prudential Standards were implemented in
South Africa. Discovery Life and Discovery Insure are regulated under the Insurance Act, while VitalityHealth and VitalityLife are
regulated under the European Solvency II regulatory regime, which was implemented from 1 January 2016.
88 Discovery Annual Financial Statements 2021

-- 89 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.5 	Capital management continued
DEBT COVENANTS
The following are the key debt covenant ratios and their proximity to breaching the covenant triggers:
Debt covenant and explanation 	Minimum requirement 	2021 	2020
Group Debt to EBITDA Ratio:
– Group debt is contractually defined and means the
aggregate consolidated financial indebtedness of
the Group and excludes items such as the 1
Discovery Place (‘1 DP’) lease and includes
guarantees issued to third parties.
– EBITDA is contractually defined and specifically
includes items such as dividends from associates,
rental paid on 1DP and excludes such items
deemed extraordinary, such as economic
assumption adjustments, and specified FinRe
arrangements.
Less than 2.5 times 	2.31 	1.96
Group financial indebtedness to embedded value
– Group financial indebtedness is as per Group Debt
in the calculation.
Less than 30% of Group
Embedded value
22.6% 	22.5%
Discovery Life Statutory Capital Requirement
(SCR) Cover
SCR cover must be more than 1.1 	1.83 times 	1.82 times
Group embedded value 	Greater than R30billion 	ZAR
74 713 million
ZAR
70 834 million
New business embedded value must not be negative 	Positive value of new business for
3 consecutive 6-month periods
June 2021:
R946 million
Dec 2020:
R945 million
June 2020:
R726 million
June 2020:
R726 million
Dec 2019:
R1 196 million
June 2019:
R1 322 million
89 Discovery Annual Financial Statements 2021

-- 90 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.6 	Fair value estimation
The Group’s financial instruments measured at fair value have been disclosed using a fair value hierarchy. The hierarchy has
three levels that reflect the significance of the inputs used in measuring fair value.
Level 1: includes financial instruments that are measured using unadjusted, quoted prices in an active market for identical
financial instruments. An active market is a market in which transactions for the asset or liability take place with sufficient
frequency and volume to provide pricing information on an ongoing basis. Quoted prices are readily and regularly available from
an exchange, dealer, broker, industry group, pricing service or regulatory agency and those prices represent actual and regularly
occurring market transactions on an arm’s length basis.
Level 2: includes financial instruments that are valued using techniques based significantly on observable market data.
Instruments in this category are valued using:
❚ 	Quoted prices for similar instruments or identical instruments in markets which are not considered to be active; or
❚ 	Valuation techniques where all the inputs that have a significant effect on the valuation are directly or indirectly based on
observable market data.
Level 3: includes financial instruments that are valued using valuation techniques that incorporate information other than
observable market data and where at least one input (which could have a significant effect on instruments’ valuation) cannot be
based on observable market data.
Group
R million 	Level 1 	Level 2 	Level 3 	Total
30 June 2021
Financial assets
Financial instruments mandatorily at fair value
through profit or loss:
– Equity portfolios 	40 530 	2 832 	– 	43 362
– Debt portfolios 	34 845 	1 640 	– 	36 485
– Money market portfolios 	6 451 	10 802 	– 	17 253
– Multi-asset portfolios 	33 837 	– 	– 	33 837
Derivative financial instruments at fair value:
– used as cash flow hedges 	– 	28 	– 	28
– not designated as hedging instruments 	– 	221 	– 	221
Total financial assets 	115 663 	15 523 	– 	131 186
Financial liabilities – not designated as hedging
instruments
Investment contracts at fair value through profit or loss 	– 	32 291 	– 	32 291
Derivative financial instruments at fair value:
– used as cash flow hedges 	– 	461 	– 	461
– not designated as hedging instruments 	– 	365 	– 	365
Total financial liabilities 	– 	33 117 	– 	33 117
90 Discovery Annual Financial Statements 2021

-- 91 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.6 	Fair value estimation continued
Group
R million 	Level 1 	Level 2 	Level 3 	Total
30 June 2020
Financial assets
Financial instruments mandatorily at fair value through
profit or loss:
– Equity portfolios 	31 185 	1 563 	– 	32 748
– Debt portfolios 	28 724 	1 856 	– 	30 580
– Money market portfolios 	3 835 	9 765 	– 	13 600
– Multi-asset portfolios 	25 786 	– 	– 	25 786
Derivative financial instruments at fair value:
– used as cash flow hedges 	– 	14 	– 	14
– not designated as hedging instruments 	– 	1 356 	– 	1 356
Total financial assets 	89 530 	14 554 	– 	104 084
Financial liabilities
Investment contracts at fair value through profit or loss 	– 	23 012 	– 	23 012
Derivative financial instruments at fair value:
– used as cash flow hedges 	– 	854 	– 	854
– not designated as hedging instruments 	– 	138 	– 	138
Total financial liabilities 	– 	24 004 	– 	24 004
There were no transfers between level 1 and 2 during the current financial year.
Specific valuation techniques used to value financial instruments in level 2
If a quoted market price is not available on a recognised stock exchange or from a broker for non-exchange traded financial
instruments, the fair value of the instrument is estimated by the asset managers, using valuation techniques including the use of
recent arm’s length market transactions, reference to the current fair value of another instrument that is substantially the same,
discounted cash flow techniques, option pricing models or other valuation techniques that provide a reliable estimate of prices
obtained in actual market transactions.
91 Discovery Annual Financial Statements 2021

-- 92 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.6 	Fair value estimation continued
Valuation techniques used in determining the fair value of assets and liabilities
Instruments 	Valuation technique 	Main inputs and assumptions
Within equity portfolios,
Equity-linked notes
The calculation of the daily value of the equity linked investments
is made by the provider of the note. Discovery has procedures in
place to ensure that these prices are correct. Aside from the daily
reasonableness checks versus similar funds and movement since
the prior day’s price, the fund values are calculated with reference
to a specific formula or index, disclosed to the policyholders,
which is recalculated by Discovery in order to check if the price
provided by the provider is correct.
For level 2 fair value hierarchy
items:
– discount rate
– spot prices of the
underlying
Multi-assets 	The fair values of third-party financial liabilities arising on the
consolidation of mutual funds are determined using the quoted
put (exit) price provided by the fund manager and discounted for
the applicable notice period. The fair value of a financial liability
with a demand feature is not less than the amount payable on
demand, discounted from the first date on which the amount
could be required to be paid.
For level 2 fair value hierarchy
items:
– discount rate
Investment contracts at
fair value through profit
or loss
Unit-linked policies: assets which are linked to the investment
contract liabilities are owned by the Group. The investment
contract obliges the Group to use these assets to settle these
liabilities. Therefore, the fair value of investment contract
liabilities is determined with reference to the fair value of
the underlying assets (i.e., amount payable on surrender of
the policies).
Annuity certain: discounted cash flow models are used to
determine the fair value of the stream of future payments.
For level 2 fair value hierarchy
items:
– discount rate
– spot price of underlying
Derivatives 	Standard derivative contracts are valued using market accepted
models and quoted parameter inputs. More complex derivative
contracts are modelled using more sophisticated modelling
techniques applicable to the instrument. Techniques include:
– Discounted cash flow model
– Black-Scholes model
– Combination technique models
For level 2 fair value hierarchy
items:
– discount rate
– spot prices of the
underlying
– correlation factors
– volatilities
– earnings yield
– valuation multiples.
92 Discovery Annual Financial Statements 2021

-- 93 of 219 --

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	MANAGEMENT OF FINANCIAL RISK continued
3.7 	Offsetting financial assets and financial liabilities
Financial assets
The following financial assets are subject to offsetting:
Group
R million
Gross
financial
assets
Gross
offsetting
financial
liabilities
Net amount
presented
30 June 2021
Cash and cash equivalents 	20 187 	(174) 	20 013
30 June 2020
Cash and cash equivalents 	21 099 	(3 190) 	17 909
Offsetting of cash and cash equivalents takes place as a result of sweeping arrangements that Discovery has in force with various
financial institutions. No other amounts presented on the financial statements are subject to netting arrangements.
Cash collateral
To reduce the credit risk exposure from the hedge derivative instruments purchased (refer to note 3.4.1), Discovery has
entered into collateral agreements with the relevant financial institutions to post cash collateral periodically, equal to the fair
value of the derivatives. A total of R289 million (2020: R407 million) cash collateral was being held by the various financial
institutions and R2 million (2020: R1 150 million) was held by Discovery at 30 June 2021.
The posting of the collateral does not result in legal settlement of the outstanding derivative balance. The collateral will only be
used to settle the derivative upon default or bankruptcy of either party. The offsetting requirements of IAS 32 Financial Instruments:
Presentation are therefore not met.
93 Discovery Annual Financial Statements 2021

-- 94 of 219 --

94 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
4. 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS
IN APPLYING ACCOUNTING POLICIES
In preparing the annual financial statements, estimates, assumptions and judgements are made that could materially affect the
reported amounts of assets and liabilities within the next financial year. Accounting estimates and judgements are regularly
reviewed and are based on historical experience, current best estimates and expectations of future outcomes as well as
anticipated changes in the environment. The following represents the most material key management assumptions applied by
management in preparing these annual financial statements.
4.1 	Policyholder liabilities assumptions and estimates, including assets
arising from insurance contracts
Discovery Life and VitalityLife
Discovery values its insurance policies issued by Discovery Life and VitalityLife using various methodologies and assumptions.
Accounting policy 13.1 sets out the methodology used in its valuation of the policyholder liabilities, including the use of available
discretionary margins in accounting policy 13.1.1.
The assumptions used are best estimate assumptions, with the addition of explicit compulsory margins required by:
❚ 	SAP 104 of the Actuarial Society of South Africa for Discovery Life; and
❚ 	INSPRU of the Prudential Regulatory Authority (PRA), SAP 104 and Benchmarking information in the UK
Per the accounting policy, the best estimate assumptions and margins are reset at every valuation date to reflect the underlying
profitability of the portfolio. The most recent valuation date is 30 June 2021.
MORTALITY AND MORBIDITY
Assumptions of future mortality and morbidity experience are derived from reinsurers and industry data and compared to actual
past experience. Where appropriate, the assumptions are adjusted to reflect actual past experience or for expected changes in
future experience.
The assumptions are modified for each policy based on actual data from underwriting performed on the policy and compared
against standard industry tables for reasonability. The key mortality and morbidity assumptions are reviewed and benchmarked
against the industry by independent actuarial consultants to ensure that the assumptions are reasonable upon implementing
significant new products for Discovery Life. An adjustment to the standard mortality and morbidity assumptions is made to
reflect the expected impact of engagement in the Vitality programme. It has been observed that higher rates of engagement
result in lower lapses.
An allowance is made for the impact of AIDS on South African mortality rates. For individual life South African business, a fixed
loading is applied to the expected best estimate mortality rates to allow for the expected effect of AIDS. The loading varies based
on socio-economic class. Discovery Life further operates in the high end of the market, where the AIDS risk is lower the full
market. The additional loading for AIDS is set in consultation with external independent actuaries and reinsurers.
For Group Life policies, a loading is applied at the underwriting stage to allow for the expected effect of AIDS. The loading varies
based on the industry and geographic area and composition of the group and is derived from advice received from the reinsurers.
The loading then forms the AIDS assumption for Group policies.
The sensitivity of the policyholder liabilities due to changes in mortality and morbidity assumptions are set out in note 2.5.1 for
Discovery Life and note 2.5.2 for VitalityLife.
SURRENDER AND LAPSE RATES
Lapse rates are based on actual past experience where available. The lapse analysis is done by considering the in–force duration
of policies. For durations longer than actual data, lapse rates are set based on expectations of future experience based on
internal and external expert advice. The lapse experience investigation covers at least the last two years of lapse experience to
identify trends.
Lapse assumptions are varied between different types of policies where the lapse experience is expected to differ significantly.
Allowance is made for the estimated impact of the economic environment. For Discovery Life, an adjustment is made to the lapse
assumptions to reflect the expected impact of engagement in the Vitality programme because it has been observed that higher
rates of engagement result in lower lapses.
For Discovery Life, the surrender rates are also based on actual past experience where available.
The sensitivity of the policyholder liabilities due to changes in lapse rate assumptions are set out in note 2.5.1 for Discovery Life
and note 2.5.2 for VitalityLife.

-- 95 of 219 --

95 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
4. 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS
IN APPLYING ACCOUNTING POLICIES continued
4.1 	Policyholder liabilities assumptions and estimates, including assets
arising from insurance contracts continued
ECONOMIC ASSUMPTIONS/INVESTMENT RETURNS
DISCOVERY LIFE
The discount rate for Discovery Life and Invest is based on the risk-free rates at 30 June 2021. The real rate assumption is based on
the average of the real rate curves for the preceding twelve months. This real rate assumption will remain unchanged over time
unless the equivalent single rate, derived based on the weighted duration of the cash flows, moves by more than 25 basis points since
the preceding valuation. The inflation assumption is set as the differential between the assumed nominal and real interest rates.
The real rate assumption was set equal to an assumed single rate. A change has been made to the Discovery Life and Invest economic
basis to align the nominal interest rate assumptions with the shape of the risk-free yield curve. Consistent with this, the real yield
assumption was set relative to the observed real yield curve, adjusted to remove volatility due to the nature of the index-linked
government bond market.
For comparison purposes, it is noted that the single risk-free rate at 30 June 2021 would have decreased to 11.1% (2020: 12.5%). The
implied single real interest rate has also increased to 4.6% in June 2021 (2020: 4.2%).
Other investment returns and economic assumptions are set relative to this yield curve. The assumptions for Discovery Life are as
follows:
Cash: 	Risk-free – 1.5%
Fixed interest: 	Risk-free
Equity: 	Risk-free + 3.5%
Property: 	Risk-free +1%
The sensitivity of the policyholder liabilities due to changes in real curve assumptions are set out in note 2.5.1.
VITALITYLIFE
The nominal investment return is set as the active market rate on UK long-term swap rates plus a fixed adjustment (based on long-
term averages) for liquidity premium, the gilt/swap spread and cash flow weighting. The best estimate inflation assumption is set in
line with long-term UK inflation expectations and observed real yields consistent with the term of the liabilities. The risk-free rate at
30 June 2021 was set at 064% (2020: 0.89%).
The investment fees and tax rates are taken into account in setting the economic assumptions.
The sensitivity of the policyholder liabilities due to changes in real curve assumptions are set out in note 2.5.2.
EXPENSE ASSUMPTIONS
Renewal expense assumptions are based on the results of the latest expense and budget information. Expenses are considered non-
recurring when they relate to the start-up of a new business area or when they are material and are specific to an event that is not
expected to occur in the future.
The allocation of expenses between initial and renewal is based on the latest expense analysis, where expenses are directly allocated
based on the function performed. Where an expense could relate to both initial and renewal functions, the expenses are allocated
proportionately based on estimates of the functions performed.
Per Discovery’s policy, expenses are projected to increase in line with consumer price inflation.
Non-recurring expenses are excluded from the expense analysis used to derive the assumption.
The sensitivity of the policyholder liabilities due to changes in expense assumptions are set out in note 2.5.1 for Discovery Life and
note 2.5.2 for VitalityLife.

-- 96 of 219 --

96 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
4. 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS
IN APPLYING ACCOUNTING POLICIES continued
4.1 	Policyholder liabilities assumptions and estimates, including assets
arising from insurance contracts continued
POLICY ALTERATIONS AND AUTOMATIC PREMIUM INCREASES
In calculating policyholder liabilities, no allowance is made for policy alterations over time, in line with actuarial guidance.
Automatic premium increases could include both contractual and voluntary increases. No allowance is made for voluntary premium
increases when calculating liabilities under insurance contracts.
Contractual premium increases are defined as increases that the policyholder cannot cancel without altering the terms of the benefits
provided under the policy. Contractual increases are included in the calculation of policyholder liabilities.
COVID-19 PROVISIONS FOR DISCOVERY LIFE AND VITALITYLIFE
The COVID-19 provision reflects management’s best estimate of the impact as at 30 June 2021. Discovery modelled the COVID
reserves based on an SEIR (multi-state) model to project future infections. The SEIR model considers different states of infection,
namely Susceptible, Exposed, Infectious and Removed. Epidemiologists typically use the SEIR model to model the progression of an
infectious disease over time. The modelling of transition rates from one state to another is calibrated to align with experience from
published information on COVID-19 infection rates, hospitalisation rates, and mortality rates.
The model parameters for new infections are determined from the emergence of infections implied by the historical observed
COVID-19 related deaths. In modelling new infections, a 15% - 25% reinfection rate on previously infected persons is also assumed.
The dynamics of new infections are driven by assumed virus reproduction factors (R factors), which summarise information about the
infectiousness of the prevailing variant.
New deaths are then calculated from the modelled infections by applying the infection fatality rates from Imperial College London
researchers on Wuhan data (Verity et al.). The estimate for excess mortality was based on an assessment of various internal and
external COVID-19 projection models and calibrated based on the risk profile of the Discovery in-force portfolio. The richness of the
Discovery data universe allows for more accurate identification of COVID-19 related deaths, and observed deaths were used except
for the Group Life business, where excess mortality was used to inform the scenarios.
An additional assumption in modelling the COVID-19 scenarios is the percentage of fully vaccinated policyholders that will mitigate
the projected infections and resulting deaths. The vaccine is assumed to be more than 85% effective in preventing deaths or to lower
the infection fatality rate, dependent on the vaccine used as well as the COVID-19 variant.
At the end of the previous period, at 30 June 2020, Discovery set up total COVID-19 reserves of R2.7 billion based on the modelling
done to mitigate any effects of the pandemic during this year under review. While many of the expected impacts of the pandemic fell
within expectation, the effects of the Beta and Delta variants were significantly greater than expected.
The impact of the Delta variant played out differently in Discovery’s core markets, resulting in the following provision for the period
ended 30 June 2021:
❚ 	In South Africa (SA), the third wave mortality rates have been substantially worse than expected. As a result, Discovery Life and
Group Life have provisions of R2 393 million and R 300 million respectively to allow for the third wave mortality claims run-off
beyond the reporting period and the expected increase in claims and lapses arising from an anticipated fourth wave.
❚ 	In the United Kingdom (UK), while the Delta variant had a significant effect on infection rates, mortality rates were low,
resulting in VitalityLife providing for R 107 million to allow for an expected increase in future claims and lapses as a result of
the COVID-19 pandemic.
This estimation reflected management’s best estimate of the impact as at 30 June 2021.
The estimate includes an allowance for a third wave and fourth wave over the next financial year, as well as COVID-19 vaccinations in
the population over the period.
The expected increase in lapses over the short term was set at 30 June 2021 in light of the worsening economic factors and experience
in the book over previous stress periods.
Sensitivities from the base estimate have been tested against internal targets for capital adequacy and liquidity. This considered
varying levels of the vaccine rollout, the emergence of new vaccine-resistant variants or a material increase in case fatality rates.
Discovery’s sensitivities affirmed the the Group remains well capitalised.

-- 97 of 219 --

97 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
4. 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS
IN APPLYING ACCOUNTING POLICIES continued
4.1 	Policyholder liabilities assumptions and estimates, including assets
arising from insurance contracts continued
R million
June
2021
At beginning of the period 	2 729
Movements:
Unwinding, utilisation and release of provisions 	(1 886)
Provisions made during the period, including in respect of new business 	2 176
Other 	(220)
At end of the period 	2 800
CHANGES IN ASSUMPTIONS
Expected profits regarding future options on products are not recognised, but expected losses in respect of such options are
allowed for, in line with actuarial guidance.
Modelling and assumptions changes were made to the valuation at 30 June 2021 to ensure that assumptions are in line with the
best estimate of future experience. For Discovery Life, the total effect of these changes on the Assets arising from insurance
contracts was a decrease in the assets on the Financial Soundness Valuation basis of R2 537 million (2020: R5 761 million
decrease). For VitalityLife, the total effect of these changes was an increase in the assets of R832 million (2020: R2 489 million
decrease).
In addition to this, for Discovery Life, discretionary margins were reset to reflect the underlying profitability of the overall portfolio.
The reset of margins increased the assets on the Financial Soundness Valuation basis by R105 million (2020: R1 367 million
increase). Refer to note 5 for an analysis of these changes.
TAXATION
Future tax is allowed according to the current tax legislation and current tax rates. It is assumed that future tax on statutory
profits will be payable at the prevailing company tax rate of 28% (2020: 28%) in South Africa. The prevailing tax rate in the UK is
19% (2020: 19%). The UK has enacted an increase in the tax rate to 25% effective from 1 April 2023.
Tax amendments for Life Insurance companies introduced a Risk Policy Fund for all new risk business written after 1 July 2016. In
terms of this legislation, Discovery Life elected to move existing risk business to this Fund. As a result of these changes, the
assessed loss in the Individual Policyholder Fund is expected to stop increasing and be utilised over time. Therefore, in terms of
IAS 12 Income Taxes, a value of R991 million (2020: R854 million), which was previously implicit in the valuation of insurance
contract liabilities, was recognised explicitly as a deferred tax asset. The value is net of deferred capital gains tax liabilities.
To calculate this value, Discovery Life performed a probability-weighted cash flow forecast of the annual cash flows expected to
arise from the utilisation of the assessed loss. The primary factors that management has considered when arriving at the
probability are the expected market growth and withdrawal rate of the Linked Asset and Guaranteed Endowment book. For
Linked Assets, given the uncertainty inherent in market growth assumptions and the fact that discounting of cash flows is not
permitted by IAS 12, future market growth was assumed to be 0% to calculate the deferred tax asset. The expected income on
the debt portfolio held to match policyholder liabilities has been fully allowed for at current rates. For both the Linked and debt
portfolio, cash flows arising from the tax asset were further reduced to account for the uncertainty of future lapse rates and
product mix as well as the broader economic and legislative environment.
REINSURANCE
All prospective liabilities are valued gross of reinsurance and then adjusted for the expected effect of reinsurance. For outstanding
reported claims and IBNR, a specific allowance is made for reinsurance recoveries.
The Global Linkage Benefit is fully reinsured. The cost of the future reinsurance is dependent on the cost at which the reinsurer
can buy assets to match the liability under this benefit. Assumptions are made around the cost at which the reinsurer can
purchase these benefits based on the current and historical costs of these assets.
FINANCIAL SOUNDNESS VALUATION
The sensitivity of the policyholder liabilities on the Financial Soundness Valuation basis is set out in note 2.5.1. The sensitivity of
the policyholder liabilities on the INSPRU basis is set out in note 2.5.2.

-- 98 of 219 --

98 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
4. 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS
IN APPLYING ACCOUNTING POLICIES continued
4.2 	Annual assessment of goodwill impairment
Refer to note 10 Goodwill for a breakdown of business acquisitions resulting in goodwill.
Under IFRS, Discovery annually assesses goodwill allocated to the respective businesses as set out in note 10.
In the prior period, the assessment of goodwill allocated to VitalityHealth and VitalityLife was also included as a significant
accounting estimate in applying accounting policies. Based on the work performed during the prior financial period and the
financial year ended 30 June 2021, management considered that there is a very low risk of material adjustment to the carrying
amount of assets and liabilities within the next financial year. Accordingly, no further information is included within this note, as
this no longer meets the requirement of significant estimation uncertainty under IAS 1 Presentation of Financial Statements.
Discovery Bank
The Discovery Bank CGU comprise the various assets that collectively produce independent cash flows for Discovery Bank.
Discovery Bank’s income streams comprise interest earned on loans to customers, interest on excess cash invested, fees (e.g.,
banking fees, interchange fees and transaction fees) from banking. For the financial years ended 30 June 2021 and 30 June 2020,
the recoverable amount of the Discovery Bank cash-generating unit (CGU) was determined based on fair value less costs to sell.
Inherent in the determination of fair value less costs to sell is estimation uncertainty. The fair value measurement of the
recoverable amount is categorized as level 3 of the fair value hierarchy as unobservable inputs have been used in the calculation
of the fair value less costs to sell using the income approach.
In determining the assets to attribute to the Discovery Bank CGU, Discovery considered the assets required to perform banking
operations, including the banking license costs, the internally developed software in use, and the goodwill associated with the
DiscoveryCard business acquisition and related assets and liabilities. Therefore, the valuation also supports the recoverability of
goodwill, intangible assets and deferred tax.
Management has reviewed its business forecast, which comprises:
– A detailed 10-year business plan. The 10-year plan considers regulatory capital requirements, macro-economic forecasts and
customer behaviour assumptions when forecasting a statement of financial position, income statement and resultant equity
cash flows to/from shareholders. The 10-year period used to assess impairment is longer than the standard 5-year forecast
model generally applied in Discovery’s impairment testing. The business is still in the start-up phase, resulting in a 5-year
forecast not adequately reflecting the business plan. Management can project beyond the 5-years due to the insights from the
DiscoveryCard business it acquired.
– The terminal value was calculated using an extended cash flow forecasting method until the growth in earnings has stabilised
in year 20 and a final value considering perpetual terminal growth. This terminal value was discounted to year 10.
– As a reasonability check, Discovery Bank translates the value of the business at year 10 into a Price-Earnings (PE) multiple,
which it benchmarks against Discovery’s PE ratio and other emerging banks within the South African environment. The ratio
was determined to be within range.
– In the near term, expected credit losses and customer spending patterns were stressed for the impact of COVID-19.

-- 99 of 219 --

99 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
4. 	SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGEMENTS
IN APPLYING ACCOUNTING POLICIES continued
4.2 	Annual assessment of goodwill impairment continued
The key assumptions used by Discovery in the estimation are as follows:
– Conservative customer growth, targeting an achievable level of customers in year 10. After that, the customer base is treated
as stable. From the point of stability in year 20, the projected growth in profits is estimated at a conservative 5.0% (2020: 6%)
considering long-term inflation and long-term nominal GDP estimations.
– System-build costs and intangible assets acquired in the business combination have been amortised over 10 years (2020: 10
years). Useful lives range between 10 and 11 years (2020: 10 years).
– The discount rate applied to the cashflows comprised as follows:
Group
2021
Group
2020
Risk-free rate based on 10-year SA bond curve 	8.90% 	9.39%
Beta factor: The beta factor is a weighted average of large SA banks and Discovery 	1.09 	0.89
Discount rate applied 	16.38% 	16.74%
For the year ended 30 June 2021, management has engaged independent external valuation experts to benchmark the key
assumptions and ratios within the South African market. As a result, the assumptions were determined to be within acceptable
ranges.
Management has further performed stress tests by increasing the discount rate to 17.38% while simultaneously decreasing the
terminal growth rate to 4.5%. Again, no impairment was triggered with these stressed scenarios.
Based on management’s assessment, Discovery did not identify impairments.

-- 100 of 219 --

100 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
5. 	ASSETS ARISING FROM INSURANCE CONTRACTS
R million
Group
2021
Group
2020
Long-term insurance contracts – gross 	50 483 	48 042
Less: ceded to reinsurers (refer to note 19) 	(10 143) 	(11 043)
Long-term insurance contracts – net 	40 340 	36 999
Current 	2 754 	3 652
Non-current 	37 586 	33 347
40 340 	36 999
Movement in assets arising from insurance contracts
Balance at beginning of the year 	36 999 	39 408
Movement for the year:
Expected movement in policyholder liabilities 	(2 102) 	(2 625)
Unwinding of discount rate 	2 711 	2 170
New business written 	3 607 	3 834
Experience variances 	1 433 	(660)
Economic 	115 	(129)
Operational 	1 318 	(531)
Modelling and method changes 	(346) 	(111)
Changes in assumptions 	(1 359) 	(7 950)
Economic 	789 	(5 478)
Operational 	(2 148) 	(2 472)
Changes in margins1 	105 	1 367
Translation differences 	(708) 	1 566
Balance at end of the year 	40 340 	36 999
1 In line with accounting policy 13.1.1, the best estimate assumptions and margins are reset at every valuation date to reflect the underlying profitability
of the overall portfolio. Assumptions and margins are not set on new business in isolation but on a portfolio level.

-- 101 of 219 --

101 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
6. 	PROPERTY AND EQUIPMENT
Group
R million
Land and
buildings
Furniture,
fittings and
equipment
Computer
equipment
and
operating
systems
Leasehold
improve-
ments
Motor
Vehicles
Telematics
devices 	Total
Year ended 30 June 2021
Opening carrying amount 	3 437 	70 	298 	740 	21 	77 	4 643
Translation differences 	(46) 	(2) 	(7) 	(9) 	– 	– 	(64)
Additions 	8 	2 	231 	21 	7 	63 	332
Disposals
– Cost 	(26) 	– 	(37) 	– 	– 	(4) 	(67)
– Accumulated depreciation 	– 	– 	20 	– 	– 	3 	23
Derecognition
– Cost 	9 	(117) 	(262) 	(1) 	(1) 	(34) 	(406)
– Accumulated depreciation 	(9) 	115 	259 	– 	1 	28 	394
Impairment
– Cost 	(6) 	– 	(3) 	(133) 	– 	– 	(142)
– Accumulated depreciation 	1 	– 	1 	123 	– 	– 	125
Depreciation charge 	(297) 	(23) 	(176) 	(103) 	(10) 	(41) 	(650)
Closing carrying amount 	3 071 	45 	324 	638 	18 	92 	4 188
At 30 June 2021
Cost 	4 011 	173 	942 	1 015 	82 	273 	6 496
Accumulated depreciation 	(940) 	(128) 	(618) 	(377) 	(64) 	(181) 	(2 308)
Carrying amount 	3 071 	45 	324 	638 	18 	92 	4 188
Year ended 30 June 2020
Opening carrying amount 	3 580 	82 	285 	796 	17 	90 	4 850
Translation differences 	66 	4 	14 	13 	– 	– 	97
Additions 	93 	23 	155 	33 	13 	48 	365
Disposals
– Cost 	– 	– 	(1) 	– 	– 	(3) 	(4)
– Accumulated depreciation 	– 	– 	1 	– 	– 	2 	3
Derecognition
– Cost 	– 	(10) 	(13) 	– 	– 	(33) 	(56)
– Accumulated depreciation 	– 	3 	10 	– 	– 	18 	31
Depreciation charge 	(302) 	(32) 	(153) 	(102) 	(9) 	(45) 	(643)
Closing carrying amount 	3 437 	70 	298 	740 	21 	77 	4 643
At 30 June 2020
Cost 	4 081 	301 	1 061 	1 145 	74 	246 	6 908
Accumulated depreciation 	(644) 	(231) 	(763) 	(405) 	(53) 	(169) 	(2 265)
Carrying amount 	3 437 	70 	298 	740 	21 	77 	4 643
Derecognition
In Discovery Insure, when policies relating to motor vehicle insurance lapse, the telematics devices installed in those vehicles are
not always recovered. The value of these unrecovered units are derecognised.

-- 102 of 219 --

102 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
6. 	PROPERTY AND EQUIPMENT continued
LEASED ASSETS
The table above includes the following assets which are leased under a finance lease:
R million
Group
2021
Group
2020
Land and buildings 	2 891 	3 232
Computer equipment and operating systems 	70 	100
Leasehold improvements 	112 	133
Motor vehicles 	– 	1
Total 	3 073 	3 466
7. 	INTANGIBLE ASSETS
Group
R million
Software
development
Business
acquisitions:
Identifiable
Intangibles
Banking
license 	Total
Year ended 30 June 2021
Opening carrying amount 	5 825 	527 	29 	6 381
Translation differences 	(218) 	(30) 	– 	(248)
Additions 	1 587 	– 	– 	1 587
Amortisation charge 	(1 200) 	(66) 	– 	(1 266)
Impairment
– Cost 	(56) 	– 	– 	(56)
– Accumulated amortisation 	12 	– 	– 	12
Derecognition
– Cost 	(1 267) 	– 	– 	(1 267)
– Accumulated amortisation 	1 228 	– 	– 	1 228
Closing carrying amount 	5 911 	431 	29 	6 371
Year ended 30 June 2021
Cost 	9 496 	1 850 	29 	11 375
Accumulated amortisation 	(3 585) 	(1 419) 	– 	(5 004)
Carrying amount 	5 911 	431 	29 	6 371
Business acquisitions
Intangibles identified in the acquisition of business combinations are amortised over their remaining useful lives and only tested
for impairment if an indication of impairment arises. There was no indication of impairment for the current reporting period.
Included in the value of business acquisitions are:
❚ 	Customer contracts represented by value-in-force business acquired in the Standard Life Healthcare and PrimeMed business
combinations. The carrying amount as at 30 June 2021 is R316 million (2020: R396 million). The Primemed customer contract
has been fully amortised at 30 June 2021; and
❚ 	Client relationships and Core Deposit Funding Benefit acquired in the DiscoveryCard business combination. The carrying
amounts as at 30 June 2021 are R100 million and R15 million respectively (2020: R113 million and R17 million).
Banking license
– During the 2018 financial year, Discovery incurred costs of R29 million in respect of the application for a banking license.
Discovery has capitalised these costs in terms of IAS 38 Intangible Assets. This asset has an indefinite useful life.

-- 103 of 219 --

103 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
7. 	INTANGIBLE ASSETS continued
Group
R million
Software
development
Business
acquisitions:
Identifiable
intangibles
Banking
license 	Total
Year ended 30 June 2020
Opening carrying amount 	5 034 	534 	29 	5 597
Translation differences 	296 	69 	– 	365
Additions 	1 840 	– 	– 	1 840
Amortisation charge 	(1 111) 	(76) 	– 	(1 187)
Impairment
– Cost 	(107) 	– 	– 	(107)
– Accumulated amortisation 	44 	– 	– 	44
Derecognition
– Cost 	(235) 	– 	– 	(235)
– Accumulated amortisation 	64 	– 	– 	64
Closing carrying amount 	5 825 	527 	29 	6 381
At 30 June 2020
Cost 	9 116 	1 780 	29 	10 925
Accumulated amortisation 	(3 291) 	(1 253) 	– 	(4 544)
Carrying amount 	5 825 	527 	29 	6 381

-- 104 of 219 --

104 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
8. 	DEFERRED ACQUISITION COSTS
R million
Group
2021
Group
2020
Balance at beginning of the year 	632 	536
Translation differences 	(46) 	93
Additions 	1 667 	1 439
Deferred acquisition costs amortised 	(1 668) 	(1 436)
Balance at end of the year 	585 	632
9. 	ASSETS ARISING FROM CONTRACTS WITH CUSTOMERS AND
CONTRACT LIABILITIES
Where either party to a contract has performed, Discovery presents either a contract asset or contract liability, depending on the
relationship between Discovery’s performance and the customer’s payment. Unconditional rights to consideration is presented
separately as a receivable.
Group
R million
Assets
arising from
contracts
with
customer1
Costs of
obtaining
contracts 1
Contract
liabilities
Contract
receivables 2
Year ended 30 June 2021
Balance at beginning of the year 	108 	846 	(808) 	1 413
Accrued income recognised during the year 	112 	– 	– 	–
Payments received 	(35) 	– 	– 	(11 287)
Costs of obtaining new contracts 	– 	488 	– 	–
Amortised during the year 	– 	(243) 	– 	–
Contract liabilities recognised in the current year 	– 	– 	(413) 	–
Revenue recognised in the year 	– 	– 	391 	11 182
Provision of impairment of contract receivables 	– 	– 	– 	11
Foreign exchange revaluations 	– 	(2) 	– 	(21)
Translation differences 	(23) 	(3) 	54 	(81)
Balance at end of the year 	162 	1 086 	(776) 	1 217
Year ended 30 June 2020
Balance at beginning of the year 	8 	744 	(433) 	1 369
Accrued income recognised during the year 	91 	– 	– 	–
Payments received 	(1) 	– 	– 	(11 098)
Costs of obtaining new contracts 	– 	309 	– 	–
Amortised during the year 	– 	(210) 	– 	–
Contract liabilities recognised in the current year 	– 	– 	(669) 	–
Revenue recognised in the year 	– 	– 	367 	11 064
Provision of impairment of contract receivables 	– 	– 	– 	(49)
Foreign exchange revaluations 	– 	– 	– 	30
Revenue recognised for changes related to prior year 	– 	– 	(12) 	–
Translation differences 	10 	3 	(61) 	97
Balance at end of the year 	108 	846 	(808) 	1 413
1 Presented as assets arising from contracts with customers.
2 Presented as part of insurance receivables, contract receivables and other receivables.

-- 105 of 219 --

105 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
9. 	ASSETS ARISING FROM CONTRACTS WITH CUSTOMERS AND
CONTRACT LIABILITIES continued
The contract liability primarily relates to the advance consideration received from customers for the initial advisor fees, for which
revenue will be recognised over the expected terms of the arrangement. It further includes the Discovery Miles liability on the
Vitality Programme.
The transaction price is allocated to remaining performance obligations, which represents the fixed revenue in future for stand
ready services, to provide Intellectual Property services for VitalityOne System.
Group
R million
Contract
amount
for future
service 	< 1 year 	2 – 3 years 	4 – 5 years 	> 5 years
Year ended 30 June 2021
Provision of stand ready Intellectual Property services 	2 374 	368 	786 	681 	539
Total 	2 374 	368 	786 	681 	539
Group
R million
Contract
amount
for future
service 	< 1 year 	2 – 3 years 	4 – 5 years 	> 5 years
Year ended 30 June 2020
Provision of stand ready Intellectual Property services 	146 	25 	44 	38 	39
Total 	146 	25 	44 	38 	39
Where performance obligations are discharged within 12 months or where contracts are cancellable giving 12 months or less
notice, without the payment of a significant penalty, a practical expedient has been applied. Discovery has excluded these contracts
from the disclosures above. Contracts that include variable considerations have also not been included in the table above.
10. 	GOODWILL
Goodwill is not amortised, but is tested on an annual basis for impairment. Any impairment is recognised immediately in profit
or loss and is not subsequently reversed.
The table below sets out the goodwill allocated to the respective cash generating units (CGU’s) which are expected to benefit from
the synergies of the business combination. Impairment of goodwill is assessed at this CGU level.
R million
Reconciliation of goodwill
Value in functional currency on
date of acquisition 	2021 	2020
Goodwill
– Vitality Health1, 2, 5, 6 	GBP 100.3 million 	1 980 	2 151
– VitalityLife1, 5, 7 	GBP 23.4 million 	462 	502
– Discovery Bank3 	ZAR 2 417 million 	2 417 	2 417
– Liberty Health Administrators4 	ZAR 20 million 	20 	–
Total 	4 879 	5 070
1 GBP 96.7 million and GBP 23.4 million of the goodwill was allocated to VitalityHealth and VitalityLife respectively as at 31 July 2010. The goodwill arose
from the acquisition of Standard Life Healthcare and related capital restructure of the Prudential joint venture.
2 GBP 2.5 million goodwill from the acquisition of Insure Your Health (25 March 2013) and GBP 1.1 million of goodwill from the acquisition of KYS
Paid Limited (30 April 2014) were allocated to the VitalityHealth CGU.
3 R2 417 million goodwill from the acquisition of the DiscoveryCard business on 1 March 2019 was allocated to the Discovery Bank CGU. See note 4.2
for information on the impairment of goodwill of Discovery Bank.
4 In October 2020, Discovery acquired Liberty Health Administrators, a wholly owned subsidiary, which performs medical aid administration for specified
medical aids.
5 As part of the annual assessment of impairment, Discovery has done significant stresses on the goodwill of VitalityHealth and VitalityLIfe. The value-in-
use considers the ‘value of in-force’ business as well as new business. The value-in-use is calculated as the present value of the best-estimate pre-tax
cash flows of the CGU for the in-force policies at the valuation date and 10 years of new business. The outcome of the calculation indicated that there
is significant headroom, with little risk for impairment.
6 Net exchange rate differences of R171 million (2020: R347 million) were recognised in the current financial year.
7 Net exchange rate differences of R40 million (2020: R81 million) were recognised in the current financial year.

-- 106 of 219 --

106 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
11. 	EQUITY-ACCOUNTED INVESTEES
R million
Group
2021
Group
2020
Carrying value of material interest in associates and joint ventures - Ping An Health 	2 198 	1 815
Carrying value of material interest in associated and joint ventures - CMT 	1 127 	695
Carrying value of individually immaterial interest in associates 	134 	178
Carrying value of individually immaterial interest in joint ventures 	– 	25
Investment in equity-accounted investees 	3 459 	2 713
11.1 Material interests in associates and joint ventures
The table below provides summarised financial information for the Group’s material joint ventures and associates. The
information disclosed reflects the amounts presented in the financial statements of the relevant associates and joint ventures
and not Discovery’s share of those amounts.
Ping An Health Insurance Company of China, Limited (Ping An Health or PAH)
Ping An Health offers policyholders in China cover for a range of private healthcare-related claims. PAH is a strategic partnership
for the group, providing access to new clients and markets in China.
Cambridge Mobile Telematics Inc. (CMT)
A United States of America based leading telematics technology provider. This partnership provides the group with expertise in
the telematics environment that Discovery Insure harnesses to manage its insurance risk.
Ping An Health 	CMT
Ownership structure 	Equity-accounted associate 	Equity-accounted associate
Nature 	Insurance 	Telematics technology
Place of business 	China 	USA
R million 	2021 	2020 	2021 	2020
% of ownership interest at end of year 	24.99% 	24.99% 	8.96% 	11.25%
Summarised statement of comprehensive income
Revenue 	25 484 	18 023 	1 537 	1 498)
Net profit/(loss) 	1 884 	1 141 	80 	(573)
Other comprehensive (loss)/income 	(8) 	74 	– 	–
Total comprehensive income 	1 876 	1 215 	80 	(573)
Summarised statement of financial position
Current assets 	16 482 	17 515 	3 292 	6 056
Non-current assets 	21 584 	17 953 	9 824 	179
Current liabilities 	(5 400) 	(6 711) 	(538) 	(471)
Non-current liabilities 	(24 941) 	(22 664) 	(308) 	(15)
Net assets 	7 725 	6 093 	12 270 	5 749
Reconciliation to carrying amounts:
Opening net assets 	6 093 	3 964 	5 749 	4 559
Profit/(loss) for the year 	1 884 	1 141 	80 	(573)
Other comprehensive (loss)/income 	(8) 	74 	– 	–
Increase in share capital and share premium 	425 	– 	7 352 	760
Foreign exchange (losses)/gains 	(669) 	914 	(911) 	1 003
Closing net assets 	7 725 	6 093 	12 270 	5 749
Group’s share of net assets 	1 931 	1 523 	1 099 	647
Goodwill 	267 	292 	28 	48
Carrying value at 30 June 	2 198 	1 815 	1 127 	695

-- 107 of 219 --

107 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
11. 	EQUITY-ACCOUNTED INVESTEES continued
11.1 Material interests in associates and joint ventures continued
DILUTION GAIN FROM CAMBRIDGE MOBILE TELEMATICS TRANSACTION
Cambridge Mobile Telematics (CMT), an associate investment of Discovery and strategic partner to Discovery Insure since 2014,
finalised the acquisition of Truemotion Inc. on 16 June 2021 for USD 650 million (R10 billion). The transaction subsequently received
the required approval from the U.S. regulators. Upon the completion of the transaction, Discovery’s effective shareholding in CMT
reduced from 9.58% to 7.89% on a fully diluted basis. Discovery’s profit from the transaction was USD 38.7 million (R537 million). The
profit has been included in the ‘Gain on dilution and disposal of equity-accounted investments’ in the Group Income statement.
Discovery Insure’s director representation and strategic partnership with CMT remains in place following the transaction.
11.2 Individually immaterial associates and joint ventures
11.2.1 Individually material transactions
IMPAIRMENT OF INVESTMENT IN AIA VITALITY (PTY) LTD
Discovery Vitality Australia (Pty) Limited (DVA), a wholly-owned subsidiary of Vitality Group International Inc. (VGI), has an associate
investment in AIA Vitality (Pty) Limited (AIAV). The value of AIAV is directly influenced by AIA Health Australia (Pty) Limited (AIAH),
an Australian health insurance joint venture between GMHBA Limited and VGI and AIA Australia via its indirect interest through
AIAV. An impairment assessment was conducted as per the Discovery impairment policy and impairment indicators were
identified.
During the current financial year the Group conducted an impairment assessment of the investment in AIAV. Objective evidence
of impairment of AIAV as a result of internal and external indicators has been identified. The impairment indicators had an impact
on the estimated future cash flows from the net investment that can be reliable, estimated and an impairment loss of AUD 12.5
million (ZAR149 million) was recognised in profit and loss.
In order to determine the recoverable amount, the fair value less cost to sell comprise of the present value of the future expected
cash flows to be derived from the investment in the associate based on a 9-year forecast of cashflows. Nine years is based on the
expectation of the health insurance to stabilise. The following variables were used in the assessment:
❚ 	Average growth rate of 20% based on the expected growth rate in the health insurance industry.
❚ 	Discount rate of 41.11 % based on the Capital Asset Pricing Model (CAPM) approach using Discovery’s beta coefficient. This
has also been caliberated to approximate a WACC approach based on Discovery’s capital structure.
❚ 	Terminal value growth rate of 3%
The key assumptions were stressed and factored decreases in future policy sales into account, varying levels of terminal values,
higher claims scenarios and adjusted discount rates.
Based on management’s valuation, the value-in-use was lower than the carrying amount.
11.2.2 Summary of financial information
The table below provides summarised information of the aggregate carrying amounts and aggregate amounts of the Group’s
share of total income:
Group
R million
Associates 	Joint ventures
2021 	2020 	2021 	2020
Aggregate carrying amount 	134 	178 	(1) 	25
Aggregate amount of the group’s share of profit (loss) 	40 	(61) 	1 	16
Impairment of equity-accounted investments 	(149) 	– 	– 	–

-- 108 of 219 --

108 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
12. 	FINANCIAL ASSETS
The Group’s investment in financial assets are summarised by measurement category in the table below:
R million
Group
2021
Group
2020
Restated
Financial assets at fair value through profit or loss – mandatorily: 	130 937 	102 714
– Equity portfolios 	43 362 	32 748
– Debt portfolios 	36 485 	30 580
– Money market portfolios 	17 253 	13 600
– Multi-asset portfolios 	33 837 	25 786
Financial assets at amortised cost: 	8 965 	4 371
Investments at amortised cost1 	5 604 	2 523
– South African Treasury Bills 	4 109 	439
– Deposits 	1 495 	2 084
Loans and advances to customers at amortised cost 	3 361 	1 848
Total investments 	139 902 	107 085
Listed 	121 057 	93 705
Unlisted 	18 845 	13 380
139 902 	107 085
Shareholder investments: 	17 854 	12 026
– Investments at amortised cost 	8 965 	4 371
– Investments at fair value through profit and loss - mandatorily 	8 889 	7 655
Policyholder investments: 	122 048 	95 059
– Investments at fair value through profit and loss - mandatorily 	122 048 	95 059
Total investments 	139 902 	107 085
1 The fair value of instruments at amortised cost approximates the carrying amount due to the relatively short term nature of the instrument.
Also see Note 3. During the current financial period Discovery has simplified the financial risk analysis by revising the unit of
account or level at which the financial risk has been analysed. The updated disclosure provides information that is reliable and
more relevant to users of the financial statements and the comparative numbers have been restated accordingly to align to the
information presented in Note 3.

-- 109 of 219 --

109 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
12. 	FINANCIAL ASSETS continued
12.1 Loans and advances to customers
Group
R million 	2021 	2020
Loans and advances (gross) – unsecured 	3 795 	2 014
Accrued interest 	31 	16
Total Gross advances 	3 826 	2 030
Less: IFRS9 Expected credit losses (ECL) 	(465) 	(182)
Total net loans and advances 	3 361 	1 848
12.1.1 Loans and advances per credit risk rating
Group
R million 	DRG 1 – 4 	DRG 5 – 7 	DRG 8 – 10 	Not rated 	Total
As at 30 June 2021
Stage 1 	1 633 	1 197 	302 	83 	3 215
Stage 2: SICR1 	1 	6 	259 	4 	270
Stage 2: Arrears 	10 	21 	35 	5 	71
Stage 3 	22 	52 	147 	18 	239
Total gross advances 	1 666 	1 276 	743 	110 	3 795
As at 30 June 2020
Stage 1 	998 	547 	– 	48 	1 593
Stage 2: SICR1 	* 	* 	303 	1 	304
Stage 2: Arrears 	9 	20 	51 	6 	86
Stage 3 	3 	6 	16 	6 	31
Total gross advances 	1 010 	573 	370 	61 	2 014
* Amount is less than R500 000.
1 Significant increase in credit risk.
The analysis above excludes accrued interest.
Discovery risk grade (DRG), is an internal client rate allocated on the basis of their risk profile. An adjusted DRG is allocated for
the purposes of calculating the expected credit losses.
Loans and advances classified as ‘not rated’ pertain to loans and advances migrated from DiscoveryCard which has not been
through Discovery Bank credit assessment, and have not been assigned a DRG. To determine the ECL on these customers,
information from the DiscoveryCard back book is used.

-- 110 of 219 --

110 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
12. 	FINANCIAL ASSETS continued
12.1.2 Reconciliation of the expected credit loss (ECL)
As at 30 June 2021
Group
R million
Stage 1
(12-month ECL)
Stage 2
(Lifetime ECL,
but no missed
payments)
Stage 2
(Lifetime ECL,
and missed
payments)
Stage 3
(Lifetime ECL,
and credit
impaired,
default) 	Total
30 June 2021
Balance at beginning of the year 	81 	52 	26 	23 	182
Total changes in ECL due to changes
in balances of advances 	101 	23 	23 	11 	158
New loans originated and acquired1 	64 	25 	24 	4 	117
Repayments and other movements 2 	41 	– 	– 	8 	49
Changes in ECL due to derecognition
other than write-off 	(4) 	(2) 	(1) 	(1) 	(8)
182 	75 	49 	34 	340
Transfers between stages 3
Transfer (to)/from stage 1 	14 	(25) 	2 	59 	50
Transfer (to)/from stage 2: SICR 	– 	– 	(1) 	46 	45
Transfer (to)/from stage 2: Arrears 	(4) 	– 	– 	69 	65
Transfer (to)/from stage 3 	– 	(9) 	(26) 	– 	(35)
Balance at end of the year 	192 	41 	24 	208 	465
30 June 2020
Balance at beginning of the year 	* 	* 	* 	* 	*
Total changes in ECL due to changes
in balances of advances 	84 	38 	20 	3 	145
New loans originated and acquired1 	45 	38 	21 	4 	108
Repayments and other movements2 	39 	* 	(1) 	* 	38
Changes in ECL due to derecognition
other than write-off 	* 	* 	* 	(1) 	(1)
84 	38 	20 	3 	145
Transfers between stages3
Transfer (to)/from stage 1 	– 	16 	7 	15 	38
Transfer (to)/from stage 2: SICR 	(2) 	– 	1 	2 	1
Transfer (to)/from stage 2: Arrears 	* 	(2) 	– 	3 	1
Transfer (to)/from stage 3 	(1) 	* 	(2) 	– 	(3)
Balance at end of the year 	81 	52 	26 	23 	182
* Amount is less than R500 000.
1 During the financial year ended 30 June 2021, new loans included platinum Visa bins migrating customers from the FNB platform to Discovery Bank
platform. Gross Loans and advances as a result of migration amounted to R1.5 billion with a related ECL of R114 million (2020: customers migrating
from FNB platform to the Discovery Bank amounted to R836 million with a related ECL of R77 million).
2 During the year ending 30 June 2021, management has adjusted for the effects of COVID-19 in considering forward looking macroeconomic factors.
The adjustment specifically associated with the factors had an increase in ECL of R 24.1million (2020: R31 million).
3 Discovery’s policy is to transfer accounts between stages based on the ECL stage at the end of the reporting period. Therefore, exposures can be
transferred directly from stage 3 to stage 1 as the curing requirements would have been satisfied during the reporting period. The expected credit loss
recognised on new exposures originated during the reporting period, which are not included in opening balances, are recognised in new loans
originated and acquired based on the exposures ECL stage as at the end of the month the account comes on book. Any change in status will be
reflected in the transfers between stages as described above.

-- 111 of 219 --

111 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
13. 	DERIVATIVE FINANCIAL INSTRUMENTS
R million
Group
2021
Assets
Group
2021
Liabilities
Group
2020
Assets
Group
2020
Liabilities
Derivatives used as cash flow hedges:
Equity price risk derivatives 	23 	(129) 	14 	(338)
Interest rate swaps 	5 	(332) 	– 	(516)
Derivatives not designated as hedging instruments:
Interest rate swaps 	27 	(243) 	1 091 	(8)
Swaptions 	135 	– 	2 	–
Equity price risk derivatives 	1 	(22) 	– 	(41)
Expected credit loss derivatives 	– 	– 	– 	(83)
Currency derivative contracts 	58 	(100) 	263 	(6)
249 	(826) 	1 370 	(992)
Current 	93 	(176) 	259 	(854)
Non-current 	156 	(650) 	1 111 	(138)
249 	(826) 	1 370 	(992)
Total return swaps and call options are entered into to hedge exposure to equity price risk related to share schemes. This includes
a day one profit or loss balance of R115 million (2020: R102 million).
The effects of the derivatives used in cash flow hedges on the Group’s financial position and performance are as follows:
Year ended 30 June 2021
Group
R million
Notional
amount of
the hedging
instrument
Carrying amount
of the hedging
instrument
Line item
in the
Statement
of financial
position
where the
hedging
instrument
is presented
Changes
in fair value
of hedging
instrument
used for
calculating
hedge
ineffective-
ness
Ineffective-
ness
recognised
in profit
or loss
Line item in
which hedge
ineffectiveness
is presented
in profit or loss	Assets 	Liabilities
Equity price risk 	851 	23 	(129) 	(171) 	(8)
Total return swaps 	791 	18 	(129) 	Financial
Asset-
Derivative/
Financial
Liability-
Derivative
(174) 	(11) Net fair value
gains on
financial assets
at fair value
through profit
or loss
Call options 	60 	5 	– 	Financial
Asset-
Derivative
3 	3 	Net fair value
gains on
financial assets
at fair value
through profit
or loss
Interest rate risk 	5 000 	5 	(332) 	(189) 	–
Interest rate swaps 	5 000 	5 	(332) 	Financial
Asset-
Derivative/
Financial
Liability-
Derivative
(189) 	– 	Net fair value
gains on
financial assets
at fair value
through profit
or loss
Refer to note 3.4.1 for a detailed description of the derivative financial instruments listed above.

-- 112 of 219 --

112 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
13. 	DERIVATIVE FINANCIAL INSTRUMENTS continued
Group
R million
Changes in
the value of
the hedging
instrument
recognised
in other
comprehen-
sive income
Amount
reclassified
from the
cash flow
hedge
reserve to
profit or
loss
Line item
in which
the
recycled
amount is
presented
in profit
or loss
Carrying amount of the
hedged item
Changes in
fair value of
hedged item
used for
calculating
hedge
ineffective-
ness
Cash flow
hedge
reserve	Assets 	Liabilities
Equity price risk1 	171 	(82) 	– 	(364) 	230 	(10)
Total return swaps 	174 	(90) 	Cash flow
hedges-gains
recycled to
profit or loss
– 	(360) 	233 	(8)
Call options 	(3) 	8 	Cash flow
hedges-gains
recycled to
profit or loss
– 	(4) 	(3) 	(2)
Interest rate risk 2 	189 	(8) 	– 	(5 034) 	(202) 	(335)
Interest rate
swaps
189 	(8) 	Cash flow
hedges-gains
recycled to
profit or loss
– 	(5 034) 	(202) 	(335)
1 The equity price risk derivatives have been recycled to the ‘Cash flow hedges – gains recycled to profit or loss’ line item in the SOCI.
2 The interest rate risk derivatives have been recycled to the ‘Cash flow hedges – gains recycled to profit or loss’ line item in the SOCI.

-- 113 of 219 --

113 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
13. 	DERIVATIVE FINANCIAL INSTRUMENTS continued
Year ended 30 June 2020
Group
R million
Notional
amount of
the hedging
instrument
Line item in
the Statement
of financial
position
where the
hedging
instrument is
presented
Changes
in fair value
of hedging
instrument
used for
calculating
hedge
ineffective-
ness
Ineffective-
ness
recognised
in profit
or loss
Line item in
which hedge
ineffective-
ness is
presented in
profit or loss
Carrying amount of the
hedging instrument
Assets 	Liabilities
Equity price risk 	1 145 	14 	(338) 	402 	13
Total return swaps 	984 	– 	(338) 	Financial
Liability –
Derivative
341 	12 	Net fair value
gains on
financial
assets at fair
value
through
profit or loss
Call options 	161 	14 	– 	Financial
Asset –
Derivative
61 	1 	Net fair value
gains on
financial
assets at fair
value
through
profit or loss
Interest rate risk 	4 500 	– 	(516) 	372 	–
Interest rate swaps 	4 500 	– 	(516) 	Financial
Liability –
Derivative
372 	– 	Net fair value
gains on
financial
assets at fair
value
through
profit or loss
Refer to note 3.4.1 for a detailed description of the derivative financial instruments listed above.
Group
R million
Changes in
the value of
the hedging
instrument
recognised
in other
comprehen-
sive income
Amount
reclassified
from the
cash flow
hedge
reserve to
profit or
loss
Line item in
which the
recycled
amount is
presented in
profit or loss
Changes in
fair value of
hedged item
used for
calculating
hedge
ineffective-
ness
Cash flow
hedge
reserve
Carrying amount of the
hedged item
Assets 	Liabilities
Equity price risk1 	(409) 	309 	– 	(389) 	27 	(87)
Total return swaps 	(348) 	249 	Cash flow
hedges –
gains
recycled to
profit or loss
– 	(381) 	68 	(81)
Call options 	(61) 	60 	Cash flow
hedges –
gains
recycled to
profit or loss
– 	(8) 	(41) 	(6)
Interest rate risk 2 	(353) 	10 	– 	(4 536) 	366 	(516)
Interest rate
swaps
(353) 	10 	Cash flow
hedges –
gains
recycled to
profit or loss
– 	(4 536) 	366 	(516)
1 	The equity price risk derivatives have been recycled to the cash flow hedges – gains recycled to profit or loss line items in the SOCI.
2 	The interest rate risk derivatives have been recycled to the cash flow hedges – gains recycled to profit or loss line item in the SOCI.

-- 114 of 219 --

114 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
14. 	INSURANCE RECEIVABLES, CONTRACT RECEIVABLES AND OTHER
RECEIVABLES
R million
Group
2021
Group
2020
Receivables arising from insurance and reinsurance contracts: 	6 158 	6 179
– Premium debtors 	668 	692
– Less provision for impairment of premium debtors 	14.1 	(63) 	(93)
– Reinsurance debtors2 	5 553 	5 580
Contract receivables 	1 217 	1 413
– Closed scheme debtors 	104 	103
– Discovery Health Medical Scheme 	662 	650
– Other contract receivables 	480 	709
– Less allowance for expected credit losses 	14.2 	(29) 	(49)
Other non-financial receivables1 	969 	1 081
– Prepayments 	851 	898
– Value-added tax asset 	53 	104
– Other debtors 	65 	79
Other financial receivables: 	2 189 	2 763
– Agents and brokers 	412 	491
– BEE partners’ rights-issue funding 	1 	19
– Cash-in-transit debtors 	220 	96
– Consolidated unit trust debtors 	587 	1 169
– FNB – DiscoveryCard receivable 	– 	52
– Loans to BEE initiatives 	220 	213
– Security deposit on derivatives 	289 	407
– Vitality partner debtors 	112 	116
– Other debtors 	809 	636
– Less allowance for expected credit losses 	14.2 	(461) 	(436)
Total insurance receivables, contract receivables and other receivables 	10 533 	11 436
Current 	7 110 	7 140
Non-current 	3 423 	4 296
10 533 	11 436
1 These non-financial assets have been excluded from the risk disclosures presented in note 3.
2 The movement for the period includes the acceleration of the reinsurance repayment. Refer note 41.
The carrying values approximate the fair value due to the short term nature of these receivables, or for longer term receivables,
they are interest bearing at market rates and fully secured.

-- 115 of 219 --

115 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
14. 	INSURANCE RECEIVABLES, CONTRACT RECEIVABLES AND OTHER
RECEIVABLES continued
14.1 Provision for impairment of premium debtors
Group
R million 	<30 days
30 – 60
days
60 – 120
days
more than
120 days 	Total
Year ended 30 June 2021
Balance at beginning of the year 	46 	33 	7 	7 	93
Increase in provision 	– 	– 	11 	8 	19
Amount utilised during the period 	(20) 	(17) 	(6) 	(6) 	(49)
Translation difference 	* 	* 	* 	* 	*
Balance at end of the year 	26 	16 	12 	9 	63
Year ended 30 June 2020
Balance at beginning of the year 	44 	25 	9 	5 	83
Increase in provision 	11 	25 	7 	5 	48
Amount utilised during the period 	(9) 	(18) 	(9) 	(4) 	(40)
Translation difference 	* 	1 	* 	1 	2
Balance at end of the year 	46 	33 	7 	7 	93
* Amount is less than R500 000.
14.2 Reconciliation of expected credit losses (ECL)
Group
R million
General model 	Simplified model
Stage 1
(12-month
ECL)
Stage 2
(Lifetime
ECL)
Stage 3
(Lifetime
ECL/credit
impaired)
Not
Credit
impaired
90 days
past due/
credit
impaired 	Total
Year ended 30 June 2021
Balance at beginning of the year 	48 	8 	249 	123 	57 	485
Increase in provision 	3 	– 	22 	8 	201 	234
Amount utilised during the period 	(40) 	– 	(41) 	(33) 	(101) 	(215)
Translation difference 	* 	* 	* 	* 	(14) 	(14)
Balance at end of the year 	11 	8 	230 	98 	143 	490
Year ended 30 June 2020
Balance at beginning of the year 	44 	3 	192 	80 	26 	345
Increase in provision 	6 	5 	57 	51 	92 	211
Amount utilised during the period 	(9) 	– 	– 	(8) 	(61) 	(78)
Translation difference 	7 	– 	– 	– 	– 	7
Balance at end of the year 	48 	8 	249 	123 	57 	485
15. 	REINSURANCE CONTRACTS
R million
Group
2021
Group
2020
Reinsurers’ share of insurance contract liabilities 	445 	400
Current 	445 	400
Amounts due from reinsurers in respect of claims paid and reported by the Group on the contracts that are reinsured are
included in Insurance receivables, contract receivables and other receivables (refer to note 14).

-- 116 of 219 --

116 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
16. 	CASH AND CASH EQUIVALENTS
R million
Group
2021
Group
2020
Cash at bank and in hand 	17 984 	16 990
Short-term deposits 	2 029 	919
20 013 	17 909
The fair value of cash and cash equivalents approximates the carrying amount due to the relatively short term nature of
the instrument.
17. 	SHARE CAPITAL AND SHARE PREMIUM
17.1 Ordinary share capital and share premium
Issued 	Treasury shares
Group
R million
Share
capital
Share
premium
Discovery
Health
BEE
share trust 	LTIP
Total
outstanding
At 1 July 2019 	1 	10 214 	(14) 	(59) 	– 	10 142
Share movements:
– treasury shares delivered 	– 	– 	– 	10 	– 	10
– treasury share purchases 	– 	– 	– 	(4) 	– 	(4)
At 30 June 2020 	1 	10 214 	(14) 	(53) 	– 	10 148
Share movements:
– share issue 	– 	907 	– 	– 	– 	907
– treasury shares delivered 	– 	– 	– 	3 	– 	3
– treasury share purchases 	– 	– 	– 	– 	(907) 	(907)
At 30 June 2021 	1 	11 121 	(14) 	(50) 	(907) 	10 151
Treasury shares
Number of shares 	Company
Discovery
Health
BEE
share trust 	LTIP
Total
outstanding
At 1 July 2019 	658 290 736 	(680 268) 	(1 007 490) 	– 	656 602 978
Share movements:
– treasury shares delivered 	– 	– 	81 030 	– 	81 030
– treasury shares purchased 	– 	– 	(40 000) 	– 	(40 000)
At 30 June 2020 	658 290 736 	(680 268) 	(966 460) 	– 	41 030
Share movements:
– share issue 	7 477 865 	– 	– 	– 	7 477 865
– treasury shares delivered 	– 	– 	160 499 	– 	160 499
– treasury shares purchased 	– 	– 	– 	(7 477 865) 	(7 477 865)
At 30 June 2021 	665 768 601 	(680 268) 	(805 961) 	(7 477 865) 	656 804 507
The total authorised number of ordinary shares is 1 billion (2020: 1 billion), with a par value of 0.1 cent per share.
Share issue in 2021 financial reporting period
Discovery issued 7 447 865 shares for cash consideration of R906 915 467. This was a specific issuance, to the Discovery Long-
Term Incentive Plan Trust.

-- 117 of 219 --

117 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
17. 	SHARE CAPITAL AND SHARE PREMIUM continued
17.2 Preference share capital
R million
Group
2021
Group
2020
Authorised
40 000 000 A no par value preference shares 	– 	–
20 000 000 B preference shares of R100 each 	2 000 	2 000
20 000 000 C no par value preference shares 	– 	–
2 000 	2 000
Issued
8 000 000 B preference shares of R100 each 	800 	800
Share issue costs 	(21) 	(21)
At 30 June 	779 	779
The B preference shares are non-compulsory, non-cumulative, non-participating, non-convertible, voluntarily redeemable (at
option of Discovery) preference shares and were issued at a coupon rate of 85% of prime rate. With the introduction of dividend
withholding tax on 1 April 2012, the coupon rate on the preference shares was increased to 100% of the prime rate.
18. 	LIABILITIES ARISING FROM INSURANCE CONTRACTS
R million
Group
2021
Group
2020
Gross
– claims reported and loss adjustment expenses 	11 234 	9 290
– claims incurred but not reported 	2 074 	1 754
– IFA liability 	82 	69
– unearned premiums 	1 091 	1 548
– additional unexpired risk reserve2 	300 	–
– unit-linked insurance contracts 	64 432 	49 752
– with fixed and guaranteed terms 	21 764 	19 998
Total liabilities arising from insurance contracts, gross 	100 977 	82 411
Recoverable from reinsurers
– claims incurred but not reported 	(439) 	(394)
– unearned premiums 	(6) 	(6)
Total reinsurers’ share of liabilities arising from insurance contracts (refer to note 15) 	(445) 	(400)
Net
– claims reported and loss adjustment expenses 	11 234 	9 290
– claims incurred but not reported 	1 635 	1 360
– IFA liability 	82 	69
– unearned premiums 	1 085 	1 542
– additional unexpired risk reserve 	300 	–
– unit-linked insurance contracts 	64 432 	49 752
– with fixed and guaranteed terms 	21 764 	19 998
Total liabilities arising from insurance contracts, net 	100 532 	82 011
Current1 	83 914 	66 677
Non-current 	16 618 	15 334
100 532 	82 011
1 Includes R69 549 million (2020: R54 646 million) which is repayable to policyholders on demand. For contractual maturity refer to note 3.2.3.
Included in the change in liabilities arising from insurance contracts on the Statement of comprehensive income is R120 million (2020: R115 million)
of benefit expenses which is a reconciling item due to the cash flow impact of these benefit expenses in this note.
2 It is expected that the claims and cost of managing the Group Life portfolio during the remaining contractual period for the policies will exceed the
premiums during the same period, as at 30 June 2021. Accordingly, an additional unexpired risk reserve (AURR) liability was recognised for the Group
Life portfolio in accordance with the liability adequacy test as set out in accounting policy 13.3.

-- 118 of 219 --

118 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
18. 	LIABILITIES ARISING FROM INSURANCE CONTRACTS continued
Movements in the liabilities are as follows:
Group
R million
2021 	2020
Gross Reinsurance 	Net 	Gross Reinsurance 	Net
Claims reported and loss
adjustment expenses and IBNR
Notified claims 	9 290 	– 	9 290 	8 428 	* 	8 428
Incurred but not reported 	1 754 	(394) 	1 360 	1 382 	(312) 	1 070
Balance at beginning of the year 	11 044 	(394) 	650 	9 810 	(312) 	9 450
Cash paid for claims settled in the year 	(11 636) 	29 	(11 607) 	(11 441) 	23 	(11 418)
Increase/(decrease) in liabilities:
– arising from current year claims 	14 994 	(171) 	14 823 	13 121 	(137) 	12 984
– arising from prior year claims 	(908) 	79 	(829) 	(742) 	65 	(677)
Translation differences 	(186) 	18 	(168) 	296 	(33) 	263
Balance at end of the year 	13 308 	(439) 	12 869 	11 044 	(394) 	10 650
Notified claims 	11 234 	– 	11 234 	9 290 	– 	9 290
Incurred but not reported 	2 074 	(439) 	1 635 	1 754 	(394) 	1 360
Balance at end of the year 	13 308 	(439) 	12 869 	11 044 	(394) 	10 650
IFA liability
Balance at beginning of the year 	69 	– 	69 	60 	– 	60
Increase in the year 	28 	– 	28 	20 	– 	20
Cash paid 	(15) 	– 	(15) 	(11) 	– 	(11)
Balance at end of the year 	82 	– 	82 	69 	– 	69
Provisions for unearned premiums
Balance at beginning of the year 	1 548 	(6) 	1 542 	544 	(2) 	542
Increase in the year 	1 496 	(6) 	1 490 	1 942 	(6) 	1 936
Release in the year 	(1 857) 	6 	(1 851) 	(1 098) 	2 	(1 096)
Translation differences 	(96) 	– 	(96) 	160 	– 	160
Balance at end of the year 	1 091 	(6) 	1 085 	1 548 	(6) 	1 542
Additional unexpired risk reserve
Balance at beginning of the year 	– 	– 	– 	– 	– 	–
Increase in the year 	300 	– 	300 	– 	– 	–
Translation differences 	– 	– 	– 	– 	– 	–
Balance at end of the year 	300 	– 	300 	– 	– 	–
* Amount is less than R500 000.
R million
Group
2021
Group
2020
Unit-linked insurance contracts
Balance at beginning of the year 	49 752 	45 411
Premiums received 	16 198 	12 542
Fair value adjustment 	8 338 	57
Withdrawals 	(7 747) 	(7 008)
Fees 	(1 234) 	(1 143)
Movement in negative insurance liability 	(223) 	(522)
Translation differences 	(652) 	415
Balance at end of the year 	64 432 	49 752
Balance is made up as follows:
Unit-linked liabilities 	69 549 	54 646
Negative insurance liability 	(5 117) 	(4 894)
64 432 	49 752
With fixed and guaranteed terms
Balance at beginning of the year 	19 998 	14 697
Expected movement in policyholder liabilities 	(4 201) 	(2 716)
Unwinding of discount rate 	888 	835
New business written 	4 396 	6 352
Experience variances 	683 	830
Balance at end of the year 	21 764 	19 998

-- 119 of 219 --

119 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
19. 	LIABILITIES ARISING FROM REINSURANCE CONTRACTS
R million
Group
2021
Group
2020
Financial reinsurance 	2 382 	1 422
Reinsurance recoveries relating to assets arising from insurance contracts (refer to note 5) 	10 143 	11 043
12 525 	12 465
Balance at beginning of the year 	12 465 	10 835
Increase in liability 	664 	462
– gross increase in liability 	(266) 	598
– receipt arising from reinsurance contracts1 	2 926 	2 588
– reinsurance premiums paid 	(1 996) 	(2 724)
Translation differences 	(604) 	1 168
Balance at end of the year 	12 525 	12 465
Current 	919 	1 278
Non-current 	11 606 	11 187
12 525 	12 465
1 During the current financial period, Discovery Life Limited entered into a financial reinsurance treaty, with risk transfer, resulting in a cash inflow of
R500 million. This treaty reinsures approximately 2.0% of the assets arising from insurance contracts at 30 June 2021. In the Group Income statement
the inflow has been disclosed as a receipt from reinsurance contracts. An equal and opposite adjustment was made to the insurance reserves, resulting
in an equal and opposite adjustment in the ‘net transfer to/ from assets and liabilities under insurance contracts’, and therefore an impact of Rnil on
profit or loss for the period.
The liabilities arising from reinsurance contracts releases with the associated underlying insurance contracts.
20. BORROWINGS AT AMORTISED COST
R million 	Ref
Group
2021
Group
2020
Borrowings from banks 	(i) 	15 230 	15 456
Lease liabilities 	(ii) 	4 263 	4 380
Balance at end of the year 	19 493 	19 836
Current 	2 065 	1 345
Non-current 	17 428 	18 491
Balance at end of the year 	19 493 	19 836
For variable rate loans, the carrying amount approximates the fair value because the variable rate is set on market related terms.
For fixed rate loans, the fair value is R3 817 million relative to the carrying value of R3 862 million.
(i) 	Borrowings from banks
Movement analysis of borrowings
R million
Group
2021
Group
2020
Balance at beginning of the year 	15 456 	11 034
Loans raised 	1 839 	10 339
Loans repaid 	(1 753) 	(6 389)
Settlement of derivative capitalised to loan by counterparty 	– 	(6)
Interest accrued 	971 	1 033
Interest paid 	(941) 	(957)
Raising fees capitalised 	(39) 	(29)
Translation differences 	(303) 	431
Balance at end of the year 	15 230 	15 456

-- 120 of 219 --

120 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
20. 	BORROWINGS AT AMORTISED COST continued
(i) 	Borrowings from banks continued
SA borrowing facilities
DISCOVERY LIMITED
Carrying value
R million
Facility amount
R million 	Variable rate
Interest
per annum
Capital repayment
and maturity date
June
2021
June
2020
Listed DMTN4,6
500 	3-month Jibar + 161bps 	9.71%1,3 	At maturity – 21 November 2022 	503 	503
500 	3-month Jibar + 205bps 	6.30%1,3 	At maturity – 21 August 2023 	503 	–
200 	– 	10.46%2 	At maturity – 21 November 2024 	202 	202
800 	3-month Jibar + 191bps 	10.31%1,3 	At maturity – 21 November 2024 	804 	805
1 200 	3-month Jibar + 191bps 	9.21%1,3 	At maturity – 21 November 2024 	1 220 	1 225
700 	3-month Jibar + 180bps 	10.29%1,3 	At maturity – 21 August 2026 	703 	704
300 	3-month Jibar + 180bps 	9.40%1,3 	At maturity – 21 August 2026 	302 	303
Unlisted DMTN4,5
1 100 	– 	8.92%3 	At maturity – 10 March 2023 	1 103 	1 101
2 500 	– 	9.62%3 	At maturity – 22 February 2025 	2 519 	2 516
Other
1 000 	3-month Jibar + 245bps 	10.28%1,3 	At maturity – 02 March 2023 	999 	997
500 	3-month Jibar + 86bps 	5.85%6 	At maturity – 30 June 2022 	659 	630
9 300 	9 517 	8 986
1 The interest rate has been fixed through interest rate swaps.
2 Interest is payable semi-annually in arrears.
3 Interest payable quarterly in arrears.
4 DMTN refers to the R10 billion Discovery Domestic Medium Term Note (DMTN) program registered in 2017.
5 During the financial year ended 30 June 2020, Discovery Limited refinanced R3.6 billion bank syndicated loans through the issue of unlisted DMTN
notes. The notes, although underwritten by a bank until maturity, are structured to enable short-term issuances into the commercial paper market on
an ongoing basis.
6 The prevailing interest rate at 30 June 2021.

-- 121 of 219 --

121 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
20. 	BORROWINGS AT AMORTISED COST continued
(i) 	Borrowings from banks continued
SA borrowing facilities
DISCOVERY CENTRAL SERVICES
Carrying value
R million
Facility amount
R million
Interest rate
per annum
Capital repayment and
maturity date
June
2021
June
2020
1 400 	10.60%1 	At maturity – 20 December 2023 	1 423 	1 430
650 	11.56%2 	Instalments – 29 October 2027 	526 	542
2 050 	1 949 	1 972
1 Interest payable quarterly in arrears.
2 Instalments of interest and capital is monthly.
DISCOVERY BANK
Carrying value
R million
Facility amount
R million
Interest rate
per annum
Capital repayment
and maturity date
June
2021
June
2020
500 	Jibar + 125 bps1 	At maturity – 19 July 20212 	– 	500
500 	Jibar + 135bps1 	At maturity – 19 July 20212 	– 	500
– 	1 000
1 Interest payable quarterly in arrears.
2 These loan facilities had a maturity date of 19 July 2021 with the ability to early settle without any penalties being incurred. The loans were settled early
on 15 February 2021.
UK borrowings Carrying value
GBP (Rand) million
Facility amount
GPB million 	Variable rate
Interest rate
per annum
Capital repayment
and maturity date
June
2021
June
2020
80 3-month Libor + 265bps1 	2.73% Instalments – 31 July 2023 GBP 73 (R1 435) 	GBP 80 (R1 719)
34 3-month Libor + 100bps1 	1.08% At maturity – 18 April 2022 GBP 26 	(R512) 	GBP 28 	(R602)
100 3-month Libor + 229bps1 	2.38% At maturity – 31 July 2023 GBP 89 (R1 817) 	GBP 55 (R1 177)
214 	GBP 188 (R3 764) 	GBP 163 (R3 498)
1 Interest payable quarterly in arrears.

-- 122 of 219 --

122 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
20. 	BORROWINGS AT AMORTISED COST continued
(ii) 	Leases
R million
Group
2021
Group
2020
Balance at beginning of the year 	4 380 	4 396
New leases entered into 	57 	44
Interest payable 	436 	441
Repayments 	(613) 	(576)
Modifications 	46 	–
Translation difference 	(43) 	75
Balance at end of the year 	4 263 	4 380
Total payments for leases for the year is R815 million (2020: R826 million).
During the 2018 financial year Discovery took occupation of a new head office building under a finance lease. A lease liability and
related asset (refer to note 6) of R3 155 million was raised. At year end, R3 388 million (2020: R3 370 million) remained outstanding.
Finance charges of R366 million (2020: R362 million) have been recognised in profit or loss and repayments of R348 million
(2020: R313 million) have been made.
21. 	INVESTMENT CONTRACTS AT FAIR VALUE THROUGH PROFIT OR LOSS
R million
Group
2021
Group
2020
The movements during the year were as follows:
Balance at beginning of the year 	23 012 	20 674
Deposits received 	12 527 	8 085
Account balances paid on withdrawal and other terminations in the year 	(6 882) 	(5 898)
Fair value adjustment 	3 634 	151
Balance at end of the year 	32 291 	23 012
Current1 	32 291 	23 012
1 There is no maturity profile for these liabilities as this will depend on policyholder behaviour. Contractually, policyholders may disinvest on demand.
The benefits offered under the Group’s unit-linked investment contracts are based on the return of selected equities, debt securities
and money market securities. The Group communicates the actual performance of these contracts to its contract holders.
Investment contracts at fair value through profit or loss are exactly matched with related assets and managed collectively as a
pool. Discovery’s credit risk is not reflected in the measurement of the assets or consequently the liability, which is measured with
reference to the underlying assets. Own credit risk has been assessed and determined to be immaterial.

-- 123 of 219 --

123 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
22. 	OTHER PAYABLES AT AMORTISED COST
R million
Group
2021
Group
2020
Commissions payable 	213 	300
Consolidated unit trust payables 	659 	432
Digicore payable 	9 	9
Due to reinsurers 	448 	667
Expired hedge payables 	21 	29
Intermediary payables 	99 	90
Payables and accrued liabilities 	3 146 	2 399
Payroll creditors 	929 	845
Policyholder unallocated funds 	961 	564
Security deposits on derivatives 	2 	1 150
Unsettled trades 	376 	148
VitalityLife working capital funding1 	6 809 	6 627
Other financial payables 	880 	673
Other non-financial payables2 	352 	300
– Value-added tax liability 	193 	155
– Premiums and fees received in advance 	159 	145
Balance at end of the year 	14 904 	14 233
Current 	7 238 	5 956
Non-current 	7 666 	8 277
14 904 	14 233
1 Includes the ‘deposit back’ of GBP 315 million (R6 210 million) (2020 GBP 288 million (R6 176 million)) related to the level premium reinsurance treaty
in respect of business written on Prudential Assurance Company’s (Prudential’s) life license, payable to the reinsurer.
2 Value-added tax liabilities and premiums received in advance are non-financial liabilities and have been excluded from the risk disclosures presented
in note 3.
23. 	DEFERRED INCOME TAX
R million
Group
2021
Group
2020
Deferred tax asset – non-current 	3 948 	3 511
Deferred tax liability – non-current 	(8 814) 	(8 514)
Total 	(4 866) 	(5 003)

-- 124 of 219 --

124 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
23. 	DEFERRED INCOME TAX continued
Deferred taxation comprises:
Charge for the year 	Charge for the year
Group
R million
Balance at
beginning of
the year
Recognised
in Profit or
loss
Recognised
in OCI
Recognised
in business
combinations
Translation
differences
Balance
at end of
the year
Year ended 30 June 2021
Assessed loss in Company Policyholder's Fund 	203 	(18) 	– 	– 	– 	185
Assessed loss in Individual Policyholder's Fund 	854 	280 	– 	– 	– 	1 134
Assessed loss in subsidiaries 	2 373 	242 	– 	6 	(182) 	2 439
Financial instruments and share based payments 	96 	91 	(16) 	– 	(2) 	169
Deferred acquisition costs 	(166) 	(60) 	– 	– 	(1) 	(227)
Contract liability 	18 	64 	– 	– 	(12) 	70
Difference between wear and tear and depreciation and leases 	(171) 	(112) 	– 	– 	7 	(276)
Intangible asset recognised on acquisition of business 	(74) 	12 	– 	– 	5 	(57)
Prepayments 	(40) 	26 	– 	– 	– 	(14)
Provisions 	225 	119 	– 	– 	(4) 	340
Difference between accounting and tax balances arising from insurance
contracts 	(8 681) 	(248) 	– 	– 	– 	(8 929)
Other 	360 	(97) 	– 	– 	37 	300
(5 003) 	299 	(16) 	6 	(152) 	(4 866)
Charge for the year 	Charge for the year
Group
R million
Balance at
beginning of
the year
Recognised
in Profit or
loss
Recognised
in OCI
Recognised
in business
combinations
Translation
differences
Balance
at end of
the year
Year ended 30 June 2020
Assessed loss in Company Policyholder's Fund 	226 	(23) 	– 	– 	– 	203
Assessed loss in Individual Policyholder's Fund 	728 	126 	– 	– 	– 	854
Assessed loss in subsidiaries 	1 313 	394 	– 	– 	78 	1 785
Unrealised gains/ (losses) on finanical instruments 	(50) 	28 	14 	1 	– 	(7)
Cash flow hedge 	(13) 	52 	13 	– 	– 	52
Deferred acquisition costs 	(167) 	(5) 	– 	– 	6 	(166)
Contract liability 	24 	(13) 	– 	– 	7 	18
Difference between accounting and tax balances arising from insurance
contracts 	(8 854) 	173 	– 	– 	– 	(8 681)
Difference between wear and tear and depreciation 	(1 150) 	(108) 	– 	– 	(1) 	(1 259)
Leases – asset and liability 	1 014 	72 	– 	– 	2 	1 088
Intangibles recognised on acquisition of businesses 	(72) 	10 	– 	– 	(12) 	(74)
Prepayments 	(41) 	1 	– 	– 	– 	(40)
Provisions 	161 	64 	– 	– 	– 	225
Share-based payments 	93 	(43) 	– 	– 	1 	51
Unutilised special transfer balances 	477 	111 	– 	– 	– 	588
Other 	(14) 	283 	– 	– 	91 	360
(6 325) 	1 122 	27 	1 	172 	(5 003)

-- 125 of 219 --

125 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
23. 	DEFERRED INCOME TAX continued
Assessed losses
Discovery did not recognise deferred tax assets in respect of the following assessed losses:
R million
Group
2021
Group
2020
Better Health Insurance Advice Ltd 	33 	–
Discovery Central Services (Pty) Ltd 	2 854 	1 356
Discovery Connect Distribution Services (Pty) Ltd 	– 	524
Discovery Group Europe Ltd 	46 	50
Discovery Life – Individual Policyholders’ Fund 	7 992 	9 994
Discovery Partner Markets Service PTE Ltd 	46 	51
Discovery Vitality Australia (Pty) Ltd 	28 	126
Grove Nursing Services (Pty) Ltd 	39 	36
Southern Rx (Pty) Ltd 	93 	80
Vitality Healty Workplace Ltd 	16 	–
11 147 	12 217
A deferred tax asset has been recognised on assessed losses in the Discovery Life Individual Policyholder Fund. Refer to note 4.1.
Deferred tax assets have been raised in respect of tax losses in Discovery Life Investment Services, Discovery Vitality, Vitality
Health, Discovery Connect Distribution Services and Discovery Insure. The Group recognises deferred tax assets on carried
forward losses to the extent there are sufficient estimated future taxable profits and/or taxable temporary differences against
which the tax losses can be utilised.
24. 	EMPLOYEE BENEFITS
R million
Group
2021
Group
2020
Leave pay
Balance at beginning of the year 	284 	260
Additional provisions raised 	312 	331
Used during the year 	(253) 	(283)
Paid to terminated employees 	(27) 	(24)
Translation differences 	(1) 	–
Balance at end of the year 	315 	284
Current 	262 	229
Non-current 	53 	55
315 	284

-- 126 of 219 --

126 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
25. 	NET INSURANCE PREMIUM REVENUE
R million
Group
2021
Group
2020
Health 	8 599 	7 688
Recurring premiums 	11 262 	9 278
Reinsurance premiums 	(1 840) 	(1 590)
Accelerated reinsurance premiums 1 	(823) 	–
Individual life and invest 	32 364 	30 176
Recurring premiums 	28 023 	23 883
Single premiums 	10 016 	10 777
Reinsurance premiums 	(5 675) 	(4 484)
Group life 	2 062 	1 945
Recurring premiums 	2 249 	2 131
Reinsurance premiums 	(187) 	(186)
Short-term insurance 	4 358 	3 658
Recurring premiums 	4 385 	3 706
Reinsurance premiums 	(27) 	(48)
47 383 	43 467
Insurance premium revenue 	55 935 	49 775
Outward reinsurance premiums 	(7 729) 	(6 308)
Accelerated reinsurance premiums 	(823) 	–
47 383 	43 467
1 Refer to note 41 Accelerated reinsurance premiums.
26. 	INVESTMENT INCOME
R million
Group
2021
Group
2020
At amortised cost interest income using the effective interest rate method 	17 	36
Cash and cash equivalents interest income using the effective interest rate method 	263 	343
280 	379
Attributable to:
– shareholders 	141 	207
– policyholders 	139 	172
280 	379

-- 127 of 219 --

127 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
27. 	NET FAIR VALUE GAINS ON FINANCIAL ASSETS AT FAIR VALUE
THROUGH PROFIT OR LOSS
R million
Group
2021
Group
2020
Investment income 	2 535 	2 496
– Interest 	2 233 	2 155
– Dividends 	302 	341
Net realised (losses)/gains 	(216) 	426
Net fair value gains/(losses) 	8 336 	(215)
Hedge ineffectiveness 	8 	(13)
Mutual fund distributions 	1 228 	1 399
11 891 	4 093
28. 	NET CLAIMS AND POLICYHOLDERS’ BENEFITS
R million
Group
2021
Group
2020
Health insurance claims 	3 991 	3 700
Gross claims 	5 315 	4 875
Less: Reinsurance recoveries 	(1 324) 	(1 175)
Individual life insurance claims 	6 380 	3 984
Death 	5 076 	2 139
Disability 	3 801 	2 704
Payback benefits 	1 588 	1 343
Less: Reinsurance recoveries 	(4 085) 	(2 202)
Group life insurance claims 	2 569 	1 566
Death 	1 606 	819
Disability 	1 262 	911
Payback benefits 	8 	8
Less: Reinsurance recoveries 	(307) 	(172)
Individual investment benefits 	12 913 	10 721
Surrenders 	12 232 	10 106
Guaranteed payments 	56 	57
Annuity payments 	625 	558
Short-term insurance claims 	2 325 	3 275
Gross claims 	2 403 	3 336
Less: Reinsurance recoveries 	(78) 	(61)
28 178 	23 246
Claims and policyholders’ benefits 	33 972 	26 856
Insurance claims recovered from reinsurers 	(5 794) 	(3 610)
Net claims and policyholders’ benefits 	28 178 	23 246
29. 	ACQUISITION COSTS
R million
Group
2021
Group
2020
Commission and other costs of obtaining contracts 	5 032 	6 550
Movement in deferred acquisition costs (refer to note 8) 	1 	(3)
5 033 	6 547

-- 128 of 219 --

128 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
30. 	MARKETING AND ADMINISTRATION EXPENSES
R million
Group
2021
Group
2020
Auditors remuneration
Audit fees 	90 	69
Fees for other services 	2 	14
Prior year 	– 	1
92 	84
Lease charges
Short-term leases 	59 	74
Low value item leases 	143 	176
202 	250
Staff costs including executive directors1
Salaries, wages and allowances 	7 516 	7 061
Medical aid fund contributions 	451 	421
Defined contribution provident fund contributions 	366 	336
Social security levies 	263 	263
Share-based payment expenses
– equity-settled 	330 	164
– cash-settled 	195 	54
– (gain)/loss on cash flow hedge 	(6) 	360
Staff training 	36 	51
Recruitment fees 	29 	36
Temporary staff 	382 	216
Provision for leave pay 	59 	48
Other 	114 	247
9 735 	9 257
Other operating costs
Amortisation of software (note 7)2 	1 200 	1 111
Building related and office costs 	508 	524
Depreciation of property and equipment (note 6) 	650 	643
Loss on derecognition of property and equipment and intangible assets 	51 	196
Gains on disposal of property and equipment 	(3) 	(3)
Impairment of property and equipment and intangible assets 	61 	63
Allowance for expected credit losses on receivables 	(11) 	90
Insurance 	44 	37
IT systems and consumables 	2 123 	1 971
Marketing and distribution costs 	1 344 	1 254
Non-executive directors fees 	30 	27
Professional fees 	774 	707
Vitality benefit expenses 	3 259 	3 964
Other operating expenses 	2 620 	1 943
12 650 	12 527
Total marketing and administration expenses 	22 679 	22 118
1 Executive directors’ and prescribed officers’ remuneration is included in employee costs. Refer to Directorate for detailed disclosure.
2 The transactions relating to business combinations are not included in marketing and administration expenses as it is disclosed separately in the
income statement.

-- 129 of 219 --

129 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
31. 	SHARE-BASED PAYMENTS AND LONG TERM INCENTIVES
Incentive schemes
Discovery operates various share-based payment and long term incentive arrangements. The details of these arrangements are
described below:
1. BEE STAFF SHARE TRUST
In 2005, 5 290 000 shares in Discovery Limited’s shares were issued to the BEE staff share trust for current and future
employees. These shares had all been allocated during prior years. Additional shares have been purchased accumulatively in
prior years, for future allocation to employees. The trusts consist of two components; the allocation scheme and the option
scheme as described below.
ALLOCATION SCHEME
Shares have been allocated to senior black employees based on level of seniority and length of past service. The shares vest
to employees two, three, four and five years after allocation at a rate of 25% per annum. On each vesting date, the trustees
shall distribute to the employees the allocated shares to which the employee may be entitled.
OPTION SCHEME
Options granted to black employees may be exercised two, three, four and five years after the option is granted at a rate of
25% per annum. Any options not exercised by the end of the fifth year from the grant date shall lapse. On exercise of the
option, the employee pays cash to the trust for the full purchase price of the option.
2. DISCOVERY’S PHANTOM SCHEME
Participants earn a cash bonus based on allocation of bonus scheme units which in turn are linked to the performance of the
Discovery Limited share price. The bonus is earned if the participant is employed on each vesting date. For units issued in
September, the vesting of the units is two, three, four and five years after allocation of the bonus units. The bonus may not
be carried forward.
The 2013 – 2018 allocations were pre-determined combinations of units that replicate the economics of a Discovery Limited
share and units that replicate the economics of a call option over a Discovery Limited share.
3. DISCOVERY’S LONG-TERM INCENTIVE PLAN (EQUITY SETTLED)
The Discovery Long-term incentive plan (LTIP) was introduced in the financial year ended 30 June 2020 and replaced the cash-
settled Discovery Phantom scheme (see point 2 above) with an equity-settled LTIP.
Participants will receive Discovery Limited shares subject to performance criteria and if the participant is employed on each
vesting date. The performance conditions are aligned to the organic growth methodology of the Group and will vest from
between the 3rd and 5th anniversary of these awards.
4. ACQUISITION SCHEMES
There are various schemes offered to franchise directors, agents and employees where participants are allocated share units
which replicate the economics of a Discovery Limited share. The share units are settled as a cash bonus on vesting. The
bonus is earned if the participant is employed on the vesting date. The vesting periods on the schemes vary from two to five
years. The bonus may not be carried forward.
5. THE VITALITY GROUP PHANTOM STOCK PLAN
Participants earn a cash bonus based on allocation of bonus scheme units which in turn are linked to the performance of
Vitality Group Inc. share price. The bonus is earned if the participant is employed on each vesting date. The units typically vest
equally over a four-year period but three year vesting grants are offered as well.
6. DISCOVERY BANK SCHEME
Participants will receive Discovery Limited shares subject to the ‘Value Created’, which references the growth in the value of
Discovery Bank business after capital invested and interest. These awards vests from between the 3rd and 7th anniversary of
the market launch date of Discovery Bank, and each vesting is settled in three equal instalments over three years, if the
participant is employed on each vesting date.
Other long term incentive schemes
The following schemes are long term staff incentives where the value is determined with reference to something other than the
Discovery Limited share price. These schemes are accounted for in terms of IAS 19: Employee benefits.
7. THE VITALITYHEALTH AND VITALITYLIFE PHANTOM SHARE SCHEME
Participants earn a cash bonus based on allocation of bonus scheme units which in turn are linked to the performance of
VitalityLife and VitalityHealth, and more specifically the Value of In Force (ViF) of VitalityLife and the Embedded Value (EV) of
VitalityHealth. The bonus is earned if the participant is employed on each vesting date. For units issued, the vesting of the
units is two, three and four years after allocation of the bonus units. The bonus may not be carried forward.

-- 130 of 219 --

130 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
31. 	SHARE-BASED PAYMENTS AND LONG TERM INCENTIVES continued
8. THE VITALITYHEALTH AND VITALITYLIFE SCHEME
Shares in Discovery Holdings Europe Limited were issued to participants. The participants had the option to sell the shares
at any point in time until 12 March 2019 at which time their holding company, Discovery Group Europe Limited, had an
obligation to purchase the shares from them.
9. OTHER DEVELOPMENT SEGMENT SCHEMES
Various other long term incentive schemes exist in the Discovery Group in the development segments. These schemes are
individually and in aggregate immaterial and as a result no further information is disclosed.
The share/option schemes mentioned in bullet 1 and 3 have been classified as equity-settled schemes and therefore a share-based
payment reserve has been recognised. The schemes mentioned in bullets 2, 3 and 5 have been classified as cash-settled schemes
and a liability is raised in terms of IFRS 2. The other long term incentive schemes, have been accounted for in terms of IAS 19.
The following is a summary of the terms and conditions of the units granted:
Date granted
Share/
Option
price
Final
vesting
date
Shares
under
option at
beginning
of year
Share/
Options
granted
during
year
Share/
Options
vested
during
year
Share/
Options
cancelled
or adjusted
during year
Shares
under
option
at end
of year
1. BEE staff share trust
01/07/2015 – 30/06/2016 	R0.00 	30/09/2021 	10 847 	– 	(10 432) 	– 	415
01/07/2015 – 30/06/2016 	R122.41 	01/03/2021 	11 029 	– 	(11 029) 	– 	–
01/07/2015 – 30/06/2016 	R121.5 	30/03/2021 	24 692 	– 	(24 692) 	– 	–
01/07/2016 – 30/06/2017 	R0.00 	02/05/2022 	65 281 	– 	(32 844) 	(1 086) 	31 351
01/07/2016 – 30/06/2017 	R113 	30/11/2021 	2 124 	– 	(1 062) 	– 	1 062
01/07/2016 – 30/06/2017 	R122.5 	30/11/2021 	101 447 	– 	(26 883) 	(2 008) 	72 556
01/07/2017 – 30/06/2018 	R0.00 	22/05/2023 	63 208 	– 	(24 711) 	(6 085) 	32 412
01/07/2018 – 30/06/2019 	R0.00 	30/04/2024 	30 126 	– 	(9 179) 	(3 427) 	17 520
01/07/2019 – 30/06/2020 	R0.00 	30/09/2025 	56 892 	– 	(25 789) 	42 992 	74 095
01/07/2020 – 30/06/2021 	R0.00 	30/04/2026 	– 	29 935 	– 	– 	29 935
2. The Discovery Limited
phantom scheme
01/07/2015 – 30/06/2016 	R0.00 	30/04/2021 	217 666 	– 	(169 065) 	(48 601) 	–
01/07/2015 – 30/06/2016 	R122.50 – R134.94 	30/04/2021 	430 450 	– 	(424 285) 	(6 165) 	–
01/07/2016 – 30/06/2017 	R0.00 	30/04/2022 	1 030 681 	– 	(410 662) 	(121 475) 	498 544
01/07/2016 – 30/06/2017 	R110.40 – R115.23 	30/04/2022 	206 087 	– 	(97 439) 	(14 863) 	93 785
01/07/2017 – 30/06/2018 	R0.00 	31/03/2023 	1 688 873 	– 	(400 559) 	(187 341) 	1 100 973
01/07/2017 – 30/06/2018 	R84.76 – R141.65 	31/03/2023 	531 754 	– 	(176 051) 	(15 904) 	339 799
01/07/2018 – 30/06/2019 	R0.00 	31/03/2024 	1 912 887 	– 	(370 542) 	(173 139) 	1 369 206
3. Discovery LTIP
(equity settled)
01/07/2019 – 30/06/2020 	R0.00 	30/09/2024 	3 580 672 	– 	– 	(123 652) 	3 457 020
01/07/2020 – 30/06/2021 	R0.00 	30/09/2025 	– 	3 953 634 	– 	(82 989) 	3 870 645
4. Acquisition schemes
01/07/2014 – 30/06/2015 	R0.00 	30/06/2019 	1 841 	– 	– 	(1 841) 	–
01/07/2015 – 30/06/2016 	R0.00 	30/06/2020 	4 141 	– 	– 	(4 141) 	–
01/07/2015 – 30/06/2016 	R0.00 	30/06/2021 	38 059 	60 172 	(31 589) 	(66 642) 	–
01/07/2016 – 30/06/2017 	R0.00 	30/06/2022 	91 284 	2 678 	(43 299) 	(15 875) 	34 788
01/07/2017 – 30/06/2018 	R0.00 	30/06/2023 	565 591 	1 832 	(464 818) 	(37 650) 	64 955
01/07/2018 – 30/06/2019 	R0.00 	30/06/2024 	648 950 	1 484 	(32 636) 	(41 215) 	576 583
01/07/2019 – 30/06/2020 	R0.00 	30/06/2025 	766 481 	9 440 	(8 360) 	(25 018) 	742 543
01/07/2020 – 30/06/2021 	R0.00 	30/06/2026 	– 	830 418 	– 	(7 391) 	803 027
5. The Vitality Group
phantom stock plan
01/10/2016 	USD 0.00 	01/10/2021 	538 596 	– 	(519 896) 	(18 700) 	–

-- 131 of 219 --

131 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
31. 	SHARE-BASED PAYMENTS AND LONG TERM INCENTIVES continued
The Black-Scholes model was used to calculate the fair value of the following options based on the assumptions in the below
table:
Spot price
Risk free
interest rate 	Exercise price 	Option term 	Volatility
Dividend
yield
BEE staff share trust
Issued in prior years 	R113 – R127.14 	7.35% – 7.71% 	R113 – R122.50 	up to 0.25 years 	26.89% – 27.37% 1.31% – 1.70%
Phantom scheme
01/07/2016 –
30/06/2017 	R126.27 	3.67% 	R114.96 	up to 0.25 years 	30.76% 	0%
01/07/2017 –
30/06/2018 	R126.27 	3.67% – 4.28% 	R141.65 	up to 1.25 years 	38.19% 	0% – 2.16%
The VitalityHealth and VitalityLife phantom share scheme is cash settled and thus repriced at each reporting date. The value of
the shares and options allocated are dependent on the performance of VitalityLife and VitalityHealth, more specifically the ViF of
VitalityLife and the EV of VitalityHealth. The valuation of the Discovery Holdings Europe Limited equity share scheme options, is
calculated on the same basis.
The Discovery Limited phantom scheme, and Acquisition schemes are equity-settled and are thus repriced at each reporting date.
As noted in Note 3.4.1, Discovery is exposed to equity price risk through its cash-settled share incentive schemes, namely the
Phantom share scheme and the Acquisition share scheme, the details of which have been described above. To manage this risk,
Discovery has purchased a combination of total return swaps and call options from Ba1 (2020: Ba2 -Ba a3) rated South African
banks to hedge a portion of its exposure to changes in the Discovery share price.
Please refer to note 13 for more detail on the derivatives.
The Discovery LTIP is equity-settled, and accordingly Discovery determines the grant date fair value at the date of allocating the
grant to the employee. The grant date fair value is then recognised over the vesting period. The significant assumptions in
determining the grant date fair value were as follows:
Spot price
Risk free
interest rate 	Volatility1 	Vesting period 	Dividend yield
Discovery LTIP
01/07/2019 - 30/06/2020 	R 113,81 	6.68% - 7.01% 	R30,89% 	3 - 5 years 	2.21% - 2.52%
01/07/2020 - 30/06/2021 	R125.52 - R153.54 	3.9% - 5.02% 	37.02% - 42.21% 	3 - 5 years 	2.26% - 2.57%
1 The expected volatility is based on both the historical average share price and implied volatility derived from traded options over the groups ordinary
shares of maturity similar to those of the employee share options.
32. 	FINANCE COSTS
R million
Group
2021
Group
2020
Interest expense on:
– Borrowings measured at amortised cost using the effective interest method 	973 	1 033
– Release from other comprehensive income 	(8) 	10
– Lease liabilities (IFRS 16) 	436 	441
– Interest on other payables using the effective interest method 	247 	34
1 648 	1 568
33. 	NET FOREIGN EXCHANGE GAINS/(LOSSES)
R million
Group
2021
Group
2020
Net foreign exchange (losses)/gains 	(389) 	578
The net foreign exchange gains and losses arised primarily from foreign denomintated loans, some which are internal.
The total amount of foreign exchange gains or losses recognised in profit or loss is R396 million (2020: R734million) presented
with various lines associated with the underlying transaction.

-- 132 of 219 --

132 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
34. 	TAXATION
R million
Group
2021
Group
2020
Charge for the year:
Current taxation 	1 274 	1 746
Normal taxation
– current year charge 	1 236 	1 723
Capital gains taxation 	38 	23
Deferred taxation 	(299) 	(1 122)
Total income tax expense recognised in profit or loss 	975 	624
% 	%
Taxation rate reconciliation
Effective taxation rate 	23.2 	78.0
Subsidiary losses not provided for 	(6.6) 	(95.5)
Prior year (under)/over provision 	(1.9) 	(0.3)
Deferred tax asset raised on prior year losses/ unrecognised prior period losses utilised
in current period 	1.1 	27.6
Alignment to 'new IFRS tax-adjusted basis' 	– 	(0.1)
Tax on Individual Policyholder Fund 	0.7 	3.3
Tax on Company Policyholder Fund 	1.4 	0.8
Capital gains tax 	(1.5) 	0.8
Capital profits and dividend income 	6.2 	14.4
Non-deductible expenditure: Capital in nature 	(2.7) 	(7.5)
Non-deductible expenditure: Other individually immaterial 	(1.1) 	(0.2)
Non-taxable income: Other individually immaterial 	0.7 	0.2
Non-taxable 	6.9 	–
Tax rate change 	0.9 	1.4
Tax rate differences 	0.7 	4.6
Tax on eliminated intergroup transactions 	– 	0.5
Standard rate of taxation 	28.0 	28.0
For South African entities that are in a tax paying position, tax has been provided at 28% (2020: 28%). Discovery uses the South
African tax rate in respect of its tax rate reconciliation as Discovery Limited (holding company listed on the JSE) is domiciled in
South African and the most significant operations are in South Africa. There has been a proposal by South Africa’s National
Treasury that the corporate tax rate should reduce to 27% for tax years commencing after 1 April 2022. Discovery does not yet
deem this rate to be substantively enacted.
Taxation in respect of the South African life insurance operations is determined in accordance with the rates and basis applicable
to section 29A of the Income Tax Act at the reporting date.
35. 	EARNINGS PER SHARE Group
2021
Group
2020
Basic earnings per share
Earnings per share is based on net profit after tax attributable to ordinary shareholders
and the weighted number of ordinary shares in issue.
Net profit attributable to ordinary shareholders (R million) 	3 157 	97
Weighted number of ordinary shares in issue (000’s) 	656 710 	656 648
Basic earnings per share (cents) 	480.7 	14.8
Diluted earnings per share
Diluted earnings per share is calculated adjusting the weighted average number of ordinary
shares outstanding to assume conversion of all dilutive potential ordinary shares.
Weighted average ordinary shares in issue (000’s) adjusted for: 	656 710 	656 648
– Weighted average ordinary shares in the staff share trusts (000’s) 	141 	181
– Weighted average ordinary shares related to long term share incentive scheme (000’s) 	7 222 	4 414
664 073 	661 242
Diluted earnings per share (cents) 	475.4 	14.7

-- 133 of 219 --

133 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
35. 	EARNINGS PER SHARE continued
Group
2021
Group
2020
Headline earnings
Headline earnings per share is based on the net profit after tax attributable to ordinary
shareholders adjusted for items of a capital nature and the weighted average number
of ordinary shares in issue.
Headline earnings reconciliation (R million) 	3 157 	97
Net profit attributable to ordinary shareholders
Adjusted for:
– gain on dilution and disposal of equity-accounted investments 	(554) 	(3)
– tax on gain on dilution and disposal of equity-accounted investments 	140 	–
– impairment of equity accounted investments 	149
– impairment of goodwill 	– 	9
– (gain)/loss on disposal of property and equipment 	(3) 	(3)
– tax on gain/loss on disposal of property and equipment 	1 	1
– impairment of intangible assets and property and equipment 	61 	63
– tax on impairment of intangible assets 	(5) 	(19)
– derecognition of intangible assets and property and equipment 	50 	196
– tax on derecognition of intangible assets and property and equipment 	(10) 	(47)
– Discovery Limited’s share of headline earnings adjustments made by equity-accounted
investees:
○ 	derecognition of intangible assets and property and equipment 	– 	2
Headline earnings 	2 986 	296
Headline earnings per share (cents):
– basic 	454.7 	45.0
– diluted 	449.7 	44.7
Refer to accounting policy 27 in Annexure A on the calculation of normalised headline
earnings.
Headline earnings 	2 986 	296
– amortisation of intangibles from business combinations 	66 	76
– deferred tax on amortisation of intangibles from business combinations 	(13) 	(16)
– deferred tax assets raised on assessed losses 	(152) 	(275)
– unrealised (gains)/losses on foreign exchange contracts not designated as a hedge 	304 	(263)
– tax on unrealised on foreign exchange contracts not designated as a hedge 	(85) 	74
– initial expenses related to Prudential Book transfer 	– 	71
– tax on expenses related to Prudential Book transfer 	– 	(14)
– changes in economic assumptions in excess of available discretionary margin 	(790) 	5 708
– tax on charges in economic assumptions in excess of available discretionary margin 	112 	(1 413)
– fair value changes on VitalityLife interest rate derivatives 	1 170 	(758)
– tax on fair value changes on VitalityLife nterest rate derivatives 	(222) 	144
– restructuring costs 	33 	100
– tax on restructuring costs 	(6) 	(20)
– transaction costs related to VitalityLife interest rate derivatives 	4 	45
– tax on transaction costs related to VitalityLife interest rate derivatives 	(1) 	(8)
Normalised headline earnings 	3 406 	3 747
Normalised headline earnings per share (cents):
– basic 	518.7 	570.7
– diluted 	512.9 	566.7

-- 134 of 219 --

134 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
36. 	CASH FLOW INFORMATION
36.1 Cash generated by operations
R million
Group
2021
Group
2020
Cash generated by operations
Profit before taxation 	4 195 	800
Adjusted for:
Investment income 	(4 043) 	(4 274)
Realised loss/(gain) on financial assets 	216 	(426)
Finance costs 	1 648 	1 568
Premiums, claims and investment charges for liabilities under investment contracts 	5 645 	2 187
Non-cash items:
Allowance for expected credit losses 	(11) 	136
Amortisation of intangibles from business combinations 	66 	76
Amortisation of software 	1 200 	1 111
Assets arising from contracts with customers 	131 	119
Contract liabilities movement 	22 	314
Deferred acquisition costs 	1 	(3)
Derecognition and impairment of property and equipment 	29 	234
Derecognition and impairment of intangible assets 	83 	25
Depreciation 	650 	643
Fair value adjustment to liabilities under investment contracts 	3 634 	151
(Gain)/loss from derivatives 	(136) 	531
Gain on dilution and disposal of equity-accounted investments 	(554) 	(3)
Hedge ineffectiveness 	8 	13
Impairment of equity-accounted investment 	149 	–
Impairment of goodwill 	– 	9
Gain on diposal of property and equipment 	(3) 	(3)
Provision for employee benefits 	59 	48
Share-based payment expenses - cash settled 	330 	54
Share-based payment expenses - equity settled 	195 	164
Share of profits from equity-accounted investments 	(523) 	(264)
Transfer to assets under insurance contracts 	(545) 	(2 038)
Transfer to assets under reinsurance contracts 	(56) 	(53)
Transfer to liabilities under insurance contracts 	17 941 	9 418
Transfer to liabilities under reinsurance contracts 	(1 755) 	462
Economic assumption differences net of discretionary margins 	(790) 	5 708
Translation differences 	395 	(460)
Unearned premiums 	(360) 	844
Unrealised gains on investments at fair value through profit or loss 	(8 336) 	215
Working capital changes:
Deposits from customers 	6 558 	2 427
Loans and advances to customers 	(1 513) 	(1 836)
Loans and receivables including insurance receivables 	(205) 	(2 121)
Trade and other payables 	2 132 	3 244
Total 	26 457 	19 000

-- 135 of 219 --

135 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
36. 	CASH FLOW INFORMATION continued
36.2 Taxation paid
R million
Group
2021
Group
2020
Balance at beginning of the year 	(611) 	(140)
Taxation charged for the year in the income statement 	(975) 	(624)
Adjustment for movement in deferred taxation 	(299) 	(1 122)
Taxation charged for the year in other comprehensive income 	– 	32
Reallocation to seperately disclosable items 	195 	–
Translation differences 	(5) 	(46)
Balance at end of the year 	(22) 	611
Total 	(1 717) 	(1 289)
36.3 Movement in borrowings
R million
Group
2021
Group
2020
Balance at beginning of the year excluding bank overdraft 	19 836 	14 682
Leased assets acquired and IFRS 16 transition 	56 	792
Increase in borrowings 	1 839 	10 339
Raising fees capitalised 	(39) 	(29)
Interest accrued on borrowings 	1 407 	1 474
Interest paid on borrowings 	(941) 	(1 289)
Repayment of borrowings 	(2 366) 	(6 639)
Modification to lease assets 	46 	–
Translation differences 	(345) 	506
Balance at end of the year excluding overdrafts with banks 	19 493 	19 836
37. 	COMMITMENTS
Capital commitments
R million
Group
2021
Group
2020
Capital expenditure approved but not contracted for at the reporting date is as follows:
Intangible assets 	140 	189
Development costs for Discovery Bank 	325 	388
464 	577
Also refer to Capital discussion in Directors’ report.

-- 136 of 219 --

136 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
38. 	DIVIDENDS PER SHARE
38.1 Dividends per ordinary share
Due to the uncertain and potentially volatile environment caused by the COVID-19 pandemic, Discovery did not pay out any
ordinary dividends for the year ended 30 June 2020.
The dividends paid in 2020 totalled R1 413 million and comprised a final dividend of 114 cents per share paid on 7 October 2019
and an interim dividend of 101 cents per share paid on 23 March 2020.
38.2 Dividends per preference share
The dividends paid in 2021 totalled R63 million and comprised a final dividend of 433.21918 (346.57534 net of withholding
tax) cents per share paid on 28 September 2020 and an interim dividend of 354.52055 (283.61644 net of withholding tax)
cents per share paid on 15 March 2021.
The dividends paid in 2020 totalled R81 million and comprised a final dividend of 508.28767 (406.63014 net of withholding
tax) cents per share paid on 23 September 2019 and an interim dividend of 505.41097 (404.32878 net of withholding tax)
cents per share paid on 16 March 2020.
39. 	CONTINGENCIES
The Group is exposed to no material contingencies at 30 June 2021.
40. 	RELATED PARTIES
40.1 List of related parties as defined
Subsidiaries
Details of subsidiaries directly and indirectly owned by Discovery Limited are contained in Company note 2. Also refer to Directors’
report ‘Nature of Business’.
Associates and Joint Ventures
Details of Discovery’s material associates and joint ventures are contained in note 11.
Corporate investors
Rand Merchant Investment Holdings Limited has a 25.04% shareholding in Discovery Limited.
Key management personnel
Key management personnel have been defined as directors of Discovery Limited, Discovery Health Proprietary Limited and
Discovery Life Limited, as these businesses constitute the majority of the Discovery Group.
A list of the directors and prescribed officers of Discovery Limited can be found in the Directors’ report.
To the extent specific transactions have occurred between Discovery and key management personnel, including close family
members of key management, (as defined in IAS 24) the details are included in the aggregate disclosure contained below under
key management and where significant, full details of all relationships and terms of the transactions are provided.

-- 137 of 219 --

137 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
40. 	RELATED PARTIES continued
40.2 Transactions with related parties
Cambridge Mobile Telematics Inc. (CMT)
Discovery Insure paid fees on a monthly basis to CMT for the collation and interpretation of data and the translating of driving
behaviour into scorable events. Fees paid for the year totalled R11 million (2020: R11 million).
Key management personnel of Discovery Limited, families of key management (as
defined in IAS 24) and entities significantly influenced or controlled by key management
INSURANCE CONTRACTS
Aggregated insured cover 	Premiums received 	Claims paid
R’000 	2021 	2020 	2021 	2020 	2021 	2020
Life insurance 	1 016 334 	1 070 749 	6 347 	6 543 	– 	–
Short-term insurance 	630 404 	444 908 	2 723 	2 154 	1 622 	424
Short-term health insurance 	– 	– 	79 	53 	27 	4
INVESTMENT CONTRACTS
Investment values 	Premiums received 	Withdrawal benefits 	Investment returns
R’000 	2021 	2020 	2021 	2020 	2021 	2020 	2021 	2020
Investment contracts 	116 523 	62 735 	56 328 	6 634 	19 216 	8 322 	6 522 	3 391
VITALITY LOYALTY PROGRAMME
Premiums received 	Amounts paid
R’000 	2021 	2020 	2021 	2020
Vitality benefits 	79 	78 	571 	1 397
During the current financial year, the DiscoveryCard benefits were migrated to Discovery Vitality. There are, there fore, no
transaction for 2021.
DISCOVERYBANK
Loans 	Savings 	Fees
R’000 	2021 	2020 	2021 	2020 	2021 	2020
DiscoveryBank 	1 345 	969 	32 141 	10 688 	244 	358
During the current financial year DiscoveryCard migrated to DiscoveryBank.
Key management personnel, their families (as defined in IAS 24) and entities significantly influenced or controlled by key
management accrued 149 388 Discovery miles as part of the DiscoveryCard loyalty programme for the year ended 30 June 2021
(2020: 80 056).
Aggregate shareholdings of key management personnel, their families (as defined in IAS 24) and entities significantly influenced
or controlled by key management, in Discovery Limited as at 30 June 2021 was 78 620 184 ordinary shares (2020: 87 263 243
ordinary shares).
During the current financial year the following transaction occurred between Discovery and key management personnel, their
families (as defined in IAS 24) and entities significantly influenced or controlled by key management:
❚ 	sponsorship and enterprise development grants to the value of R1.9 million (2020: R1.7 million) were made to organisations
where members of key management personnel have significant influence.

-- 138 of 219 --

138 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
40. 	RELATED PARTIES continued
40.3 Major customers and other Discovery entities not part of
Discovery Group
Discovery Health Medical Scheme (DHMS)
Discovery Health administers DHMS and provides managed care services for which it charges an administration fee and a
managed healthcare fee respectively. These fees are determined on an annual basis and approved by the trustees of DHMS. The
fees totaled R6 403 million (2020: R6 190 million). Discovery offers the members of DHMS access to the Vitality programme.
Discovery Health also provides wellness services to DHMS. The fees received for these services totaled R12 million (2020:
R38 million).
Discovery Third Party Recovery Services (DTPRS) paid DHMS R10 million (2020: R16 million) to purchase all the risks and rewards
of ownership to the claims due from the Road Accident Fund up to 15 January 2021 (2020: 9 September 2019). DTPRS also
provides a service to DHMS to recover all claims that are due from the Compensation for Occupational Injuries and Diseases.
DTPRS received R22 million (2020: R15 million) for this service. DTPRS owes DHMS R3 million (2020: R3 million) at year-end.
Discovery Vitality receives monthly contributions from DHMS members that have activated the Vitality Wellness programme
through various product integrations. The membership fees totaled R1 660 million for the year ended 30 June 2021 (2020:
R1 687 million).
DHMS owes the Discovery Group R650 million (2020: R646 million) at year-end.
Discovery Central Services receives monthly rent from DHMS for office space at 1 Discovery Place which totalled R7 million for
the year ended 31 June 2021, (2020: R 6 million).
Closed schemes
Discovery Health administers the following restricted membership medical schemes:
– Anglo Medical Scheme 	– Naspers Medical fund
– Anglovaal Group Medical Scheme 	– Netcare Medical Scheme
– Bankmed Medical Scheme 	– Quantum Medical Aid Society (Amalgamation with DHMS 1 August 2021)
– BMW Employees Medical Aid Society 	– Remedi Medical Scheme
– Engen Medical Benefit Fund 	– Retail Medical Scheme
– Glencore Medical Scheme 	– SAB Medical Aid Scheme
– LA Health Medical Scheme 	– TFG Medical Scheme
– Lonmin Medical Scheme 	– Tsogo Sun Group Medical Scheme
– Malcor Medical Scheme 	– UKZN Medical Scheme
Discovery Health charges these schemes administration fees which are determined on an annual basis and approved by the
trustees of the respective closed schemes. The fees totaled R1 174 million (2020: R1 141 million).
DTPRS paid Bankmed R3 million (2020: R1 million) to purchase all the risks and rewards of ownership for the claims due from the
Road Accident Fund up to 20 October 2020 (2020: 31 July 2018). DTPRS also provides a service to Bankmed to recover all claims
that are due from the Compensation for Occupational Injuries and Diseases. DTPRS received R0.4 million (2020: R1 million) for
this service.
Discovery Vitality receives monthly contributions from the closed scheme members that have activated the Vitality Wellness
programme through various product integrations. The membership fees totaled R91 million (2020: R99 million).
Amounts due to the Discovery Group at year-end totaled R104 million (2020: R104 million).
Discovery Franchises
Discovery has established a network of 29 franchises in order to establish a national footprint for its products. Discovery has paid
R251 million (2020: R239 million) in fees to the franchises.
The franchises participate in the Acquisition Scheme (refer to note 31 for further details). During the year, R17 million
(2020: R4 million) was accrued for in terms of this scheme.
The Discovery Foundation
The Discovery Foundation, which is an independent shareholder of Discovery, has become self-sustaining from the dividends
received on its shareholding in Discovery Limited and no further contributions or fees were received during the prior and
current year.

-- 139 of 219 --

139 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
40. 	RELATED PARTIES continued
40.3 Major customers & other Discovery entities not part of
Discovery Group continued
The Discovery Fund
A fund for sustainable non-governmental healthcare projects, especially in primary healthcare. These projects complement the
delivery of primary and preventative care in the public sector and help to relieve the burden on state facilities.
The Discovery Fund received contributions from Discovery of R23 million during the year (2020: R23 million). Discovery also paid
a management fee of R4 million (2020: R2 million).
Discovery Retirement Funds
In February 2020 the Discovery Limited Board appointed the Discovery Retirement Funds comprising funds underwritten by
Discovery Life and registered as the Discovery Life Pension Umbrella Fund and the Discovery Life Provident Umbrella Fund, as
retirement fund provider to the Discovery Staff.
At 30 June 2021 the Discovery Staff Pension Fund and Discovery Staff Provident Fund, the two standalone Funds previously
providing retirement benefits to Discovery Staff, were in the process of moving their member’s assets across to the Discovery
Retirement Funds, subject to the regulated Section 14 transfer process. The assets of the Discovery Staff Pension Fund amounting
to R1 787 million were transferred across to the Discovery Retirement Funds in June 2021. The movement of the assets of the
Discovery Staff Provident Fund amounting to R1 550 million is pending S14 approval by the FSCA.
Contributions to the Discovery Retirement Funds by Discovery Staff during the year amounted to R497 million (2020: Rnil). The
Discovery Retirement Funds have R2 288 million invested in unit linked insurance policies with Discovery Life (2020: Rnil) on
behalf of Discovery Staff. R1 969 million (2020: Rnil) of the insurance policies are in turn linked to unit trusts managed by Discovery
Life Collective Investments.
Contributions to the Discovery Staff Pension Fund and Discovery Staff Provident Fund by Discovery Staff stopped during the
current financial year (2020: R461 million).
The Board of the Discovery Staff Pension Fund and Discovery Staff Provident Fund have resolved to close the Funds after the
transfer is completed and there are no assets remaining in either of the Funds.

-- 140 of 219 --

140 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
41. 	ACCELERATED REINSURANCE PREMIUMS – VITALITYHEALTH
VitalityHealth uses quota share reinsurance treaties as one of the mechanisms to manage initial acquisition cost strain and
underwriting experience risk. During the current financial year, repayments on these existing reinsurance contracts were
accelerated, reducing net premiums received for the year under review and consequently reducing repayment obligations in
future years. The strategic rationale for this is set out below.
The COVID-19 pandemic resulted in a temporary reduction in claims ratios for VitalityHealth for the year ended 30 June 2021
compared to pre-pandemic levels, as various medical treatments could not be accessed or were delayed by policyholders. It is
anticipated that these delayed treatments will result in claims ratios being substantially higher than pre-pandemic levels during
the next two financial years. This is expected as a result of a catch up of delayed treatments, combined with increased severity of
conditions due to those delays. The ongoing impact of VitalityHealth returning value to customers during the pandemic, including
restricting premium increases upon renewal, will further impact the claims ratios.
VitalityHealth has recognised reserves as permitted by IFRS. However, VitalityHealth as a short-term insurer, is constrained in its
ability to set aside reserves for those claims that are expected to arise in future renewal periods beyond the contract boundary.
To protect itself against the expected increased claims ratio over the next two financial years, VitalityHealth has modified certain
of its existing quota share reinsurance treaties to adjust the repayment profile. The modification resulted in VitalityHealth making
additional repayments of GBP 39.7 million (R823 million) in the current financial year, with GBP19.8 million of reduced repayments
in the financial year ending 30 June 2022 and 2023 respectively. The net impact in profit or loss over the three-year period to
30 June 2023, is nil.
The additional repayments in the current financial year have been recognised as additional reinsurance premiums. The impact
of accelerated reinsurance payments can be summarised as follows:
R million
VitalityHealth
June 2021
VitalityHealth
June 2020
Insurance premium revenue 	11 705 	9 100
Reinsurance premium 	(1 839) 	(1 589)
Accelerated reinsurance repayments 	(823) 	–
Net insurance premium revenue 	8 413 	7 511
Claims and policyholders’ benefits 	(5 219) 	(4 796)
Insurance claims recovered from reinsurers 	1 325 	1 173
Net claims and policyholders’ benefits 	(3 894) 	(3 623)
Net underwriting results 	4 518 	3 888
Change in liabilities arising from insurance contracts 	(155) 	(28)
Ratios
Gross claims ratio – claims and policyholders’ benefits adjusted for change in liabilities
arising from insurance contracts as a percentage of insurance premium revenue 	45,73% 	53,01%
Claims ratio – net claims and policyholders’ benefits adjusted for change in liabilities
arising from insurance contracts as a percentage of net insurance premium revenue 	44,45% 	48,61%
Claims ratio – net claims and policyholders’ benefits adjusted for change in liabilities
arising from insurance contracts as a percentage of net insurance premium revenue 	40,49% 	–

-- 141 of 219 --

141 Discovery Annual Financial Statements 2021
NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
42. 	EVENTS AFTER REPORTING DATE
B preference share cash dividend declaration
On 26 August 2021, the directors declared a final gross cash dividend of 347.12329 cents (277.69863 cents net of dividend
withholding tax) per B preference share for the period 1 January 2021 to 30 June 2021, payable from the income reserves of the
Company. A dividend withholding tax of 20% will be applicable to all shareholders who are not exempt.
The issued preference share capital at the declaration date is 8 million B preference shares.
The salient dates for the dividend will be as follows
Last day of trade to receive a dividend 	Monday, 20 September 2021
Shares commence trading “ex” dividend 	Tuesday, 21 September 2021
Record date 	Thursday, 23 September 2021
Payment date 	Monday, 27 September 2021
B Preference share certificates may not be dematerialised or rematerialised between Tuesday, 21 September 2021 and Thursday,
23 September 2021, both days inclusive.
Ordinary share cash dividend declaration:
Due to uncertain and potentially volatile economic environment caused by the COVID-19 pandemic, Discovery will not be
recommending the payment of ordinary dividends. The reintroduction of dividends will be considered when appropriate.

-- 142 of 219 --

DISCOVERY
COMPANY ANNUAL
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE
2021

-- 143 of 219 --

R million 	Notes
Company
2021
Company
2020
Assets
Deferred income tax asset 	13 	113 	–
Investments in subsidiaries 	2 	27 458 	25 658
Investment in associate and joint venture 	3 	1 097 	991
Financial assets
– Loans to subsidiaries 	5 	8 758 	7 856
– Loans to BEE partners 	6 	149 	116
– Other receivables 	7 	112 	358
– Derivatives at fair value through profit or loss 	4 	27 	242
Cash and cash equivalents 	20.5 	93 	188
Total assets 	37 807 	35 409
Equity
Capital and reserves
Ordinary share capital and share premium 	8.1 	10 281 	10 331
Preference share capital 	8.2 	779 	779
Other reserves 	510 	4
Retained earnings 	7 926 	5 085
Total equity 	19 496 	16 199
Liabilities
Deferred income tax 	13 	– 	1
Financial liabilities
– Borrowings at amortised cost 	9 	8 858 	8 356
– Financial guarantee contracts 	21 	27 	52
– Trade and other payables 	11 	8 147 	9 088
– Loans from subsidiaries 	12 	853 	1 102
– Derivatives at fair value through profit or loss 	10 	426 	522
Current income tax liabilities 	* 	89
Total liabilities 	18 311 	19 210
Total liabilities and equity 	37 807 	35 409
* Amount is less than R500 000.
The order in which individual line items are presented in the Statement of financial position has been amended to better reflect their
respective liquiditiy, as far as possible, from least liquid to the most liquid items. No values were reclassified or restated between line items.
COMPANY STATEMENT OF FINANCIAL POSITION
at 30 June 2021
143 Discovery Annual Financial Statements 2021

-- 144 of 219 --

R million 	Notes
Company
2021
Company
2020
Investment income 	14 	3 845 	1 625
Other income 	15 	61 	35
Net fair value (losses)/gains on financial instruments at fair value through
profit or loss 	16 	(307) 	263
Marketing and administration expenses 	17 	(14) 	(14)
Movement in allowance for expected credit losses 	18 	18 	9
Profit from operations 	3 603 	1 918
Finance costs 	(867) 	(832)
Foreign exchange (losses)/gains 	(169) 	370
Profit before tax 	2 567 	1 456
Taxation 	19 	112 	(184)
Profit for the year 	2 679 	1 272
Attributable to:
– ordinary shareholders 	2 616 	1 191
– preference shareholders 	63 	81
2 679 	1 272
R million
Company
2021
Company
2020
Profit for the year 	2 679 	1 272
Items that are or may be reclassified subsequently to profit or loss:
Cash flow hedges 	182 	(350)
– unrealised gains/(losses) 	189 	(360)
– (gains)/losses reclassified to profit or loss 	(7) 	10
Other comprehensive income for the year, net of tax 	182 	(350)
Total comprehensive income for the year 	2 861 	922
Attributable to:
– ordinary shareholders 	2 798 	841
– preference shareholders 	63 	81
2 861 	922
COMPANY INCOME STATEMENT
for the year ended 30 June 2021
COMPANY STATEMENT OF OTHER COMPREHENSIVE INCOME
for the year ended 30 June 2021
144 Discovery Annual Financial Statements 2021

-- 145 of 219 --

R million 	Notes
Company
2021
Company
2020
Cash flow from operating activities 	1 029 	3 882
Cash (utilised in)/generated by operations 	20.1 	(1 420) 	3 408
Dividends received 	3 271 	1 155
Interest received 	96 	113
Interest paid 	(829) 	(744)
Taxation paid 	20.2 	(89) 	(50)
Cash flow from investing activities 	(1 569) 	(3 780)
Increase investment in subsidiary 	20.3 	(884) 	(2 753)
Increase investment in associate 	(106) 	–
Increase in loans granted to subsidiaries 	5 	(2 274) 	(2 302)
Proceeds from settlement of subsidiary loans 	5 	1 695 	1 275
Cash flow from financing activities 	445 	2
Proceeds on treasury shares 	10 	–
Proceeds from long-term borrowings 	20.4 	498 	5 104
Repayment of long-term borrowings 	20.4 	– 	(3 606)
Dividends paid to ordinary shareholders 	– 	(1 415)
Dividends paid to preference shareholders 	(63) 	(81)
Net (decrease)/increase in cash and cash equivalents 	(95) 	104
Cash and cash equivalents at beginning of the year 	188 	84
Cash and cash equivalents at end of the year 	20.5 	93 	188
COMPANY STATEMENT OF CASH FLOWS
for the year ended 30 June 2021
145 Discovery Annual Financial Statements 2021

-- 146 of 219 --

Company
R million
Share
capital
and share
premium
Preference
share
capital
Hedging
reserve
Share-
based
payment
reserve
Retained
earnings 	Total
Year ended 30 June 2020
At beginning of the year 	10 331 	779 	(166) 	358 	5 309 	16 611
Total comprehensive income for the year 	– 	81 	(350) 	– 	1 191 	922
Profit for the year 	– 	81 	– 	– 	1 191 	1 272
Other comprehensive income 	– 	– 	(350) 	– 	– 	(350)
Transactions with owners 	– 	(81) 	– 	162 	(1 415) 	(1 334)
Increase in treasury shares 	– 	– 	– 	162 	– 	162
Dividends paid to ordinary shareholders 	– 	– 	– 	– 	(1 415) 	(1 415)
Dividends paid to preference shareholders 	– 	(81) 	– 	– 	– 	(81)
Balance at 30 June 2020 	10 331 	779 	(516) 	520 	5 085 	16 199
Year ended 30 June 2021
At beginning of the year 	10 331 	779 	(516) 	520 	5 085 	16 199
Total comprehensive income for the year 	– 	63 	182 	– 	2 616 	2 861
Profit for the year 	– 	63 	– 	– 	2 616 	2 679
Other comprehensive income 	– 	– 	182 	– 	– 	182
Transactions with owners 	(50) 	(63) 	– 	324 	225 	436
Issue of shares 	907 	– 	– 	– 	– 	907
Increase in treasury shares 	(957) 	– 	– 	(5) 	67 	(895)
Gain on common control transaction 	– 	– 	– 	– 	158 	158
Employee share option schemes:
– Value of employee services 	– 	– 	– 	329 	– 	329
Dividends paid to preference shareholders 	– 	(63) 	– 	– 	– 	(63)
Balance at 30 June 2021 	10 281 	779 	(334) 	844 	7 926 	19 496
COMPANY STATEMENT OF CHANGES IN EQUITY
for the year ended 30 June 2021
146 Discovery Annual Financial Statements 2021

-- 147 of 219 --

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies applied in the preparation of these separate financial statements are consistent with those set out in
Annexure A. In addition to those policies, the following policies apply specifically to these separate financial statements.
1. 	Investment in subsidiaries, associates and joint ventures
Investments in subsidiaries, are accounted for at cost less impairment. Cost is adjusted to reflect changes in consideration arising
from contingent consideration amendments. Costs also includes directly attributable cost of the investment.
Discovery assesses at each reporting date whether there is objective evidence that the investment in subsidiaries, associate or a
joint venture is impaired. If such evidence of impairment exists, Discovery calculates the amount of impairment as the difference
between the recoverable amount of the investment and its carrying value.
1.1 	Common control transactions
Common control transactions is a business combination in which all the combining entities or businesses are ultimately controlled
by the same party (or parties) before and after the combination. This includes businesses which are associates and joint ventures.
Discovery Limited applies book value accounting to account for common control transactions. Discovery Limited will dispose of
its investment at the carrying amount. Any difference between the consideration received and the carrying amount of the
investment disposed of is recognised as an equity transaction with shareholders in equity. No gain or loss is recognised in profit
or loss on disposal.
2. 	Financial guarantee contracts
The Company accounts for financial guarantee contracts (FGCs) in accordance with IFRS 9 Financial Instruments (IFRS 9). The
Company issues FGCs to assist in securing funding for its subsidiaries.
FGCs are contracts which require the Company as the issuer of the contract, to make specified payments to reimburse the holder
for a loss that the holder incurs because the specified debtor fails to make payment when it is due under the original or modified
terms of the debt instrument.
The Company measures the FGC:
❚ 	Initially at fair value; and
❚ 	Subsequently at the higher of:
– The amount of expected credit losses determined under IFRS 9 (calculation 1); and
– The amount initially recognised less, when appropriate, the cumulative amount of income recognised under the principles
of IFRS 15 Revenue from Contracts with Customers (calculation 2).
2.1 	Initial recognition
In the instances where the Company issues FGCs for the debt of a related entity in the Discovery Group, the Company determines
the fair value. These FGCs are seen as transactions in a capacity as shareholder and are treated as capital contributions.
In some instances, the other Discovery Group entity can also pay a premium to the issuer of the FGCs. The Company then
determines if the price represents the fair value, or whether there is still an additional benefit of the FGC that the Company
should recognise.
In the instance where the Company does not receive all the premiums upfront, it recognises the FGC using a net approach. The
net approach requires that the Company presents the financial guarantee as its fair value less all future premiums.
NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS
for the year ended 30 June 2021
147 Discovery Annual Financial Statements 2021

-- 148 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES continued
2. 	Financial guarantee contracts continued
2.2 	Subsequent measurement
The Company recognises financial guarantee fee income as follows:
❚ 	Amortises the fair value recognised on initial recognition over the period that the FGC is outstanding, being generally the
period of the underlying debt;
❚ 	Recognises any premiums received for issuing the FGC also as financial guarantee fee income; and
❚ 	Where the Company has applied the net approach, the Company adjusts for the premiums subsequently received to ensure
it takes into account all premiums in using calculation 2.
The Company calculates the lifetime expected credit losses for purposes of calculation 1.
Where the outcome is such that calculation 1 is more than calculation 2, differences are recognised and presented as part of
expected credit losses.
Where the outcome is such that calculation 2 is more than calculation 1, no adjustments are required. Any previously recognised
expected credit losses can be reversed, but limited to the total value previously recognised.
2.3 	Derecognition
The Company derecognises FGCs when the FGC is extinguished, expires or the underlying debt is extinguished.
At the date of derecognition:
❚ 	Where the FGC is extinguished in exchange for a new FGC to the same holder and in respect of the same guaranteed entity,
the FGC derecognised is seen as compensation for the new FGC; or
❚ 	In all other instances, the FGC is derecognised with an associated gain or loss in profit or loss.
3. 	Share based payments
Also refer to Accounting Policies 17 'Employee benefits' set out in Annexure A and Group note 31 'Share-based payments and
long-term incentives'.
Two of the schemes that Discovery operates, namely the BEE staff share trust and Discovery long-term incentive plan (equity
settled), are both equity-settled share based payment arrangements in accordance with the requirements of IFRS 2 Share-based
Payment. In these schemes, Discovery Limited grants the awards to the employees within the Discovery Group of entities.
Discovery classifies the share-based payment transaction according to whether the entity has the obligation to settle. As it is
Discovery Limited’s shares being awarded to employees, Discovery classifies the transaction as equity-settled.
Under IFRS, Discovery does not consider any repayment or recharge arrangements in determining the classification of these
group share based payment. Any recharge payments Discovery receives from its subsidiaries is treated as a return on capital
from the subsidiary. Any excess of recharge above the carrying amount of investment in subsidiary is recognised immediately as
dividend income.
Discovery manages two share trusts. Discovery treats the share trusts set up to facilitate the share-based payment arrangements
as an agent, i.e., an extension of Discovery. In other words, shares held by the trust is treated as treasury shares of Discovery
Limited.
❚ 	BEE Staff Share Trust: Shares and option to acquire shares have been allocated to senior black employees based on level of
seniority and length of past service. The trust will hold shares until the date of vesting of the shares to the employee or
exercise date of the option.
❚ 	Discovery LTIP Trust: Participants will receive Discovery Limited shares subject to performance criteria and if the participant
is employed on each vesting date. The trust will hold shares until the date of vesting of the shares to the employee.
148 Discovery Annual Financial Statements 2021

-- 149 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
1. 	MANAGEMENT OF FINANCIAL RISK
The Company’s activities expose it to a variety of financial risks. Financial risks include market risk, credit risk and liquidity risk.
Refer to Group Note 3 ”Management of financial risk” for a detailed explanation of financial risks and how they are managed.
1.1 	Interest rate risk
Sensitivity to changes in interest rates is relevant to financial assets or liabilities bearing floating interest rates due to the risk that
future cash flows fluctuate. However, sensitivity will also be relevant to fixed-rated financial assets and financial liabilities that are
re-measured to fair value.
The table below details the specific interest rate risk that the Company is exposed to:
Company
R million
Carrying
amount 	Fixed 	Floating
Non-interest
bearing
At 30 June 2021
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	22 	– 	– 	22
– Used as cash flow hedges1 	5 	5 	– 	–
Loan to subsidiaries 	8 758 	2 001 	6 428 	329
Loans to BEE partners 	149 	– 	149 	–
Other receivables 	112 	– 	– 	112
Cash and cash equivalents 	93 	7 	86
Total financial assets 	9 139 	2 013 	6 663 	463
Borrowings at amortised cost 	8 858 	3 824 	5 034 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	94 	– 	– 	94
– Used as cash flow hedges 	332 	332 	– 	–
Financial guarantee contracts 	27 	– 	– 	27
Trade and other payables 	8 147 	– 	– 	8 147
Loans from subsidiaries 	853 	– 	723 	130
Total financial liabilities 	18 311 	4 156 	5 757 	8 398
At 30 June 2020
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	242 	– 	– 	242
Loan to subsidiaries 	7 856 	1 807 	3 367 	2 682
Loans to BEE partners 	116 	– 	116 	–
Other receivables 	358 	– 	– 	358
Cash and cash equivalents 	188 	52 	136 	–
Total financial assets 	8 760 	1 859 	3 619 	3 282
Borrowings at amortised cost 	8 356 	3 819 	4 537 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	6 	– 	– 	6
– Used as cash flow hedges1 	516 	516 	– 	–
Financial guarantee contracts 	52 	– 	– 	52
Trade and other payables 	9 088 	– 	– 	9 088
Loans from subsidiaries 	1 102 	– 	682 	420
Total financial liabilities 	19 120 	4 335 	5 219 	9 566
A change of 1% in the interest rate would result in an increase/decrease of R19 million (2020: R34 million) in interest income and
R58 million (2020: R49 million) in finance costs. The sensitivity is based on the assumption that the interest rate has increased/
decreased by 1% with all other variables held constant.
1 For further information on the use of interest rate swaps to manage the interest rate risk of Discovery Limited, refer to the following notes in the Group
financials, which equally apply to Discovery Limited:
– Note 3.4 Shareholder financial assets and liabilities, "Borrowings at amortised cost and related hedges", page 77–78.
149 Discovery Annual Financial Statements 2021

-- 150 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
1. 	MANAGEMENT OF FINANCIAL RISK continued
1.2 	Currency risk
The Company operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily
with respect to the US dollar and the UK pound. Foreign exchange risk arises from future commercial transactions and recognised
assets and liabilities.
The following table segregates the currency exposure by major currency:
Company
R million 	Total 	Rand 	GBP 	USD
At 30 June 2021
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	22 	22 	– 	–
– Used as cash flow hedges 	5 	5 	– 	–
Loans to subsidiaries 	8 758 	7 020 	1 738 	–
Loans to BEE partners 	149 	149 	– 	–
Other receivables 	112 	66 	46 	–
Cash and cash equivalents 	93 	22 	52 	19
Total financial assets 	9 139 	7 284 	1 836 	19
Borrowings at amortised cost 	8 858 	8 858 	– 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	94 	94 	– 	–
– Used as cash flow hedges 	332 	332 	– 	–
Financial guarantee contracts 	27 	19 	8 	–
Other payables 	8 147 	8 147 	– 	–
Loans from subsidiaries 	853 	853 	– 	–
Total financial liabilities 	18 311 	18 303 	8 	–
At 30 June 2020
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	242 	242 	– 	–
Loans to subsidiaries 	7 856 	5 544 	2 312 	–
Loans to BEE partners 	116 	116 	– 	–
Other receivables 	358 	110 	248 	–
Cash and cash equivalents 	188 	140 	48 	–
Total financial assets 	8 760 	6 152 	2 608 	–
Borrowings at amortised cost 	8 356 	8 356 	– 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	6 	6 	– 	–
– Used as cash flow hedges 	516 	516 	– 	–
Financial guarantee contracts 	52 	47 	5 	–
Other payables 	9 088 	9 088 	– 	–
Loans from subsidiaries 	1 102 	1 102 	– 	–
Trade and other payables 	19 120 	19 115 	5 	–
A 10% increase on respective decrease in the respective foreign exchange rates of GBP: ZAR would result in additional gains of
R196 million, or in the case of decrease, a loss of R196 million, recognised in profit or loss.
1.3 	Credit risk
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge
an obligation.
Key areas where the Company is exposed to credit risk are:
❚ 	Financial assets comprising money market and debt instruments – The Company is exposed to the issuer’s credit standing on
these instruments which is monitored by the CCIC by setting a minimum credit rating. The aggregate credit risk exposure for
financial assets categorised by credit ratings is provided on the next page.
❚ 	Cash and cash equivalents – This risk is managed by monitoring exposure to external financial institutions against limits set by
the CCIC.
150 Discovery Annual Financial Statements 2021

-- 151 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
1. 	MANAGEMENT OF FINANCIAL RISK continued
1.3 	Credit risk continued
Credit exposure for debt instruments, money market instruments and cash and cash
equivalents
The following table provides information regarding the credit risk exposure categorised by Moody’s credit ratings. These are
credit ratings for assets in stage 1 (refer to note 18) in the Company financial statements:
Company
R million 	Total 	Aaa 	Aa1-3 	A1-3 	Baa1-3 	Ba1-3 	Govt 1
Internally
rated/
assessed
At 30 June 2021
Derivative financial instruments
at fair value:
– Not designated as hedging
instruments 	22 	– 	– 	– 	– 	22 	– 	–
– Used as cash flow hedges 	5 	– 	– 	– 	– 	5 	– 	–
Loans to subsidiaries 	8 758 	– 	– 	– 	– 	– 	– 	8 758
Loans to BEE partners 	149 	– 	– 	– 	– 	– 	– 	149
Other receivables 	110 	110
Cash and cash equivalents 	93 	3 	6 	1 	– 	83 	– 	–
9 137 	3 	6 	1 	– 	110 	– 	9 017
At 30 June 2020
Derivative financial instruments
at fair value:
– Not designated as hedging
instruments 	242 	– 	– 	65 	177 	– 	– 	–
Loans to subsidiaries 	7 856 	– 	– 	– 	– 	– 	– 	7 856
Loans to BEE partners 	116 	– 	– 	– 	– 	– 	– 	116
Other receivables 	248 	248
Cash and cash equivalents 	188 	78 	50 	– 	59 	– 	1 	–
8 650 	78 	50 	65 	236 	– 	1 	8 220
1 These instruments are held in the South African government.
Long-term credit ratings were used in the above credit risk analysis.
Discovery Limited has issued financial guarantees as security of loans incurred by subsidiaries in the group. The maximum
credit risk that Discovery Limited is exposed to on these contracts is the carrying amount, which amounted to R6 522 million
(2020: R5 979 million).
Loans to subsidiaries do not have external credit ratings. Credit ratings are internally assigned to subsidiaries relative to the
Discovery Group ratings. Loans to BEE partners are not assigned formal credit ratings externally or internally. These loans are
structured considering creditworthiness of the individual partners, and the purpose of the BEE relationship. These loans are
managed and monitored on an individual basis, and ECL is accordingly recognised on an individual basis using management’s
best estimate.
1.4 	Liquidity risk
Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities due to
insufficient cash available to meet commitments as and when due.
Cash flow forecasting is performed by the Company and liquidity requirements are monitored to ensure it has sufficient cash to
meet operational needs. Such forecasting takes into consideration the Company’s debt financing plans and covenant compliance.
Cash held by the Company is managed by Group Treasury. Treasury invests it in interest-bearing accounts, term deposits and
money market deposits, choosing instruments with appropriate maturities or sufficient liquidity to provide headroom as
determined by the above-mentioned forecasts. At the reporting date, the Company had money market funds and cash and cash
equivalents of R93 million (2020: R188 million).
151 Discovery Annual Financial Statements 2021

-- 152 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
1. 	MANAGEMENT OF FINANCIAL RISK continued
1.4 	Liquidity risk continued
The table below analyses Discovery Limited’s financial liabilities into relevant maturity groupings based on the remaining period
at the reporting date to the contractual maturity date. These amounts do not agree to the Statement of financial position as these
are the undiscounted contractual payments.
Company
R million 	Total 	<1 year
1 – 2
years
3 – 5
years
6 – 10
years
At 30 June 2021
Borrowings 	10 842 	643 	3 186 	5 995 	1 018
Derivative financial instruments:
– used as cash flow hedges 	635 	193 	171 	260 	11
– not designated as hedging instruments 	94 	94 	– 	– 	–
Trade and other payables 	8 147 	8 147 	– 	– 	–
Loans from subsidiaries:
– interest free loans 	130 	– 	– 	130 	–
– interest-bearing loans 	766 	766 	– 	– 	–
20 614 	9 843 	3 357 	6 385 	1 029
Financial guarantees 	6 522 	6 522 	– 	– 	–
27 136 	16 365 	3 357 	6 385 	1 029
At 30 June 2020
Borrowings 	11 060 	635 	1 137 	8 208 	1 080
Derivative financial instruments:
– used as cash flow hedges 	719 	169 	167 	333 	50
– not designated as hedging instruments 	6 	6 	– 	– 	–
Trade and other payables 	9 088 	9 088 	– 	– 	–
Loans from subsidiaries:
– interest free loans 	420 	– 	– 	420 	–
– interest-bearing loans 	624 	– 	– 	624 	–
21 915 	9 896 	1 304 	9 585 	1 130
Financial guarantee contracts 	5 979 	5 979 	– 	– 	–
27 894 	15 875 	1 304 	9 585 	1 130
1.5 	Fair value estimation
Discovery Limited’s financial instruments measured at fair value have been disclosed using a fair value hierarchy. The hierarchy
has three levels that reflect the significance of the inputs used in measuring fair value. These are as follows:
Level 1: includes financial instruments that are measured using unadjusted, quoted prices in an active market for identical
financial instruments. An active market is a market in which transactions for the asset or liability take place with sufficient
frequency and volume to provide information on an ongoing basis. Quoted prices are readily and regularly available from an
exchange, dealer, broker, industry group, pricing service or regulatory agency and those prices represent actual and regularly
occurring market transactions on an arm’s length basis.
Level 2: includes financial instruments that are valued using techniques based significantly on observable market data.
Instruments in this category are valued using:
(a) Quoted prices for similar instruments or identical instruments in markets which are not considered to be active; or
(b) Valuation techniques where all the inputs that have a significant effect on the valuation are directly or indirectly based on
observable market data.
Level 3: includes financial instruments that are valued using valuation techniques that incorporate information other than
observable market data and where at least one input (which could have a significant effect on instrument’s valuation) cannot be
based on observable market data.
152 Discovery Annual Financial Statements 2021

-- 153 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
1. 	MANAGEMENT OF FINANCIAL RISK continued
1.5 	Fair value estimation continued
Company
R million 	Total 	Level 1 	Level 2 	Level 3
At 30 June 2021
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	22 	– 	22 	–
– Used as cash flow hedges 	5 	– 	5 	–
Total financial assets 	27 	– 	27 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	94 	– 	94 	–
– Used as cash flow hedges 	332 	– 	332 	–
Total financial liabilities 	426 	– 	426 	–
At 30 June 2020
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	242 	– 	242 	–
Total financial assets 	242 	– 	242 	–
Derivative financial instruments at fair value:
– Not designated as hedging instruments 	6 	– 	6 	–
– Used as cash flow hedges 	516 	– 	516 	–
Total financial liabilities 	522 	– 	522 	–
2. 	INVESTMENTS IN SUBSIDIARIES
Issued ordinary
capital
R million
Effective
percentage holding
%
Investment
in subsidiaries4
R million
2021 	2020 	2021 	2020 	2021 	2020
Vitality Group International Inc1 	3 319 	2 621 	100 	100 	1 434 	815
Discovery Connect 	555 	555 	100 	100 	554 	555
Discovery Central Services 	* 	* 	100 	100 	42 	33
Discovery Finance Co Europe Limited 2 	393 	393 	100 	100 	394 	394
Discovery Group Europe Limited2 	13 802 	13 340 	100 	100 	13 790 	13 332
Discovery Health 	271 	271 	100 	100 	243 	527
Discovery Insure 	2 402 	2 402 	100 	100 	1 463 	1 515
Discovery Life 	1 416 	1 416 	100 	100 	1 510 	1 722
Discovery Life Collective Investments 	15 	15 	100 	100 	15 	15
Discovery Life Investment Services 	3 	3 	100 	100 	3 	3
Discovery Mauritius Asset Management 	1 	– 	100 	– 	1 	–
Discovery International Collective
Investments Plc 	* 	– 	100 	– 	* 	–
Discovery Pref Holdings Company Ltd5 	* 	* 	100 	100 	– 	*
Discovery Vitality 	* 	* 	100 	100 	– 	11
Discovery Vitality International Asia3 	211 	211 	100 	100 	113 	113
Discovery Bank Holdings Company 	7 689 	6 495 	100 	100 	7 896 	6 623
Balance at the end of the year 	27 458 	25 658
* Amount is less than R500 000.
1 Incorporated in the United States of America.
2 Incorporated in England and Wales.
3 Incorporated in Singapore.
4 Investments in subsidiaries include cost less impairments plus the value of share options issued to subsidiary staff.
5 Deregistered November 2020.
Refer to Company note 20.3 for a detailed movement analysis.
153 Discovery Annual Financial Statements 2021

-- 154 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
3. 	INVESTMENT IN ASSOCIATES
R million
% ownership interest Company
2021
Company
2020	2021 	2020
Investment at cost:
– Ping An Health Insurance Company in China, Limited 	25% 	25% 	1 097 	991
– AIA Vitality (Hong Kong) Limited1 	0% 	44% 	– 	*
1 097 	991
* Amount is R103.
1 At 31 December 2020, Discovery Limited transferred the investment to Vitality Group International, a wholly owned subsidiary, for shares in Vitality
Group International.
Refer to Group note 11 for disclosure of the investment in associate and joint ventures.
4. 	DERIVATIVES AT FAIR VALUE THROUGH PROFIT OR LOSS
R million
Company
2021
Company
2020
Interest rate swap- used as cash flow hedge 	5 	–
Derivatives not designated as hedging instrument 	22 	242
Total 	27 	242
Current 	22 	242
Non-current 	5 	–
Total 	27 	242
Refer to the Group note 3.4.1 for a detailed description of the derivative financial instruments listed above.
5. 	LOANS TO SUBSIDIARIES1
R million
Company
2021
Company
2020
Balance at beginning of the year 	7 856 	6 135
Additional loan granted 	2 274 	2 302
Repayment of loans 	(1 695) 	(1 275)
Interest receivable 	475 	352
Movement in allowance for expected credit losses 	– 	34
Exchange differences 	(152) 	308
Balance at end of the year 	8 758 	7 856
Discovery Group Europe Ltd 	2 200 	2 312
Discovery Health (Pty) Ltd 	3 120 	2 862
Discovery Central Services (Pty) Ltd 	3 109 	2 263
Discovery Life Investment Services (Pty) Ltd 	329 	419
Balance at end of the year 	8 758 	7 856
Current 	3 109 	3 317
Non-current 	5 649 	4 539
8 758 	7 856
1 All loans to subsidiaries are measured at amortised cost, which approximates to fair value, as the loans bear interest at market related terms.
154 Discovery Annual Financial Statements 2021

-- 155 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
5. 	LOANS TO SUBSIDIARIES continued
GBP denominated
Discovery Limited has granted GBP denominated loans to subsidiaries, the terms are as follows:
Carrying value
GBP/ Rand million
Subsidiary
the loan was
granted to
Loan
Value
GBP
million 	Variable rate
Capital repayment
and maturity date
June 2021 	June 2020
Rand 	GBP 	Rand 	GBP
DGEL 	11.9
3-month Libor +
400bps
At maturity –
31 July 2025 	301 	15.3 	315 	14.7
DGEL 	24.7
3-month Libor +
600bps
At maturity –
1 April 2027 	485 	24.6 	527 	24.7
DGEL 	6.0
3-month Libor +
600bps
At maturity –
1 November 2027 	118 	6.0 	128 	6.0
DGEL 	10.5
3-month Libor +
600bps
At maturity –
1 June 2028 	207 	10.50 	224 	10.5
DGEL 	9.0
3-month Libor +
600bps
At maturity –
21 August 2028 	177 	9.0 	192 	9.0
DGEL 	6.5
3-month Libor +
600bps
At maturity –
24 November 2028 	128 	6.5 	139 	6.5
DGEL 	2.8
Bank of England base
rate + 615bps
At maturity –
1 March 2029 	55 	2.8 	60 	2.8
DGEL 	7.1
Bank of England base
rate + 615bps
At maturity –
1 June 2029 	140 	7.1 	152 	7.1
DGEL 	6.5
Bank of England base
rate + 615bps
At maturity –
31 July 2029 	128 	6.5 	139 	6.5
1 739 	88.3 	1 876 	87.80
DGEL – Discovery Group Europe Limited
ZAR denominated
Discovery Limited has granted ZAR denominated loans to subsidiaries, the terms are as follows:
Carrying value
Rand million
Subsidiary the loan
was granted to
Loan
value
Rand
million 	Variable rate
Capital repayment and maturity
date
June
2021
June
2020
Discovery Group
Europe Limited 	268 	3-month Libor + 200bps 	At maturity – 11 November 2022 	461 	436
Discovery Health1 	727 	3-month Libor + 400bps 	At maturity – 30 June 2026 	1 119 	2 862
Discovery Health 1 	1 283 	3-month Libor + 400bps 	At maturity – 31 July 2027 	2 001 	–
Discovery Central
Services 	2 932
South African prime
lending rate 	– 	3 109 	2 263
Discovery Life
Investment Services2 	330 	3-month Libor + 400bps 	At maturity – 31 July 2027 	329 	419
7 019 	5 980
1 Interest payable quarterly in arrears, with the option available for Discovery Health to capitalise the interest to the value of the loan.
2 The loan is an interest-free subordinated loan.
For the loans to Discovery Group Europe Limited, interest of R130 million was earned in respect of these loans in the current financial
year (2020: R143 million) and R152 million foreign exchange gains was recognised in profit and loss (2020: R307 million gain).
155 Discovery Annual Financial Statements 2021

-- 156 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
6. 	LOANS TO BEE PARTNERS1
R million
Company
2021
Company
2020
Balance at the beginning of the year 	116 	73
Interest receivable 	4 	3
Additional loan granted 	48 	40
Repayment of loans 	(19) 	–
Balance at the end of the year 	149 	116
Current 	149 	116
Non-current 	– 	–
Balance at the end of the year 	149 	116
1 All loans to BEE partners are measured at amortised cost, which approximates to fair value.
Financial assistance was provided to Discovery's BEE Partners in April 2015 to assist them in following their rights in terms of the
Discovery Limited's rights issue. Interest accrues at a rate of prime less 0.5% and is repayable on 31 March 2021. However,
the outstanding balance is repayable immediately if they are no longer a BEE partner. Discovery further increased bridge loans
by R48 million (2020: R40 million) at an interest rate of prime less 2%. There is no fixed term to this loan.
7. 	OTHER RECEIVABLES
R million
Company
2021
Company
2020
Value-added tax 	– 	*
Intercompany receivables 	110 	248
Prepayments 	2 	110
Balance at the end of the year 	112 	358
Intercompany receivables include:
– Discovery Holdings Europe Ltd 	7 	235
– Discovery Finance Co Europe Ltd 	39 	13
– Discovery Insure Ltd 	64 	–
Balance at the end of the year 	110 	248
* Amount is less than R500 000.
8. 	SHARE CAPITAL AND SHARE PREMIUM
8.1 	Ordinary share capital and share premium
Number
of shares
Share
capital
R million
Share
premium
R million
Total
R million
Issued
At 1 July 2019 	658 290 736 	1 	10 330 	10 331
At 30 June 2020 	658 290 736 	1 	10 330 	10 331
Share movements:
– shares issued 	7 477 865 	– 	907 	907
– treasury shares purchased 	(8 283 826) 	* 	(957) 	(957)
At 30 June 2021 	659 096 697 	1 	10 280 	10 281
* Amount is less than R500 000.
The total authorised number of ordinary shares is 1 billion (2019: 1 billion), with a par value of 0.1 cent per share.
156 Discovery Annual Financial Statements 2021

-- 157 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
8. 	SHARE CAPITAL AND SHARE PREMIUM continued
8.2 	Preference share capital
R million
Company
2021
Company
2020
Authorised
40 000 000 A no par value preference shares 	– 	–
20 000 000 B preference shares of R100 each 	2 000 	2 000
20 000 000 C no par value preference shares 	– 	–
2 000 	2 000
Issued
8 000 000 B preference shares of R100 each 	800 	800
Share issue costs 	(21) 	(21)
At 30 June 2021 	779 	779
The preference shares are non-compulsory, non-cumulative, non-participating, non-convertible, voluntarily redeemable (at
option of Discovery Limited) preference shares and were issued at a coupon rate of 85% of prime rate. With the introduction of
dividend withholding tax on 1 April 2012, the coupon rate on the preference shares was increased to 100% of the prime rate.
9. 	BORROWINGS AT AMORTISED COST
R million
Company
2021
Company
2020
Borrowings from banks1 	8 858 	8 356
Current 	54 	53
Non-current 	8 804 	8 303
Balance at the end of the year 	8 858 	8 356
1 Collateral in the form of financial guarantees by Discovery Health and Discovery Vitality has been given to secure these borrowings.
The borrowings were acquired for general corporate purposes in order to fund the various growth initiatives within the Group.
Credit rating
Following the downgrade of the South African Government’s issuer rating to Ba2 from Ba1 on 20 November 2020, Moody’s
Investors Service (“Moody’s”) downgraded Discovery Limited’s Global scale long term issuer rating to Ba3 from Ba2 on
25 November 2020. Similar to the country’s outlook, the credit outlook assigned by Moody’s remains negative. The national scale
long term issuer rating of Discovery was reaffirmed at A1.za
157 Discovery Annual Financial Statements 2021

-- 158 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
9. 	BORROWINGS AT AMORTISED COST continued
Carrying value
R million
Facility amount
R million 	Variable rate
Interest
per annum
Capital repayment and
maturity date
June
2021
June
2020
Listed DMTN4,6
500 	3-month Jibar + 161bps 	9.71%1,3 At maturity – 21 November 2022 	503 	503
500 	3-month Jibar + 205bps 	6.30%1,3 	At maturity – 21 August 2023 	503 	–
200 	– 	10.46%2 	At maturity – 21 November 2024 	202 	202
800 	3-month Jibar + 191bps 	10.31%1,3 At maturity – 21 November 2024 	804 	805
1 200 	3-month Jibar + 191bps 	9.21%1,3 At maturity – 21 November 2024 	1 220 	1 225
700 	3-month Jibar + 180bps 	10.29%1,3 	At maturity – 21 August 2026 	703 	704
300 	3-month Jibar + 180bps 	9.40% 1,3 	At maturity – 21 August 2026 	302 	303
Unlisted DMTN4,5
1 100 	– 	8.92%3 	At maturity – 10 March 2023 	1 103 	1 101
2 500 	– 	9.62%3 	At maturity – 22 February 2025 	2 519 	2 516
Other
1 000 	3-month Jibar + 245bps 	10.28%1,3 At maturity – 02 March 2023 	999 	997
8 800 	8 858 	8 356
1 The interest rate has been fixed through interest rate swaps.
2 Interest is payable semi-annually in arrears.
3 Interest payable quarterly in arrears.
4 DMTN refers to the R10 billion Discovery Domestic Medium Term Note (DMTN) program registered in 2017.
5 During the financial year ended 30 June 2020, Discovery Limited refinanced R3.6 billion bank syndicated loans through the issue of unlisted DMTN
notes. The notes, although underwritten by a bank until maturity, are structured to enable short-term issuances into the commercial paper market on
an ongoing basis.
The borrowings are unsecured senior debt and are not callable or convertible. Interest is payable quarterly in arrears other
footnote 2 in the table above. Refer to company note 20.4 for movement analysis and Group Note 20.
10. 	DERIVATIVES AT FAIR VALUE THROUGH PROFIT OR LOSS
R million
Company
2021
Company
2020
Interest rate swap – used as cash flow hedges1 	332 	516
Derivatives not designated as hedging instruments 	94 	6
Balance at the end of the year 	426 	522
Current 	94 	6
Non-current 	332 	516
Balance at the end of the year 	426 	522
1 For further information, refer to Group Note 13, which sets out information on the 'Interest Rate Swaps' which equally apply to the Company.
158 Discovery Annual Financial Statements 2021

-- 159 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
11. 	TRADE AND OTHER PAYABLES
R million
Company
2021
Company
2020
Accrued expenditure 	10 	6
Dividends due to shareholders 	9 	10
Intercompany payables 	8 128 	9 072
8 147 	9 088
Intercompany payables include:
– Discovery Health (Pty) Ltd 	i 	3 078 	3 973
– Discovery Connect Distribution Services (Pty) Ltd 	– 	*
– Discovery Life Limited 	ii 	4 839 	5 099
– Discovery Vitality (Pty) Ltd 	iii 	211 	–
8 128 	9 072
* Amount is less than R500 000.
i. 	Discovery Limited receives funds from Discovery Health (Pty) Ltd through a loan account, based on operational requirements.
The loan is interest free and is settled as and when sufficient cash becomes available.
ii. 	Discovery Limited received funds from Discovery Life Limited in 2020 to assist with operational requirements. The loan is
interest-free and is settled as and when sufficient cash becomes available.
iii. Discovery Limited received funds from Discovery Vitality (Pty) Ltd in 2021 to assist with operational requirements. The loan is
interest-free and is settled as and when sufficient cash becomes available.
The amortised cost of the trade and other payables approximate the fair value due to the short-term nature of these payables.
12. 	LOANS FROM SUBSIDIARIES
R million
Company
2021
Company
2020
Discovery Life Limited 	i 	853 	1 102
853 	1 102
i. Discovery Limited issued 5-year term Investment Notes totalling R500 million to Discovery Life on 30 June 2017. Investment
Notes bear interest at variable 3-month JIBAR, currently 5.85% per annum (2020: 8.44%) and is repayable in arrears together
with capital on 30 June 2022. Discovery Life further granted Discovery Limited an interest-free loan of R500 million in 2019,
which matures on 20 June 2024. The amortised cost of these instruments approximates the fair value. R290 million was repaid
during the financial year.
13. 	DEFERRED INCOME TAX (LIABILITY)/ASSET
R million
Company
2021
Company
2020
Deferred tax asset – non-current 	113 	–
Deferred tax liability – non-current 	– 	(1)
Total 	113 	(1)
Movement summary:
Balance at beginning of the year 	(1) 	23
Income statement charge 	112 	(24)
Increase in treasury shares 	2 	–
Balance at end of the year 	113 	(1)
Deferred taxation comprises:
Assessed losses 	114 	*
Unrealised gains on financial instruments 	(1) 	(1)
113 	(1)
* Amount is less than R500 000.
159 Discovery Annual Financial Statements 2021

-- 160 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
14. 	INVESTMENT INCOME1
R million
Company
2021
Company
2020
At amortised cost interest income, using the effective interest rate 	574 	470
Dividends received from subsidiaries and equity-accounted investments 	3 271 	1 155
3 845 	1 625
Dividends received from subsidiaries and equity-accounted investments:
– Discovery Health (Pty) Ltd 	3 000 	1 148
– Discovery Vitality (Pty) Ltd 	21 	–
– Discovery Partner Markets Services (Pte) Ltd 	16 	7
– AIA Vitality (Hong Kong) Limited 	34 	–
– Discovery Life Collective Investments (Pty) Ltd 	200 	–
3 271 	1 155
1 Investment income for Discovery Limited is seen as Revenue.
15. 	OTHER INCOME
R million
Company
2021
Company
2020
Guarantee fees 	i 	54 	22
Amortisation of financial guarantee contract 	ii 	7 	13
61 	35
i. Discovery Limited issued guarantees in respect of Discovery Finance Company Europe obligations. A guarantee fee is charged
by Discovery Limited to Discovery Finance Company Europe.
ii. Amortisation of initial financial guarantee contracts over the term of the loan. Refer to Company note 21 for a list of all the
guarantees that Discovery Limited has issued.
16. 	NET FAIR VALUE GAINS/(LOSSES) ON FINANCIAL INSTRUMENTS AT
FAIR VALUE THROUGH PROFIT OR LOSS
R million
Company
2021
Company
2020
Realised loss on non-hedge derivatives 	(2) 	(3)
Fair value (losses)/gains on non-hedge derivatives 	(305) 	266
(307) 	263
17. 	MARKETING AND ADMINISTRATION EXPENSES
R million
Company
2021
Company
2020
Marketing and administration expenses comprises:
– Audit fees 	7 	3
– Professional fees 	4 	8
– Other 	3 	3
14 	14
160 Discovery Annual Financial Statements 2021

-- 161 of 219 --

NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
18. 	MOVEMENT IN ALLOWANCE FOR EXPECTED CREDIT LOSSES1
R million
Company
2021
Company
2020
Loans to subsidiaries:
– Discovery Health (Pty) Ltd 	– 	(10)
– Discovery Life Investment Services (Pty) Ltd 	– 	1
– Discovery Pref Holding Company (RF) Limited 	– 	*
– Discovery Group Europe Limited 	– 	(24)
– Discovery Connect Distribution Services (Pty) Ltd 	– 	(1)
– Discovery Holdings Europe Limited 	– 	*
– Discovery Finance Company Europe Limited 	– 	*
Financial guarantee contracts:
– Discovery Central Services Pty Ltd 	(25) 	25
– Discovery Finance Company Europe Limited 	7 	–
Decrease in allowance for expected credit losses 	(18) 	(9)
* Amount is less than R500 000.
1 In determining the expected credit loss, Discovery assigned risk ratings to subsidiaries relative to Discovery Limited where a Moody’s rating was not
available. All these loans are high quality.
12 month
credit losses
Lifetime
credit losses 	Total
30 June 2021
Balance at beginning of the year 	34 	– 	34
Increase in allowance 	(18) 	– 	(18)
Balance at end of the year 	16 	– 	16
30 June 2020
Balance at beginning of the year 	43 	– 	43
Increase in allowance 	(9) 	– 	(9)
Balance at end of the year 	34 	– 	34
19. 	TAXATION
R million
Company
2021
Company
2020
Charge for the year:
Current taxation 	– 	(160)
Normal taxation
– current year charge 	– 	(160)
Deferred taxation 	112 	(24)
– current year charge 	112 	(24)
Total income tax expense recognised in profit or loss 	112 	(184)
% 	%
Taxation rate reconciliation
Effective taxation rate 	4.4 	(12.6)
Capital profits and dividend income 	(35.7) 	(22.2)
Exempt income 	(0.1) 	–
Disallowed expenditure: Capital in nature 	3.1 	6.7
Taxable Income: International tax adjustments 	0.3 	0.1
Standard rate of taxation 	(28.0) 	(28)
* Amount is less than R500 000.
Tax has been provided at 28% (2020: 28%). The Company uses the South African tax rate in respect of its tax rate reconciliation
as Discovery Limited (holding company listed on the JSE) is domiciled in South African and the most significant operations are in
South Africa. There has been a proposal by South Africa’s National Treasury that the corporate tax rate should reduce to 27%
for tax years commencing after 1 April 2022. Discovery does not yet deem this rate to be substantively enacted.
161 Discovery Annual Financial Statements 2021

-- 162 of 219 --

20. 	CASH FLOW INFORMATION
20.1 Cash generated by operation
R million
Company
2021
Company
2020
Profit before taxation 	2 567 	1 456
Adjusted for:
Interest received 	(574) 	(470)
Dividends received 	(3 271) 	(1 155)
Realised gains on derivatives not designated as hedging instruments 	* 	–
Finance costs 	867 	832
Non-cash items:
Movement in expected credit losses 	(18) 	(9)
Fee income from financial guarantee contracts 	(7) 	(13)
Fair value (gains)/losses on derivatives not designated as hedging instruments 	307 	(263)
Unrealised foreign exchange (gains)/losses 	169 	(370)
Working capital changes:
Loans and receivables 	197 	(298)
Trade and other payables and loans from subsidiaries 	(1 657) 	3 698
(1 420) 	3 408
* Amount is less than R500 000.
20.2 Taxation paid
R million
Company
2021
Company
2020
Balance at beginning of the year 	(89) 	21
Current taxation charged for the year in the income statement 	– 	(160)
Balance at end of the year 	* 	89
(89) 	(50)
* Amount is less than R500 000.
20.3 Increase in investment in subsidiary
R million
Company
2021
Company
2020
Balance at beginning of the year 	25 658 	22 739
Value of share options issued to subsidiary staff 	330 	162
Financial guarantee contracts raised 	1 	9
Financial guarantee contracts derecognised 	– 	(5)
Non-cash restructure of investment in subsidiary 	427 	–
Common control transaction (asset for share) 	158 	–
Balance at end of the year 	(27 458) 	(25 658)
Increase in investment in subsidiary 	(884) 	(2 753)
20.4 Long-term borrowings
R million
Company
2021
Company
2020
Balance at beginning of the year 	8 356 	6 841
Interest accrued 	640 	708
Interest paid 	(636) 	(691)
Settlement of derivative capitalised to loan by counterparty 	– 	(6)
Increase in borrowings 	500 	5 120
Raising fees capitalised 	(2) 	(16)
Repayment of borrowings 	– 	(3 600)
Balance at end of the year 	8 858 	8 356
NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
162 Discovery Annual Financial Statements 2021

-- 163 of 219 --

20.5 Cash and cash equivalents
R million
Company
2021
Company
2020
Cash at bank and in hand 	78 	57
Short-term deposits 	15 	131
93 	188
21. 	FINANCIAL GUARANTEE CONTRACTS
R million
Company
2021
Company
2020
Discovery Limited has provided guarantees for the following subsidiaries:
Discovery Finance Co Europe Limited 	i 	3 	1
Discovery Central Services 	ii 	18 	47
Discovery Holdings Europe Limited 	iii 	5 	4
Discovery Bank 	iv 	1 	*
Balance at the end of the year 	27 	52
* Amount is less than R500 000.
i 	Discovery Limited has issued a guarantee for 2 facilities in respect of the obligations of Discovery Finance Company Europe
Limited in the amount of GBP 80 million and GBP 28 million. As at 30 June 2021, Discovery Finance Company Europe Limited
owed GBP 98.7 million (2020: GBP 108.2 million) in respect of these borrowing facilities.
ii During 2018, Discovery Central Services entered into borrowing facilities for an amount of R650 million to fund the systems
build of Discovery Bank. The full amount has been drawn down and the balance outstanding at 30 June 2021 is R526 million
(2020: R596 million). In 2019, Discovery Central Services entered into a 5 year borrowing facility for an amount of R1.4 billion.
These funds were acquired for general corporate purposes and the full facility was used. Discovery Health, Discovery Vitality
and Discovery Limited have provided guarantees in respect of these facilities.
iii During 2020, Discovery Holdings Europe Limited entered into borrowing facilities for an amount of GBP 55 million, which was
increased to GBP 100 million in 2021 to fund its operations. This facility has been guaranteed by Disovery Limited.
iv Discovery Limited issued a guarantee for a facility in respect of the obligations of Discovery Bank in the amount of R800 million.
22. 	EVENTS AFTER REPORTING DATE
Refer to Group note 42 for a list of the events after reporting date.
NOTES TO THE COMPANY ANNUAL FINANCIAL STATEMENTS continued
for the year ended 30 June 2021
163 Discovery Annual Financial Statements 2021

-- 164 of 219 --

DISCOVERY
ANNEXURES

-- 165 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES
for the year ended 30 June 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies applied in the preparation of these consolidated and separate financial statements are set out below. These
policies have been consistently applied to all the years presented. Other interpretations, amendments and annual improvements effective
for the first time in the current year have been considered and have no impact on the current reporting period.
1. 	Basis of presentation
The consolidated and separate Annual Financial Statements have been prepared in accordance with International Financial
Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB), its interpretations adopted by the
IASB, the South African Institute of Chartered Accountants (SAICA), Financial Reporting Guides as issued by the Accounting Practices
Committee, the JSE Listings Requirements, JSE Debt Listings Requirement as well as the South African Companies Act. They have
been prepared in accordance with the going concern principle using the historical cost basis except where otherwise stated in the
accounting policies below.
The preparation of financial statements in conformity with IFRS requires the use of certain critical accounting estimates. It also
requires management to exercise its judgement in the process of applying Discovery’s accounting policies. The areas involving a
higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial
statements, are outlined in Group note 4 to the Annual Financial Statements.
All monetary information and figures presented in these financial statements are stated in millions of Rand (R million), unless
otherwise indicated.
New standards and amendments which became effective during the financial year
INTEREST RATE BENCHMARK REFORMS
A fundamental reform of major interest rate benchmarks is being undertaken globally, including the replacement of some
interbank offered rates (IBORs) with alternative nearly risk-free rates (referred to as ’IBOR reform’). The Group has exposures to
IBORs on its financial instruments which has been or will be replaced or reformed as part of these market-wide initiatives, such
as Libor and Jibar. There is uncertainty over the timing and the methods of transition in some jurisdictions that the Group
operates in, such as South Africa. The United Kingdom has seen a change from the GBP Libor to the Reformed Sterling Overnight
Index Average (SONIA).
The International Accounting Standards Board (IASB) has undertaken a two-phase project to consider potential reliefs from the
effect of IBOR reforms. The project was concluded, and the amendments and relief are mandatorily effective from 1 July 2021 for
the Discovery. However, Discovery has elected to early adopt the amendments to cater for changes in specified UK transactions
which has already changed the contractual rate.
❚ 	For change in contractual cash flows (i.e., GBP Libor to SONIA), the reliefs have the effect that the changes are necessary as a
direct consequence of IBOR reform and are economically equivalent will not result in an immediate gain or loss in the income
statement.
❚ 	The hedge accounting reliefs will allow most hedge relationships that are directly affected by IBOR reform to continue, with
additional consideration for ineffectiveness.
The Group anticipates that IBOR reform will impact some of its Jibar risk management and hedge accounting relationships in the
longer term. The South African Reserve Bank is still in the early stages of the replacement project. The Group does not have Libor
hedge accounting relationships.
165 Discovery Annual Financial Statements 2021

-- 166 of 219 --

1. 	Basis of presentation continued
New standards and amendments to published standards not yet effective
❚ 	Discovery has not early adopted any accounting standards, amendments or annual improvements issued but not yet effective.
❚ 	The accounting standards, amendments and annual improvements described below are those that are expected to have an
impact on Discovery’s results and/or disclosures. Accounting standards, amendments and annual improvements not
mentioned below are not expected to have a significant impact on recognised amounts.
Title and
Effective date 	Scope 	Potential impact
IFRS 17 Insurance
Contracts
Effective date:
1 July 2023
IFRS 17 was issued in May 2017, with amendments
issued in June 2020.
General model
INITIAL RECOGNITION
Under IFRS 17, the general model requires entities to
measure an insurance contract at initial recognition at:
❚ 	the total of the fulfilment cash flows, comprising:
– the estimated future cash flows;
– an adjustment to reflect the time value of
money; and
– an explicit risk adjustment for non- financial
risk; and
❚ 	the contractual service margin (CSM).
Discovery has implemented an IFRS 17 transition
programme under the sponsorship of the Chief
Financial 	Officer. 	Discovery 	has 	allocated
sufficient resources over the project life to
ensure successful implementation.
The CFO heads up the Steering Committee who
comprises of the respective Insurance business
CFOs, Chief Actuaries, Internal Audit and IT
specialist. The Steering Committee is supported
by a Technical Advisory Group comprising of
IFRS Specialists, Actuaries, Financial Managers,
Tax and external auditors.
IFRS 17 Insurance
Contracts
Effective date:
1 July 2023
SUBSEQUENTLY
Subsequent to initial recognition, the liability of a
group of insurance contracts comprises the liability of
remaining coverage (fulfilment cash flows and CSM) as
well as the liability for incurred claims (claims and
expenses already incurred but not yet paid).
❚ 	The fulfilment cash flows are remeasured at each
reporting period to reflect current estimates.
Changes in fulfilment cash flows are treated in a
number of ways:
– Change in time value of money (i.e. yields) and
financial risk (e.g. inflation indices) are reflected in
profit or loss, or other comprehensive income or
both dependent on accounting policy elections;
– Changes in past and current services are
recognized in profit or loss; and
– Changes related to future services are recognized
in the CSM to the extent there is CSM. Any excess
is recognized in profit or loss immediately.
❚ 	The 	CSM 	(representing 	unearned 	profit) 	is
recognised as the entity provides services over the
coverage period.
PRESENTATION
❚ 	Insurance revenue, derived from change in liability
for remaining coverage;
❚ 	Investment 	components 	are 	excluded 	from
insurance revenue and insurance services expenses;
❚ 	Insurance 	finance 	income 	and 	expenses 	is
presented separately from insurance revenue; and
❚ 	Entities can choose to disaggregate the presentation
of insurance finance income or expenses between
profit or loss and other comprehensive income (OCI).
During 2018 to 2020 Discovery completed the
initial impact assessments, including several
pilot projects on selected products aimed at
assessing the financial impacts of the standard.
Significant progress has been made on the
development of accounting and actuarial
policies and methodologies.
The most significant impact will be within the
long-term insurance businesses of Discovery
Life and VitalityLife, including their respective
investment businesses.
It is expected that that the impact will be
minimal 	within 	the 	short-term 	insurance
businesses, which are expected to apply the
PAA. These businesses include Discovery Insure,
Group Life and Vitality Health.
The following tentative observations are made
in the IFRS 17 project:
❚ 	Discovery is considering the accounting
policy election of IFRS 17 to present
‘insurance finance income and expenses’ in
other 	comprehensive 	income 	with 	a
subsequent release to profit or loss;
❚ 	Discovery believes it has sufficient robust
data to enable it to apply IFRS 17 with full
retrospective statement; and
❚ 	Discovery believes that many of its accounting
policies today (e.g. discounting at a current
rate, build-up of compulsory and discretionary
margins as well as its best estimates of
income and costs) places it in a strong position
to transition smoothly to IFRS 17.
ANNEXURE A – GROUP ACCOUNTING POLICIES continued
166 Discovery Annual Financial Statements 2021

-- 167 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
1. 	Basis of presentation continued
Title and
Effective date 	Scope 	Potential impact
Simplified model
Aside from this general model, the standard provides,
as a simplification, the premium allocation approach
(PAA). This simplified approach is applicable for certain
types of contract, including those with a coverage
period of one year or less.
Variable fee approach
For insurance contracts with direct participation
features, the variable fee approach applies. The
variable fee approach is a variation on the general
model. When applying the variable fee approach, the
entity’s share of the fair value changes of the underlying
items is included in the contractual service margin. As
a consequence, the fair value changes are not
recognised in profit or loss in the period in which they
occur but over the remaining life of the contract.
The focus within the next period is the
formalization and sign-off of policies and
methodologies internally by all committees and
external auditors. Discovery aims to implement
the CSM engine and models into production to
produce required disclosures.
2. 	Consolidation
The consolidated financial statements include the assets, liabilities and results of the operations of the holding company and its
subsidiaries, joint ventures and associates.
2.1 	Business combinations
The acquisition method of accounting is used to account for business combinations by the Group. The consideration transferred
for the acquisition of a business is the fair values of the assets transferred, the liabilities incurred and the equity interests issued
by the Group. The consideration transferred includes the fair value of any asset or liability resulting from a contingent
consideration arrangement. Acquisition-related costs are expensed as incurred.
Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at
their fair values at the acquisition date. On an acquisition-by-acquisition basis, Discovery recognises any non-controlling interest
in the acquiree either at fair value or at the non-controlling interest’s proportionate share of the acquiree’s net assets. The excess
of the consideration transferred, being the amount of any non-controlling interest in the acquiree and the acquisition-date fair
value of any previous equity interest in the acquiree over the fair value of the identifiable net assets acquired, is recorded as
goodwill. If this is less than the fair value of the net assets of the subsidiary acquired in the case of a bargain purchase, the
difference is recognised directly in profit or loss.
2.2 	Consolidation of entities in which the Group holds less than 50%
Discovery analysed its relationships with the Discovery Unit Trusts and has determined that it has significant power to direct the
relevant activities of the funds, has sufficient exposure to the variable returns of the funds and the ability to use its power over
the investee to affect its returns. This analysis concluded that Discovery has control of the Discovery Unit Trusts even if the
economic interest is less than 50% and is therefore required to consolidate these funds.
Discovery controls these unit trusts as it has right to the variable returns in the form of fund management fees that it receives
from its involvement with the funds. Furthermore, Discovery exercises control over these unit trust through the setting of the
mandates as well as the appointment of the independent trustees. Discovery can, within the regulatory framework, also amend
the mandates and change the independent trustee.
Of the 27 (2020: 27) Discovery Unit Trusts consolidated at 30 June 2021 Discovery holds less than a 50% economic interest in
1 (2020: 3) of these funds. Refer to page 25 for a list of consolidated unit trusts.
167 Discovery Annual Financial Statements 2021

-- 168 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
2. 	Consolidation continued
2.3 	Subsidiaries
Subsidiaries are all entities (including structured entities) over which Discovery has control. Discovery controls an entity when it
is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns
through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to Discovery.
Consolidation is discontinued from the date on which control ceases.
Intra-group transactions, balances and unrealised gains on intra-group transactions are eliminated. Unrealised gains or losses
are also eliminated. Subsidiaries’ accounting policies have been changed where necessary to ensure consistency with the policies
adopted by Discovery. Intra-group foreign exchange gains or losses arising on intra-group balances do not eliminate.
2.4 	Associates and joint arrangements
ASSOCIATES AND JOINT VENTURE
Associates are entities over which Discovery has the ability to exercise significant influence but not control over the financial and
operational policies. Significant influence is determined based primarily on percentage voting rights, generally between 20% and
50%, together with other factors such as board participation and participation in the policy-making process. In certain instances,
Discovery holds less than 20% equity interests, but holds rights that still give it significant influence. These are equity accounted.
A joint venture is a joint arrangement whereby the parties have joint control of an arrangement and have rights to the net assets
of the arrangement.
Discovery recognises its interest in an associate or a joint venture as an investment and accounts for that investment using the
equity method. Under the equity method, on initial recognition the investment in an associate or a joint venture is recognised at
cost. The carrying amount is adjusted to recognise Discovery’s share of the post-acquisition profit or loss of the investee and is
recognised in profit or loss. Distributions received from an investee reduce the carrying amount of the investment. Adjustments
to the carrying amount may also be necessary for changes in Discovery’s proportionate interest in the investee arising from
changes in the investee’s other comprehensive income. Such changes include those arising from foreign exchange translation
differences. Discovery’s share of those changes is recognised in other comprehensive income. Discovery will discontinue the use
of the equity method from the date when its investment ceases to be an associate or a joint venture.
Discovery discontinues equity accounting when the carrying amount of the investment in an associate or a joint venture reaches
zero, unless it has incurred obligations, guaranteed obligations or made payments on behalf of the associate or the joint venture.
Discovery resumes equity accounting only after its share of the profits equals the share of losses not recognised. Discovery increases
the carrying amount of investments with its share of the associate’s or joint venture’s income when equity accounting is resumed.
Discovery’s investment in an associate or a joint venture includes goodwill identified on acquisition. Discovery assesses at each
reporting date whether there is objective evidence that an associate or a joint venture is impaired. If such evidence of impairment
exists, Discovery calculates the amount of impairment as the difference between the recoverable amount of the investment and
its carrying value.
Unrealised gains or losses on transactions between Discovery and its associates or joint ventures are eliminated to the extent of
the Group’s interest in these entities unless the transaction provides evidence of an impairment of the asset transferred.
Accounting policies of associates and joint ventures have been changed where necessary to ensure consistency with the policies
adopted by the Group. The carrying amount of equity-accounted investments are tested for impairment (see accounting policy 9.3
for the policy on impairment).
A decrease in interest while an investment continues to be classified as an associate can also result from a dilution. The gain or
loss on the dilution of in an equity-accounted investee is calculated as the difference between:
❚ 	the entity’s ownership interest in the new assets received by the investee for the subscription of the new shares (e.g. the cash
paid by the other party); and
❚ 	the reduction in ownership interest in the previous carrying amount.
JOINT OPERATIONS
A joint operation is a joint arrangement whereby the parties have joint control of an arrangement and rights to the assets and
obligations for the liabilities relating to the arrangement.
Discovery recognises its share of those assets, liabilities, revenues and expenses that the operators incur jointly.
168 Discovery Annual Financial Statements 2021

-- 169 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
3. 	Foreign currency translation
3.1 	Functional and presentation currency
Items included in the financial statements of each of Discovery’s entities are measured using the currency of the primary
economic environment in which the entity operates (the functional currency). The consolidated financial statements are
presented in Rand, which is the functional and presentation currency of Discovery Limited.
3.2 	Transactions and balances
Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the
transactions. Foreign exchange gains and losses resulting from:
❚ 	The settlement of trading transactions is included in the results of operating activities in profit or loss;
❚ 	The settlement of financing transactions and from the translation at year-end exchange rates of assets and liabilities
denominated in foreign currencies are recognised in profit or loss as foreign exchange gains and losses; and
❚ 	Qualifying cash flow hedges are deferred in the statement of other comprehensive income and are recycled to profit or loss
in the periods in which the hedged item affects profit or loss.
3.3 	Group companies
The results and financial position of all Discovery entities (none of which has the currency of a hyperinflationary economy) that
have a functional currency different from the presentation currency are translated into the presentation currency as follows:
❚ 	Assets and liabilities for each Statement of financial position presented are translated at the closing rate at the date of that
statement of financial position;
❚ 	Income and expenses for each Income statement are translated at average exchange rates (unless this average is not a
reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and
expenses are translated at rates at the date of the transactions); and
❚ 	All resulting exchange differences are recognised as a separate component of equity, namely the foreign currency
translation reserve.
On consolidation, exchange differences arising from the translation of the net investment in foreign entities are recognised in the
foreign currency translation reserve in the Statement of other comprehensive income. When a foreign operation is partially
disposed of or sold, such exchange differences are recognised in profit or loss as part of the gain or loss on sale. Goodwill and
fair value adjustments arising on the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and
translated at the closing rate.
4. 	Property and equipment
Property and equipment are stated at historical cost less depreciation and impairment. Historical cost includes expenditure that
is directly attributable to the acquisition of the items.
Subsequent costs are included in the asset’s carrying amount or recognised as a separate asset, as appropriate, only when it is
probable that future economic benefits associated with the item will flow to Discovery and the cost of the item can be measured
reliably. All other repairs and maintenance are charged to profit or loss during the financial period in which they are incurred.
Property and equipment are depreciated using the straight-line method to allocate their cost to their residual values over their
estimated useful lives, as follows:
Owner occupied property 	40 years
Leasehold improvements 	Shorter of estimated life or period of lease
Leased asset 	3 – 15 years
Computer equipment 	3 – 7 years
Furniture, fittings and building fit out 	5 – 15 years
Motor vehicles 	4 years
Telematics devices 	2 – 5 years
The assets’ residual values and useful lives are reviewed at each reporting period and adjusted if appropriate. An asset’s carrying
amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated
recoverable amount. The recoverable amount is the higher of the asset’s fair value less costs to dispose and value-in-use.
Gains or losses on disposals are determined by comparing the proceeds with the carrying amount. These are recorded in profit
or loss.
169 Discovery Annual Financial Statements 2021

-- 170 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
5. 	Intangible assets
5.1 	Computer software development costs
Costs associated with maintaining computer software programmes are recognised as an expense as incurred. Development
costs that are directly attributable to the design and testing of identifiable software products controlled by Discovery are
recognised as intangible assets when the following criteria are met:
❚ 	It is technically feasible to complete the software product so that it will be available for use;
❚ 	Management intends to complete the software product and use or sell it;
❚ 	There is an ability to use or sell the software product;
❚ 	It can be demonstrated how the software product will generate probable future economic benefits;
❚ 	Adequate technical, financial and other resources to complete the development and to use or sell the software product are
available; and
❚ 	The expenditure attributable to the software product during its development can be reliably measured.
Directly attributable costs that are capitalised as part of the software product, include the software development employee costs
and an appropriate portion of directly attributable overheads.
Other development expenditures that do not meet these criteria are recognised as an expense as incurred. Development costs
previously recognised as an expense are not recognised as an asset in a subsequent period.
Computer software development costs are recognised as assets from the point where the recognition criteria above are satisfied,
and are amortised once the asset is ready for use, over their useful lives (between three and ten years). The amortisation is
reflected under marketing and administration expenses in profit or loss.
Computer software development costs recognised as assets are amortised over their useful lives.
Software 	3 – 7 years
Core Systems 	11 years (2020: 10 years)
5.2 	Other intangible assets
Discovery does not recognise costs incurred to internally developed trademarks, patents and similar rights and assets, including
franchises and management contracts. These costs are recognised in profit or loss in the period in which they are incurred.
Purchased intangible assets which represent rights to receive future profits are capitalised at their fair values, represented by the
estimated net present value of future cash flows relating to existing business, or at a value as determined by an independent
valuer. These intangible assets are amortised into profit or loss as profits are expected to emerge and only tested for impairment
if an indication of impairment arises.
Intangible assets acquired as part of business combinations were capitalised at their fair value, represented by the estimated net
present value of future cash flows relating to existing business, or at a value as determined by an independent valuer. These
intangible assets are amortised over their useful lives and only tested for impairment if an indication of impairment arises.
6. 	Deferred acquisition costs
The direct costs of acquiring new business, which are expected to be recovered out of future revenue margins, are deferred over
the period in which the related performance obligations are satisfied and recognised as an asset in the Statement of financial
position. The accounting policies relating specifically to deferred acquisition costs for insurance are detailed in accounting policies 13.
7. 	Goodwill
Goodwill arises on the acquisition of businesses and represents the excess of the consideration transferred, the amount of any
non-controlling interest in the acquiree and the acquisition-date fair value of any previous equity interest in the acquiree over the
fair value of the identifiable net assets acquired.
Goodwill is reviewed for impairment annually or more frequently if events or changes in circumstances indicate a potential
impairment. The carrying value of the cash generating unit (CGU) containing the goodwill is compared to the recoverable amount,
which is the higher of value in use and the fair value less costs of disposal. Any impairment is recognised immediately as an
expense and is not subsequently reversed.
For the purpose of impairment testing, goodwill acquired in a business combination is allocated to each of the CGUs, or groups
of CGUs that is expected to benefit from the synergies of the combination. Each unit or group of units to which the goodwill is
allocated represents the lowest level within the entity at which the goodwill is monitored for internal management purposes.
Goodwill is monitored at the operating segment level.
170 Discovery Annual Financial Statements 2021

-- 171 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
8. 	Impairment of non-financial assets
Goodwill is tested annually for impairment or more frequently if events or changes in circumstances indicate that goodwill may
be impaired.
Other assets, including equity accounted investments, intangible assets and costs of obtaining contracts, other than those
relating to insurance contracts (see accounting policy 13), are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount may not be recoverable. Such indicators include continued losses, changes in
technology, market, economic, legal and operating environments.
An impairment loss is recognised for the amount by which the asset’s carrying amount exceeds its recoverable amount. The
recoverable amount is measured using the higher of the fair value less costs to sell and the value-in-use. Value-in-use is the
present value of projected cash flows covering the remaining useful life of the asset. An impairment loss is recognised in profit or
loss immediately.
Other assets, other than goodwill, that suffered an impairment are reviewed for possible reversal of the impairment at the end
of each reporting period.
9. 	Financial instruments
Discovery initially recognises financial instruments when it becomes party to the contract.
Financial instruments are measured at initial recognition at fair value net of directly attributable transaction costs, unless the
financial instrument is classified as fair value through profit or loss. For instruments classified at fair value through profit or loss
attributable transaction costs are immediately expensed.
9.1 	Financial assets
9.1.1 	RECOGNITION, CLASSIFICATION, MEASUREMENT AND DERECOGNITION
At initial recognition, the Group considers the appropriate classification as at Amortised cost (AC); Fair value through profit or loss
(FVTPL) or Fair value through other comprehensive income (FVOCI) for debt instruments. Discovery considers:
❚ 	Whether the contractual cash flows of the financial asset are solely payments of principal and interest (SPPI). Such contractual
cash flows are consistent with a basic lending arrangement, and compensates Discovery for the elements of time value of
money, credit risk and other basic lending risks and a profit margin. Examples of such instruments include Treasury Bills,
Government Bonds, cash and fixed term deposits. It excludes instruments such as equity-linked financial assets or puttable
investments in unit trusts; and
❚ 	The business model for holding the financial assets.
Based on the criteria above, Discovery will classify a debt instrument as at:
❚ 	Amortised cost, if the financial asset meets the SPPI criterion and is held for the purpose to collect the contractual cash flows.
Examples of this include loans and advances to customers (e.g. credit card advances) and fixed term deposits;
❚ 	Fair value with changes in other comprehensive income (debt instruments), if the financial asset meets the SPPI criterion and
is held both to collect contractual cash flows and by selling the financial assets. Discovery currently does not hold financial
assets in this category. However, specified associates do have certain of their debt instruments in the category.
❚ 	Fair value through profit or loss, for all other financial assets that do not meet the criteria above (mandatorily). In addition,
Discovery can designate financial assets into this category if this will reduce measurement inconsistencies (i.e. ‘accounting
mismatch’) (designated). Discovery’s business includes, amongst others, providing unit-linked insurance, unit-linked
investment and non-linked insurance products to customers. Financial assets and liabilities in these portfolios are managed
to achieve the objectives of the portfolio and to ensure that liabilities are appropriately matched with assets. In considering
whether the objective of a portfolio is to collect contractual cash flows or to trade in financial instruments, Discovery considers
the purpose for which instruments are held, the methods of risk management in a portfolio, the manner of performance
reporting on a portfolio and the basis for determining compensation to managers for asset performance. For those financial
assets backing insurance contracts, Discovery measures these financial assets at fair value through profit or loss. Unit-linked
investment contracts are also mandatorily classified at fair value through profit or loss.
For equity instruments Discovery is permitted to make the irrevocable election to present changes in fair value in other
comprehensive income, however cumulative gains or losses recognised cannot be reclassified to profit or loss on disposal. This
election is available on an instrument-by-instrument basis. This election has only been made in the accounting records of
specified associates. All other equity instruments are measured at FVTPL.
171 Discovery Annual Financial Statements 2021

-- 172 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
9. 	Financial instruments continued
9.1 	Financial assets continued
9.1.1 	RECOGNITION, CLASSIFICATION, MEASUREMENT AND DERECOGNITION continued
Subsequent measurement
Amortised cost (AC) 	These instruments are measured at amortised cost using the effective interest
method. Movements in the balance of the instrument relate to expected credit
losses, interest income and foreign exchange gains and losses which are
recognised on profit or loss.
Fair value through
profit or loss (FVTPL)
These instruments are measured at fair value with gains and losses recognised in
other comprehensive income and are never reclassified to profit or loss.
Dividends are recognised in profit or loss
Fair value through other comprehensive
income (FVOCI) – equity
These instruments are measured at fair value with gains and losses recognised in
other comprehensive income. Dividends are recognised in profit or loss.
Fair value through other comprehensive
income (FVOCI) – debt
These instruments are measured at fair value with changes in fair value recognised
in other comprehensive income. Discovery recognises interest using effective
interest method, movements in the balance related to expected credit losses,
interest income and foreign exchange gains and losses which in profit or loss. On
derecognition, gains and losses accumulated in OCI are reclassified to profit
or loss
There are no financial assets that have been designated at fair value through profit or loss.
The business model for managing a group of financial instruments is expected to remain stable, in rare instances where the
business model changes there can be a reclassification of the business model. Any reclassifications are applied prospectively
from the first day of the first reporting period after the change in business model, with no restatement of any previously
recognised gains, losses or interest. Discovery has not had any changes in business models in the current reporting period and
consequently there have been no reclassifications.
Financial assets are derecognised when the rights to receive cash flows from them have expired or where they have been
transferred and Discovery has also transferred substantially all risks and rewards of ownership.
9.1.2 	EXPECTED CREDIT LOSSES
Expected credit losses are recognised on the following items:
❚ 	Debt instrument at amortised cost, which includes treasury bills, banking loans and advances and fixed deposits. This also
includes loan commitment for undrawn credit facilities;
❚ 	Lease receivables;
❚ 	Financial guarantee contracts;
❚ 	Other receivables which are financial assets at amortised cost; and
❚ 	Contract receivables and contracts assets with non-insurance customers and cash and cash equivalents.
Discovery has a multitude of different debtors and loans included in other receivables which are financial assets, which do not
represent a homogeneous group of assets. The approach to determining credit losses varies according to the asset type, past bad
debt experience and the potential to incorporate forward looking information. In certain instances, financial assets have been
grouped based on shared characteristics (i.e. debt payment pattern similarities, financial instruments with collateral, debtor
type), and expected credit losses determined on a collective basis.
The general expected credit loss approach requires that Discovery assess the credit risk of the instrument and determine whether
there has been a significant increase in credit risk since initial recognition.
❚ 	Where there has not been a significant increase in credit risk since initial recognition expected credit losses are measured as
the 12-month expected credit losses.
❚ 	Where there has been a significant increase in credit risk, expected credit losses are recognised as the life-time credit losses.
172 Discovery Annual Financial Statements 2021

-- 173 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
9. 	Financial instruments continued
9.1 	Financial assets continued
9.1.2 	EXPECTED CREDIT LOSSES continued
Discovery measures expected credit losses on:
❚ 	financial assets that are not credit-impaired at the reporting date as the present value of all cash shortfalls (i.e. the difference
between the cash flows due to the entity in accordance with the contract and the cash flows that Discovery expects to receive);
❚ 	financial assets that are credit-impaired at the reporting date: as the difference between the gross carrying amount and the
present value of estimated future cash flows; and
❚ 	undrawn loan commitments: as the present value of the difference between the contractual cash flows that are due to Discovery
if the commitment is drawn down and the cash flows that Discovery expects to receive (adjusted using a credit conversion factor).
Discovery does not recognise expected credit losses on Treasury Bills issued by the South African Reserve Bank as well as cash
and cash equivalents receivable on demand due to the assessment that it is immaterial
SIGNIFICANT INCREASE IN CREDIT RISK
At each reporting date, Discovery assesses whether the credit risk on a financial asset has increased significantly since initial
recognition. When making the assessment, an entity shall use the change in the risk of a default occurring over the expected life
of the financial instrument instead of the change in the amount of expected credit losses.
Qualitative 	Quantitative
❚ 	when contractual payments are more than 30 days past
due the presumption is applied in conjunction with
Discovery Risk Grade (DRG).
❚ 	the eligibility rules used in the credit under-writing and
account management strategies are considered as triggers
of significant increase in credit risk, since they provide a
view in terms of how the client performs on their other
credit facilities outside Discovery Bank. The rules comprise
of a list of statuses at the bureau such as: judgements;
adverse; deceased; and debt counselling statuses.
❚ 	performing (up-to-date and current) accounts that have
shown deterioration with respect to Discovery Bank risk
grades will also be regarded as a significant increase in
credit risk.
Currently the Discovery Bank is not considering the
quantitative triggers of significant increase in credit risk due
to lack of origination data on the back book (ie DiscoveryCard
joint venture data). As the book in Discovery Bank matures it
will be in a position to perform the assessment.
CREDIT IMPAIRED AND DEFAULT
Discovery considers a financial instrument to be credit-impaired where current circumstances and economic conditions indicate
that the expected future cash flows from a financial instrument may not be recoverable. These circumstances include but are not
limited to evidence of financial or operational challenges for the debtor and missed contractual payments.
Default is defined on a facility level and considers both quantitative and qualitative factors as provided in the Basel capital
framework. The qualitative criterion requires banks to identify credit deterioration before the exposure becomes delinquent
“unlikeliness to pay” events, while the quantitative criterion requires banks to look at the material delinquency status.
The following factors are what constitutes default from a qualitative and quantitative perspective, and it is in line with the
South African Reserve Bank definition.
Qualitative 	Quantitative
❚ 	The borrower is placed in debt counselling/debt review;
❚ 	The borrower is deceased;
❚ 	The facility has undergone a distressed restructure/special
arrangement;
❚ 	The facility has been transferred to charge off/legal status; or
❚ 	The client is under debt review;
❚ 	The client is insolvent; or
❚ 	The facility is written off
A material amount on the facility is 90 days or more in
arrears, whereby material is set to avoid technical defaults.
173 Discovery Annual Financial Statements 2021

-- 174 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
9. 	Financial instruments continued
9.1 	Financial assets continued
9.1.2 	EXPECTED CREDIT LOSSES continued
WRITE-OFF
Discovery Bank will reduce the gross carrying amount of a financial asset when it has no reasonable expectation of recovering a
financial asset in its entirety or a portion thereof. Currently the write-off point is based on time in default and is set as 12 months
in default. To ensure the appropriateness of the write-off point, the proposed write-off point will be assessed on an annual basis
and both time in default and recency of repayments will be considered.
Where Discovery has no reasonable expectation of recovery of a debt the amount is written off, this is considered to occur when
all avenues of legal recourse to recover the debt have been unsuccessful.
9.2 	Financial liabilities
At initial recognition, the Group considers the appropriate classification as at Amortised costs (AC) or Fair value through profit or
loss (FVTPL).
Financial liabilities are measured at FVTPL if:
❚ 	is it is held for trading; or
❚ 	if the financial liabilities are part of a group of financial assets and financial liabilities which are managed and performance
evaluated on a fair value basis. These include financial liabilities held within the portfolios of unit-linked insurance, unit-linked
investments.
All other financial liabilities in Discovery, which is in scope of IFRS 9, is measured at amortised cost.
Qualitative 	Subsequent measurement
Amortised cost (AC) 	These instruments are measured at amortised cost using the effective interest method. Interest
income and foreign exchange gains and losses are recognised on profit or loss.
Fair value through profit
or loss (FVTPL)
These instruments are measured at fair value with gains and losses and any interest recognised
in profit or loss.
Discovery has investment contracts which have financial risk, and are consequently recognised and measured in terms of IFRS 9
rather than IFRS 4 Insurance Contracts. These contracts are classified at fair value through profit or loss. The policies are linked to
the return on underlying financial assets and are directly matched. The movement on Discovery’s own credit risk is considered
immaterial. The remaining financial liabilities are carried at amortised cost.
Financial liabilities are derecognised when the obligation is extinguished.
9.3 	Offset
Financial assets and liabilities are offset and the net amount reported in the Statement of financial position when there is a legally
enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and
settle the liability simultaneously. The legally enforceable right must not be contingent on future events and must be enforceable
in the normal course of business and in the event of default, insolvency or bankruptcy of Discovery or the counterparty.
9.4 	Modifications
Where an existing financial asset or liability is replaced by another with the same counterparty on substantially different terms,
or the terms of an existing financial asset or liability are substantially modified, such an exchange or modification is treated as a
derecognition of the original asset or liability and the recognition of a new asset or liability at fair value, including calculating a
new effective interest rate, with the difference in the respective carrying amounts being recognised in other gains and losses on
financial instruments within non-interest revenue. The date of recognition of a new asset is consequently considered to be the
date of initial recognition for impairment calculation purposes.
If the terms are not substantially different for financial assets or financial liabilities, the group recalculates the new gross carrying
amount by discounting the modified cash flows of the financial asset or financial liability using the original effective interest rate.
The difference between the new gross carrying amount and the original gross carrying amount is recognised as a modification
gain or loss within credit impairments (for distressed financial asset modifications) or in other gains and losses on financial
instruments within non-interest revenue (for all other modifications).
In assessing whether a financial asset was substantially modified, Discovery performs a qualitative assessment to determine if
the terms were substantially modified. In assessing whether a financial liability has been substantially modified, Discovery
performs both a qualitative and quantitative (10% threshold) assessment to determine if the terms were substantially modified.
174 Discovery Annual Financial Statements 2021

-- 175 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
10. 	Derivative financial instruments
Derivative financial instruments are classified as held for trading unless they are designated as effective hedging instruments.
Discovery initially recognises derivative financial instruments in the Statement of financial position at fair value on the date which
a derivative contract is entered into (the best evidence of fair value on day one is the transaction price) and subsequently re-
measures these instruments to fair value. The method of recognising the resulting fair value gain or loss depends on whether the
derivative is designated as a hedging instrument, and if so, the nature of the item being hedged. Fair values are obtained from
quoted prices in active markets, including recent market transactions, and valuation techniques, including discounted cash flow
models and options pricing models, as appropriate. All derivatives are carried as assets when the fair value is positive and as
liabilities when the fair value is negative.
Discovery is permitted to designate certain derivatives as either:
❚ 	Hedges of the fair value of recognised assets or liabilities or firm commitments (fair value hedges); or
❚ 	Hedges of highly probable forecast transactions (cash flow hedges).
Discovery documents at the inception of the transaction the relationship between hedging instruments and hedged items, as well
as its risk management objective and strategy for undertaking various hedge transactions. Discovery also documents its
assessment, both at hedge inception and on an ongoing basis, of whether the derivatives that are used in hedging transactions are
expected to be and have been highly effective in offsetting changes in fair values or cash flows of hedged items. Discovery continues
to apply hedge accounting, as permitted in IFRS, consistent with IAS 39 Financial Instruments: Recognition and Measurement.
10.1 	Cash flow hedge
Discovery recognises the effective portion of fair value changes of derivatives that are designated as cash flow hedges in the cash
flow hedging reserve in the Statement of other comprehensive income. The gain or loss relating to the ineffective portion is
recognised immediately in profit or loss, within net fair value gains on financial assets at fair value through profit or loss in the
income statement.
Amounts accumulated in the Statement of other comprehensive income are recycled to profit or loss in the period in which the
hedged item will affect profit or loss. Where the forecast transaction or a foreign currency firm commitment results in the
recognition of a non-financial asset or liability, the gains and losses previously deferred are transferred from the Statement of
other comprehensive income and included in the initial measurement of the cost of the non-financial asset or liability. Where the
forecast transaction subsequently results in the recognition of a financial asset or liability, gains or losses deferred in equity are
transferred from the statement of other comprehensive income when the financial asset or liability is sold or impaired.
When a hedging instrument expires or is sold, or when a hedge no longer meets the criteria for hedge accounting, any cumulative
gain or loss existing in equity at that time remains in equity and is recognised when the forecast transaction is ultimately
recognised in profit or loss. When a forecast transaction is no longer expected to occur, the cumulative gain or loss that was
reported in equity is immediately transferred to profit or loss.
10.2 	Derivatives that do not qualify for hedge accounting
Certain derivative instruments do not qualify for hedge accounting. Changes in the fair value of all such derivative instruments
are recognised immediately in profit or loss, within net fair value gains on financial assets at fair value through profit or loss in
the income statement.
10.3 	Hedging reserve
The hedging reserve includes the cash flow hedge reserve. The cash flow hedge reserve is used to recognise the effective portion
of gains or losses on derivatives that are designated and qualify as cash flow hedges. Amounts are subsequently recycled to profit
or loss as follows:
❚ 	For the effective portion recycled for hedges relating to share-based payments, as part of marketing and administration
expenses (staff costs); and
❚ 	For the effective portion recycled for hedges relation to interest rate risk, as part of finance costs.
175 Discovery Annual Financial Statements 2021

-- 176 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
11. 	Cash and cash equivalents
Cash and cash equivalents comprise:
❚ 	Cash in hand;
❚ 	Deposits held at call and short notice; and
❚ 	Balances with banks.
Cash and cash equivalents only include items held for the purpose of meeting short-term cash commitments rather than for
investing or other purposes. Cash and cash equivalents have a maturity of less than three months from the date of acquisition.
Cash and cash equivalents are carried at amortised cost (or in specified instances at fair value through profit or loss) which due
to their short-term nature approximates fair value.
Due to Discovery’s sweeping arrangements in force with various financial institutions, positive and negative cash balances are
presented on a net basis for the purpose of presenting cash and cash equivalents in the statement of cash flows.
12. 	Share capital
Shares are classified as equity when there is no contractual obligation to transfer cash or other financial assets to the holder.
Incremental costs directly related to the issue of new shares or options are shown in equity as a deduction from the proceeds,
net of tax.
Where any Group company purchases Discovery Limited equity share capital (treasury shares), the consideration paid, including
any directly attributable incremental costs (net of income taxes), is deducted from equity attributable to Discovery Limited equity
holders. Where such shares are subsequently sold, reissued or otherwise disposed of, any consideration received is included in
equity attributable to Discovery Limited equity holders, net of any directly attributable incremental transaction costs and the
related income tax effects.
13. 	Insurance contracts
Insurance contracts are those contracts that transfer significant insurance risk. Such contracts may also transfer financial risk.
Discovery defines significant insurance risk as the possibility of having to pay benefits, on the occurrence of an insured event, that
are significantly more than the benefits payable if the insured event did not occur.
Discovery developed its accounting policies for insurance contracts before the adoption of IFRS 4. As provided for in IFRS 4,
Discovery continues to apply these same accounting policies for the recognition and measurement of obligations arising from
insurance contracts that it issues and reinsurance contracts that it holds.
13.1 	Recognition and measurement
Insurance contracts are classified into four main categories, depending on the duration of the risk and the type of risk insured.
13.1.1 INDIVIDUAL LIFE INSURANCE
These contracts insure against a comprehensive spectrum of risks, including life, disability, severe illness and income continuation
cover. These contracts are long-term in nature.
VALUATION OF POLICYHOLDER LIABILITIES
For the published accounts, the actuarial value of policyholder liabilities is determined based on a prospective discounted cash
flow valuation basis calculated as the difference between the present value of future benefit payments plus expenses and the
present value of future premiums. Best estimate assumptions regarding the future expected claims experience, premium
income, expenses and commission are used. Where the same policy includes both insurance and investment components and
where the policy is classified as an insurance policy, the liability for the insurance benefits and investment benefits are separately
calculated. These components of the liability are not unbundled for reporting purposes. (Refer to accounting policy 14 for the
recognition and measurement of investment benefit liabilities).
Where the value of policyholder liabilities is negative in aggregate, this is shown as assets arising from insurance contracts.
Applying the valuation basis using the best estimate assumptions described above, would result in a gain at initial recognition.
Compulsory and discretionary margins are therefore added to the best estimate assumption to avoid the premature recognition
of future profits. At initial recognition, profits are recognised to the extent of the actual acquisition costs incurred but considering
the premium loadings available on the total portfolio to recoup acquisition costs.
176 Discovery Annual Financial Statements 2021

-- 177 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
13. 	Insurance contracts continued
13.1 	Recognition and measurement continued
13.1.1 INDIVIDUAL LIFE INSURANCE continued
Discretionary and compulsory margins are therefore added to the best estimate assumptions within the following framework.
❚ 	All margins are at least equal to the compulsory margins prescribed by regulations;
❚ 	For the discount rate and lapse rate margins, the direction of the margins may vary based on policy type and duration to
ensure that the margin is in the conservative direction, overall;
❚ 	Given the level of uncertainty in the best estimate assumptions for lapse, mortality and morbidity, margins are added to
protect against future possible adverse experience;
❚ 	Additional margins are added to allow for the release of profit over the term of the policy;
❚ 	Margins are released over the term of a policy in line with the risk borne;
❚ 	The best estimate assumptions and margins are reset at every valuation date to reflect the underlying profitability of the
portfolio. Changes to assumptions, models and benefits are therefore offset at the portfolio level through an increase in
discretionary margin (or release if sufficient discretionary margin exists). The impact of experience variances (with the
exception of lapse and mortality experience) on the end-of-period prospective liability recognised in respect of in-force
policies is offset at the portfolio level against an increase in discretionary margin (or release if sufficient discretionary margin
exists). The impact of experience variances on the in-period cash flows is accounted for in profit or loss for the period and not
offset through changes in discretionary margins;
❚ 	Discovery has established a procedure to utilise the available discretionary margin in a specified order. First, Discovery will
utilise available discretionary margins to absorb all experience items on in-force policies. This is after in period experience
variances which are recognised immediately in profit or loss as noted in policy above. Secondly, Discovery utilises available
discretionary margins to offset non-economic assumption variances, model, and benefit changes. Lastly, the discretionary
margins are utilised to offset the last economic assumption changes. In subsequent periods;
❚ 	Where there are insufficient discretionary margins to offset losses arising from negative changes in non-economic
assumptions, models and benefit and or negative changes in economic assumptions, those losses in excess of the discretionary
margin are recognised immediately in profit or loss; and
❚ 	In subsequent periods, positive changes in economic assumptions and positive variance in non-economic assumptions,
models and benefits are first recognised separately in profit or loss to extent that it reverses related losses previously
recognised in profit or loss. This is in the reversed sequence in which the negative variances were utilised against discretionary
margin and any excess previously recognised in profit or loss.
Contractual premium and benefit increases are included in the valuation of the policyholder liability. It is further assumed that
no voluntary benefits are taken up where a future take-up of these benefits would reduce the liability. This is in line with South
African actuarial guidance which requires that expected profits in respect of future options that may be taken up by policyholders
should not be recognised in the policyholder liability.
The actuarial liabilities are calculated gross of reinsurance. The expected impact of reinsurance is valued separately.
The valuation basis meets the requirement of the liability adequacy test as required by IFRS 4 for individual life insurance and no
additional tests are performed.
The liability estimates are reviewed at every reporting period and any changes in estimates to the liability are reflected in profit
or loss as they occur.
PREMIUM REVENUE
For individual life insurance contracts, premiums are recognised as revenue when due. Premiums are shown net of premium
discounts received, premiums provided for as bad debts and before the deduction of commission. Premiums exclude taxes
and levies.
INSURANCE BENEFITS AND CLAIMS
Insurance benefits and claims relating to individual life insurance contracts are recognised in profit or loss based on the estimated
liability for benefits owed to the contract holder. Death, disability and severe illness and surrender claims are accounted for when
notified. These claims include claims reported but not yet validated. The estimate is determined taking into account the likelihood
of the claim being valid and the expected severity of the claim given that the claim is valid. The proportion to be included is
estimated separately for each benefit type. An estimate of the expected claim amount is charged to profit or loss and included in
liabilities under insurance contracts. Maturity and income disability are recorded as incurred. Liabilities are held to reflect
incurred but not yet reported (IBNR) claims. The IBNR liabilities are modified to reflect actual current operating conditions. The
liabilities are calculated gross of reinsurance. An asset is then raised to allow for the expected recoveries from reinsurers.
177 Discovery Annual Financial Statements 2021

-- 178 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
13. 	Insurance contracts continued
13.1 	Recognition and measurement continued
13.1.1 INDIVIDUAL LIFE INSURANCE continued
ACQUISITION COSTS
Acquisition costs for these contracts represent commission and other costs that relate to the securing of new contracts and the
renewing of existing contracts. The valuation basis for valuing insurance contracts makes implicit allowance for the deferral of
acquisition costs and hence no explicit deferred acquisition cost asset is recognised in the Statement of financial position. These
are expensed in profit or loss.
13.1.2 GROUP LIFE INSURANCE
These contracts insure against a comprehensive spectrum of protection benefits on a group basis. Life cover, severe illness,
disability and income continuation benefits are offered. These contracts are short-term in nature.
PREMIUM REVENUE
For group life insurance contracts, premiums are recognised as revenue when due. Premiums are shown net of premiums
provided for as bad debts, before the deduction of commission and exclude taxes and levies.
INSURANCE BENEFITS AND CLAIMS
Insurance benefits and claims relating to group life insurance contracts are recognised in profit or loss based on the estimated
liability for benefits owed to the contract holder. Death, disability and severe illness and surrender claims are accounted for when
notified. These claims include claims reported but not yet validated. The estimate is determined taking into account the likelihood
of the claim being valid and the expected severity of the claim given that the claim is valid. The proportion to be included is
estimated separately for each benefit type. An estimate of the expected claim amount is charged to profit or loss and included in
liabilities under insurance contracts. Maturity and income disability are recorded as incurred. Liabilities are held to reflect IBNR
claims. The IBNR is modified to reflect actual current operating conditions. The liabilities are calculated gross of reinsurance. An
asset is then raised to allow for the expected recoveries from reinsurers.
ACQUISITION COSTS
Acquisition costs for group life insurance contracts comprise all direct costs arising from the sale of insurance contracts.
Commissions are expensed as incurred.
13.1.3 HEALTH INSURANCE
These contracts insure policyholders against healthcare-related claims.
PREMIUM REVENUE
Health insurance premiums received in respect of annual contracts are recognised proportionally over the period of the coverage. The
portion of the premium received on in-force contracts that relates to unexpired risks at the reporting period is reported as unearned
premiums within liabilities arising from insurance contracts. The unearned premium income is amortised on a straight- line basis.
INSURANCE BENEFITS AND CLAIMS
Benefits payable under health insurance contracts are accounted for as incurred. Liabilities are held to reflect IBNR claims. The
IBNR calculation is performed using the chain ladder approach. This allows for the historic patterns of claims payment in
determining the likely future emergence of claims. The IBNR is further modified to reflect current operational conditions or known
events. The liabilities are calculated gross of reinsurance. An asset is then raised to allow for the expected recovery from reinsurers.
DEFERRED ACQUISITION COSTS
The direct costs (commissions) of acquiring short-term health insurance business which are incurred during the year, but which
are expected to be recoverable out of future revenue margins, are deferred and disclosed as an asset in the Statement of
financial position (gross of tax). The costs are deferred over the period of the contract and amortised on a straight-line basis in
line with unearned premiums.
FINANCIAL REINSURANCE
Where a financial reinsurance contract is taken out to protect against lapses, all acquisition costs related to the policy are
effectively deferred over the period of the reinsurance contract.
13.1.4 SHORT-TERM INSURANCE
These monthly contracts insure policyholders against a comprehensive spectrum of short-term risks including, but not limited to,
motor vehicle and household cover.
178 Discovery Annual Financial Statements 2021

-- 179 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
13. 	Insurance contracts continued
13.1 	Recognition and measurement continued
13.1.4 SHORT-TERM INSURANCE continued
PREMIUM REVENUE
Short-term insurance premiums received in respect of monthly contracts are recognised as revenue when due. Premiums are
shown before the deduction of commission, less the fuel cash back rewards described below, and exclude value-added tax.
UNEARNED PREMIUM PROVISION
An unearned premium provision is created at the commencement of each insurance contract and is released as the risk covered
by the contract expires. The Unearned Premium Provision, represents a proportion of premiums underwritten in the current
year, which relate to risks which have not expired by the end of the financial year. This is calculated on a time-proportionate basis
for even risks. Therefore, the unearned premium is released over the period of insurance using a method which approximates
the time period of the risk covered. The unearned premium provision is calculated on a gross basis.
REINSURANCE COMMISSION INCOME
Reinsurance commission income is recognised in profit or loss over the period of the related direct insurance business assumed.
INSURANCE BENEFITS AND CLAIMS
Claims are accounted for as incurred and consist of claims paid, movement in the provision for outstanding claims and related
claims handling expenses.
The provision for outstanding claims is based on estimates of the cost of settling all claims incurred but unpaid at the reporting
date, whether reported or not. Related anticipated reinsurance recoveries are disclosed separately as assets in the Statement of
financial position and are included in recoveries from reinsurers in profit or loss.
SALVAGE AND SUBROGATION RECOVERIES
Certain short-term insurance contracts allow Discovery to sell property acquired as a result of a claim (salvage). Discovery may
also have the legal right to pursue third parties for payment of some or all of the costs (subrogation).
The estimated salvage and subrogation reimbursements are treated as a reduction in the measurement of claims liability.
ACQUISITION COSTS
Acquisition costs for these contracts comprise all direct costs arising from the sale of insurance contracts and are recognised in
profit or loss for monthly policies and deferred in acquisition costs for future periods, over the term of the contract.
INSURE FUNDER ACCOUNT (IFA)
This relates to a benefit on a short-term insurance product. A fuel cash back can be used to either reduce the premium that the
policyholder is required to pay for the month in question or can be doubled and paid into an IFA.
Where the policyholder has used the fuel cash back to reduce the monthly premium, the reduction has been shown in insurance
premium revenue in profit or loss as incurred.
If the policyholder has elected to double the fuel cash back and paid it into an IFA, an IFA liability is raised. The IFA liability is
calculated using a discounted cash flow approach and is disclosed in liabilities arising from insurance contracts in the Statement
of financial position and the movement is disclosed in the transfer to liabilities under insurance contracts.
When the member uses funds in the IFA to pay for his excess or other costs, the excess is paid by Discovery and an expense is
included in claims in the income statement.
Where the member withdraws the funds after three years, the member is paid out in cash and an expense is disclosed against
insurance premium revenue in the income statement.
13.2 	Embedded derivatives arising from insurance contracts
A unit-linked insurance contract is an insurance contract with an embedded derivative linking payments on the contract to units
of an investment fund purchased with the consideration received from the contract holders. This embedded derivative meets the
definition of an insurance contract and is therefore not accounted for separately from the host insurance contract. The liability
for such contracts is adjusted for all changes in the fair value of the underlying assets.
179 Discovery Annual Financial Statements 2021

-- 180 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
13. 	Insurance contracts continued
13.2 	Embedded derivatives arising from insurance contracts contiunued
Discovery does not separately measure embedded derivatives that meet the definition of an insurance contract or options to
surrender insurance contracts for a fixed amount (or amount based on a fixed amount and an interest rate). All other embedded
derivatives are separated and carried at fair value if they are not closely related to the host insurance contract and meet the
definition of a derivative. Embedded derivatives that are separated from the host contract are fair valued through profit or loss.
13.3 	Liability adequacy test
At the reporting date, liability adequacy tests are performed to ensure the adequacy of the contract liabilities net of related
deferred acquisition costs. In performing these tests, current best estimates of future contractual cash flows and claims handling
and administration expenses are used. Any deficiency is immediately charged to profit or loss initially by writing off deferred
acquisition costs and by subsequently establishing a provision for losses arising from the liability adequacy test.
13.4 	Reinsurance contracts
Contracts entered into by Discovery with reinsurers under which Discovery is compensated for insured events on one or more
contracts that meet the classification requirements for insurance contracts are classified as reinsurance contracts. Contracts that
do not meet these classification requirements are classified as financial assets.
Amounts recoverable from or due to reinsurers are measured consistently with the amounts associated with the reinsured
insurance contracts and in accordance with the terms of each reinsurance contract.
The amounts Discovery is required to pay under its reinsurance contracts held are recognised as reinsurance liabilities (liabilities
arising from reinsurance contracts).
Outward reinsurance premiums are recognised as an expense and are accounted for when due under the reinsurance contract. The
amounts due to Discovery under its reinsurance contracts are recognised as reinsurance assets (classified within insurance receivables).
Discovery assesses its reinsurance assets for impairment on an annual basis.
In certain cases there is a net gain or loss at inception of a reinsurance contract:
❚ 	Where these amounts relate directly to a reimbursement of expenses the gain is disclosed as a recovery of expenses from
reinsurers; or
❚ 	Other gains or losses are amortised over the life of the reinsurance contract on a consistent basis as the profit is expected to
emerge on the underlying policies but considering the contractual terms and intent of the specific reinsurance contract.
In certain cases there is a net gain or loss upon early termination of a reinsurance contract. Where these amounts result directly
from the termination, they are recognised as at the termination date and disclosed as recapture of reinsurance in profit or loss.
13.5 	Receivables and payables related to insurance contracts
Receivables and payables are recognised when due. These include amounts due to and from agents, brokers and insurance
contract holders. Amounts due are measured consistently and where applicable, provisions for impairments are recognised.
14. 	Investment contracts
Investment contracts are those contracts that transfer financial risk without significant insurance risk. Financial risk refers to the
risk of a possible future change in the value of an asset or financial instrument due to a change in interest rate, commodity price,
index of prices, foreign exchange rate or other measurable variables.
Discovery issues investment contracts without fixed benefits (e.g. unit-linked and structured products) and investment contracts
with fixed and guaranteed benefits (e.g. term certain annuity).
Valuation of policyholder liabilities
Investment contracts without fixed benefits are financial liabilities whose fair value is dependent on the fair value of the underlying
financial assets and derivatives (unit-linked) which are classified at fair value through profit or loss. Discovery designates these
investment contracts to be measured at fair value through profit or loss because it eliminates or significantly reduces a
measurement or recognition inconsistency that would otherwise arise from measuring assets or liabilities or recognising the
gains and losses on them on different bases. See accounting policy 7 for the financial assets backing these liabilities.
180 Discovery Annual Financial Statements 2021

-- 181 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
14. 	Investment contracts continued
Valuation of policyholder liabilities contnued
Discovery’s main valuation techniques incorporate all factors that market participants would consider and are based on
observable market data. The fair value of a unit-linked financial liability is determined using the current unit price that reflects the
fair values of the financial assets contained within Discovery’s unitised investment funds linked to the financial liability. The fair
value of the financial liabilities is obtained by multiplying the number of units attributed to each policyholder at the reporting date
by the unit price for the same date.
For investment contracts with fixed and guaranteed terms, valuation techniques are used to establish the fair value at inception
and at each reporting date. Valuation techniques include discounted cash flow analysis using current market rates of interest and
reference to other instruments that are substantially the same.
Premium revenue
All premiums received under investment contracts are recorded as deposits to investment contract liabilities and claims incurred
on investment contracts are recorded as deductions from investment contract liabilities.
Fees on investment contracts
Service fee income on investment management contracts is recognised over time as and when the related performance obligation
is satisfied. Refer accounting policy note 20. Fees on investment contracts are included in fee income from administrative business.
A deferred revenue liability (DRL) is recognised as a contract liability to contracts with customers in respect of upfront fees for
financial advice, investment management and other services which are directly attributable to a contract that are charged for
securing the investment management service contract. The DRL is then released to revenue when the performance obligations
are satisfied, which corresponds to the underlying expected profit signature of the contract.
Regular fees are charged to the customer monthly either directly or by making a deduction from invested funds.
Costs of obtaining contracts
Deferred acquisition costs on investment contracts represent the contractual customer relationship and the right to receive
future investment management fees. Incremental costs directly attributable to securing rights to receive policy fees for services
sold with investment contracts, are recognised as an asset where they can be identified separately and measured reliably and it
is probable that they will be recovered. An incremental cost is one that would not have been incurred if the Group had not
secured the investment contract.
The asset represents the Group’s contractual right to benefit from providing asset management services and is amortised over
the expected life of the contract as the entity recognises the related revenue.
15. 	Borrowings
Borrowings are recognised initially at fair value, net of transaction costs incurred. Borrowings are subsequently measured at
amortised cost. Any difference between the proceeds and the redemption value is recognised in profit or loss over the period of
the borrowings using the effective interest method.
Fees paid on the establishment of loan facilities are recognised as transaction costs against the loan to the extent that it is
probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs. To the
extent there is no evidence that it is probable that some or all of the facility will be drawn down, the fee is capitalised as a
prepayment and amortised over the period of the facility to which it relates.
Preference shares, which are mandatorily redeemable on a specific date, are classified as liabilities. The dividends on these
preference shares are recognised in profit or loss as finance costs using the effective interest method.
16. 	Deferred income tax
Discovery calculates deferred income tax on all temporary differences using the Statement of financial position approach.
Deferred tax liabilities or assets are calculated by applying corporate tax rates that have been substantively enacted to the
temporary differences between the tax values of assets and liabilities and their carrying amount, where such temporary
differences are expected to result in taxable or deductible amounts in determining taxable income for future periods when the
carrying amount of the assets or liabilities are recovered or settled.
Discovery recognises deferred tax assets if the directors of Discovery consider it probable that future taxable income will be
available against which the tax losses can be utilised.
181 Discovery Annual Financial Statements 2021

-- 182 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
16. 	Deferred income tax continued
Temporary differences arise primarily from the difference between accounting and tax balances arising from insurance contracts,
depreciation of property and equipment, effect of accounting for leases, revaluation of certain financial assets and liabilities,
provisions for leave pay, provisions for share-based payments and tax losses carried forward. For leases, Discovery assesses the
lease asset and lease liability together as a single transaction and assesses the temporary difference on a net basis.
Deferred income tax is not accounted for if it arises from initial recognition of an asset or liability in a transaction other than a
business combination that at the time of the transaction affects neither accounting nor taxable income.
Deferred tax related to cash flow hedges, which are charged or credited directly to the statement of other comprehensive income,
is also credited or charged directly to the statement of other comprehensive income and is subsequently recognised in profit or
loss when the gain or loss is realised.
Deferred income tax assets and liabilities are offset when:
❚ 	There is a legally enforceable right to offset current tax assets against current tax liabilities; and
❚ 	When the deferred income tax assets and liabilities relate to income taxes levied by the same taxation authority on either the
taxable entity or different taxable entities where there is an intention to settle the balances on a net basis.
If offsetting does not apply, Discovery separately discloses the deferred tax asset and deferred tax liability.
17. 	Employee benefits
17.1 	Post-employment benefits
Discovery operates defined contribution schemes, the assets of which are held in separate private trustee-administered funds.
Discovery pays contributions to these funds on a mandatory basis. These funds are registered in terms of the Pension Funds Act,
1956, and membership is compulsory for all Discovery employees. Qualified actuaries perform annual valuations. Discovery has
no further payment obligations once the contributions have been paid. The contributions are recognised as an employee benefit
expense when they are due.
17.2 	Share-based compensation
Discovery operates equity-settled and cash-settled share-based compensation plans.
EQUITY-SETTLED SHARE-BASED COMPENSATION PLANS
Discovery expenses the fair value of the employee services received in exchange for the grant of the options, over the vesting period
of the awards, as employee costs, with a corresponding credit to a share-based payment reserve in the Statement of changes in
equity. The total value of the services received is calculated with reference to the fair value of the options on grant date.
The fair values of the options are determined excluding non-market vesting conditions. These vesting conditions are included in the
assumptions of the number of options expected to vest. At each reporting date, Discovery revises its estimate of the number of
options expected to vest. Any changes to the estimated number of options are recognised in profit or loss immediately.
CASH-SETTLED SHARE-BASED COMPENSATION PLANS
Discovery recognises employee services received in exchange for cash-settled share-based payments at the fair value of the
liability incurred and expenses these services over the vesting period of the benefits, as employee costs.
The liability is re-measured at each reporting period to its fair value, with all changes recognised immediately in profit or loss.
17.3 	Leave pay
Discovery accrues in full the employees’ rights to annual leave entitlement in respect of past service. This is expensed over the
period the services are rendered.
17.4 	Profit share and bonus plan
Discovery operates several other profit sharing and bonus compensation arrangements and recognises these when a constructive
obligation has been created by past practice. These are calculated with reference to predetermined formulae. The Group has
other deferred compensation schemes in place where employees are incentivised based on a variable other than the share price
of Discovery Limited, such as embedded value, value of in-force and earnings multiples. Discovery recognises a liability and the
related expense is included in employee costs in profit or loss.
182 Discovery Annual Financial Statements 2021

-- 183 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
18. 	Trade and other payables
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from
suppliers. Trade payables are classified as current liabilities if payment is due within one year or less from the reporting date. If
not, they are presented as non-current liabilities.
Trade payables are recognised initially at fair value and subsequently measured at amortised cost using the effective
interest method.
19. 	Contingent liabilities
Discovery discloses a contingent liability when:
❚ 	It has a possible obligation arising from past events, the existence of which will be confirmed only by the occurrence or non-
occurrence of one or more uncertain future events not wholly within the control of the entity; or
❚ 	It has a present obligation that arises from past events but not recognised because:
– It is not probable that an outflow of resources will be required to settle an obligation; or
– The amount of the obligation cannot be measured with sufficient reliability.
20. 	Revenue recognition
The Group’s primary source of revenue arises on the sale of insurance contracts which are accounted for under IFRS 4 Insurance
Contracts and are excluded from the scope of IFRS 15 Revenue from Contracts with Customers. IFRS 15 is applicable to the Group’s
revenue from administration business, Vitality income and banking fee and commission income.
IFRS 15 requires that once contracts have been identified, the entity identifies the performance obligations in the contract. This
is determined on the basis of whether the customer can benefit from the promised good or service individually or together with
other readily available resources and whether the performance obligation is distinct in the context of the contract. For the Group,
most contracts contained a single performance obligation.
The timing of revenue recognition is dependent on whether the entity transfers control over the good or service over time or at a point
in time. In determining the appropriate timing for revenue recognition, the Group considers whether the customer benefits as the
entity performs. For most revenue types, Group entities provide stand ready services to customers, where customers benefit as the
entities services are consumed. In limited instances where revenue is not recognised over time it is recognised at a point in time when
control transfers. For revenue recognised over time the stand ready service is recognised straight line over the term of the contract.
In determining the amount of revenue to recognise, the Group considers any uncertainty created through variable consideration
contained in the contract, and constrains the recognition of revenue in order to recognise revenue only to the extent that it is highly
probably that a significant reversal in the amount of cumulative revenue recognised will not occur when the associated uncertainty is
resolved. The Group also considers the impact of the timing of receiving payments for revenue transactions and determines whether
a significant financing component should be taken into account in the measurement of the transaction price. As the Group’s contracts
routinely include single performance obligations, there is limited complexity in allocating transaction prices to performance obligations.
Payment terms vary across the different revenue types earned by the Group.
Where contracts with customers involve a third party, the Group considers whether it is acting as the principal or the agent in the
delivery of the promised goods or services to the customer. This assessment is based on whether the Group controls the goods
or services before it is transferred to the customer.
For certain contracts with customers, Discovery receives income in advance of discharging the related performance obligation. In
these instances, the amount is recognised as a contract liability incurred in the acquisition or fulfilment of a contract. Discovery
considers whether there are costs incurred for the acquisition or fulfilment of a contract. These costs are recognised as an asset
and amortised over the expected period over which performance obligations under the contract are satisfied. Contract costs
incurred that are considered to be of a general and administrative nature, that are not explicitly recovered from the customer,
are expensed as incurred.
Where the transaction price included in a contract is payable less than 12 months from the date of satisfying the related
performance obligation the practical expedient is applied in that a significant financing component is not recognised. Similarly,
where costs of obtaining a contract would be amortised over 1 year or less, the costs are not recognised as a separate asset.
183 Discovery Annual Financial Statements 2021

-- 184 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
20. 	Revenue recognition continued
Fee income from administration business 	Vitality Income
Banking fee and
commission income
Nature of
performance
obligations
Fee 	income 	is 	recognised 	on 	health
administration and managed care services
rendered. Fee income is also generated on
asset administration and fees earned on use
of intellectual property. In the respective
business these are considered revenue and
are seen as single performance obligations in
the respective legal entities. These are
separated by underlying reported entity in
the segmental report shown in note 1.
Vitality income includes the
fee income that members of
corporations pay to access
the Vitality benefit, as well as
various activation fees for
activating additional benefits.
The performance obligation
relates to access to the Vitality
rewards 	programme 	and
partner benefits provided to
members.
Banking fee and commission
income 	includes 	banking
service 	fees 	for 	banking
services. The performance
obligation 	relates 	to 	the
access 	to 	banking 	and
banking services rendered.
Commission income relates
to the interchange fees which
Discovery Bank earns on
transactions using debit or
credit cards. The performance
obligation 	relates 	to
settlement of transactions via
the card network.
When does
control pass –
Point in time
(PIT) vs over
time
Performance 	obligation 	to 	provide
administration services are considered
stand ready services, the customer obtains
control over the service as the entity makes its
services available on an “as and when” basis.
As a result, revenue is recognised over time, as
the respective entity makes the services
available, based on the passage of time.
Performance obligations to
provide access to benefits
are considered stand ready
services as the customers
obtains benefits over the
duration of the contract
and when required by the
customers. 	As 	a 	result
revenue is recognised over
time based on the passage
of time.
The performance obligation
associated with the banking
fee and commission income
passes over time because the
client obtains substantially all
of the remaining benefits
from the service over the
period of the month for which
the banking fee was charged.
When are
amounts
payable
Amounts 	are 	billed 	on 	health
administration and managed care business
at the end of the respective month with
amounts paid within 30 days. For fees on
asset administration business, amounts are
disinvested for the units held at the end of
the related month. Certain fees for example
advisor fees are received upfront but are
deferred as a contract liability over the
expected term of the entity’s performance.
Amounts are billed either
monthly, 	payable 	within
30 	days, 	or 	billed 	on
activation of the benefit,
payable immediately.
Banking fees are charged
monthly 	and 	payment 	is
immediate. 	Interchange
income is charged at a point
of payment and settled daily
in batch format.
184 Discovery Annual Financial Statements 2021

-- 185 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
20. 	Revenue recognition continued
Fee income from administration business 	Vitality Income
Banking fee and
commission income
Variable
consideration
and estimates
There is no potential for amounts of revenue
to vary relating to discounts or rebates on
the health administration business.
For the asset administration business, fees are
determined with reference to assets under
management at a point in time. There are no
benchmark performance based fees. The
nature of the integrated products that
Discovery sells related to the invest business
allows for fee discounts and rebates to be
determined based on client behaviour.
Revenue is estimated and recognised in line
with the constraint on variable consideration,
only to the extent that it is highly probable
that there will not be a significant reversal of
revenue 	already 	recognised 	once 	the
uncertainty is resolved.
The fee discounts and rebates are determined
according to a fixed methodology incorporating
policyholder specific information including
Vitality status. Discovery has experience in
estimating these amounts, which are based on
a limited number of outcomes. There is no
financing component.
There are no adjustments to
the transaction price as a result
of any variable consideration.
There 	is 	no 	significant
financing component.
There are no adjustments to
the transaction price as a result
of any variable consideration.
There is no significant financing
component.
Costs to
capitalise
Where costs are incurred directly to secure a
new health administration customer, and
the contract is expected to exceed 12
months, the costs are capitalised and
amortised over the expected term of the
contract. Costs are routinely incurred on the
asset administration business related to
commission and other incremental costs of
entering into the contract. These are
capitalised and recognised over the expected
duration of the customer relationship. These
assets are tested for impairment to the
extent that the carrying amount of the asset
exceeds the expected remaining net cash
inflows from the customer contract.
In respect of the Apple watch
benefit, 	Discovery 	incurs
costs upfront to purchase
the device and provide it to
the customer. These costs
are deferred and recognised
over the two year term of the
benefit.
None.
Insurance premium revenue
Insurance premium revenue includes individual life insurance premiums, group life insurance premiums, health insurance
premiums and short-term insurance premiums. These are accounted for as described in accounting policy 13.
185 Discovery Annual Financial Statements 2021

-- 186 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
21. 	Other non-revenue income
21.1 	Investment income
Investment income comprises dividends and interest received from assets held at amortised cost and cash and cash equivalents.
Discovery recognises dividends when Discovery’s right-to-receive payment is established. This is on the “last day to trade” for
listed shares and on the “date of declaration” for unlisted shares. Dividend income includes scrip dividends, irrespective of
whether there is an option to receive cash instead of shares.
Interest is accounted for on an accrual basis using the effective interest method.
21.2 	Net fair value gains on financial assets at fair value through profit or loss
Net fair value gains on financial assets at fair value through profit or loss include gains arising from interest, dividends and net
realised and unrealised gains on financial assets held at fair value through profit or loss.
22. 	Leases
IDENTIFICATION OF A LEASE
At inception of a contract, Discovery assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the
contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. To assess
whether a contract conveys the right to control the use of an identified asset, Discovery uses the definition of a lease in IFRS 16.
Contracts where the service provider has a substantive right to substitute the asset for an alternative asset during the lease term
is not regarded as a lease, but instead a service contract. Accordingly, these contracts are not accounted for in accordance with
IFRS 16. For Discovery, such contracts include items such as vending machines.
22.1 	As a lessee
At commencement or on modification of a contract that contains a lease component, Discovery allocates the consideration in the
contract to each lease component on the basis of its relative stand-alone prices. However, for the leases of property Discovery has
elected not to separate non-lease components and account for the lease and non-lease components as a single lease component.
Discovery recognises a right-of-use asset and a lease liability at the lease commencement date. Discovery presents right-of-use
assets in ‘Property and equipment’ and lease liabilities in ‘Borrowings at amortised cost’ in the Statement of financial position.
Discovery leases the following assets with a range of lease terms:
– Large offices 	5 – 15 years
– Small offices/Franchise offices (SA only) 	1 – 3 years
– Computer equipment (e.g. servers) (SA only) 	3 – 4 years
– Motor vehicles (UK only) 	3 years
MEASUREMENT
LEASE LIABILITY
The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date,
discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the lessee’s incremental
borrowing rate. Generally, Discovery uses its incremental borrowing rate as the discount rate.
Discovery determines its incremental borrowing rate by obtaining interest rates from various external financing sources and
makes certain adjustments to reflect the terms of the lease and type of the asset leased. The incremental borrowing rates were
calculated for each legal entity within Discovery that entered into lease arrangements. The incremental borrowing rate considers
a base interest rate reflective of the jurisdiction in which the legal entity operates (South Africa, United Kingdom and United
States of America), the term of the lease arrangement and the nature of the assets.
186 Discovery Annual Financial Statements 2021

-- 187 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
22. 	Leases continued
22.1 As a lessee continued
Lease payments included in the measurement of the lease liability comprise the following:
❚ 	fixed payments, including in-substance fixed payments;
❚ 	variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;
❚ 	amounts expected to be payable under a residual value guarantee; and
❚ 	the exercise price under a purchase option that Discovery is reasonably certain to exercise, lease payments in an optional
renewal period if Discovery is reasonably certain to exercise an extension option, and penalties for early termination of a lease
unless Discovery is reasonably certain not to terminate early.
Extension or termination options are included in a number of the building leases across Discovery. These terms are used to
maximise operational flexibility in terms of managing contracts. In determining the lease term, management considers all facts
and circumstances that create an economic incentive to exercise an extension option, or not exercise a termination option.
Extension options (or periods after termination options) are considered in the lease term when there is reasonable certainty that
those options will be exercised.
The lease liability is measured at amortised cost using the effective interest method. It is remeasured when there is a change in
future lease payments arising from a change in an index or rate, if there is a change in Discovery’s estimate of the amount
expected to be payable under a residual value guarantee, if Discovery changes its assessment of whether it will exercise a
purchase, extension or termination option or if there is a revised in-substance fixed lease payment. When the lease liability is
remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or is recorded in
profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.
RIGHT-OF-USE ASSET
The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease
payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle
and remove the underlying asset or to restore the underlying asset, less any lease incentives received. Discovery receives
incentives such as reimbursements for installations or rent-free periods.
The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the end of
the lease term, unless the lease transfers ownership of the underlying asset to Discovery by the end of the lease term or the cost
of the right-of-use asset reflects that Discovery will exercise a purchase option.
In that case the right-of-use asset will be depreciated over the useful life of the underlying asset, which is determined on the same
basis as those of property and equipment. In addition, the right-of-use asset is periodically reduced by impairment losses, if any,
and adjusted for certain remeasurements of the lease liability.
SHORT-TERM LEASES AND LOW VALUE ITEMS
Discovery has elected not to recognise right-of-use assets and lease liabilities for leases of low-value assets and short-term
leases. Discovery recognises the lease payments associated with these leases as an expense on a straight-line basis over the
lease term.
Leases of low value assets relate to those categories of assets which at inception of the lease typically have a value, if bought new,
of no more than approximately R70 000. For Discovery, these categories include computer equipment such as desktops, laptops,
monitors and related IT peripherals.
Short-term leases are those leases with a lease term of less than 12 months.
187 Discovery Annual Financial Statements 2021

-- 188 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
22. 	Leases continued
22.2 	As a lessor
At inception or on modification of a contract that contains a lease component, Discovery allocates the consideration in the
contract to each lease component on the basis of their relative standalone prices.
CLASSIFICATION
To classify the lease, Discovery makes an overall assessment of whether the lease transfers substantially all of the risks and
rewards incidental to ownership of the underlying asset. If this is the case, then the lease is a finance lease; if not, then it is an
operating lease.
As part of this assessment, Discovery considers indicators such as whether the lease is for the major part of the economic life of
the asset, the specialised nature of the asset and the present value of lease payments.
Discovery leases out portions of its leased property in the form of subleases. Discovery has classified these leases as operating
leases.
MEASUREMENT
As Discovery is an intermediate lessor, it accounts for its interests in the head lease and the sub-lease separately. It assesses the
lease classification of a sub-lease with reference to the right-of-use asset arising from the head lease, not with reference to the
underlying leased asset.
If an arrangement contains lease and non-lease components, Discovery applies IFRS 15 Revenue from Contracts with Customers
to allocate the consideration in the contract.
Discovery recognises lease payments received under operating leases as income on a straightline basis over the lease term as
part of ‘other income’.
23. 	Marketing and administration expenses
Marketing and administration expenses include marketing and development expenditure, all other non-acquisition related
expenditure and benefits paid under the Vitality programme. These costs are expensed in profit or loss as incurred.
24. 	Finance costs
Finance costs (net of investment income earned on the temporary investment of specific borrowings pending their expenditure
on qualifying assets) directly attributable to the acquisition, construction or production of assets that necessarily take a substantial
period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are
substantially ready for their intended use or sale. All other finance costs are recognised as an expense in profit or loss on an
accrual basis using the effective interest method.
In addition, finance costs include any recycled gains or losses from other comprehensive income arising from cash flow hedges
of interest rates, amortisation of financing related fees such as loan commitment fees and letter of credit fees as well as
modification gains and losses on borrowings.
25. 	Direct and indirect taxes
Direct taxes include South African and foreign jurisdiction corporate tax payable and are disclosed as taxation in profit or loss.
Indirect taxes include various other taxes paid to central and local governments, including value-added tax and skills development
levies. Indirect taxes are included as part of marketing and administration expenses in profit or loss.
The charge for current tax is based on the results for the year as adjusted for items which are non-taxable or disallowed. It is
calculated using taxation rates that have been enacted or substantively enacted by the reporting date, in each particular
jurisdiction within which the Discovery entities operate.
Taxation in respect of the South African life insurance operations is determined in accordance with the rates and basis applicable
to section 29A of the Income Tax Act at the reporting date.
26. 	Dividend distribution
Dividend distribution to Discovery Limited’s shareholders is recognised as a liability in the Group’s financial statements in the
period in which the dividends are approved.
188 Discovery Annual Financial Statements 2021

-- 189 of 219 --

ANNEXURE A – GROUP ACCOUNTING POLICIES continued
27. 	Normalised headline earnings
Discovery assesses its performance using Normalised Headline Earnings, an alternative non-IFRS profit measure, alongside its
IFRS profit. Management considers that Normalised Headline Earnings Per Share (NHEPS) is an appropriate alternative
performance measure to enhance the comparability and understanding of the financial performance of Discovery.
Non-IFRS measures are not uniformly defined or used by all entities and may not be comparable with similarly labelled measures
and disclosures provided by other entities. Discovery has set out its policy to calculate NHEPS below.
Discovery calculates headline earnings in accordance with the latest SAICA Circular ‘Headline Earnings’. NHEPS is calculated by
starting with headline earnings and adjusted to exclude material items that are not considered to be part of Discovery’s normal
operations as follows:
❚ 	Once-off transactions, for example, debt restructuring costs resulting from the DiscoveryCard business transaction,
restructuring costs and transaction costs related to interest rate derivatives.
❚ 	Unusual items - Discovery considers items to be unusual when they have limited predictive value and it is reasonable that
items of similar nature would not necessarily arise for several future annual reporting periods. These adjustments include
those gains or losses associated with changes in economic assumptions recognised in profit or loss, net of any gains or losses
on derivatives to offset such changes in economic assumptions. Adjustments are shown net of tax; or
❚ 	Income or expenses not considered to be part of Discovery’s normal operations, for example, amortisation of intangibles
from business combinations, fair value (gains)/losses certain foreign exchange contracts not designated as hedges and
specified foreign exchange gains or losses.
Management is responsible for the calculation of NHEPS and determining the inclusions and exclusions in accordance with the
policy. The Discovery Limited Audit Committee (DLAC) reviews the normalised headline earnings for transparency and consistency.
During the financial period, Discovery has made the following adjustments in the determination of NHEPS:
Adjustment 	Explanation
Changes in economic
assumptions in excess of
available discretionary margin
(in future, this will also include
the reversals of economic
assumptions recognised in profit
or loss)
Economic assumptions include changes associated with interest rates as well as
currency exchange rates. The adjustment reflects changes in economic assumptions
for the time value of money and forex rates and the effect on insurance contracts
resulting from changes in the long-term interest rates as well as forex rates.
Under IFRS, where there are insufficient discretionary margins to offset losses arising
from negative changes in economic assumptions, those losses in excess of the
discretionary margin are recognised immediately in profit or loss. In subsequent
periods, positive changes in economic assumptions are first recognised separately in
profit or loss to the extent that it reverses related losses previously recognised in
profit or loss before it increases discretionary margins.
The effect of these economic assumptions is unusual and provides little predictive
value for future periods. This is because the value is dependent on available
discretionary margins at a given point in time and the long-term interest rates which
could vary period to period – thereby introducing volatility and inability to be
predictive on results during future periods. These adjustments are therefore excluded
in assessing the normal business operations of Discovery.
Intrinsic fair value changes on
VitalityLife derivatives
VitalityLife has entered into interest rate derivative instruments to offset the impact of
changes in economic assumptions on insurance contracts.
The adjustment reflects the intrinsic value of fair value gains or losses on these
derivative instruments. The intrinsic value of fair value gains or losses on these
derivative instruments are excluded from NHEPS to be consistent with the treatment
of the changes in economic assumptions recognised in profit or loss.
Translation losses/(gains) on
long-term intercompany loans
that eliminate on consolidation
The adjustment reflects those foreign exchange (gains) or losses associated with the
translation of foreign denominated long-term intercompany loans. Long-term loans
include those loans with final settlement terms beyond 12 months after the reporting
date. Discovery considers these loans to form part of its interest in the entity.
The translation of a foreign denominated loan into the functional currency of the
respective entity results in foreign exchange gains or losses. These foreign exchange
gains or losses can result in volatility in profit or loss, which fluctuates over the period
during which the long-term loans remain outstanding. This volatility is therefore
excluded in assessing the normal business operations of Discovery, as these foreign
exchange gains or losses are seen to form part of the interest in the entity.
189 Discovery Annual Financial Statements 2021

-- 190 of 219 --

27. 	Normalised headline earnings continued
Adjustment 	Explanation
Fair value (gains)/losses on
foreign exchange contracts not
designated as a hedge
The adjustment reflects fair value gains or losses on foreign exchange contracts
entered in anticipation of the Prudential Book Transfer. These derivative instruments
are not designated as a hedge and as a result, the fair value adjustments are
recognised in profit or loss.
The fair value adjustments of these derivative instruments can result in volatility in
profit or loss and is therefore excluded in assessing the normal business operations of
Discovery as it relates specifically to a future once-off transaction.
Amortisation of intangibles from
business combinations
The adjustment reflects the amortisation of intangible assets which arose from the
purchase of various subsidiaries within Discovery and recognised in accordance with
IFRS 3 Business Combinations.
Intangible assets recognised from business combinations provide little predictive value
of the earnings from the business, as these assets will not be reacquired, renewed, or
replaced once depleted. Discovery also infrequently acquires businesses. The
amortisation of these assets is therefore excluded in assessing the normal business
operations of Discovery.
Deferred tax assets raised on
assessed losses
The adjustment reflects the initial recognition of deferred tax assets in respect of
assessed losses in prior financial periods, after evaluating that there is future taxable
income that will arise in the respective business.
The initial recognition of this deferred tax asset results in a once-off income
recognised in profit or loss. It provides no predictive value in assessing the normal
business operations of Discovery.
Initial expenses related to the
Prudential Book Transfer
The adjustment reflects professional fees and legal fees of the book transfer incurred
in anticipation of the Prudential Book Transfer.
As these expenses relate to a future once-off transaction it provides no predictive
value in assessing the normal business operations of Discovery and has therefore
been excluded from earnings.
Restructuring Costs 	The adjustment reflects restructuring costs which are once-off costs incurred to
restructure specified business areas.
These transaction costs are infrequent and therefore excluded in assessing the normal
business operations of Discovery.
Transaction costs related to
interest rate derivatives
Transaction costs paid to acquire specified derivative instruments for VitalityLife are
excluded from NHEPS.
These transaction costs are infrequent and therefore excluded in assessing the normal
business operations of Discovery.
ANNEXURE A – GROUP ACCOUNTING POLICIES continued
190 Discovery Annual Financial Statements 2021

-- 191 of 219 --

ANNEXURE B – DIRECTORATE
REMUNERATION AND FEES
Payment to directors for the year ended 30 June 2021 for services rendered are set out in the table below. It should be noted that these
payments reflect cash payments made to directors during the financial year and therefore all variable pay components are reflective of
performance measurements relating to previous periods. The variable pay components relating to the current year under review are
physically paid in the following financial year and are analysed in detail in the Group’s annual remuneration report and are more reflective
of the performance of the period under review.
Payments to directors for the year ended 30 June 2021 for services rendered are as follows:
R’000
Services
as
directors 1
Basic
salary1
Perfor-
mance
bonus
Phantom
scheme
payments
Provident
fund
contri-
butions
Other
benefits2, 7 	Total
Executive
A Gore 	– 	7 052 	7 112 	1 547 	1 094 	365 	17 170
HD Kallner 	– 	5 273 	9 539 	4 871 	272 	164 	20 119
NS Koopowitz3 	– 	18 340 	9 917 	5 726 	49 	528 	34 560
Dr A Ntsaluba 	– 	4 425 	4 371 	987 	343 	274 	10 400
A Pollard4 	– 	6 524 	4 373 	3 119 	221 	303 	14 540
B Swartzberg 	– 	4 993 	4 649 	2 808 	534 	182 	13 166
DM Viljoen 	– 	4 581 	4 843 	3 033 	722 	82 	13 261
Sub-total 	– 	51 188 	44 804 	22 091 	3 235 	1 898 	123 216
Non-executive
ME Tucker5 	5 975 	– 	– 	– 	– 	– 	5 975
HL Bosman6 	1 822 	– 	– 	– 	– 	– 	1 822
Dr BA Brink 	1 416 	– 	– 	– 	– 	– 	1 416
SE De Bruyn 	1 364 	– 	– 	– 	– 	– 	1 364
R Farber 7 	2 281 	– 	– 	– 	– 	3 295 	5 576
FN Khanyile8 	1 104 	– 	– 	– 	– 	– 	1 104
D Macready 	1 663 	– 	– 	– 	– 	– 	1 663
DR TV Maphai 	1 728 	– 	– 	– 	– 	– 	1 728
H Mayers 	315 	– 	– 	– 	– 	– 	315
M Schreuder 	679 	– 	– 	– 	– 	– 	679
SV Zilwa9 	1 832 	– 	– 	– 	– 	– 	1 832
Sub-total 	20 179 	– 	– 	– 	– 	3 295 	23 474
Total 	20 179 	51 188 	44 804 	22 091 	3 235 	5 193 	146 690
Less: paid by subsidiaries 	(20 179) 	(51 188) 	(44 804) 	(22 091) 	(3 235) 	(5 193) 	(146 690)
Paid by holding company 	– 	– 	– 	– 	– 	– 	–
1 Responding to the challenges of COVID-19 and in response to the call by the President of South Africa, all South African executive directors, and certain non-
executive directors and foreign-based executive directors, committed one third of their gross salaries and Board fees for three months to add to Discovery’s
contributions towards the Solidarity Fund and other COVID-19-related causes. Executive directors committed R0.9 million in the current year (2020: Executive
directors forfeited R1.7 million and non-executive directors forfeited R1.4 million).
2 “Other benefits” comprise medical aid contributions, travel and other allowances.
3 Salary and incentive are paid in GBP.
4 Salary and incentive are paid in USD.
5 Director's fees for services rendered are paid in GBP.
6 Director's fees for services rendered by HL Bosman were paid to Rand Merchant Insurance Holdings Limited.
7 Director’s fees for services and fees for other consulting services rendered by R Farber were paid in AUD. Director's fees for consulting services are included as
part of other benefits.
8 Director's fees for services rendered by F Khanyile were paid to WDB Investment Holdings Proprietary Limited.
9 Black non-executive directors participated in the Discovery Limited BEE transaction. SV Zilwa has a loan outstanding to the Company of R1 million as at
30 June 2021.
191 Discovery Annual Financial Statements 2021

-- 192 of 219 --

ANNEXURE B – DIRECTORATE continued
REMUNERATION AND FEES continued
Payment to directors for the year ended 30 June 2020 for services rendered are set out in the table below. It should be noted that these
payments reflect cash payments made to directors during the financial year and therefore all variable pay components are reflective of
performance measurements relating to previous periods. The variable pay components relating to the current year under review are
physically paid in the following financial year and are analysed in detail in the Group’s annual remuneration report and are more reflective
of the performance of the period under review.
Payments to directors for the year ended 30 June 2020 for services rendered are as follows:
R’000
Services
as
directors 9
Basic
salary 9
Perfor-
mance
bonus
Phantom
scheme
payments
Provident
fund
contri-
butions
Other
benefits1,7 	Total
Executive
A Gore 	– 	6 767 	4 375 	3 636 	1 088 	413 	16 279
HD Kallner 	– 	5 105 	7 258 	11 036 	271 	168 	23 838
NS Koopowitz 2,10 	– 	19 858 	18 798 	44 887 	214 	541 	84 298
HP Mayers 3,10 	– 	11 644 	7 598 	50 258 	1 160 	1 205 	71 865
Dr A Ntsaluba 	– 	4 281 	3 417 	2 400 	342 	273 	10 713
A Pollard4 	– 	7 857 	4 323 	5 191 	197 	298 	17 866
B Swartzberg 	– 	4 902 	3 682 	3 166 	470 	173 	12 393
DM Viljoen 	– 	4 419 	3 350 	2 331 	722 	89 	10 911
Sub-total 	– 	64 833 	52 801 	122 905 	4 464 	3 160 	248 163
Non-executive
ME Tucker5 	5 448 	– 	– 	– 	– 	– 	5 448
HL Bosman6 	1 524 	– 	– 	– 	– 	– 	1 524
Dr BA Brink 	944 	– 	– 	– 	– 	– 	944
SE De Bruyn 	1 364 	– 	– 	– 	– 	– 	1 364
R Farber 7 	2 445 	– 	– 	– 	– 	3 764 	6 209
FN Khanyile8 	769 	– 	– 	– 	– 	– 	769
D Macready 	693 	– 	– 	– 	– 	– 	693
DR TV Maphai* 	1 263 	– 	– 	– 	– 	– 	1 263
HP Mayers 	420 	– 	– 	– 	– 	– 	420
AL Owen5 	2 224 	– 	– 	– 	– 	185 	2 409
SV Zilwa* 	1 832 	– 	– 	– 	– 	– 	1 832
Sub-total 	18 926 	– 	– 	– 	– 	3 949 	22 875
Total 	18 926 	64 833 	52 801 	122 905 	4 464 	7 109 	271 038
Less: paid by subsidiaries 	(18 926) 	(64 833) 	(52 801) 	(122 905) 	(4 464) 	(7 109) 	(271 038)
Paid by holding company 	– 	– 	– 	– 	– 	– 	–
1 “Other benefits” comprise medical aid contributions, travel and other allowances.
2 Salary and incentive are paid in GBP.
3 Remuneration consists of GBP and Rands components.
4 Salary and incentive are paid in USD.
5 Director's fees for services rendered are paid in GBP.
6 Director's fees for services rendered by HL Bosman are paid to Rand Merchant Investment Holdings Limited.
7 Director’s fees for services and fees for other consulting services rendered by R Farber were paid in AUD. Director's fees for consulting services are included as
part of other benefits.
8 Director's fees for services rendered by F Khanyile are paid to WDB Investment Holdings Proprietary Limited.
9 In response to the Presidents call, all executive and certain non-executive directors heeded by forfeiting an effective one-month's salaries/fees to enable the
Company to donate further towards the Solidarity Fund and similar charities. Executive directors forfeited R1.7m and non-executive directors forfeited R1.4m.
Executive directors forfeited a further R0.9m in FY21.
10 The phantom scheme payment amounts for NS Koopowitz and HP Mayers include the once-off vesting of special phantom share allocations linked to the final
buy-out in 2014 of Vitality UK and therefore represents a multi-year scheme with single maturity. These special phantom allocations were designed to align
with the VitalityHealth and VitalityLife minority interest share participation in which other UK senior management obtained a physical minority share interests
and where participants had the option to sell such shares to Discovery Group Europe Limited after maturity. NS Koopowitz and HP Mayers were not participants
in the physical share scheme but were awarded phantom shares that replicated the scheme and also forfeited the normal 2014 long term incentive plan
awards. The once-off and final amounts paid under this phantom scheme amounted to £1,453,400 each (R28.7 million).
* Black non-executive directors participated in the Discovery Limited BEE transaction and have R18.6m loans outstanding to the Company.
192 Discovery Annual Financial Statements 2021

-- 193 of 219 --

ANNEXURE B – DIRECTORATE continued
DIRECTORS’ PARTICIPATION IN LONG-TERM INCENTIVE SCHEMES
Discovery’s directors and prescribed officers participate in the various long-term incentive schemes offered by the Group and their
participation is disclosed below. Refer to Group note 31 for a detailed description of the various schemes offered.
Discovery Limited phantom share scheme
Directors and prescribed officers participation as at 30 June 2021:
Directors and prescribed officers
Outstanding
shares
Date
granted
Strike
price
R
Final
vesting
date
Value at
30 June 2021
R
A Gore 	8 106 	30/09/2016 	– 	30/09/2021 	1 023 545
27 894 	30/09/2017 	– 	30/09/2022 	3 522 175
36 021 	30/09/2018 	– 	30/09/2023 	4 548 372
HD Kallner 	18 980 	30/09/2016 	– 	30/09/2021 	2 396 541
18 708 	30/09/2017 	– 	30/09/2022 	2 362 259
146 628 	01/04/2018 	– 	31/03/2023 	18 514 654
24 159 	30/09/2018 	– 	30/09/2023 	3 050 557
A Ntsaluba 	9 557 	30/09/2016 	– 	30/09/2021 	1 206 794
19 733 	30/09/2017 	141.65 	30/09/2022 	-
9 866 	30/09/2017 	– 	30/09/2022 	1 245 780
21 234 	30/09/2018 	– 	30/09/2023 	2 681 217
A Pollard 	1 897 	30/09/2016 	– 	30/09/2021 	239 503
3 794 	30/09/2016 	114.96 	30/09/2021 	42 907
3 796 	30/09/2017 	– 	30/09/2022 	479 258
7 591 	30/09/2017 	141.65 	30/09/2022 	-
4 920 	30/09/2018 	– 	30/09/2023 	621 248
B Swartzberg 	10 873 	30/09/2016 	– 	30/09/2021 	1 372 965
3 929 	30/09/2017 	– 	30/09/2022 	496 115
7 858 	30/09/2017 	141.65 	30/09/2022 	-
8 456 	30/09/2018 	– 	30/09/2023 	1 067 739
DM Viljoen 	18 946 	01/05/2017 	– 	30/04/2022 	2 392 343
11 225 	30/09/2017 	– 	30/09/2022 	1 417 381
22 450 	30/09/2017 	141.65 	30/09/2022 	-
22 791 	30/09/2018 	– 	30/09/2023 	2 877 820
193 Discovery Annual Financial Statements 2021

-- 194 of 219 --

ANNEXURE B – DIRECTORATE continued
DIRECTORS’ PARTICIPATION IN LONG-TERM INCENTIVE SCHEMES continued
Discovery Limited long-term incentive plan
Directors and prescribed officers participation as at 30 June 2021:
Directors and prescribed officers
Outstanding
shares
Date
granted
Strike
price
R
Final
vesting
date
Value at
30 June 2021
R
A Gore 	76 399 	30/09/2019 	– 	30/09/2024 	9 646 902
30 434 	30/09/2020 	– 	30/09/2023 	3 842 901
69 707 	30/09/2020 	– 	30/09/2025 	8 801 903
HD Kallner 	51 240 	30/09/2019 	– 	30/09/2024 	6 470 075
98 985 	30/09/2020 	– 	30/09/2023 	12 498 836
46 752 	30/09/2020 	– 	30/09/2025 	5 903 375
A Ntsaluba 	45 253 	30/09/2019 	– 	30/09/2024 	5 714 096
17 846 	30/09/2020 	– 	30/09/2023 	2 253 414
41 289 	30/09/2020 	– 	30/09/2025 	5 213 562
A Pollard 	14 662 	30/09/2019 	– 	30/09/2024 	1 851 371
3 145 	30/09/2020 	– 	30/09/2023 	397 119
22 362 	30/09/2020 	– 	30/09/2025 	2 823 650
B Swartzberg 	15 372 	30/09/2019 	– 	30/09/2024 	1 941 022
11 501 	30/09/2020 	– 	30/09/2023 	1 452 231
23 376 	30/09/2020 	– 	30/09/2025 	2 951 688
DM Viljoen 	48 340 	30/09/2019 	– 	30/09/2024 	6 103 892
24 797 	30/09/2020 	– 	30/09/2023 	3 131 117
44 105 	30/09/2020 	– 	30/09/2025 	5 569 138
The Vitality Group Cash-settled plan
Directors and prescribed officers
Directors and prescribed officers
Outstanding
units
Date
granted
Exercise
price
US$
Final
vesting
date
Value at
30 June 2021
US$
A Pollard 	122 805 	30/09/2017 	– 	30/09/2022 	165 458
109 395 	30/09/2018 	– 	30/09/2023 	147 390
278 536 	30/09/2019 	– 	30/09/2024 	325 887
153 330 	30/09/2020 	– 	30/09/2025 	179 396
B Swartzberg 	127 122 	30/09/2017 	– 	30/09/2022 	171 274
187 991 	30/09/2018 	– 	30/09/2023 	253 284
287 542 	30/09/2019 	– 	30/09/2024 	336 424
160 279 	30/09/2020 	– 	30/09/2025 	187 526
The VitalityHealth and VitalityLife phantom share schemes
Directors and prescribed officers participation as at 30 June 2021:
Directors and prescribed officers
Outstanding
shares
Date
granted
Exercise
price
GBP
Final
vesting
date
Value at
30 June 2021
GBP
NS Koopowitz 	4 875 	06/11/2017 	– 	2021 	152 490
9 360 	05/11/2018 	– 	2022 	285 293
13 007 	01/03/2020 	– 	2023 	379 544
194 Discovery Annual Financial Statements 2021

-- 195 of 219 --

ANNEXURE B – DIRECTORATE continued
DIRECTORS’ PARTICIPATION IN LONG-TERM INCENTIVE SCHEMES continued
Directors’ interests in shares
According to the Register of Directors’ Interests, maintained by Discovery in accordance with the provisions of section 30(4)(d) of the
Companies Act, directors and prescribed officers of Discovery have disclosed the following interest in the ordinary shares of the Company
at 30 June 2021:
Directors and prescribed officers
Direct
beneficial
Indirect
beneficial
Total
2021
Direct
beneficial
Indirect
beneficial
Total
2020
A Gore 	– 	49 396 5591 	49 396 559 	– 	50 496 775 	50 496 775
H Bosman 	– 	77 027 	77 027 	– 	77 027 	77 027
SE de Bruyn 	1 800 	– 	1 800 	1 800 	– 	1 800
R Farber 	55 076 	– 	55 076 	55 076 	– 	55 076
HD Kallner 	100 398 	– 	100 398 	100 398 	– 	100 398
F Khanyile 	1 300 	– 	1 300 	800 	– 	800
NS Koopowitz 	– 	962 004 	962 004 	– 	962 004 	962 004
Dr TV Maphai 	1 919 	196 505 	198 424 	1 919 	407 395 	409 314
HP Mayers2 	– 	– 	– 	36 948 	7 699 716 	7 736 664
A Ntsaluba 	90 164 	– 	90 164 	90 164 	– 	90 164
A Pollard 	1 193 099 	– 	1 193 099 	1 193 099 	– 	1 193 099
B Swartzberg 	3 202 227 	22 635 1153 	25 837 342 	3 384 227 	22 733 115 	26 117 342
DM Viljoen 	10 000 	– 	10 000 	10 000 	– 	10 000
SV Zilwa 	– 	6 680 	6 680 	– 	12 780 	12 780
4 655 983 	73 273 890 	77 929 873 	4 874 431 	82 388 812 	87 263 243
1 Includes 42 400 000 (2020: 42 400 000) ordinary shares which are subject to security.
2 On 26 November 2020, when Mr HP Mayers retired. His direct beneficial holding was 36 948 shares and his indirect beneficial holding was 4 699 716 shares
in Discovery Limited, which were subject to security. (2020: 7 699 716)
3 Includes 10 200 000 (2020: 10 200 000) ordinary shares which are subject to security.
There has been no change in the directors’ interests in Discovery Limited’s shares between 30 June 2021 and the date of publication of
this annual report.
195 Discovery Annual Financial Statements 2021

-- 196 of 219 --

ANNEXURE C – ANALYSIS OF SHAREHOLDERS
at 30 June 2021
ORDINARY SHAREHOLDERS
Number of
shareholders
% of total
shareholders
Number of
shares
% of
issued
capital
Shareholder spread
1 – 1 000 shares 	26 060 	83.67 	4 977 909 	0.75
1 001 – 10 000 shares 	4 042 	12.98 	11 433 580 	1.72
10 001 – 100 000 shares 	762 	2.45 	23 743 280 	3.56
100 001 – 1 000 000 shares 	202 	0.65 	63 087 052 	9.48
1 000 001 shares and over 	79 	0.25 	562 526 780 	84.49
31 145 	100 	665 768 601 	100
Public/non-public shareholders
Non-public shareholders (more than 5%) 	25 	0.08 	319 105 911 	47.93
– Directors of the Company, including their associates 	14 	0.04 	77 929 873 	11.71
– Employee share trusts 	2 	0.01 	8 284 690 	1.24
– Own holdings 	1 	0.00 	680 268 	0.1
– Key management personnel and trustees of pension funds 	6 	0.02 	690 746 	0.1
– Strategic holdings (more than 10%) 	2 	0.01 	231 520 334 	34.78
Public shareholders 	31 120 	99.92 	346 662 690 	52.07
31 145 	100 	665 768 601 	100
Number of
shares 	%
Beneficial shareholders’ holding of 5% or more
Rand Merchant Invesment Holdings Limited 	164 810 590 	24.75
Government Employees Pension Fund 	66 709 744 	10.02
Baillie Gifford & Co 	42 123 782 	6.33
Comgest SA 	33 355 006 	5.01
B PREFERENCE SHAREHOLDERS
Number of
shareholders
% of total
shareholders
Number of
shares
% of
issued
capital
Shareholder spread
1 – 1 000 shares 	1 833 	69.01 	341 241 	4.27
1 001 – 10 000 shares 	709 	26.70 	2 145 905 	26.82
10 001 – 100 000 shares 	97 	3.65 	2 626 634 	32.83
100 001 – 1 000 000 shares 	17 	0.64 	2 886 220 	36.08
2 656 	100 	8 000 000 	100
Public/non-public shareholders
Non-public shareholders (more than 5%) 	2 	0.08 	2 052 968 	25.66
– Strategic holdings (more than 5%) 	2 	0.08 	2 052 968 	25.66
Public shareholders 	2 654 	99.92 	5 947 032 	74.34
2 656 	100 	8 000 000 	100
Number of
shares 	%
Beneficial shareholders’ holding of 5% or more
Outsurance Insurance Company Ltd 	500 000 	6.25
196 Discovery Annual Financial Statements 2021

-- 197 of 219 --

ANNEXURE D – EMBEDDED VALUE
REPORT ON THE REVIEW OF THE EMBEDDED VALUE STATEMENT
OF DISCOVERY LIMITED AND ITS SUBSIDIARIES TO THE DIRECTORS OF DISCOVERY LIMITED
INTRODUCTION
We have reviewed the Embedded Value Statement of Discovery Limited (the “Company”) and its subsidiaries (together the “Group”) for
the year ended 30 June 2021, as set out on pages 198 to 209 of the Discovery Annual Financial Statements for the year ended 30 June 2021
(the “Report”). The Report is prepared for the for the purpose of determining the value and performance of the Group. The directors of
Discovery Limited are responsible for the preparation and presentation of the Report in accordance with the embedded value basis set
out in the Basis of Preparation section of the Report and for determining that the basis of preparation is acceptable in the circumstances.
Our responsibility is to express a conclusion on this Report based on our review.
SCOPE OF REVIEW
We conducted our review in accordance with the International Standard on Review Engagements ISRE 2410 “Review of Interim Financial
Information Performed by the Independent Auditor of the Entity.” A review of financial information consists of making inquiries, primarily
of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially
less in scope that an audit conducted in accordance with International Standards on Auditing and consequently does not enable us to
obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not
express an audit opinion.
CONCLUSION
Based on our review, nothing has come to our attention that causes us to believe that the Report is not prepared, in all material respects,
in accordance with the basis set out in the Basis of Preparation section of the Report.
BASIS OF ACCOUNTING AND RESTRICTION ON USE
Without modifying our conclusion, we draw attention to the Basis of Preparation section of the Report, which describes the basis of
accounting. The Report is prepared for the purpose of determining the value and performance of the Group. As a result, the Report may
not be suitable for another purpose. Our report is intended solely for the directors of Discovery Limited and should not be used by any
other parties. We agree to the publication of our report in the Discovery Annual Financial Statements for the year ended 30 June 2021
provided it is clearly understood by the recipients of the Discovery Annual Financial Statements for the year ended 30 June 2021 that they
enjoy such receipt for information only and that we accept no duty of care to them in respect of our report.
PricewaterhouseCoopers Inc.
Director: Andrew Graham Taylor
Registered Auditor
Johannesburg
2 September 2021
197 Discovery Annual Financial Statements 2021

-- 198 of 219 --

ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
The embedded value of Discovery consists of the following components:
❚ 	the adjusted net worth attributed to the business at the valuation date;
❚ 	plus: the present value of expected future shareholder cash flows from the in-force covered business;
❚ 	less: the cost of required capital.
The present value of future shareholder cash flows from the in-force covered business is calculated as the value of projected future after-
tax shareholder cash flows of the business in-force at the valuation date, discounted at the risk discount rate.
The required capital are the assets attributed to the covered business above the amount required to back covered business liabilities,
whose distribution to shareholders is restricted as they are allocated to cover regulatory and internal capital requirements.
The value of new business is the present value, at the point of sale, of the projected future after-tax shareholder cash flows of the new
business written by Discovery, discounted at the risk discount rate, less an allowance for the reserving strain, initial expenses and cost of
required capital. The value of new business is calculated using the current reporting date assumptions.
The embedded value includes the insurance and administration profits of the covered business in the Discovery Limited Group. Covered
business includes business written in South Africa through Discovery Life (“Life”), Discovery Invest (“Invest”), Discovery Health (“Health”)
and Discovery Vitality (“Vitality”), and in the United Kingdom through VitalityLife and VitalityHealth. For Vitality Group, Ping An Health, AIA
Health, Discovery Insure, Discovery Bank, VitalityInvest and Umbrella Funds, no published value has been placed on the current in-force
business as the businesses have not yet reached suitable scale with predictable experience.
In August 2011, Discovery raised R800 million through the issue of non-cumulative, non-participating, non-convertible preference shares.
For embedded value purposes this capital, net of share issue expenses, has been excluded from the adjusted net worth.
The 30 June 2021 embedded value results and disclosures were subjected to an external review.
198 Discovery Annual Financial Statements 2021

-- 199 of 219 --

TABLE 1: GROUP EMBEDDED VALUE
R million
30 June
2021
30 June
2020
%
change
Shareholders’ funds 	46 419 	44 553 	4
Adjustment to shareholders’ funds from published basis1 	(34 184) 	(32 080)
Adjusted net worth2 	12 235 	12 473
Value of in-force covered business before cost of required capital 	67 175 	64 305
Cost of required capital 	(4 765) 	(5 944)
Discovery Limited embedded value 	74 645 	70 834 	5
Number of shares (millions) 	656.8 	656.6
Embedded value per share 	R113.65 	R107.88 	5
Diluted number of shares (millions) 	665.1 	657.6
Diluted embedded value per share 3 	R112.23 	R107.71 	4
1 A breakdown of the adjustment to shareholders’ funds is shown in the table below. Note that where relevant, adjustments have been converted using the
closing exchange rate of R19.74/GBP (June 2020: R21.44/GBP).
R million
30 June
2021
30 June
2020
Life net assets under insurance contracts 	(20 675) 	(18 564)
Vitality Life Limited and Discovery funded VitalityLife business on the Prudential licence net assets under
insurance contracts 	(7 703) 	(6 320)
VitalityHealth financial reinsurance asset 	(2 353) 	(3 078)
VitalityHealth and Vitality Health Insurance Limited deferred acquisition costs (net of deferred tax) 	(407) 	(467)
VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) 	(12) 	(21)
Goodwill relating to the acquisition of Standard Life Healthcare and the Prudential joint venture 	(2 442) 	(2 653)
Intangible assets (net of deferred tax) in covered businesses 	(830) 	(945)
Net preference share capital 	(779) 	(779)
Reversal of 1 Discovery Place IAS 17 financial lease accounting 	975 	747
Equity settled share based payment provision adjustment 	42 	–
(34 184) 	(32 080)
The ‘equity settled share based payment provision adjustment’ reflects the difference between the provision in the IFRS equity and the mark-to-market
value of the equity settled share based payments.
2 	The following table sets out the capital position of the covered businesses with the required capital on a consistent basis to that used in the embedded
value:
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
199 Discovery Annual Financial Statements 2021

-- 200 of 219 --

R million
30 June
2021
30 June
2020
Shareholders’ funds 	46 419 	44 553
Adjustment to shareholders' funds 	(34 184) 	(32 080)
Adjusted net worth 	12 235 	12 473
Excess of available capital over adjusted net worth 	30 718 	23 231
Available capital 	42 953 	35 704
Required capital 	32 699 	29 932
Excess available capital 	10 254 	5 772
The excess of available capital over adjusted net worth reflects the difference between the adjusted net worth and the available capital.
This includes:
○ The net preference share capital of R779 million which is included as available capital.
○ The difference between Vitality Life Limited’s Solvency II Pillar 1 Own Funds and its adjusted net worth and adds back the negative
reserves eliminated on the Discovery funded VitalityLife business on the Prudential licence.
○ The difference between Life’s Pillar 1 Own Funds and its adjusted net worth.
The following table sets out the required capital for each of the covered businesses:
R million
30 June
2021
30 June
2020
Health and Vitality 	973 	935
Life and Invest 	22 059 	18 544
VitalityHealth 	2 847 	2 963
VitalityLife 	6 820 	7 490
Total Required Capital 	32 699 	29 932
○ For Health and Vitality, the required capital was set equal to two times the monthly renewal expense and Vitality benefit cost.
○ For Life and Invest, the required capital was set equal to 1.25 times the SAM Pillar 1 Solvency Capital Requirement.
○ For VitalityHealth, the required capital amount was set equal to 1.35 times the Solvency II Pillar 1 Solvency Capital Requirement.
○ For the VitalityLife business on the Prudential licence, the required capital was set equal to the UK Solvency I long-term insurance
capital requirement as per the agreement with Prudential up to the Part VII transfer, thereafter it is set equal to 1.5 times the
Solvency II Pillar 1 Solvency Capital Requirement. For the business sold on the Vitality Life Limited licence, the required capital was
set equal to 1.4 times the Solvency II Pillar 1 Solvency Capital Requirement up to the Part VII transfer and 1.5 times thereafter.
3 The diluted embedded value per share adjusts for treasury shares held in the Discovery BEE Share Trust and as part of Discovery’s
Long-term Incentive Plan where the impact is dilutive.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
200 Discovery Annual Financial Statements 2021

-- 201 of 219 --

TABLE 2: VALUE OF IN-FORCE COVERED BUSINESS
R million
Value
before
cost of
required
capital
Cost of
required
capital
Value
after
cost of
required
capital
at 30 June 2021
Health and Vitality 	22 503 	(422) 	22 081
Life and Invest1 	27 777 	(1 183) 	26 594
VitalityHealth 2 	8 230 	(462) 	7 768
VitalityLife 2 	8 665 	(2 698) 	5 967
Total 	67 175 	(4 765) 	62 410
at 30 June 2020
Health and Vitality 	22 321 	(419) 	21 902
Life and Invest1 	23 752 	(1 244) 	22 508
VitalityHealth 2 	10 077 	(495) 	9 582
VitalityLife 2 	8 155 	(3 786) 	4 369
Total 	64 305 	(5 944) 	58 361
1 Included in the Life and Invest value of in-force covered business is R1 675 million (June 2020: R1 440 million) in respect of investment management services
provided on off balance sheet investment business. The net assets of the investment service provider are included in the adjusted net worth.
2 The value of in-force has been converted using the closing exchange rate of R19.74/GBP (June 2020: R21.44/GBP).
TABLE 3: GROUP EMBEDDED VALUE EARNINGS
R million
30 June
2021
30 June
2020
Embedded value at end of period 	74 645 	70 834
Less: embedded value at beginning of period 	(70 834) 	(71 217)
Increase in embedded value 	3 811 	(383)
Net change in capital1 	(914) 	–
Dividends paid 	63 	1 494
Transfer to hedging reserve 	(260) 	430
Employee share option schemes 	(330) 	(164)
Increase in treasury shares 	907 	4
Acquisition of subsidiaries with non-controlling interest 	– 	(6)
IFRS transitional arrangements2 	– 	41
Embedded value earnings 	3 277 	1 416
Annualised return on opening embedded value 	4.6% 	2.0%
1 The net change in capital reflects share issues (net of costs) and an increase (decrease) in treasury shares in the period.
2 The IFRS transitional arrangements reflects the retrospective adjustments arising from the adoption of IFRS 9 and IFRS 15 to the opening balances at
1 July 2018.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
201 Discovery Annual Financial Statements 2021

-- 202 of 219 --

TABLE 4: COMPONENTS OF GROUP EMBEDDED VALUE EARNINGS
Year ended
30 June
2021
Year ended
30 June
2020
R million
Net
worth
Cost of
required
capital
Value of
in-force
covered
business
Embedded
value
Embedded
value
Total profit from new business (at point of sale) 	(4 540) 	(262) 	6 693 	1 891 	1 922
Profit from existing business
○ 	Expected return 	4 958 	107 	1 356 	6 421 	6 388
○ 	Change in methodology and assumptions1 	1 006 	1 176 	(7 738) 	(5 556) 	(8 759)
○ 	Experience variances 	1 081 	(143) 	3 979 	4 917 	133
Impairment, amortisation and fair value adjustment2 	(14) 	– 	– 	(14) 	(16)
Increase in goodwill and intangibles 	(336) 	– 	– 	(336) 	(313)
Other initiative costs3,5 	(324) 	– 	36 	(288) 	(781)
Non-recurring expenses 	(85) 	– 	– 	(85) 	(181)
Acquisition costs4 	(41) 	– 	1 	(40) 	(12)
Finance costs5,6 	(2 104) 	– 	– 	(2 104) 	(1 946)
Foreign exchange rate movements6 	(1 160) 	301 	(1 457) 	(2 316) 	3 922
Other7 	(8) 	– 	– 	(8) 	19
Return on shareholders’ funds5,8 	795 	– 	– 	795 	1 040
Embedded value earnings 	(772) 	1 179 	2 870 	3 277 	1 416
1 The changes in methodology and assumptions will vary over time to reflect adjustments to the model and assumptions as a result of changes to the
operating and economic environment. The current period’s changes are described in detail in Table 6 below (for previous periods refer to previous
embedded value statements).
2 This item reflects the amortisation of the intangible assets reflecting the banking costs, the PrimeMed acquisition and capital expenditure in VitalityInvest
and Discovery Group Europe Limited.
3 This item includes the profits of non-covered businesses (including Discovery Insure, Vitality Group and Ping An Health) and costs of start-up businesses
(including Discovery Bank, VitalityInvest, a commercial offering in Discovery Insure, and an Umbrella Fund offering in Invest). Head office costs which relate
to non-covered business are also included in this item.
4 Acquisition costs relate to commission paid on the Life and Invest business and expenses incurred in writing Health and Vitality business that has been
written over the period but will only be activated and on risk after the valuation date. These policies are not included in the embedded value or the value
of new business and therefore the costs are not deducted from the value of new business.
5 Finance costs are aligned to the segmental earnings view of finance costs, before IFRS reporting adjustments. From 30 June 2021, the segmental view of
finance costs is shown gross of finance costs relating to intercompany loans between entities within the Group (R824 million for the twelve months to 30
June 2021 and R720 million for the twelve months ended 30 June 2020). Similar offsetting adjustments, which had previously been included as investment
return components in other initiative costs and return on shareholders’ funds, have been reallocated and are now entirely included in the return on
shareholders’ funds. The prior period comparatives have been restated to reflect this reallocation.
6 From 30 June 2021, foreign exchange gains / (losses) emerging through the income statement have been reallocated out of finance costs and into foreign
exchange rate movements. The prior period comparatives have been restated to reflect this reallocation.
7 This item includes, among other items, the tax benefits or losses that will emerge as the VitalityHealth DAC and intangible software assets amortise or
increase.
8 The return on shareholders’ funds is shown net of tax and management charges.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
202 Discovery Annual Financial Statements 2021

-- 203 of 219 --

TABLE 5: EXPERIENCE VARIANCES
Health and Vitality 	Life and Invest 	VitalityHealth 	VitalityLife
R million
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force 	Total
Renewal expenses 	229 	– 	(10) 	2 	(4) 	– 	17 	– 	234
Lapses and surrenders 1 	23 	130 	(29) 	1 029 	– 	160 	(100) 	491 	1 704
Mortality and morbidity2 	– 	– 	(681) 	87 	938 	– 	108 	– 	452
Policy alterations1 	– 	9 	(438) 	420 	– 	– 	21 	10 	22
Premium and fee income1 	66 	– 	(47) 	(71) 	89 	– 	5 	18 	60
Economic 3 	33 	579 	69 	870 	– 	– 	– 	– 	1 551
Commission 	– 	– 	– 	– 	21 	– 	– 	– 	21
Tax 4 	75 	– 	339 	(352) 	65 	– 	(8) 	– 	119
Reinsurance 	– 	– 	– 	– 	(4) 	– 	(102) 	(67) 	(173)
Maintain modelling term5 	– 	362 	– 	188 	– 	79 	– 	– 	629
Vitality benefits 	(8) 	– 	– 	– 	– 	– 	41 	– 	33
Other 6 	2 	– 	(136) 	100 	152 	– 	355 	(208) 	265
Total 	420 	1 080 	(933) 	2 273 	1 257 	239 	337 	244 	4 917
1 For Life and Invest, the combined lapse and surrender experience, policy alterations experience and premium and fee income experience is relative to
assumptions which include an allowance for a Short term stress set at 30 June 2020 in response to deteriorating experience from COVID-19 related
impacts. For VitalityLife, the lapse and surrender experience is relative to assumptions which include the allowance for a short term stress for lapses
introduced at 30 June 2020.
2 The mortality and morbidity experience for Life and Invest reflects claims in excess of the COVID-19 claims provision set at 30 June 2020. The mortality and
morbidity experience for VitalityHealth relates to experience emerging after the inclusionof a short-term premium deferral provision for treatments delayed
due to ongoing national lockdowns from the pandemic.
3 For Health and Vitality, the economic experience variance relates to the impact on administration and managed care fees of in-period inflation being
higher than that assumed. The experience for Life and Invest arises largely due to higher than expected linked asset growth for the period under review.
4 The tax variance for Life and Invest arises due to the timing difference between the expected tax payments and actual payments.
5 For Health and Vitality, Life and Invest and VitalityHealth, the projection term is rebased at each Year-end. Therefore, an experience variance arises because
the total term of the in-force covered business is effectively increased by twelve months.
6 The key Other experience relates to cash flow timing variances in Life and Invest, profits and losses from companies within the VitalityHealth and VitalityLife
segments which are not part of covered business, and movements in the value of the swaption in VitalityLife.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
203 Discovery Annual Financial Statements 2021

-- 204 of 219 --

TABLE 6: METHODOLOGY AND ASSUMPTION CHANGES
Health and Vitality 	Life and Invest 	VitalityHealth 	VitalityLife
R million
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force
Net
worth
Value of
in-force 	Total
Modelling changes1 	– 	44 	(38) 	207 	– 	(64) 	2 	138 	289
Expenses 	– 	(597) 	(34) 	(273) 	– 	– 	36 	100 	(768)
Lapses2 	– 	– 	(6) 	(4) 	– 	– 	(622) 	(1 811) 	(2 443)
Mortality and morbidity3 	– 	– 	– 	(1 439) 	– 	(604) 	(151) 	2 171 	(23)
Benefit changes 	– 	16 	– 	– 	– 	– 	– 	– 	16
Tax 4 	– 	– 	– 	– 	– 	(469) 	– 	(235) 	(704)
Economic assumptions 5 	– 	(2 004) 	(21) 	395 	– 	(240) 	(269) 	487 	(1 652)
Premium and fee income 	– 	(45) 	– 	(131) 	– 	– 	– 	– 	(176)
Reinsurance and financing6 	– 	– 	2 107 	(2 125) 	– 	(25) 	– 	41 	(2)
Other 	– 	– 	2 	(95) 	– 	– 	– 	– 	(93)
Total 	– 	(2 586) 	2 010 	(3 465) 	– 	(1 402) 	(1 004) 	891 	(5 556)
1 For Life and Invest, a correction was made to the calculation of the overall tax adjustment to the value of in-force. In addition, the Group Life business’s
expense allocation was revised and the projection term was extended from ten to twenty years. For VitalityHealth, the modelling changes relate to a
correction to the premium recorded against certain lapsed policies. For VitalityLife, the modelling changes include a reduction of the premium increases
on index-linked policies as per product specifications under current low inflation rates and several other minor refinements to the calculation of the value
of in-force and cost of capital.
2 For VitalityLife, the lapse assumption change relates to a reduction in the lapse rates for the whole of life business.
3 For Life and Invest, the mortality and morbidity assumption change relates to the COVID-19 provision raised in respect of an expected third and fourth
wave in South Africa. For VitalityLife, the change relates to a review of the mortality basis for the whole of life business. For VitalityHealth, the change relates
to a short-term stressed provision established for COVID-19 related impacts.
4 For VitalityHealth and VitalityLife, the tax assumption change relates to an increase in the UK corporation tax rate from 19% to 25% from April 2023.
5 For Life and Invest and Health and Vitality, the economic assumptions item relates to the impact of updating the assumptions relative to the Johannesburg
Stock Exchange (“JSE”) nominal and real yield risk-free curves at 30 June 2021. For Life and Invest this also includes the impact of updating exchange rate
assumptions. For VitalityLife the item includes the impact of updating the assumptions relative to the Solvency II yield curves and the IFRS interest rates,
offset by the net change in the interest rate hedge.
6 For Life and Invest, the reinsurance and financing item primarily relates to the impact of financing arrangements.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
204 Discovery Annual Financial Statements 2021

-- 205 of 219 --

TABLE 7: EMBEDDED VALUE OF NEW BUSINESS
R million
30 June
2021
30 June
2020
%
Change
Health and Vitality
Present value of future profits from new business (at point of sale) 	789 	910
Cost of required capital 	(24) 	(27)
Present value of future profits from new business (at point of sale) after cost
of required capital 	765 	883 	(13)
New business annualised premium income1 	3 704 	3 972 	(7)
Life and Invest
Present value of future profits from new business (at point of sale)2 	825 	668
Cost of required capital 	(82) 	(82)
Present value of future profits from new business (at point of sale) after cost
of required capital 	743 	586 	27
New business annualised premium income3 	2 947 	2 886 	2
Annualised profit margin4 	3.0% 	2.5%
Annualised profit margin excluding Invest business 	5.7% 	5.8%
VitalityHealth5
Present value of future profits from new business (at point of sale) 	143 	262
Cost of required capital 	(61) 	(56)
Present value of future profits from new business (at point of sale) after cost
of required capital 	82 	206 	(60)
New business annualised premium income6 	1 263 	1 308 	(3)
Annualised profit margin4 	0.9% 	2.5%
VitalityLife7
Present value of future profits from new business (at point of sale) 	396 	353
Cost of required capital 	(95) 	(106)
Present value of future profits from new business (at point of sale) after cost
of required capital 	301 	247 	22
New business annualised premium income 	871 	956 	(9)
Annualised profit margin4 	4.1% 	3.2%
1 Health new business annualised premium income is the gross contribution to the medical schemes. The new business annualised premium income shown
above excludes premiums in respect of members who join an existing employer where the member has no choice of medical scheme, as well as premiums
in respect of new business written during the period but only activated after 30 June 2021.
The total Health and Vitality new business annualised premium income written over the period was R6 103 million (June 2020: R6 236 million).
2 Included in the Life and Invest embedded value of new business is R53 million (June 2020: R29 million) in respect of investment management services
provided on off balance sheet investment business.
Risk business written prior to the valuation date allows certain Invest business to be written at financially advantageous terms, the impact of which has
been recognised in the value of new business.
3 Life new business is defined as Life policies to which Life became contractually bound during the reporting period, including policies whose first premium
is due after the valuation date. Invest new business is defined as business where at least one premium has been received and which has not been refunded
after receipt. Invest new business also includes Discovery Retirement Optimiser policies to which Life and Invest became contractually bound during the
reporting period, including policies whose first premium is due after the valuation date.
The new business annualised premium income of R2 947 million (June 2020: R2 886 million) (single premium APE: R1 490 million (June 2020: R1 453
million)) shown above excludes automatic premium increases and servicing increases in respect of existing business. The total new business annualised
premium income written over the period, including automatic premium increases of R1 414 million (June 2020: R1 496 million) and servicing increases of
R640 million (June 2020: R576 million), was R5 001 million (June 2020: R4 958 million) (single premium APE: R1 569 million (June 2020: R1 507 million)).
Single premium business is included at 10% of the value of the single premium.
Policy alterations and internal replacement policies, including Discovery Retirement Optimisers added to existing Life Plans, are shown in Table 5 as
experience variances and not included as new business. Term extensions on existing contracts are not included as new business.
4 The annualised profit margin is the value of new business expressed as a percentage of the present value of future premiums.
5 The VitalityHealth value of new business is calculated as the value at point of sale of the new business written premium in-force at the valuation date
multiplied by the Margin multiplied by the Annuity Factor less the new business cash flows from point of sale to the valuation date. The assumptions for
the Margin and Annuity Factor are shown in Table 8.
6 VitalityHealth new business is defined as individuals and employer groups which incepted during the reporting period. The new business annualised
premium income shown above has been adjusted to exclude premiums in respect of members who join an existing employer group after the first month,
as well as premiums in respect of new business written during the period but only activated after 30 June 2021.
7 VitalityLife new business is defined as policies to which VitalityLife became contractually bound during the reporting period, including policies whose first
premium is due after the valuation date.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
205 Discovery Annual Financial Statements 2021

-- 206 of 219 --

BASIS OF PREPARATION
TABLE 8: EMBEDDED VALUE ECONOMIC ASSUMPTIONS
30 June
2021
30 June
2020
Beta coefficient 	0.75 	0.75
Equity risk premium (%) 	3.5 	3.5
Risk discount rate (%)
– Health and Vitality1 	13.125 	14.125
– Life and Invest1 	13.625 	15.125
– VitalityHealth 	3.46 	2.89
– VitalityLife 	3.263 	3.065
Rand / GBP exchange rate
Closing 	19.74 	21.44
Average 	20.74 	19.75
Margin over Expense inflation to derive Medical inflation (%)
South Africa 	3.00 	3.00
Expense inflation (%)2
South Africa 	– Health and Vitality 	6.14 	7.39
– Life and Invest 	6.23 	8.33
United Kingdom 	2.50 	2.50
Pre-tax investment return (%)
South Africa 	– Cash1 	9.50 	11.00
– Life and Invest bonds3 	11.00 	12.50
– Health and Vitality bonds3 	10.50 	11.50
– Equity1 	14.50 	16.00
United Kingdom 	– VitalityHealth risk-free rate 	0.84 	0.27
– VitalityLife risk-free rate 	0.64 	0.44
– VitalityLife IFRS interest rate 	1.80 	1.35
– VitalityLife investment return 	1.44 	2.59
Corporation tax rate (%)
South Africa 	28 	28
United Kingdom – Long-term 	25 	19
VitalityHealth Assumptions
– Margin (net of tax and cost of capital) (%) 	12.0 	13.7
– Annuity Factor 	6.18 	6.37
Projection term
– Health and Vitality 	20 years 	20 years
– Discovery Life – VIF 	40 years 	40 years
– Group Life 	20 years 	10 years
– VitalityLife 	No cap 	No cap
– VitalityHealth4 	20 years 	20 years
1 Derived as a margin over (or below for cash) the respective pre-tax investment return for bonds.
2 The inflation assumption is derived as the difference between the nominal and real yield curve at each duration. As an indication, the cash flow weighted
average inflation is shown in the table. For the United Kingdom, the expense inflation assumption is aligned with the Bank of England inflation target.
3 As indications, the cash flow weighted averages derived from the relevant yield curve(s) are shown.
4 The VitalityHealth projection term of 20 years is used in the derivation of the Annuity Factor.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
206 Discovery Annual Financial Statements 2021

-- 207 of 219 --

The Discovery Limited embedded value is calculated based on a risk discount rate using the CAPM approach with specific reference to the
Discovery beta coefficient. The assumed beta is fixed at 0.75. This has been set such that the risk discount rate proxies the result of a
Weighted Average Cost of Capital approach with reference to the capital structure of the Group and the observed beta calculated using
daily returns over a long time period. The observed beta is calculated with reference to the ALSI. The assumed beta will only change if the
capital structure of the Group and / or the observed beta calculated using daily returns over a long time period suggest the beta
assumption should depart significantly from the assumption at the financial Year-end. As beta values reflect the historic performance of
share prices relative to the market they may not allow fully for non-market related and non-financial risk. Investors may want to form
their own view on an appropriate allowance for these risks which have not been modelled explicitly.
Life and Invest mortality, morbidity and lapse and surrender assumptions were derived from internal experience, where available,
augmented by reinsurance and industry information.
The Health and Vitality lapse assumptions were derived from the results of recent experience investigations.
The VitalityHealth assumptions were derived from internal experience.
VitalityLife assumptions were derived from internal experience, where available, augmented by reinsurance, industry and Discovery
Limited group information.
Renewal expense assumptions were based on the results of the latest expense and budget information.
The initial expenses included in the calculation of the embedded value of new business are the actual costs incurred excluding expenses
of an exceptional or non-recurring nature.
From 30 June 2020, the yield curves underlying the embedded value calculations were changed from the Prudential Authority yield curves
to the JSE yield curves. The South African investment return assumptions for Life, Invest, Health and Vitality were based on the publically
available JSE risk-free nominal yield curve. The real yield assumption was set based on the publically available JSE risk-free real yield curve,
adjusted to remove volatility due to the nature of the index-linked government bond market. Other economic assumptions were set
relative to these two yield curves.
The current and projected tax position of the policyholder funds within the Life company has been taken into account in determining the
net investment return assumption.
The risk-free rate assumption for VitalityHealth and VitalityLife was based on the single interest rate derived from the Prudential
Regulatory Authority yield curve. The inflation rate is consistent with the Bank of England inflation target.
From 30 June 2018, VitalityHealth calculate the value of in-force at the valuation date as the in-force written premium multiplied by the
Margin multiplied by the Annuity Factor, as set out in the table above. The Annuity Factor assumption is derived from assumed future
lapse rates and premium increases. The Margin assumption reflects profit margins after tax and Cost of Capital. The assumptions
underlying the Annuity Factor and Margin are set taking into account the current experience in the business at different durations.
The cost of required capital is calculated using the difference between the risk discount rate and the net of tax asset return on tangible
assets. The Vitality Life Limited and the VitalityLife business on the Prudential licence required capital amount is assumed to earn the
investment return assumption, which is set based on the return on a portfolio of government and corporate bonds assumed to back the
required capital. The Life and Invest cost of required capital is calculated assuming shareholder cash flow is limited to the cash flow
available after having met both the required capital amount and an internally defined liquidity target capital requirement of tangible
assets.
The embedded value has been calculated in accordance with the Actuarial Society of South Africa’s Advisory Practice Note (“APN”) 107:
Embedded Value Reporting, except the recommended disclosure of Free Surplus and Required Capital has been adjusted to take into
account the nature of the capital requirements in the covered businesses, as can be seen in Table 1 note 2.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
207 Discovery Annual Financial Statements 2021

-- 208 of 219 --

SENSITIVITY TO THE EMBEDDED VALUE ASSUMPTIONS
The risk discount rate uses the CAPM approach with specific reference to the Discovery beta coefficient. As beta values reflect the
historic performance of share prices relative to the market they may not allow fully for non-market related and non-financial risk.
Investors may want to form their own view on an appropriate allowance for these risks which have not been modelled explicitly. The
sensitivity of the embedded value and the embedded value of new business at 30 June 2021 to changes in the risk discount rate is
included in the tables below.
For each sensitivity illustrated below, all other assumptions have been left unchanged. No allowance has been made for management
action such as risk premium increases where future experience is worse than the base assumptions.
TABLE 9: EMBEDDED VALUE SENSITIVITY
Health and Vitality
R million
Adjusted
net worth2
Value
of
in-force
Cost of
required
capital
Base 	12 235 	22 503 	(422)
Impact of:
Risk discount rate +1% 	12 235 	21 254 	(458)
Risk discount rate – 1% 	12 235 	23 884 	(382)
Lapses – 10% 	11 962 	23 236 	(443)
Interest rates – 1%1 	10 969 	22 431 	(406)
Equity and property market value – 10% 	12 197 	22 503 	(422)
Equity and property return +1% 	12 235 	22 503 	(422)
Renewal expenses – 10% 	12 302 	24 722 	(390)
Mortality and morbidity – 5% 	12 446 	22 503 	(422)
Projection term +1 year 	12 235 	22 768 	(426)
1 All economic assumptions were reduced by 1%.
2 The sensitivity impact on the VitalityLife net of tax change in negative reserves is included in the adjusted net worth column.
The following table shows the effect of using different assumptions on the embedded value of new business.
TABLE 10: VALUE OF NEW BUSINESS SENSITIVITY
Health and Vitality
R million
Value of
new
business
Cost of
required
capital
Base 	789 	(24)
Impact of:
Risk discount rate +1% 	723 	(26)
Risk discount rate – 1% 	861 	(22)
Lapses – 10% 	839 	(26)
Interest rates – 1%1 	796 	(23)
Equity and property return +1% 	789 	(24)
Renewal expense – 10% 	908 	(22)
Mortality and morbidity – 5% 	789 	(24)
Projection term +1 year 	803 	(24)
Acquisition costs – 10% 	817 	(24)
1 All economic assumptions were reduced by 1%.
ANNEXURE D – EMBEDDED VALUE STATEMENT continued
for the year ended 30 June 2021
208 Discovery Annual Financial Statements 2021

-- 209 of 219 --

Life and Invest 	VitalityHealth 	VitalityLife
Embedded
value
%
change
Value
of
in-force
Cost of
required
capital
Value
of
in-force
Cost of
required
capital
Value
of
in-force
Cost of
required
capital
27 777 	(1 183) 	8 230 	(462) 	8 665 	(2 698) 	74 645
25 145 	(1 258) 	7 789 	(438) 	8 323 	(3 489) 	69 103 	(7)
30 885 	(1 094) 	8 717 	(488) 	9 049 	(1 608) 	81 198 	9
30 289 	(1 241) 	9 338 	(520) 	9 413 	(3 003) 	79 031 	6
28 003 	(1 168) 	8 641 	(488) 	6 774 	(2 658) 	72 098 	(3)
27 236 	(1 201) 	8 230 	(462) 	8 665 	(2 698) 	74 048 	(1)
28 155 	(1 186) 	8 230 	(462) 	8 665 	(2 698) 	75 020 	1
28 346 	(1 156) 	8 868 	(462) 	8 825 	(2 663) 	78 392 	5
29 741 	(1 062) 	9 584 	(462) 	8 943 	(2 682) 	78 589 	5
27 864 	(1 187) 	8 290 	(465) 	8 665 	(2 698) 	75 046 	1
Life and Invest 	VitalityHealth 	VitalityLife
Value of
new
business
%
change
Value of
new
business
Cost of
required
capital
Value of
new
business
Cost of
required
capital
Value of
new
business
Cost of
required
capital
825 	(82) 	143 	(61) 	396 	(95) 	1 891
620 	(88) 	67 	(57) 	311 	(101) 	1 449 	(23)
1 064 	(76) 	227 	(65) 	492 	(80) 	2 401 	27
1 035 	(86) 	252 	(67) 	545 	(122) 	2 370 	25
838 	(81) 	217 	(65) 	156 	(88) 	1 750 	(7)
856 	(83) 	143 	(61) 	396 	(95) 	1 921 	2
874 	(81) 	220 	(61) 	427 	(93) 	2 172 	15
924 	(74) 	307 	(61) 	431 	(90) 	2 202 	16
831 	(83) 	152 	(61) 	396 	(95) 	1 919 	1
954 	(82) 	181 	(61) 	519 	(95) 	2 209 	17
Discovery Annual Financial Statements 2021 209

-- 210 of 219 --

ANNEXURE E – FIVE-YEAR REVIEW
for the year ended 30 June 2021
Group
2017
Group
2018
Group
2019
Group
2020
Group
2021
Compound
growth %
Income statement extracts (R million)
Profit from operations 	6 245 	8 260 	7 536 	1 532 	5 304 	(4)
Headline earnings 	4 404 	5 803 	5 147 	296 	2 986 	(9)
Abnormal expenses/(income) 	252 	(402) 	(112) 	3 451 	420 	–
Normalised headline earnings 	4 656 	5 401 	5 035 	3 747 	3 406 	(8)
Diluted normalised headline earnings per share
(cents) 	721.5 	836.9 	771.6 	566.7 	512.9 	(8)
Statement of financial position extracts
(R million)
Total assets 	130 923 	157 982 	180 233 	210 328 	246 694 	17
Shareholders’ funds 	32 290 	37 594 	43 083 	44 549 	46 415 	9
Embedded value
Embedded value (R million) 	57 294 	65 624 	71 217 	70 834 	74 645 	7
Diluted embedded value per share (R) 	88.67 	101.56 	108.30 	107.71 	112.23 	6
Key ratios
Return on average equity (%) 	14 	16 	16 	0.4 	7.1 	–
Return on average assets (%) 	4 	4 	4 	0.1 	1.4 	–
Exchange rates
Rand/US$
– Closing 	13.12 	13.81 	14.15 	17.41 	14.28 	–
– Average 	13.61 	12.86 	14.17 	15.70 	15.42 	–
Rand/GBP
– Closing 	17.03 	18.16 	17.98 	21.44 	19.74 	–
– Average 	17.29 	17.33 	18.32 	19.75 	20.74 	–
Share statistics
Number of ordinary shares in issue
– Weighted average (000’s) 	644 651 	645 014 	652 295 	656 648 	656 710 	–
– Diluted weighted average (000’s) 	645 236 	645 408 	652 568 	661 242 	664 073 	–
– End of period (000’s) 	646 845 	646 845 	658 291 	658 291 	665 769 	–
Price/diluted headline earnings (times) 	17.7 	17.6 	19.3 	18.3 	24.7 	–
Share price (cents per share):
– High 	13 748 	19 000 	17 830 	15 163 	15 738 	–
– Low 	10 910 	12 719 	13 287 	5 815 	10 047 	–
– Closing 	12 792 	14 750 	14 911 	10 455 	12 667 	–
Market capitalisation (R million) 	82 744 	95 410 	98 158 	68 824 	84 333 	–
210 Discovery Annual Financial Statements 2021

-- 211 of 219 --

ANNEXURE F – PRODUCT DESCRIPTIONS
Discovery enters into contracts that carry insurance risk or financial risk or both. For further information on the products and business
lines, refer to the "Additional analysis information" on the Discovery investor relationship website.
DISCOVERY LIFE
Discovery Life offers policyholders a range of insurance and financial solutions. The Discovery Life products reflect Discovery’s underlying
philosophy to make members healthier and to enhance and protect their lives.
Discovery Life offers some unique benefits that integrate with the benefits offered by Discovery Health, Discovery Vitality, DiscoveryCard,
Discovery Bank, Discovery Insure and Discovery Invest.
Discovery Life Plan
The Discovery Life Plan provides protection against a comprehensive spectrum of risks. Discovery Life offers a Classic Life Plan with broad
and comprehensive protection for the policyholder and his or her immediate family and an Essential Life Plan which offers cost effective
protection for the principal policyholder and his or her spouse.
The Discovery Life Plan covers:
❚ 	Life Cover Benefits;
❚ 	Disability Benefits;
❚ 	Severe Illness Benefits; and
❚ 	Income Continuation Benefits.
The Life Fund forms the base amount of cover insured under the Life Plan (the basic sum assured amount). The Life Fund can be linked
to a benefit escalation rate, for example inflation, and will then automatically increase at each policy anniversary.
The key risk benefits are defined as a percentage of the Life Fund. The Life Fund is reduced by the amount of benefits paid from the Life
Fund. The Life Fund can be protected against claims by means of the Minimum Protected Fund. Multiple claims are allowed against the
Life Fund from the same benefit.
There are a number of risk benefits that are defined in monetary terms or in the form of indemnity benefits, rather than being expressed
as a percentage of the Life Fund. These benefits include:
❚ 	Income Continuation Benefit;
❚ 	Global Education Benefit; and
❚ 	Global Health Protector.
The Life Plan has unique features allowing policyholders to add benefits for other family members. The Global Education Protector,
Global Health Protector, Childbirth Benefit, Child Severe Illness Benefit, Parent Severe Illness Benefit and Family Trauma Benefit allow
protection for the whole immediate family.
By actively maintaining and improving their health, Discovery Life policyholders, through the Integrator Benefit, could receive premium
discounts and refunds of premiums and/or increases in cover.
The Life Plan provides whole of life cover. Premium guarantees are offered and quantified on most benefits. For example, the premiums
for Life Cover are guaranteed not to increase by more than 25% for any 10-year period over and above contractual premium increases.
This percentage can be further reduced through engagement in the Vitality programme.
Premiums are payable monthly. There are various funding methods that allow policyholders a choice of premium funding patterns.
A combination of level premium funding patterns and annually increasing premium patterns are offered. The higher the compulsory
future premium increase, the lower the starting premium.
The Dollar Life Plan, offers the ability to specify the sum insured in US Dollars and pay premiums in Rands, but linked to the Rand/Dollar
exchange rate. The Business Life Plan is tailored to the needs of business owners.
The Smart Life Plan enhances Discovery Life’s offering to a younger clientele, providing benefits which are tailored to appeal to individuals
aged between 18 and 29.
211 Discovery Annual Financial Statements 2021

-- 212 of 219 --

ANNEXURE F – PRODUCT DESCRIPTIONS continued
Health Plan Protector (discontinued)
The Health Plan Protector funds contributions to the Discovery Health Medical Scheme in the event of death, disability or severe illness.
It further rewards members for positive health management through the PayBack benefit, Health Fund and Health Dividends. The Health
Plan Protector can be added to the Life Plan or can be bought on a stand-alone basis. The Health Plan Protector provides cover up to
age 65, however premiums are not guaranteed.
Medical Premium Waiver
The Medical Premium Waiver funds contributions to a client’s Health Plan in the event of death, disability or severe illness and can be
bought on a stand-alone basis. Medical Premium Waiver provides cover up to age 65, however premiums are not guaranteed.
DiscoveryCard Protector (discontinued)
The DiscoveryCard Protector covers the outstanding balance on the Discovery Bank credit card/previous DiscoveryCard (first issued before
the launch of Discovery Bank) in the event of death, disability or severe illness. It further provides a monthly benefit for a defined period
equal to the average Discovery Bank credit card/previous DiscoveryCard spend in the six-month period prior to the life changing event.
Global Education Protector
The Global Education Protector funds education costs for children in the event of death, disability or severe illness of the insured life.
Cover is provided to the earlier of the insured life reaching age 65 or the child reaching age 24. This benefit can be purchased on a
standalone basis.
Supplementary Illness Benefit
The Supplementary Illness Benefit (previously Supplementary Gap Cover) benefit offers lump sum cover for defined severe illnesses,
funding for genomic sequencing of certain cancers, a home support benefit as well as a health premium waiver given a defined life
changing event.
Supplementary Cancer Protector
The Supplementary Cancer Protector benefit will pay defined monthly amounts which can be used to meet costs that arise when a family
is affected by cancer.
Funeral Cover
The Funeral Cover benefit will pay out a defined lump sum in the event of death which can be used to cover the costs of a funeral. This
lump sum is doubled in the event of accidental death. An education benefit is automatically included at a defined amount which aims to
fund the education costs for children upon death of the principal member or spouse. Optional memorial and grocery benefits may be
added to the policy.
Estate Preserver
The Estate Preserver benefit provides indemnification against certain expenses involved in winding up an estate. These include executor
fees, testamentary trust fees and property conveyancing fees. The product also provides immediate liquidity benefit. Clients select an
Asset Cap, which defines the level of risk cover provided by both the indemnity and non-indemnity benefits. Premiums and benefits are
fully reviewable.
DISCOVERY EMPLOYEE BENEFITS
Discovery Employee Benefits offers employers retirement funds and group risk solutions for their employees.
Group Life
Discovery Employee Benefits offers a comprehensive spectrum of protection benefits on a group basis. Life Cover, Severe Illness,
Disability and Income Continuation Benefits are offered. The policies offered under Group Life can be cancelled or the premiums adjusted
at the end of the contract term (usually one year). These benefits are written on the Discovery Life licence.
Umbrella Fund
Discovery Umbrella Fund, launched in May 2018, offers employer groups a unique platform for the investment of retirement assets for
their employees. Pension and provident funds are offered as well as in-fund preservation for members leaving the fund. Policies are
annual and all fees are reviewable annually.
212 Discovery Annual Financial Statements 2021

-- 213 of 219 --

ANNEXURE F – PRODUCT DESCRIPTIONS continued
The Fund offers a wide range of investment options to members on internal and external asset portfolios that are offered by Discovery
Invest; all funds offered are Regulation 28 compliant. Discovery Umbrella offers unique benefits in the form of investment boosts and fee
discounts for low-income members.
Discovery Invest
Discovery Invest offers investors access to a comprehensive and flexible range of investment solutions which can be tailored to the needs
of each investor.
A range of investment wrappers are provided to ensure flexibility and to optimise the investments according to the investment objectives
and time horizon of the investor. A wrapper is the legal structure that allows policyholders to make underlying investments with different
tax and other legal implications.
The following wrappers are available:
❚ 	Endowment: A medium-term, local or offshore, investment vehicle that provides tax efficiencies for an investor with a five to ten-year
time horizon.
❚ 	Flexible investment: A flexible investment vehicle that allows tailor made investment solutions whilst providing immediate access
to funds.
❚ 	Retirement plan: A long-term investment vehicle providing a tax efficient structure for saving towards retirement.
❚ 	Preserver plans: An investment vehicle that helps to ensure retirement benefits continue to grow on a tax efficient basis once a
policyholder has left the retirement plan of an employer.
❚ 	Retirement income plan: Fixed and linked annuities are provided giving flexibility to meet retirement needs.
A comprehensive range of investment fund choices are provided including unique Discovery Invest funds. The funds include:
❚ 	Discovery Invest funds: Includes a comprehensive range of Discovery Invest’s single- and multi-manager funds across a range of
asset classes.
❚ 	Dynamically protected funds: Unique Discovery Invest funds that are designed to protect investors against the major risks associated
with investment choice, for example, underperformance by fund, asset class and geographic region.
❚ 	Special purpose funds: These funds are designed to provide solutions to investors looking to save for specific goals, such as retirement.
These funds provide alternative and innovative management expertise.
❚ 	External funds: Discovery Invest provides a broad range of externally managed funds.
Invest offers various benefits which reduces the cost of investment and enhances benefits available under the Invest plans.
❚ 	Investment Integrator: Uses inter alia the health improvements from Vitality and tax efficiencies created to offer a cost effective
endowment and increase the value of the investment. A fee reduction of up to 100% can be achieved on both administration and asset
management fees. This benefit is no longer available to new business.
❚ 	Annuity Integrator: By releasing the value of a policyholder’s life cover at retirement, the Annuity Integrator creates enhanced
benefits for Discovery Retirement Income Plan investors. The benefits include increased retirement income, protection against
longevity, protection against ill-health and protection against poor performance of underlying assets.
❚ 	Guaranteed return plans: Guaranteed return plans include the following:
– The Guaranteed Growth Plan is a single premium endowment that provides a guaranteed return at the end of five years.
– The Guaranteed Income Plan provides a guaranteed return at the end of five years on the chosen percentage of the lump sum
contribution. The remainder of the lump sum will provide a monthly or annual income.
❚ 	Upfront Investment Integrator: Provides an upfront boost to the member’s investment value of the lump sum Endowment plan.
❚ 	Life Booster: Provides a boost to the investment fund value on death of between 5% and 15% depending on the member’s Vitality status.
❚ 	Retirement Income Investment Integrator: Boosts annual annuity payments received by up to 50% depending on the member’s
Vitality status and chosen annual annuity income.
❚ 	Retirement Upfront Investment Integrator: Provides an upfront boost to the member’s investment value of the lump sum
Retirement and Preserver plans.
❚ 	Classic Benefits: Consists of a range of benefits which enhance and protect the member’s investment fund offered on the lump sum
Retirement plans, Preserver plans and lump sum Flexible Investment plans.
❚ 	Administration Fee Integrator: A fee discount of up to 100% can be achieved on the administration fee of the Investment plan,
where the discount is based on Vitality status and invested term.
❚ 	Flexible Pan Retirement Integrator: Provides a boost to the Retirement Upfront Investment Integrator of up to 50% of asset
management fees paid in the Flexible Investment Plan.
213 Discovery Annual Financial Statements 2021

-- 214 of 219 --

ANNEXURE F – PRODUCT DESCRIPTIONS continued
❚ 	Discovery Retirement Optimiser: Offers funding for retirement and offers unique benefits that, together with a Discovery Life Plan,
boosts retirement funding. Policyholders have a choice of linked investment portfolios or a portfolio that offers a guaranteed return
in real terms. Funds offering a guaranteed return have been closed to new business.
❚ 	Currency Enhancer: Offers the opportunity to effectively invest at an exchange rate which is better than the prevailing exchange rate
on the Global Endowment.
VITALITYLIFE
VitalityLife Plan
The VitalityLife Plan is a lifestyle protection plan which allows customers to select from a menu of benefits which includes:
❚ 	Life cover.
❚ 	Serious illness cover.
❚ 	Capital disability cover.
❚ 	Income protection insurance.
❚ 	Family income cover.
❚ 	Education cover.
❚ 	Waiver of premium on death, serious illness and/or incapacity.
❚ 	Additional optional serious illness cover for children.
❚ 	Lifestyle care cover.
❚ 	Protected Life and Serious Illness cover.
❚ 	Dementia and Frail Care cover.
The VitalityLife Plan has at its basis a Plan Account. The Plan Account defines the amount paid out under any benefit that is attached to it
(the sum assured). The benefits that are attached to the Plan Account are expressed as a percentage of the Plan Account’s value.
The Plan Account can be structured to provide cover that is level, increasing or decreasing.
The VitalityLife Plan can be written on a single or joint life basis and cover may be stand-alone or limited to the Plan Account whereby
claims would accelerate payment of the Plan Account. Premiums are payable monthly in advance and can be guaranteed or reviewable.
Premiums can either be level, increase at a fixed rate or increase at a rate related to the Retail Price Index in the UK. The Plan does not
offer any surrender value. The VitalityLife Plan provides extensive severity-based cover for serious illness.
Essentials Plan
The Essentials Plan is a lower cost version of the VitalityLife Plan and provides roughly the same type of benefits and has the same structure.
Guaranteed 50 Plus Plan (run off existing book)
The Guaranteed 50 Plus Plan will pay out a fixed cash lump sum in the event of death, provided that the policy has been held for at least
one year. It also provides guaranteed acceptance for people aged between 50 and 75, living in the UK.
Relevant Life Plan
The Relevant Life Plan is a Life cover only plan with substantial tax benefits for employers wanting to provide life cover for their employees.
The structure is the same as for life cover on the above mentioned plans and includes the option to take different Vitality wellness
program benefits.
Business Protection Plan
The Business Protection Plan provides insurance protection for businesses via key person cover, shareholder/partnership cover and/or
loan protection.
Mortgage Plus Plan
The Mortgage Plus Plan provides insurance protection for individuals and families against death, disability and serious illness when taking
out a mortgage on their home.
Vitality Optimiser
The Vitality Optimiser offers an upfront premium discount that varies in size depending on the policy term. Depending on engagement in
the Vitality wellness programme, the premium discount can be increased, maintained or will be eroded over time.
214 Discovery Annual Financial Statements 2021

-- 215 of 219 --

ANNEXURE F – PRODUCT DESCRIPTIONS continued
Whole of Life Optimiser
The Whole of Life Premium Optimiser and Interest Rate Optimiser follows a similar structure to the Vitality Optimiser policy, offering an
upfront premium discount and premium changes at each anniversary. Unlike Vitality Optimiser, where premiums change depending on
Vitality Status, the annual premium changes are either fixed or depend on long-term interest rates.
Wellness Optimiser
Wellness Optimiser offers customers an upfront discount, similar to Vitality Optimiser. The future premiums will change annually depending
on the policyholder’s Wellness Status, and Vitality Status, which will be determined by the results of the on-going biennial health checks.
VITALITYHEALTH
VitalityHealth offers three main product types:
Individual product
This is offered to the retail market either direct or via a broker. The product features include:
❚ 	Private Medical Insurance: Cover is offered for a range of private healthcare-related claims. The cover is dependent on the plan type
chosen and includes hospital and outpatient cover for selected conditions;
❚ 	Renewal pricing: Prices offered at renewal depend on claims and Vitality status; and
❚ 	Vitality rewards: A full Vitality package is offered, including gym offering and activity and status-based healthcare-related rewards.
SME product
This is an age-rated product offered to small groups (typically 2-100 employees) either direct or via a broker. The product features include:
❚ 	Private Medical Insurance: Cover is offered for a range of private healthcare-related claims. The cover is dependent on the plan type
chosen and includes hospital and outpatient cover for selected conditions;
❚ 	Cashback for employers: A cashback is provided to employers after renewal depending on the levels of engagement achieved by
their employees in the previous year; and
❚ 	Vitality rewards for employees: A full Vitality package is offered, including gym offering and activity and status-based healthcare-
related rewards.
Corporate Product
This is an experience-rated product offered by brokers and employee benefit consultants. The product features include:
❚ 	Private Medical Insurance: Cover is offered for a range of private healthcare-related claims. The cover is dependent on the plan type
chosen and includes hospital and outpatient cover for selected conditions. Administration of healthcare trusts providing medical
benefits to employees of large corporates is also available; and
❚ 	Vitality rewards for employees: A base level Vitality package is offered to all members, including gym offering and healthcare-
benefits. Employers can choose to add activity – and status-dependent rewards. A ‘stand-alone’ Vitality programme is also available to
large corporates where medical benefits are not provided.
DISCOVERY INSURE
Discovery Insure underwrites both personal and more recently commercial lines business, specific products are as follows:
Motor
Provides cover for loss, damage and liabilities arising from the use or ownership of motor vehicles. The cover includes comprehensive,
third party, fire, theft and third-party liability cover, and warranty cover for vehicles (buy-up benefit).
Property
Provides cover for loss or damage from specified events – such as fire, storm, theft etc. – to movable and immovable property belonging
to the insured.
Liability
Provides cover for risks relating to the insured incurring personal liability to specified third parties which are not specifically covered
under another insurance contract.
215 Discovery Annual Financial Statements 2021

-- 216 of 219 --

ANNEXURE F – PRODUCT DESCRIPTIONS continued
Health Gap Cover
Provides cover shortfalls on specialist accounts for hospital admissions, shortfalls for specific treatment before and after hospital
admissions, as well as additional funds for cancer treatment. Note that this product is sold as part of personal lines insurance only.
PrimaryCare
The PrimaryCare benefit is a healthcare product that is sold to employer groups. The product provides indemnity cover for low-income
employees for primary healthcare including GP visits, dental benefits, and optical benefits. The PrimaryCare product is administered by
Discovery Health, but is written on the Discovery Insure licence. Policies are annually reviewable.
VITALITYINVEST
VitalityInvest plans are structured between two main product types:
VitalityInvest Retirement Plan
The Retirement Plan is a defined contribution personal pension plan (also known as a ‘money purchase’ personal pension plan) that
allows an investment towards retirement in a tax-efficient way. The invested pension pot can then be used to provide an income during
retirement, or with one or more cash lump sums.
The plan will be invested in a unit-linked life insurance policy (the ‘policy’) issued to the pension scheme trustee for the investor’s benefit.
All payments made to the plan will be invested in the policy and the value of the policy will be linked to the value of underlying funds.
A range of different investment funds can be linked to the policy, covering a range of different investment assets, geographical regions
and investment strategies. The investor will not be the legal or beneficial owner of these investment funds but rather the pension scheme
trustee will be on behalf of the investor.
Depending on the version of the product chosen, the plan also provides the opportunity to qualify for boosts on the value of the plan and
to receive discounts on the charges that apply. These features are:
For all plans
❚ 	Healthy Living Discount: The Healthy Living Discount is a reduction in the product charge based on the Vitality status and the
proportion of the plan invested in eligible funds.
For versions of the plan with Boosters
❚ 	Investment Booster: This applies if the value of the policy is linked to eligible funds for a continuous period of at least five years.
At the end of each five year period, the value of the policy that has remained linked to eligible funds will be boosted.
❚ 	Retirement Booster: This applies if all or part of the pension pot is designated for flexi-access drawdown. A boost will be provided to
the value of the plan each year based on the amount of income taken, the Vitality status and the proportion of the plan linked to
eligible funds.
VitalityInvest ISA and Junior ISA
The ISA and Junior ISA are stocks and shares ISAs (‘Individual Savings Accounts’), which are accounts that can be used to invest in a tax
efficient way. These plans invest in a unit-linked life insurance policy issued by VitalityInvest to the Investor’s benefit, or for Junior ISAs for
the child’s benefit. All payments made to the plan will be invested in the policy and the value of the policy will be linked to the value of
funds chosen.
Depending on the version of the product chosen, the plan also provides the opportunity to qualify for boosts on the value of the plan and
to receive discounts on the charges that apply. These features are:
For all plans
❚ 	Healthy Living Discount: The Healthy Living Discount is a reduction in the product charge based on the Vitality status and the
proportion of the plan invested in eligible funds.
For versions of the plan with Boosters
❚ 	Investment Booster: This applies if the value of the policy is linked to eligible funds for a continuous period of at least five years.
At the end of each five year period, the value of the policy that has remained linked to eligible funds will be boosted.
216 Discovery Annual Financial Statements 2021

-- 217 of 219 --

GLOSSARY OF TERMS
Abbreviation 	Meaning
CAE 	Chief Audit Executive
CCIC 	Capital, Currency and Investment Committee (CCIC)
CEO 	Chief Executive Officer
CFO 	Chief Financial Officer
CGU 	Cash generating unit
CIPC 	Companies and Intellectual Property Commission
Companies Act 	South African Companies Act, 71 of 2008
CRO 	Chief Risk Officer
Discovery 	Discovery Limited Group
DRG 	Discovery Risk Grades
ECL 	Expected credit losses
FinRe 	Financial Reinsurance - with risk transfer
FRC 	United Kingdom Financial Reporting Council
HAF 	Head of Actuarial Function
IFA 	Insurance Fund Account
IFRS 	International Financial Reporting Standards
IRBA 	South African Independent Regulatory Board of Auditors
JSE 	Johannesburg Stock Exchange
MAFR 	Mandatory audit firm rotation
Morbidity 	Morbidity claims are claims which arise as a result of an impairment of life due to an
illness or disability event insured by the policyholder
Mortality 	Mortality claims are claims which arise from the death of an insured life
NCD 	Negotiable certificates of deposits
OCR 	Oustanding Claims Reserve
PAH 	Ping An Health Insurance Company of China Ltd
SAICA 	South African Institute of Chartered Accountants
217 Discovery Annual Financial Statements 2021

-- 218 of 219 --

Discovery Annual Financial Statements 2021 218
Discovery
+27 11 529 2888 | askthecfo@discovery.co.za | www.discovery.co.za
Subsidiaries of Discovery Limited are authorised financial services providers.

-- 219 of 219 --